
<html lang="en"     class="pb-page"  data-request-id="a737e2fb-c3f5-4c5b-9a06-5b7935e0090e"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;wgroup:string:ACHS website Group;website:website:acspubs;article:article:10.1021/acs.jmedchem.0c00245;pageGroup:string:Publication Pages;subPage:string:Full Text;issue:issue:10.1021/jmcmar.2020.63.issue-10"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="citation_journal_title" content="Journal of Medicinal Chemistry" /></meta><meta name="dc.Title" content="Discovery of Potent, Selective, and Orally Bioavailable Inhibitors of USP7 with In Vivo Antitumor Activity" /></meta><meta name="dc.Creator" content="Paul R.  Leger" /></meta><meta name="dc.Creator" content="Dennis X.  Hu" /></meta><meta name="dc.Creator" content="Berenger  Biannic" /></meta><meta name="dc.Creator" content="Minna  Bui" /></meta><meta name="dc.Creator" content="Xinping  Han" /></meta><meta name="dc.Creator" content="Emily  Karbarz" /></meta><meta name="dc.Creator" content="Jack  Maung" /></meta><meta name="dc.Creator" content="Akinori  Okano" /></meta><meta name="dc.Creator" content="Maksim  Osipov" /></meta><meta name="dc.Creator" content="Grant M.  Shibuya" /></meta><meta name="dc.Creator" content="Kyle  Young" /></meta><meta name="dc.Creator" content="Christopher  Higgs" /></meta><meta name="dc.Creator" content="Betty  Abraham" /></meta><meta name="dc.Creator" content="Delia  Bradford" /></meta><meta name="dc.Creator" content="Cynthia  Cho" /></meta><meta name="dc.Creator" content="Christophe  Colas" /></meta><meta name="dc.Creator" content="Scott  Jacobson" /></meta><meta name="dc.Creator" content="Yamini M.  Ohol" /></meta><meta name="dc.Creator" content="Deepa  Pookot" /></meta><meta name="dc.Creator" content="Payal  Rana" /></meta><meta name="dc.Creator" content="Jerick  Sanchez" /></meta><meta name="dc.Creator" content="Niket  Shah" /></meta><meta name="dc.Creator" content="Michael  Sun" /></meta><meta name="dc.Creator" content="Steve  Wong" /></meta><meta name="dc.Creator" content="Dirk G.  Brockstedt" /></meta><meta name="dc.Creator" content="Paul D.  Kassner" /></meta><meta name="dc.Creator" content="Jacob B.  Schwarz" /></meta><meta name="dc.Creator" content="David J.  Wustrow" /></meta><meta name="dc.Description" content="USP7 is a promising target for cancer therapy as its inhibition is expected to decrease function of oncogenes, increase tumor suppressor function, and enhance immune function. Using a structure-bas..." /></meta><meta name="Description" content="USP7 is a promising target for cancer therapy as its inhibition is expected to decrease function of oncogenes, increase tumor suppressor function, and enhance immune function. Using a structure-bas..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="April 17, 2020" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.0c00245" /></meta><meta name="dc.Language" content="en" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="Copyright © 2020 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.0c00245" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.0c00245" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.0c00245" /></link>
        
    
    

<title>Discovery of Potent, Selective, and Orally Bioavailable Inhibitors of USP7 with In Vivo Antitumor Activity | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.0c00245" /></meta><meta property="og:title" content="Discovery of Potent, Selective, and Orally Bioavailable Inhibitors of USP7 with In Vivo Antitumor Activity" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.0c00245/20200520/images/large/jm0c00245_0029.jpeg" /></meta><meta property="og:description" content="USP7 is a promising target for cancer therapy as its inhibition is expected to decrease function of oncogenes, increase tumor suppressor function, and enhance immune function. Using a structure-based drug design strategy, a new class of reversible USP7 inhibitors has been identified that is highly potent in biochemical and cellular assays and extremely selective for USP7 over other deubiquitinases. The succinimide was identified as a key potency-driving motif, forming two strong hydrogen bonds to the allosteric pocket of USP7. Redesign of an initial benzofuran-amide scaffold yielded a simplified ether series of inhibitors, utilizing acyclic conformational control to achieve proper amine placement. Further improvements were realized upon replacing the ether-linked amines with carbon-linked morpholines, a modification motivated by free energy perturbation (FEP+) calculations. This led to the discovery of compound 41, a highly potent, selective, and orally bioavailable USP7 inhibitor. In xenograft studies, compound 41 demonstrated tumor growth inhibition in both p53 wildtype and p53 mutant cancer cell lines, demonstrating that USP7 inhibitors can suppress tumor growth through multiple different pathways." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.0c00245"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.0c00245">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.0c00245&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.0c00245&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.0c00245&amp;href=/doi/10.1021/acs.jmedchem.0c00245" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2020</span><span class="cit-fg-volume">, 63</span><span class="cit-fg-issue">, 10</span><span class="cit-fg-pageRange">, 5398-5420</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/63/10" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.0c00203" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/acs.jmedchem.0c00305" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Discovery of Potent, Selective, and Orally Bioavailable Inhibitors of USP7 with In Vivo Antitumor Activity</span></h1><ul class="loa"><li><span><span class="hlFld-ContribAuthor">Paul R. Leger</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Paul R. Leger</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">RAPT Therapeutics, Inc., 561 Eccles Avenue, South San Francisco, California 94080, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Paul+R.++Leger">Paul R. Leger</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-3490-6412" title="Orcid link">http://orcid.org/0000-0002-3490-6412</a></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Dennis X. Hu</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Dennis X. Hu</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">RAPT Therapeutics, Inc., 561 Eccles Avenue, South San Francisco, California 94080, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Dennis+X.++Hu">Dennis X. Hu</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Berenger Biannic</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Berenger Biannic</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">RAPT Therapeutics, Inc., 561 Eccles Avenue, South San Francisco, California 94080, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Berenger++Biannic">Berenger Biannic</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Minna Bui</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Minna Bui</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">RAPT Therapeutics, Inc., 561 Eccles Avenue, South San Francisco, California 94080, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Minna++Bui">Minna Bui</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Xinping Han</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Xinping Han</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">RAPT Therapeutics, Inc., 561 Eccles Avenue, South San Francisco, California 94080, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Xinping++Han">Xinping Han</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Emily Karbarz</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Emily Karbarz</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">RAPT Therapeutics, Inc., 561 Eccles Avenue, South San Francisco, California 94080, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Emily++Karbarz">Emily Karbarz</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Jack Maung</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Jack Maung</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">RAPT Therapeutics, Inc., 561 Eccles Avenue, South San Francisco, California 94080, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Jack++Maung">Jack Maung</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Akinori Okano</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Akinori Okano</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">RAPT Therapeutics, Inc., 561 Eccles Avenue, South San Francisco, California 94080, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Akinori++Okano">Akinori Okano</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Maksim Osipov</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Maksim Osipov</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">RAPT Therapeutics, Inc., 561 Eccles Avenue, South San Francisco, California 94080, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Maksim++Osipov">Maksim Osipov</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Grant M. Shibuya</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Grant M. Shibuya</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">RAPT Therapeutics, Inc., 561 Eccles Avenue, South San Francisco, California 94080, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Grant+M.++Shibuya">Grant M. Shibuya</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Kyle Young</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Kyle Young</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">RAPT Therapeutics, Inc., 561 Eccles Avenue, South San Francisco, California 94080, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Kyle++Young">Kyle Young</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Christopher Higgs</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Christopher Higgs</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Schrödinger, 120 West 45th Street, New York, New York 10036, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Christopher++Higgs">Christopher Higgs</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Betty Abraham</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Betty Abraham</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">RAPT Therapeutics, Inc., 561 Eccles Avenue, South San Francisco, California 94080, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Betty++Abraham">Betty Abraham</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Delia Bradford</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Delia Bradford</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">RAPT Therapeutics, Inc., 561 Eccles Avenue, South San Francisco, California 94080, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Delia++Bradford">Delia Bradford</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Cynthia Cho</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Cynthia Cho</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">RAPT Therapeutics, Inc., 561 Eccles Avenue, South San Francisco, California 94080, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Cynthia++Cho">Cynthia Cho</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Christophe Colas</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Christophe Colas</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">RAPT Therapeutics, Inc., 561 Eccles Avenue, South San Francisco, California 94080, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Christophe++Colas">Christophe Colas</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Scott Jacobson</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Scott Jacobson</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">RAPT Therapeutics, Inc., 561 Eccles Avenue, South San Francisco, California 94080, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Scott++Jacobson">Scott Jacobson</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Yamini M. Ohol</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Yamini M. Ohol</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">RAPT Therapeutics, Inc., 561 Eccles Avenue, South San Francisco, California 94080, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Yamini+M.++Ohol">Yamini M. Ohol</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Deepa Pookot</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Deepa Pookot</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">RAPT Therapeutics, Inc., 561 Eccles Avenue, South San Francisco, California 94080, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Deepa++Pookot">Deepa Pookot</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Payal Rana</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Payal Rana</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">RAPT Therapeutics, Inc., 561 Eccles Avenue, South San Francisco, California 94080, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Payal++Rana">Payal Rana</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Jerick Sanchez</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Jerick Sanchez</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">RAPT Therapeutics, Inc., 561 Eccles Avenue, South San Francisco, California 94080, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Jerick++Sanchez">Jerick Sanchez</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Niket Shah</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Niket Shah</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">RAPT Therapeutics, Inc., 561 Eccles Avenue, South San Francisco, California 94080, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Niket++Shah">Niket Shah</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Michael Sun</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Michael Sun</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">RAPT Therapeutics, Inc., 561 Eccles Avenue, South San Francisco, California 94080, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Michael++Sun">Michael Sun</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Steve Wong</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Steve Wong</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">RAPT Therapeutics, Inc., 561 Eccles Avenue, South San Francisco, California 94080, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Steve++Wong">Steve Wong</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Dirk G. Brockstedt</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Dirk G. Brockstedt</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">RAPT Therapeutics, Inc., 561 Eccles Avenue, South San Francisco, California 94080, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Dirk+G.++Brockstedt">Dirk G. Brockstedt</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Paul D. Kassner</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Paul D. Kassner</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">RAPT Therapeutics, Inc., 561 Eccles Avenue, South San Francisco, California 94080, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Paul+D.++Kassner">Paul D. Kassner</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Jacob B. Schwarz</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Jacob B. Schwarz</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">RAPT Therapeutics, Inc., 561 Eccles Avenue, South San Francisco, California 94080, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Jacob+B.++Schwarz">Jacob B. Schwarz</a></span></div></div></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor">David J. Wustrow</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">David J. Wustrow</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">RAPT Therapeutics, Inc., 561 Eccles Avenue, South San Francisco, California 94080, United States</div></div><span class="conrtib-corresp"><strong>*</strong>Email: <a href="/cdn-cgi/l/email-protection#7c180b090f080e130b3c0e1d0c08521f1311"><span class="__cf_email__" data-cfemail="452132303631372a3205372435316b262a28">[email protected]</span></a></span><span class="conrtib-corresp"></span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=David+J.++Wustrow">David J. Wustrow</a></span></div></div></span></li><span class="comma-separator"></span></ul><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.0c00245&amp;href=/doi/10.1021%2Facs.jmedchem.0c00245" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2020</span></span><span class="cit-volume">, 63</span><span class="cit-issue">, 10</span><span class="cit-pageRange">, 5398–5420</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">April 17, 2020</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>20 February 2020</li><li><span class="item_label"><b>Published</b> online</span>17 April 2020</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 28 May 2020</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.0c00245" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c00245</a></div><div class="article_header-article-copyright"><strong>Copyright © 2020 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D5398%26pageCount%3D23%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DPaul%2BR.%2BLeger%252C%2BDennis%2BX.%2BHu%252C%2BBerenger%2BBiannic%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D63%26issueNum%3D10%26contentID%3Dacs.jmedchem.0c00245%26title%3DDiscovery%2Bof%2BPotent%252C%2BSelective%252C%2Band%2BOrally%2BBioavailable%2BInhibitors%2Bof%2BUSP7%2Bwith%2BIn%2BVivo%2BAntitumor%2BActivity%26numPages%3D23%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D5420%26publicationDate%3DMay%2B2020">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.0c00245"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">3214</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">12</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.0c00245" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Discovery of Potent, Selective, and Orally Bioavailable Inhibitors of USP7 with In Vivo Antitumor Activity&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Paul&quot;,&quot;last_name&quot;:&quot;R. Leger&quot;},{&quot;first_name&quot;:&quot;Dennis&quot;,&quot;last_name&quot;:&quot;X. Hu&quot;},{&quot;first_name&quot;:&quot;Berenger&quot;,&quot;last_name&quot;:&quot;Biannic&quot;},{&quot;first_name&quot;:&quot;Minna&quot;,&quot;last_name&quot;:&quot;Bui&quot;},{&quot;first_name&quot;:&quot;Xinping&quot;,&quot;last_name&quot;:&quot;Han&quot;},{&quot;first_name&quot;:&quot;Emily&quot;,&quot;last_name&quot;:&quot;Karbarz&quot;},{&quot;first_name&quot;:&quot;Jack&quot;,&quot;last_name&quot;:&quot;Maung&quot;},{&quot;first_name&quot;:&quot;Akinori&quot;,&quot;last_name&quot;:&quot;Okano&quot;},{&quot;first_name&quot;:&quot;Maksim&quot;,&quot;last_name&quot;:&quot;Osipov&quot;},{&quot;first_name&quot;:&quot;Grant&quot;,&quot;last_name&quot;:&quot;M. Shibuya&quot;},{&quot;first_name&quot;:&quot;Kyle&quot;,&quot;last_name&quot;:&quot;Young&quot;},{&quot;first_name&quot;:&quot;Christopher&quot;,&quot;last_name&quot;:&quot;Higgs&quot;},{&quot;first_name&quot;:&quot;Betty&quot;,&quot;last_name&quot;:&quot;Abraham&quot;},{&quot;first_name&quot;:&quot;Delia&quot;,&quot;last_name&quot;:&quot;Bradford&quot;},{&quot;first_name&quot;:&quot;Cynthia&quot;,&quot;last_name&quot;:&quot;Cho&quot;},{&quot;first_name&quot;:&quot;Christophe&quot;,&quot;last_name&quot;:&quot;Colas&quot;},{&quot;first_name&quot;:&quot;Scott&quot;,&quot;last_name&quot;:&quot;Jacobson&quot;},{&quot;first_name&quot;:&quot;Yamini&quot;,&quot;last_name&quot;:&quot;M. Ohol&quot;},{&quot;first_name&quot;:&quot;Deepa&quot;,&quot;last_name&quot;:&quot;Pookot&quot;},{&quot;first_name&quot;:&quot;Payal&quot;,&quot;last_name&quot;:&quot;Rana&quot;},{&quot;first_name&quot;:&quot;Jerick&quot;,&quot;last_name&quot;:&quot;Sanchez&quot;},{&quot;first_name&quot;:&quot;Niket&quot;,&quot;last_name&quot;:&quot;Shah&quot;},{&quot;first_name&quot;:&quot;Michael&quot;,&quot;last_name&quot;:&quot;Sun&quot;},{&quot;first_name&quot;:&quot;Steve&quot;,&quot;last_name&quot;:&quot;Wong&quot;},{&quot;first_name&quot;:&quot;Dirk&quot;,&quot;last_name&quot;:&quot;G. Brockstedt&quot;},{&quot;first_name&quot;:&quot;Paul&quot;,&quot;last_name&quot;:&quot;D. Kassner&quot;},{&quot;first_name&quot;:&quot;Jacob&quot;,&quot;last_name&quot;:&quot;B. Schwarz&quot;},{&quot;first_name&quot;:&quot;David&quot;,&quot;last_name&quot;:&quot;J. Wustrow&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2020&quot;,&quot;month&quot;:&quot;04&quot;,&quot;day&quot;:&quot;17&quot;,&quot;issue&quot;:&quot;10&quot;,&quot;volume&quot;:&quot;63&quot;,&quot;pages&quot;:&quot;5398-5420&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.0c00245&quot;},&quot;abstract&quot;:&quot;USP7 is a promising target for cancer therapy as its inhibition is expected to decrease function of oncogenes, increase tumor suppressor function, and enhance immune function. Using a structure-based drug design strategy, a new class of reversible USP7 inhibitors has been identified that is highly potent in biochemical and cellular assays and extremely selective for USP7 over other deubiquitinases. The succinimide was identified as a key potency-driving motif, forming two strong hydrogen bonds to the allosteric pocket of USP7. Redesign of an initial benzofuran-amide scaffold yielded a simplified ether series of inhibitors, utilizing acyclic conformational control to achieve proper amine placement. Further improvements were realized upon replacing the ether-linked amines with carbon-linked morpholines, a modification motivated by free energy perturbation (FEP+) calculations. This led to the discovery of compound 41, a highly potent, selective, and orally bioavailable USP7 inhibitor. In xenograft studies, compo&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.0c00245&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.0c00245" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.0c00245&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.0c00245" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.0c00245&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.0c00245" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.0c00245&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.0c00245&amp;href=/doi/10.1021/acs.jmedchem.0c00245" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.0c00245" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.0c00245" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (6 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c00245&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.0c00245%26sid%3Dliteratum%253Aachs%26pmid%3D32302140%26genre%3Darticle%26aulast%3DLeger%26date%3D2020%26atitle%3DDiscovery%2Bof%2BPotent%252C%2BSelective%252C%2Band%2BOrally%2BBioavailable%2BInhibitors%2Bof%2BUSP7%2Bwith%2BIn%2BVivo%2BAntitumor%2BActivity%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D63%26issue%3D10%26spage%3D5398%26epage%3D5420%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (2)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=291285" title="Ethers">Ethers</a>,</li><li><a href="/action/doSearch?ConceptID=291350" title="Assays">Assays</a>,</li><li><a href="/action/doSearch?ConceptID=292528" title="Inhibitors">Inhibitors</a>,</li><li><a href="/action/doSearch?ConceptID=291793" title="Inhibition">Inhibition</a>,</li><li><a href="/action/doSearch?ConceptID=292524" title="Peptides and proteins">Peptides and proteins</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/63/10" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/jmcmar.2020.63.issue-10/20200528/jmcmar.2020.63.issue-10.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="_i1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.0c00245/20200520/images/medium/jm0c00245_0029.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.0c00245/20200520/images/large/jm0c00245_0029.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00245&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">USP7 is a promising target for cancer therapy as its inhibition is expected to decrease function of oncogenes, increase tumor suppressor function, and enhance immune function. Using a structure-based drug design strategy, a new class of reversible USP7 inhibitors has been identified that is highly potent in biochemical and cellular assays and extremely selective for USP7 over other deubiquitinases. The succinimide was identified as a key potency-driving motif, forming two strong hydrogen bonds to the allosteric pocket of USP7. Redesign of an initial benzofuran-amide scaffold yielded a simplified ether series of inhibitors, utilizing acyclic conformational control to achieve proper amine placement. Further improvements were realized upon replacing the ether-linked amines with carbon-linked morpholines, a modification motivated by free energy perturbation (FEP+) calculations. This led to the discovery of compound <b>41</b>, a highly potent, selective, and orally bioavailable USP7 inhibitor. In xenograft studies, compound <b>41</b> demonstrated tumor growth inhibition in both p53 wildtype and p53 mutant cancer cell lines, demonstrating that USP7 inhibitors can suppress tumor growth through multiple different pathways.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_46607" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_46607" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Ubiquitin-specific protease 7 (USP7), also known as HAUSP, is an enzyme that cleaves ubiquitin groups from specific ubiquitinated client proteins.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> This de-ubiquitination activity can rescue the client proteins from proteasome-mediated degradation and result in a net increase in concentration of these proteins. Through this mechanism, USP7 is proposed to stabilize the oncogenic E3 ubiquitin ligase MDM2, a negative regulator of the tumor suppressor p53.<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a> USP7 has also been reported to play a role in stabilizing FOXP3, an essential transcription factor for the development and function of regulatory T cells and hence may play a role in the suppression of immune responses to tumors.<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a> Additionally, USP7 may stabilize several proteins involved in DNA damage repair.<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a> Pharmacological inhibition of USP7 may therefore be beneficial for cancer therapy through multiple mechanisms.</div><div class="NLM_p">A number of USP7-selective reversible inhibitors have recently been reported.<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a> These include 4-hydroxy piperidine inhibitors <b>1–4</b> (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>) disclosed by Hybrigenics,<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a> FORMA Therapeutics,<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> Almac Discovery,<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a> Servier,<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a> and others,<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> as well as tri-aryl inhibitors such as <b>5</b> disclosed by Genentech.<a onclick="showRef(event, 'ref11 ref12'); return false;" href="javascript:void(0);" class="ref ref11 ref12">(11,12)</a> 4-hydroxy piperidine inhibitors such as <b>2–4</b> have been reported to bind to an allosteric pocket in the “palm” domain of USP7 (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>). Small molecule binding to this allosteric site is believed to stabilize an inactive conformation of USP7, preventing USP7 catalytic activity.<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a> The tri-aryl inhibitors such as <b>5</b> are reported to bind in a different allosteric pocket in the “palm” domain of USP7.</div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.0c00245/20200520/images/medium/jm0c00245_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.0c00245/20200520/images/large/jm0c00245_0001.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Examples of previously described USP7 inhibitors.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.0c00245/20200520/images/large/jm0c00245_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00245&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.0c00245/20200520/images/medium/jm0c00245_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.0c00245/20200520/images/large/jm0c00245_0003.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. (Left) Schematic of the catalytic domain of USP7 (orange) bound to ubiquitin (blue), with the palm region (below purple dashed line), tunnel area (red box), and catalytic site (green circle) highlighted. The yellow arrow indicates the compound binding region highlighted in the structures on the right. (Right) Comparison of cocrystal structures of 4-hydroxy piperidine inhibitor <b>1</b> and pyridylbenzofuran compound <b>7</b>. Both inhibitors bind to the same allosteric site of USP7 and are selective inhibitors of USP7. The PDB code for <b>1</b> bound to USP7 is <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6VN4">6VN4</a>. The PDB code for <b>7</b> bound to USP7 is <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6VN5">6VN5</a>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.0c00245/20200520/images/large/jm0c00245_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00245&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">Many studies interrogating the biological functions of USP7 have employed irreversible active-site dual inhibitors of USP7 and USP47, such as P22077 (<b>6</b>, <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>).<a onclick="showRef(event, 'ref13 ref14'); return false;" href="javascript:void(0);" class="ref ref13 ref14">(13,14)</a> Potent, deubiquitinase (DUB)-selective, and reversible inhibitors of USP7 of diverse chemotypes would be useful tools in clarifying and assessing the many potential biological roles of USP7 and its relevance as a target for human cancer therapy. Here we report an optimization campaign resulting in a new class of highly potent, selective, reversible, and bioavailable inhibitors of USP7. These inhibitors have recently aided the clarification of the biological activities of USP7.<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a></div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i3">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_60126" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_60126" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i4" class="anchor-spacer"></div><h3 class="article-section__title" id="_i4"> Pyridylbenzofurans as Starting Chemical Matter</h3><div class="NLM_p">Our drug discovery campaign for USP7 inhibitors began with an evaluation of compounds derived from a focused library screen of known DUB inhibitors as well as other structurally related compounds. Anticipating DUB-selectivity to be a major challenge for a USP7 program based on the conserved nature of DUB active sites, early chemical matter was tested for biochemical activity against USP7 as well as against USP1, UCH-L3, and USP47. Among the USP7-active compounds evaluated, the 7-pyridylbenzofuran compound <b>7</b> (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>) stood out as an attractive starting point for optimization due to its relatively high selectivity for USP7 over related de-ubiquitinating enzymes. Interestingly, cocrystallizations of 4-hydroxy piperidine compound <b>1</b> and benzofuran <b>7</b> with USP7 revealed that both inhibitors occupy the same allosteric pocket of the palm region, even though they belong to different chemotypes (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>).</div><div class="NLM_p">Benzofuran compound <b>7</b> and 4-hydroxy piperidine compound <b>1</b> form many similar interactions with the USP7 protein despite their distinct structures. Both compounds form hydrogen-bonds with the backbone nitrogen of Val-296, the phenol moiety of Tyr-465, and the carboxylate of Asp-295. Importantly, despite the two compounds’ similar potencies, there appeared to be interactions made by compound <b>1</b> with USP7 that were not made by compound <b>7</b> (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>), suggesting that it should be possible to enhance compound <b>7</b>’s affinity toward USP7 by introducing novel elements that would take advantage of additional interactions in the binding pocket. It was hypothesized that the potency of a compound such as benzofuran <b>7</b> could be improved by introducing functionality which could target the backbone hydrogen bond donor of Phe-409 with an appropriately linked hydrogen-bond acceptor or which could better engage the glutamine side chain of Gln-297.</div><figure id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.0c00245/20200520/images/medium/jm0c00245_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.0c00245/20200520/images/large/jm0c00245_0004.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Comparison of USP7 binding interactions of 4-hydroxy piperidine inhibitor <b>1</b> and pyridylbenzofuran inhibitor <b>7</b>. Boxed residues indicate potential hydrogen-bonding interactions that are not utilized by compound <b>7</b>. The PDB code for <b>1</b> bound to USP7 is <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6VN4">6VN4</a>. The PDB code for <b>7</b> bound to USP7 is <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6VN5">6VN5</a>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.0c00245/20200520/images/large/jm0c00245_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00245&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">WaterMap<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> analysis of the holo structure (ligand removed) revealed several unfavorable hydration sites in the binding site of <b>7</b> (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>). Unfavorable hydration sites can be characterized as sites that have a predicted free energy Δ<i>G</i> of >0 kcal/mol upon adding water while favorable hydration sites have a predicted free energy Δ<i>G</i> of <0 kcal/mol. Binding of compound <b>7</b> likely displaces several of the water molecules as shown by the magnified hydration sites of <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>A, including a high-energy site filled by the aryl chloride moiety of <b>7</b>. However, sites adjacent to the aminopyridine are not displaced by the ligand, corroborating the proposed hypothesis that adding appropriate functionality in this region could lead to improved potency. This was further confirmed by a WaterMap analysis with compound <b>7</b> present in the complex, showing that the ligand indeed does not displace water sites adjacent to the aminopyridine (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>B). In fact, the free energy Δ<i>G</i> of these sites is even more unfavorable than predicted from the structure with ligand removed, likely due to a loss of entropy as the waters are somewhat trapped between the ligand and protein. The combined structural and computational analysis strongly suggests that efforts to improve the potency of compound <b>7</b> should be focused on changes to the upper pyridine section of the molecule.</div><figure id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.0c00245/20200520/images/medium/jm0c00245_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.0c00245/20200520/images/large/jm0c00245_0005.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. WaterMap analysis of USP7 binding pocket. Hydration sites are shown as spheres colored by their predicted free energies (Δ<i>G</i>). Green spheres indicate a favorable free energy Δ<i>G</i> while red spheres indicate an unfavorable Δ<i>G</i>. (A) Hydration sites calculated with the ligand (compound <b>7</b>) removed. Overlay of compound <b>7</b> indicates that the magnified (enlarged) spheres are predicted to be displaced by compound <b>7</b> while the other (smaller) spheres are not. (B) Hydration sites with compound <b>7</b> present. Three unfavorable water sites (red/orange) near the 2-aminopyridyl headgroup of <b>7</b> suggest opportunities to further improve the potency of this inhibitor. WaterMap analysis based on cocrystal structure of compound <b>7</b> and USP7, PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6VN5">6VN5</a>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.0c00245/20200520/images/large/jm0c00245_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00245&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i5" class="anchor-spacer"></div><h3 class="article-section__title" id="_i5"> Addition to the Pyridyl Moiety Improves Potency</h3><div class="NLM_p">Several bicyclic analogues of <b>7</b> were first prepared as scaffolds for a potential hydrogen-bond acceptor (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>). Azaindole <b>8</b> was isoefficient to 2-aminopyridine <b>7</b>, having increased potency of comparable magnitude to its increased lipophilicity. In agreement with the selective cocrystallization of the <i>R</i>-isomer from racemic 2-aminopyridine <b>7</b> with USP7, asymmetric synthesis of the enantiomers indicated that the <i>R</i>-isomer <b>9</b> was significantly more active against USP7, while the <i>S</i>-isomer <b><i>ent</i>-9</b> was found to be inactive. Alternative bicyclic scaffolds to the azaindole motif were surveyed. Thienopyridine <b>10</b> was found to be more potent and isoefficient to the corresponding aza-indole, but with one less hydrogen-bond donor. Substitution of the thienopyridine with a methyl group (compound <b>11</b>) did not lead to a gain in potency, but substitution with a hydroxymethylene group (compound <b>12</b>) did lead to an improvement in potency while simultaneously reducing lipophilicity. Consistent with the binding mode of these inhibitors to an allosteric pocket uniquely accessible in USP7, these inhibitors generally did not display significant activity against USP47 or USP1.<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a></div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Evaluation of Heterocyclic scaffolds<a class="ref internalNav" href="#t1fn1" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.0c00245/20200520/images/medium/jm0c00245_0016.gif" alt="" id="GRAPHIC-d7e716-autogenerated" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.0c00245/20200520/images/medium/jm0c00245_0017.gif" alt="" id="gr16" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup><sup>a</sup></sup><p class="last">Data represent the mean of <i>n</i> = 2 or more determinations.</p></div><div class="footnote" id="t1fn2"><sup><sup>b</sup></sup><p class="last">USP7 biochemical assay.</p></div><div class="footnote" id="t1fn3"><sup><sup>c</sup></sup><p class="last">USP47 biochemical assay.</p></div><div class="footnote" id="t1fn4"><sup><sup>d</sup></sup><p class="last">USP1 biochemical assay.</p></div><div class="footnote" id="t1fn5"><sup><sup>e</sup></sup><p class="last">Calculated using ChemDraw.</p></div><div class="footnote" id="t1fn6"><sup><sup>f</sup></sup><p class="last">LipE = <i>p</i>(IC<sub>50</sub>) – clog <i>P</i>.</p></div><div class="footnote" id="t1fn7"><sup><sup>g</sup></sup><p class="last">Racemic compound.</p></div></div><div></div></div><div class="NLM_p">To further improve potency toward USP7, compounds with an additional hydrogen bond donor or acceptor near the thienopyridine were explored. It was expected that additional binding affinity could be achieved in this region by simultaneously forming interactions with the backbone N–H motifs of either Arg-408 or Phe-409 and the amide side chain of Gln-297. Interactions with these two residues are evident in cocrystal structures of USP7 with 4-hydroxy piperidine inhibitor <b>1</b> (see <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>) but are not fully utilized by thienopyridine alcohol <b>12</b>. Introduction of an oxetane with the intention of engaging the side chain of Gln-297 resulted in compound <b>13</b> which was not more potent than compound <b>12</b> (<a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>). Serendipitously, the chlorohydrin <b>14</b> resulting from HCl-mediated chlorinolysis of <b>13</b> was found to be significantly more active against USP7 while decreasing overall lipophilicity. Cocrystallization of <b>14</b> with USP7 confirmed that this compound was forming the originally desired contacts with Arg-408 and Gln-297 while binding in a reversible manner (<a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>).</div><figure id="fig5" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.0c00245/20200520/images/medium/jm0c00245_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.0c00245/20200520/images/large/jm0c00245_0006.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Compound <b>14</b> cocrystal structure with USP7, highlighting key interactions with the binding pocket. The PDB code for <b>14</b> bound to USP7 is <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6VN6">6VN6</a>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.0c00245/20200520/images/large/jm0c00245_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00245&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. Evaluation of Heteroatom-Containing headgroups<a class="ref internalNav" href="#t2fn1" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.0c00245/20200520/images/medium/jm0c00245_0018.gif" alt="" id="GRAPHIC-d7e825-autogenerated" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.0c00245/20200520/images/medium/jm0c00245_0019.gif" alt="" id="gr17" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2fn1"><div class="footnote" id="t2fn1"><sup><sup>a</sup></sup><p class="last">Data represent the mean of <i>n</i> = 2 or more determinations.</p></div><div class="footnote" id="t2fn2"><sup><sup>b</sup></sup><p class="last">USP7 biochemical assay.</p></div><div class="footnote" id="t2fn3"><sup><sup>c</sup></sup><p class="last">USP47 biochemical assay.</p></div><div class="footnote" id="t2fn4"><sup><sup>d</sup></sup><p class="last">Calculated using ChemDraw.</p></div><div class="footnote" id="t2fn5"><sup><sup>e</sup></sup><p class="last">LipE = <i>p</i>(IC<sub>50</sub>) – clog <i>P</i>.</p></div></div><div></div></div><div class="NLM_p">Alternative functional groups to the chloro-diol present in compound <b>14</b> were evaluated (<a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>). The pyrimidinone side chain, whose derivatives are present in the hydroxy-piperidine compounds <b>1–4</b>, resulted in compound <b>15</b> which was found to have slightly better potency than alcohol <b>12</b>. Amide or lactam-containing molecules <b>16</b> and <b>17</b> were not found to have improved potency. However, the addition of a second hydrogen-bond acceptor resulted in succinimide <b>18</b>, a compound with sub-nanomolar biochemical activity against USP7 and excellent lipophilic efficiency. X-ray cocrystallization confirmed that this succinimidyl functional group was making both interactions with Phe-409 and Gln-297 (<a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>). No effect was observed on the potency of USP7 inhibition with preincubation of the succinimide-based inhibitor, indicating that the compound behaves as a reversible inhibitor as suggested by the crystal structure.<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a></div><figure id="fig6" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.0c00245/20200520/images/medium/jm0c00245_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.0c00245/20200520/images/large/jm0c00245_0007.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. X-ray cocrystal structure of compound <b>18</b> with USP7, highlighting key interactions with the binding pocket. The PDB code for <b>18</b> bound to USP7 is <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6VN2">6VN2</a>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.0c00245/20200520/images/large/jm0c00245_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00245&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i8" class="anchor-spacer"></div><h3 class="article-section__title" id="_i8"> Simplified Ether Series</h3><div class="NLM_p">Compound <b>18</b> was evaluated in rodent pharmacokinetics (PK) and found to have very high clearance and poor oral exposure, despite reasonable stability in an in vitro hepatocyte stability assay (<a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a></a>). The low oral exposure was suspected to be in part due to transporter-mediated efflux resulting from the basic amine moiety of the molecule; however, compounds without the basic amine motif, which makes key interactions with Asp-295 and a backbone carbonyl, were orders of magnitude less active against USP7. Additionally, stability to incubation with hepatocytes was still found to be low for these compounds. Several isosteric analogues of <b>18</b> were prepared where the amide linker was replaced with a heterocyclic linker in an attempt to improve permeability and stability, a subset of which is shown in <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a></a>. Oxazole <b>19</b> was found to be less potent than amide <b>18</b> and be less stable to hepatocytes. Isoxazole <b>20</b> was found to have good potency but poor metabolic stability, clearance, and oral exposure. Pyrazole <b>21</b> was found to be more stable to hepatocytes, but unfortunately, this did not extend to a significantly reduced clearance in vivo.</div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. Evaluation of Piperazine-Amide Replacements</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.0c00245/20200520/images/medium/jm0c00245_0020.gif" alt="" id="GRAPHIC-d7e952-autogenerated" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.0c00245/20200520/images/medium/jm0c00245_0021.gif" alt="" id="gr18" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t3fn1"><div class="footnote" id="t3fn1"><sup><sup>a</sup></sup><p class="last">Data represent the mean of <i>n</i> = 2 or more determinations.</p></div><div class="footnote" id="t3fn2"><sup><sup>b</sup></sup><p class="last">USP7 biochemical assay.</p></div><div class="footnote" id="t3fn3"><sup><sup>c</sup></sup><p class="last">% remaining after 60 min incubation with rat (R) or human (H) hepatocytes.</p></div><div class="footnote" id="t3fn4"><sup><sup>d</sup></sup><p class="last">Sprague-Dawley rats, dose of 0.5 mg/kg IV, 2 mg/kg PO. N.D. = not determined.</p></div></div><div></div></div><div class="NLM_p">Having been unsuccessful at improving PK properties by simple amide replacement, we were motivated to make more significant modifications to the dihydrofuran-amide scaffold that had been omnipresent in our inhibitors. Additionally, these dihydrofuran-containing compounds required relatively lengthy syntheses, resulting in a slower discovery effort (see <a class="ref internalNav" href="#sch2" aria-label="Scheme 2">Scheme 2</a>). A simplified and metabolically stable replacement for this bottom portion was desired, but one that maintained the key contacts with the binding pocket (as highlighted in <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>).</div><div class="NLM_p">It was believed that a simplified structure such as ether-linked pyrrolidine <b>22</b> might maintain the desired binding interactions while providing better metabolic stability, a simpler synthesis, and reduced molecular weight (<a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a></a>). However, this modification resulted in a 1000-fold potency loss. It became quite clear that while many aspects of the dihydrofuran-amide did not interact with the binding pocket, it served an important scaffolding role to help place the basic nitrogen in a productive spatial orientation. Computational modeling indicated that the lowest energy conformation of dihydrofuran-amide <b>18</b> is one in which the piperazine ring is oriented upward, syn- to the pyridine ring system—the same conformation that is adopted upon binding to USP7 (see <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>). Conversely, the ground state of simplified system <b>22</b> has the basic nitrogen directed anti- to the pyridine ring system. This is a nonproductive conformation and a significant energy penalty is required to achieve proper amine placement in the binding pocket. To help overcome this unproductive ground state conformation, A-(1,3) strain was leveraged by installing a methyl group ortho- to the ether linkage (as in pyrrolidine <b>23</b>). This raises the energy of the global minimum conformation of <b>23</b> relative to its bound conformation, increasing the overall free energy of binding with USP7. We were pleased to see that this simple modification results in a greater than 100-fold potency gain. A USP7 cocrystal structure of <b>23</b> was obtained and showed the pyrrolidine nitrogen making the same contacts with Asp-295 and Met-292 as the previous piperazine-amide (<a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">8</a></a>). Gratifyingly, compound <b>23</b> also demonstrated moderate clearance and nonzero oral bioavailability.</div><figure id="fig7" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.0c00245/20200520/images/medium/jm0c00245_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.0c00245/20200520/images/large/jm0c00245_0008.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Scaffold switch from the benzofuran-amide to a simplified ether is productive with the inclusion of an <i>ortho</i>-methyl group.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.0c00245/20200520/images/large/jm0c00245_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00245&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="fig8" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.0c00245/20200520/images/medium/jm0c00245_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.0c00245/20200520/images/large/jm0c00245_0009.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. X-ray cocrystal structure of ether <b>23</b> with USP7, highlighting key interactions with the binding pocket. The PDB code for <b>23</b> bound to USP7 is <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6VN3">6VN3</a>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.0c00245/20200520/images/large/jm0c00245_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00245&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">This structural simplification enabled extensive structure–activity relationship (SAR) exploration of the basic amine portion of these molecules. Analogues were assessed based on their biochemical USP7 inhibition as well as in a cellular assay to measure elevated p53 levels.<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> This was accomplished by utilizing a p53 response element-driven luciferase reporter assay in engineered RKO cells. In addition to pyrrolidines such as <b>23</b>, many other ring systems were well tolerated with respect to USP7 potency (<a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a></a>). 3- and 4-piperidinyl compounds such as <b>24</b> and <b>25</b> were both tolerated, as were azetidines such as <b>26</b>. Even exocyclic amines such as cyclobutane <b>27</b> showed potent USP7 inhibition. However, most of these compounds still demonstrated only moderate clearance and bioavailability. After screening many substituents on these ring systems, it was found that a single methyl group afforded a drastic change in the PK profile of the 4-substituted-piperidine set of compounds. Relative to piperidine <b>25</b>, methyl-piperidine <b>28</b> had 5-fold lower rat IV clearance and 20-fold greater PO AUC. The methylated compound <b>28</b> was also more potent in line with its greater lipophilicity relative to the parent compound <b>25</b>.</div><div class="NLM_table-wrap" id="tbl4"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 4. Highlights of Compounds in the Simplified Ether Series</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.0c00245/20200520/images/medium/jm0c00245_0022.gif" alt="" id="GRAPHIC-d7e1092-autogenerated" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.0c00245/20200520/images/medium/jm0c00245_0023.gif" alt="" id="gr19" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t4fn1"><div class="footnote" id="t4fn1"><sup><sup>a</sup></sup><p class="last">Data represent the mean of <i>n</i> = 2 or more determinations.</p></div><div class="footnote" id="t4fn2"><sup><sup>b</sup></sup><p class="last">USP7 biochemical assay.</p></div><div class="footnote" id="t4fn3"><sup><sup>c</sup></sup><p class="last">p53-reporter gene assay in RKO cells.</p></div><div class="footnote" id="t4fn4"><sup><sup>d</sup></sup><p class="last">Calculated using ChemDraw.</p></div><div class="footnote" id="t4fn5"><sup><sup>e</sup></sup><p class="last">LipE = <i>p</i>(IC<sub>50</sub>) – clog <i>P</i>.</p></div><div class="footnote" id="t4fn6"><sup><sup>f</sup></sup><p class="last">Sprague-Dawley rats, dose of 0.5 mg/kg IV, 2 mg/kg PO. N.D. = not determined.</p></div></div><div></div></div></div><div id="sec2_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i11" class="anchor-spacer"></div><h3 class="article-section__title" id="_i11"> Re-Examination of the Succinimide Side Chain</h3><div class="NLM_p">Having established this new piperidine ether as providing an improved PK profile relative to the benzofuran series, the succinimide side chain was re-evaluated. Although the succinimide was a key potency-driver, this moiety was also chemically labile and slowly hydrolyzed under aqueous conditions. Fortunately, substitution on the succinimide backbone with a cyclopropyl ring mitigated hydrolysis while maintaining potency (<b>29</b>, <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a></a>). Further succinimide substitution with a <i>gem</i>-dimethylcyclopropyl ring resulted in a compound with greater biochemical potency in line with an increase in lipophilicity (<b>30</b>), as well as with greatly enhanced chemical stability. Replacement of the succinimide for a substituted uracil as in <b>31</b> also resulted in a potent compound; however, the PK properties for uracil-containing compounds were suboptimal, in part due to greater efflux.</div><div class="NLM_table-wrap" id="tbl5"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 5. Cyclic Imide SAR</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.0c00245/20200520/images/medium/jm0c00245_0024.gif" alt="" id="GRAPHIC-d7e1164-autogenerated" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.0c00245/20200520/images/medium/jm0c00245_0025.gif" alt="" id="gr20" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t5fn1"><div class="footnote" id="t5fn1"><sup><sup>a</sup></sup><p class="last">Data represent the mean of <i>n</i> = 2 or more determinations.</p></div><div class="footnote" id="t5fn2"><sup><sup>b</sup></sup><p class="last">USP7 biochemical assay.</p></div><div class="footnote" id="t5fn3"><sup><sup>c</sup></sup><p class="last">p53-reporter gene assay in RKO cells.</p></div><div class="footnote" id="t5fn4"><sup><sup>d</sup></sup><p class="last">Calculated using ChemDraw.</p></div><div class="footnote" id="t5fn5"><sup><sup>e</sup></sup><p class="last">LipE = <i>p</i>(IC<sub>50</sub>) – clog <i>P</i>.</p></div><div class="footnote" id="t5fn6"><sup><sup>f</sup></sup><p class="last">Sprague-Dawley rats, dose of 0.5 mg/kg IV, 2 mg/kg PO. N.D. = not determined.</p></div></div><div></div></div><div class="NLM_p">Out of the above compounds, <i>gem</i>-dimethylcyclopropylsuccinimide <b>30</b> had the best combination of potency and PK properties. Additionally, <b>30</b> was found to be potent against the MM.1S and H526 cell lines. It is well-established that the MM.1S cell line, a p53-wildtype multiple myeloma cell line, is sensitive to USP7 inhibition and other mechanisms of p53 activation.<a onclick="showRef(event, 'ref6 ref8'); return false;" href="javascript:void(0);" class="ref ref6 ref8">(6,8)</a> Furthermore, we have recently discovered that certain p53-mutant cancer cell lines are also sensitive to USP7 inhibitors, including H526, a small-cell lung cancer cell line.<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> This activity is presumably mediated through a different mechanism other than p53 elevation because the p53 pathway is expected to be nonfunctional in H526 cells.<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> Additionally, target engagement was demonstrated for compound <b>30</b> in MM.1S cells, highlighting that our inhibitors are capable of preventing USP7 from binding and conjugating to an active-site ubiquitin probe.<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a></div><div class="NLM_p last">Compound <b>30</b> possessed significant cytotoxic activity against both the MM.1S and H526 cell lines, demonstrating a CC<sub>50</sub> of 140 and 440 nM, respectively. Additionally, <b>30</b> was tested against a wide variety of DUBs and was found to have exquisite selectivity for USP7. Compound <b>30</b> showed an IC<sub>50</sub> > 10 μM for all the >40 DUBs that were assayed, corresponding to a >50,000-fold selectivity for USP7 over the other DUBs.<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> Unfortunately, <b>30</b> also exhibited some general cytotoxicity, observed by sharply reduced ATP levels at 3.4 μM in RKO cells, suggestive of physicochemical toxicity. Additionally, substantial hERG inhibition was observed with this compound in a simple hERG binding assay (0.4 μM) as well as mild CYP3A4 inhibition (6.2 μM). These suboptimal properties along with the above-mentioned cytotoxicity encouraged further SAR exploration into a somewhat different chemical space from ether-linked compound <b>30</b>.</div></div><div id="sec2_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i13" class="anchor-spacer"></div><h3 class="article-section__title" id="_i13"> Carbon-Linked Compounds Replace the Ether Series</h3><div class="NLM_p">The ether oxygen atom had been omnipresent in our USP7 inhibitors up to this point (first in the benzofurans and later in the simplified ethers) because it was assumed that the buried hydrogen bond to Tyr-465 (as observed in cocrystal structures with USP7) was critical for binding activity. The importance of this interaction, however, had never been experimentally established. FEP+ calculations<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> had been successfully used throughout this program to assess different modifications in order to help prioritize compounds, especially in occasions involving challenging or lengthy syntheses. Using FEP+, the relative binding free energy was calculated for compounds where the ether oxygen had been replaced with a nitrogen or carbon atom. Much to our surprise, carbon-linked analogues were predicted to be equipotent to the standard ether-linked compounds; nitrogen-linked analogues were predicted to be even more potent. These calculations were validated when aniline <b>33</b> and methylene-analogue <b>34</b> were synthesized and assayed (<a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">9</a></a>). Compared to ether-linked compound <b>32</b>, carbon-linked compound <b>34</b> was slightly more potent. Nitrogen-linked compound <b>33</b> displayed marked improvements in potency, especially in the cellular p53 assay. This phenomenon was rationalized by reanalyzing the USP7 crystal structure, which revealed a small hole on the side of the protein opposite to the ligand binding site which enables Tyr-465 to be solvent exposed.<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> This could help make up for loss of hydrogen bond when moving to the carbon-linker and enable additional hydrogen bonding when Tyr-465 switches from an H-bond donor to an H-bond acceptor when bound to aniline <b>33</b>.</div><figure id="fig9" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.0c00245/20200520/images/medium/jm0c00245_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.0c00245/20200520/images/large/jm0c00245_0010.jpeg" id="gr9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 9. Biochemical and cellular potencies with oxygen-, nitrogen-, and carbon-linked compounds.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.0c00245/20200520/images/large/jm0c00245_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00245&amp;id=fig9"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">SAR of the new nitrogen-linked series showed that while these compounds were quite potent, they had poor PK properties, likely in part due to an additional hydrogen-bond donor. Additionally, this series was undesirable because it introduced an aniline toxicophore. The carbon-linked series was found to be more promising—by removing a heteroatom from the linker position, it enabled the introduction of a heteroatom into the piperidine ring to forge either piperazines or morpholines. These saturated heterocycles would result in less basic compounds and help mitigate the hERG inhibition seen in ether-linked compound <b>30</b>.</div><div class="NLM_p">Initially, simple piperazine <b>35</b> was not a very potent compound (<a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">Table <a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">6</a></a>). However, the addition of methyl groups to the 2- and 6-positions of the piperazine ring significantly influenced potency, as evidenced from the progression of piperazine <b>35</b> to methyl piperazine <b>36</b> to di-methyl piperazine <b>37</b>. It is likely that these groups aid in reinforcing the U-shape required to properly position the basic amine in the binding pocket. Dimethyl piperazine <b>37</b> displayed excellent PK with low clearance and a large PO exposure and showed a hERG IC<sub>50</sub> of 2.7 μM, almost a 10-fold improvement over ether <b>30</b>. However, cellular potencies against the MM.1S and H526 cell lines were suboptimal for compound <b>37</b>.</div><div class="NLM_table-wrap" id="tbl6"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 6. Effects of Methyl Substitutions in the Piperazine and Morpholine series<a class="ref internalNav" href="#t6fn1" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.0c00245/20200520/images/medium/jm0c00245_0026.gif" alt="" id="GRAPHIC-d7e1342-autogenerated" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.0c00245/20200520/images/medium/jm0c00245_0027.gif" alt="" id="gr21" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t6fn1"><div class="footnote" id="t6fn1"><sup><sup>a</sup></sup><p class="last">Data represent the mean of <i>n</i> = 2 or more determinations.</p></div><div class="footnote" id="t6fn2"><sup><sup>b</sup></sup><p class="last">USP7 biochemical assay.</p></div><div class="footnote" id="t6fn3"><sup><sup>c</sup></sup><p class="last">p53-reporter gene assay in RKO cells.</p></div><div class="footnote" id="t6fn4"><sup><sup>d</sup></sup><p class="last">Cytotoxicity assay in MM.1S cells.</p></div><div class="footnote" id="t6fn5"><sup><sup>e</sup></sup><p class="last">Cytotoxicity assay in H526 cells.</p></div><div class="footnote" id="t6fn6"><sup><sup>f</sup></sup><p class="last">Calculated using ChemDraw.</p></div><div class="footnote" id="t6fn7"><sup><sup>g</sup></sup><p class="last">LipE = <i>p</i>(IC<sub>50</sub>) – clog <i>P</i>.</p></div><div class="footnote" id="t6fn8"><sup><sup>h</sup></sup><p class="last">Racemic compound. N.D. = not determined.</p></div></div><div></div></div><div class="NLM_p last">The morpholine series yielded extremely potent USP7 inhibitors (<a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">Table <a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">6</a></a>). Unsubstituted morpholine <b>38</b> demonstrated remarkable potency, displaying an enzymatic potency of 160 pM. As with the piperazine series, the reduced basicity and lipophilicity of morpholine <b>38</b> resulted in a further reduction in hERG inhibition, displaying an IC<sub>50</sub> of 8 μM. Unlike the piperazine series, the addition of methyl groups at either the 3- or 6-positions did not result in a dramatic increase in potency (see compounds <b>39</b> and <b>40</b>).</div></div><div id="sec2_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i15" class="anchor-spacer"></div><h3 class="article-section__title" id="_i15"> In Vivo Xenograft Studies</h3><div class="NLM_p">With these new promising piperazine and morpholine series, the most potent cyclic imide side chains were re-evaluated. Among the compounds surveyed, morpholine <b>41</b> demonstrated the optimal balance of cellular potencies and PK properties and was selected for in vivo xenograft studies (<a class="ref showTableEvent internalNav" data-ID="tbl7" href="#tbl7">Table <a class="ref showTableEvent internalNav" data-ID="tbl7" href="#tbl7">7</a></a>). Several other compounds (such as piperazine <b>37</b>) had excellent PK properties but lacked sufficient potency in the MM.1S and H526 cellular assays. Compound <b>41</b> showed excellent activity in cellular assays and maintained a good therapeutic index as demonstrated by a high RKO CC<sub>50</sub>. While compound <b>41</b> displayed excellent PK properties in rat, murine PK studies indicated that <b>41</b> had slightly worse oral exposure in NOD-SCID or nude mice—animals required for the subsequent xenograft studies.<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> Consequently, an elevated oral dose of 50 mg/kg BID was chosen for these in vivo efficacy studies.<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a></div><div class="NLM_table-wrap" id="tbl7"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 7. Properties of Compound <b>41</b></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.0c00245/20200520/images/medium/jm0c00245_0028.gif" alt="" id="GRAPHIC-d7e1458-autogenerated" /></img><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col></colgroup><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">USP7 IC<sub>50</sub></td><td class="colsep0 rowsep0" align="left">0.44 nM</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">p53 EC<sub>50</sub></td><td class="colsep0 rowsep0" align="left">25 nM</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">MM.1S CC<sub>50</sub></td><td class="colsep0 rowsep0" align="left">89 nM</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">H526 CC<sub>50</sub></td><td class="colsep0 rowsep0" align="left">450 nM</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">RKO CC<sub>50</sub></td><td class="colsep0 rowsep0" align="left">13 μM</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">hERG IC<sub>50</sub></td><td class="colsep0 rowsep0" align="left">4.2 μM</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" colspan="2" align="center">PO <a href="/cdn-cgi/l/email-protection" class="__cf_email__" data-cfemail="2a6b7f696a191a">[email protected]</a> mg/kg (h × ng/mL)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Balb/C</td><td class="colsep0 rowsep0" align="left">9400</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">NOD/SCID</td><td class="colsep0 rowsep0" align="left">5500</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">nude</td><td class="colsep0 rowsep0" align="left">4600</td></tr></tbody></table></div></div><div class="NLM_p">The ability of compound <b>41</b> to suppress tumor growth was assessed in an MM.1S xenograft model using NOD-SCID mice. When given a 50 mg/kg oral dose of compound <b>41</b> twice daily, nearly complete tumor growth inhibition was observed (<a data-tab="pane-pcw-Figures" href="#fig10" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig10" id="" class=" internalNav">10</a></a>a). This dose was generally well tolerated among the animals, but in the few cases where body weight dropped to less than 90% of their original weight, a dosing holiday was given. This resulted in a rebound of the animal’s body weight, whereupon regular dosing was resumed.</div><figure id="fig10" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 10</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.0c00245/20200520/images/medium/jm0c00245_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.0c00245/20200520/images/large/jm0c00245_0002.jpeg" id="gr10" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 10. Xenograft studies with (a) NOD-SCID mice engrafted with MM.1S tumors, or (b) athymic nude mice engrafted with H526 tumors. For each study, compound <b>41</b> was dosed PO at 50 mg/kg BID for the indicated time and tumor volume was measured. If the tumor volume exceeded 1500 mm<sup>3</sup>, the animals were taken down from the study (****<i>p</i> < 0.0001).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.0c00245/20200520/images/large/jm0c00245_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00245&amp;id=fig10"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">Tumor growth inhibition in the MM.1S xenograft model is suspected to be primarily mediated through increases in p53, but a subset of p53-mutant cell lines are also sensitive to USP7 inhibition.<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> Compound <b>41</b> inhibited the growth of p53-mutant small cell lung cancer cell line H526 at a CC<sub>50</sub> of 450 nM, implying that tumor growth suppression might be observed in an in vivo setting. For the H526 xenograft model, athymic nude mice were administered twice daily oral doses of compound <b>41</b> for 24 days (<a data-tab="pane-pcw-Figures" href="#fig10" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig10" id="" class=" internalNav">10</a></a>b). At 50 mg/kg, significant tumor growth inhibition was observed which resulted in strikingly improved survival as compared to the vehicle control group. Because compound <b>41</b> is less potent toward H526 cells than MM.1S cells in vitro, it is not surprising that there is slightly inferior tumor growth inhibition in the H526 xenograft model as compared to the MM.1S study. Nevertheless, this in vivo activity demonstrates that USP7 inhibitors can suppress tumor growth through multiple different pathways, potentially widening the utility of USP7 inhibitors beyond p53-sensitive tumors.</div></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i17">Synthetic Chemistry</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_61263" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_61263" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">USP7 inhibitors were synthesized in a convergent manner by palladium-catalyzed coupling between the upper thienopyridine piece and the lower aryl portion. The thienopyridine pieces were synthesized according to <a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>. Commercial thienopyridine chloride <b>42</b> was elaborated to aldehyde <b>43</b> by trapping the corresponding lithium anion with dimethylformamide (DMF) at low temperature.<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> Simple reduction of aldehyde <b>43</b> produced alcohol <b>44</b>, which could be converted to succinimidyl side chain <b>45</b> via chlorination and subsequent S<sub>N</sub>2 displacement. This piece could be borylated to produce boronic ester <b>46</b> for subsequent Suzuki coupling. Alternatively, alcohol <b>44</b> can be protected as the silyl ether <b>47</b> and borylated to produce <b>48</b>. The silyl ether moiety was useful for late-stage diversification of the imide side chain.</div><figure id="sch1" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.0c00245/20200520/images/medium/jm0c00245_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.0c00245/20200520/images/large/jm0c00245_0011.jpeg" id="gr11" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of Thienopyridine Pieces<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.0c00245/20200520/images/large/jm0c00245_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00245&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents: (a) <i>n</i>-BuLi, −78 °C, DMF, 90%. (b) NaBH<sub>4</sub>, MeOH, 96%. (c) SOCl<sub>2</sub>, DCM, 99%. (d) Pyrrolidine-2,5-dione, K<sub>2</sub>CO<sub>3</sub>, acetone, 63%. (e) B<sub>2</sub>Pin<sub>2</sub>, Pd(dppf)Cl<sub>2</sub>, dppf, KOAc, dioxane, 110 °C, 83–99%. (f) TBS-Cl, imidazole, DMF, 85%.</p></p></figure><div class="NLM_p">The benzofuran-amide portion was prepared from 2-bromo-4-chlorophenol (<b>49</b>, <a class="ref internalNav" href="#sch2" aria-label="Scheme 2">Scheme 2</a>). Phenol <b>49</b> was allylated with allyl bromide and was converted to 2-allylphenol <b>50</b> by a Claisen rearrangement.<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> Epoxidation with <i>meta</i>-chloroperoxybenzoic acid (<i>m</i>-CPBA) afforded <b>51</b>, which underwent facile cyclization under basic conditions to afford alcohol <b>52</b>. (2,2,6,6-Tetramethylpiperidin-1-yl)oxyl (TEMPO)-catalyzed oxidation of <b>52</b> afforded the racemic carboxylic acid, which was enantioenriched to the (<i>R</i>)-acid <b>53</b> by classical resolution with napthylamine <b>54</b>, affording <b>53</b> in 99% ee on multigram scale. This enantioenriched acid was converted to piperazine-amide <b>55</b> by T3P coupling. This compound could be converted to the aryl stannane <b>56</b> for subsequent Stille coupling. The final products were prepared via one of two protocols—via Stille coupling of chloropyridine <b>57</b> and stannane <b>56</b> followed by acidic deprotection, or via Suzuki coupling of pyridine boronic ester <b>58</b> and aryl bromide <b>55</b> followed by deprotection under acidic conditions.</div><figure id="sch2" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.0c00245/20200520/images/medium/jm0c00245_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.0c00245/20200520/images/large/jm0c00245_0012.jpeg" id="gr12" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis of Benzofuran-Amide USP7 Inhibitors<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.0c00245/20200520/images/large/jm0c00245_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00245&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>(a) Allyl bromide, K<sub>2</sub>CO<sub>3</sub>, acetone, 55 °C. (b) Mesitylene, 180 °C, 73% over 2 steps. (c) <i>m</i>-CPBA, DCM. (d) KOH, MeOH/H<sub>2</sub>O. (e) TEMPO (cat.), KBr (cat.), NaOCl, NaHCO<sub>3</sub>, THF, H<sub>2</sub>O, 0 °C (52% over 3 steps). (f) <b>54</b>, MeOH, recrystallization (x2), 42%. (g) <i>N</i>-Boc-piperazine, 1-methylimidazole, propanephosphonic anhydride, EtOAc, 81%. (h) PdCl<sub>2</sub>(PPh<sub>3</sub>)<sub>2</sub> (cat.), (Sn(<i>n</i>-Bu)<sub>3</sub>)<sub>2</sub>, 1,4-dioxane, 110 °C, 72%. (i) Pd(PPh<sub>3</sub>)<sub>2</sub>Cl<sub>2</sub>, Cu<sub>2</sub>O, 1,4-dioxane, 100 °C. (j) HCl or TFA, DCM, 90–99%. (k) Pd(PPh<sub>3</sub>)<sub>2</sub>Cl<sub>2</sub>, aq Na<sub>2</sub>CO<sub>3</sub>, EtOH, PhMe, 85 °C.</p></p></figure><div class="NLM_p">To prepare the simplified ether analogues, phenol <b>60</b> and substituted alcohol <b>61</b> were brought together in a Mitsunobu reaction to form ether <b>62</b> (<a class="ref internalNav" href="#sch3" aria-label="Scheme 3">Scheme 3</a>). Suzuki coupling with boronic ester <b>46</b> followed by protecting group removal afforded the final compound <b>63</b>. Analogues with diverse imide side chains could also be generated by late-stage substitution via intermediates such as <i>tert</i>-butyldimethylsilyl (TBS)-ether <b>64</b>. Accordingly, Suzuki coupling of aryl bromide <b>62</b> with boronic ester <b>48</b> yielded coupled product <b>64</b>. Silyl cleavage followed by chlorination with methanesulfonyl chloride enabled facile displacement by a range of cyclic imides or other nucleophiles. Deprotection under acidic conditions produced the final compounds.</div><figure id="sch3" data-index="13" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.0c00245/20200520/images/medium/jm0c00245_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.0c00245/20200520/images/large/jm0c00245_0013.jpeg" id="gr13" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Synthesis of the Simplified Ether Series of Compounds<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.0c00245/20200520/images/large/jm0c00245_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00245&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents: (a) PPh<sub>3</sub>, DIAD, THF, 51–80%. (b) <b>46</b>, Pd(PPh<sub>3</sub>)<sub>2</sub>Cl<sub>2</sub>, aq Na<sub>2</sub>CO<sub>3</sub>, EtOH, PhMe, 85 °C, 20–69%. (c) TFA or HCl, DCM, 90–99%. (d) <b>48</b>, Pd(PPh<sub>3</sub>)<sub>2</sub>Cl<sub>2</sub>, aq Na<sub>2</sub>CO<sub>3</sub>, EtOH, PhMe, 85 °C, 21–61%. (e) TBAF, THF, 67–94%. (f) MsCl, DIPEA, DCM, then cyclic imide, Cs<sub>2</sub>CO<sub>3</sub>, MeCN, 60 °C, 45–65%.</p></p></figure><div class="NLM_p">Synthesis of the piperazine series of inhibitors is outlined in <a class="ref internalNav" href="#sch4" aria-label="Scheme 4">Scheme 4</a>. Starting from 4-chloro-2-methylbenzoic acid (<b>66</b>), large amounts of benzyl bromide <b>67</b> could be prepared via a 3-step sequence of carboxylate-directed C–H iodination, reduction, and bromination. Treatment of benzyl bromide <b>67</b> with mono-Boc-protected piperazine <b>68</b> and sodium hydride afforded benzylic piperazine <b>69</b>. Suzuki coupling with boronic ester <b>46</b> followed by deprotection afforded the final compounds.</div><figure id="sch4" data-index="14" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.0c00245/20200520/images/medium/jm0c00245_0014.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.0c00245/20200520/images/large/jm0c00245_0014.jpeg" id="gr14" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. Synthesis of Carbon-Linked Compounds: Piperazines and Morpholines<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.0c00245/20200520/images/large/jm0c00245_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00245&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents: (a) NIS, Pd(OAc)<sub>2</sub>, DMF, 120 °C, 30%. (b) Borane-DMS, THF, 50 °C, 73%. (c) PBr<sub>3</sub>, DCM, 88%. (d) NaH, DMF, 42–83%. (e) <b>46</b>, Pd(PPh<sub>3</sub>)<sub>2</sub>Cl<sub>2</sub>, aq Na<sub>2</sub>CO<sub>3</sub>, EtOH, PhMe, 85 °C, 20–69%. (f) TFA, or HCl, DCM 90–99%. (g) LDA, THF, −78 °C, 43–62%. (h) Borane-THF, THF, 70 °C, 62–88%. (i) Chloroethyl chloroformate, DCE, then MeOH, 70 °C, 84–98%. (j) Boc<sub>2</sub>O, imidazole, THF, 63–99%. (k) Chiral SFC separation.</p></p></figure><div class="NLM_p">The morpholine-containing compounds were synthesized through alkylation of <i>para</i>-methoxybenzyl (PMB)-protected morpholinone <b>71</b> with benzyl bromide <b>67</b>, followed by lactam reduction to give racemic morpholine <b>72</b> (<a class="ref internalNav" href="#sch4" aria-label="Scheme 4">Scheme 4</a>). Protecting group exchange from PMB to Boc and then chiral separation afforded chiral morpholine <b>73</b>. Suzuki coupling with boronic ester <b>46</b> followed by deprotection gave the final compounds.</div><div class="NLM_p">In order to synthesize multigram quantities of compound <b>41</b> for in vivo studies, an improved synthetic route to enantiopure morpholine <b>79</b> was designed (<a class="ref internalNav" href="#sch5" aria-label="Scheme 5">Scheme 5</a>). Readily available 2-bromo-4-chloro-6-methylaniline (<b>75</b>) was first converted to epoxide <b>76</b> through a two-step procedure of allylation<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> followed by epoxidation. Epoxide <b>76</b> could be opened regioselectively with ethanolamine to give amino-diol <b>77</b>. Boc protection followed by Mitsunobu ring closure and treatment with HCl afforded racemic morpholine <b>78</b>. From epoxide <b>76</b>, morpholine <b>78</b> can be accessed in 59% yield over 4 steps without column chromatographic purification. Neutralization of the HCl salt generated the morpholine free base which was utilized to develop a large-batch resolution/recrystallization procedure. The addition of 0.5 equivalents of <i>N</i>-Ac-<span class="smallcaps smallerCapital">d</span>-Leu allowed for enrichment of the desired morpholine enantiomer, and repeated recrystallization followed by Boc protection enabled production of chiral morpholine <b>79</b> in 99% ee on multigram scale. Standard Suzuki coupling with boronic ester <b>48</b> afforded compound <b>80</b> that was converted into compound <b>41</b> by silyl cleavage, chlorination, displacement with 6,6-dimethyl-3-azabicyclo[3.1.0]hexane-2,4-dione, and deprotection under acidic conditions.</div><figure id="sch5" data-index="15" class="article__inlineFigure"><h2 class="fig-label">Scheme 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.0c00245/20200520/images/medium/jm0c00245_0015.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.0c00245/20200520/images/large/jm0c00245_0015.jpeg" id="gr15" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 5. Synthetic Route to Access Multigram Quantities of Enantiopure Compound <b>41</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.0c00245/20200520/images/large/jm0c00245_0015.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00245&amp;id=sch5"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents: (a) allyl bromide, <i>t</i>BuONO, MeCN, 73%. (b) <i>m</i>-CPBA, DCM, 63%. (c) Ethanol amine, THF, 60 °C. (d) Boc<sub>2</sub>O, imidazole, THF. (e) DIAD, PPh<sub>3</sub>, MTBE. (f) HCl, DCM, 59% over 4 steps. (g) NaOH, DCM. (h) <i>N</i>-Ac-<span class="smallcaps smallerCapital">d</span>-Leu (0.5 equiv), DCE, recrystallization (x3). (i) Boc<sub>2</sub>O, Et<sub>3</sub>N, DCM, 31% over 3 steps. (j) <b>48</b>, Pd(PPh<sub>3</sub>)<sub>2</sub>Cl<sub>2</sub>, Na<sub>2</sub>CO<sub>3</sub>, EtOH, PhMe, 85 °C. (k) TBAF, THF, 78% over 2 steps. (l) MsCl, DIPEA, DCM, then 6,6-dimethyl-3-azabicyclo[3.1.0]hexane-2,4-dione, Cs<sub>2</sub>CO<sub>3</sub>, MeCN, 60 °C. (m) HCl, DCM, 65% over 2 steps.</p></p></figure></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i23">Conclusions</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_38480" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_38480" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">Cocrystal structures of USP7 with two micromolar inhibitors of different chemotypes revealed both compounds bound to the same allosteric site adjacent to the catalytic site of the enzyme. Careful analysis of the binding of a novel pyridylbenzofuran series suggested possibilities for establishing additional interactions and displacing unfavorable water molecules within this site. Introduction of a succinimide side chain to a thienopyridine functionality resulted in significantly increased potency. In order to improve the pharmacokinetic properties of these inhibitors, nonbenzofuran chemotypes were developed. Key to this success was the redesign of the benzofuran-amide template to a simplified <i>ortho</i>-methyl ether series of compounds employing acyclic conformational control. Drug-like properties and cellular potencies were further improved by switching from ether-linked compounds to carbon-linked piperazines and morpholines, leading to the discovery of compound <b>41</b>. This USP7 inhibitor demonstrates marked tumor growth inhibition in both p53-wild type and p53-mutant tumors, suggesting that USP7 inhibition can suppress tumor growth in vivo through both p53 dependent and independent mechanisms. Further elucidation of these intricate pathways could delineate a future clinical pathway for these potent, selective, and orally bioavailable USP7 inhibitors.</div></div><div id="sec5" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i24">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_32734" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_32734" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec5_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i25" class="anchor-spacer"></div><h3 class="article-section__title" id="_i25"> General Chemistry</h3><div class="NLM_p last">All chemicals were purchased from commercial suppliers and used as received. An inert atmosphere of nitrogen or argon was used for reactions involving air- or moisture-sensitive reagents. Analytical thin layer chromatography (TLC) was performed using 2.5 × 7.5 cm Merck silica gel 60 F<sub>254</sub> thin layer plates (EMD Millipore 1.15341.0001) visualized using combinations of UV visualization, <i>p</i>-anisaldehyde, potassium permanganate, and/or iodine staining. Silica gel column chromatography was performed using Teledyne ISCO RediSep Rf normal phase (35–70 μm) silica gel columns on a Teledyne ISCO CombiFlash Rf or CombiFlash Rf<sup>+</sup> purification system (detection at 254 nm). Reversed-phase preparative high-performance liquid chromatography (HPLC) was carried out using a Gemini-NX-C18 column (10 μm, 250 × 30 mm, Phenomenex, Torrance, CA) eluting with a linear gradient from 5 to 100% acetonitrile in water containing 0.1% trifluoroacetic acid (TFA) over 30 min on a Teledyne ISCO EZ Prep, Teledyne ISCO ACCQPrep HP125, or Agilent 1200 Series purification system. Analytical reverse-phase HPLC was performed using a Gemini-NX-C18 column (5 μm, 250 × 4.6 mm, Phenomenex, Torrance, CA) eluting with MeCN in water with 0.1% TFA on an Agilent 1200 Series purification system (detection at 254 nm). Proton NMR spectra were recorded on a Varian Oxford 400 MHz spectrometer and carbon NMR spectra were recorded at 101 MHz. Chemical shifts are expressed in δ ppm referenced to tetramethylsilane (δ = 0 ppm). Abbreviations used in describing peak signal multiplicity are as follows: s = singlet, d = doublet, dd = double doublets, t = triplet, q = quartet, m = multiplet, br = broad peak. Analytical liquid chromatography–mass spectroscopy (LC–MS) was performed using a ZORBAX SB-C18 column (1.8 μm, 2.1 × 50 mm, 600 bar, Agilent, Santa Clara, CA) eluting with a linear gradient from 0 to 100% B over 2 min and then 100% B for 3 min (A = 5% MeCN in H<sub>2</sub>O with 0.1% formic acid, B = MeCN + 0.1% formic acid, flow rate 0.4 mL/min) using an Agilent 1260 Infinity II LC System (detection at 254 nm) equipped with an Agilent 6120 Quadrupole LC–MS in electrospray ionization mode (ESI<sup>+</sup>). The purity of all compounds used in bioassays was determined by this method to be >95% pure.</div></div><div id="sec5_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i26" class="anchor-spacer"></div><h3 class="article-section__title" id="_i26"> 7-Chlorothieno[3,2-<i>b</i>]pyridine-2-carbaldehyde (<b>43</b>)</h3><div class="NLM_p last">To a solution of 7-chlorothieno[3,2-<i>b</i>]pyridine (65.2 g, 0.384 mol) in anhydrous tetrahydrofuran (THF, 0.64 L, 0.6 M) at −78 °C was added a solution of <i>n</i>-BuLi (0.2 L, 0.5 mol, 1.3 equiv) over 0.5 h using an addition funnel. The mixture was stirred at −78 °C for 2 h before the addition of DMF (98 mL, 1.27 mol, 3.3 equiv). The mixture was stirred for an additional 2 h before warming to 0 °C. 2 N aq HCl (0.8 L) was added to acidify the mixture. The resulting precipitate was collected by filtration and dried in vacuo to yield the desired product as a yellow solid (68.5 g, 90% yield).</div></div><div id="sec5_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i27" class="anchor-spacer"></div><h3 class="article-section__title" id="_i27"> (7-Chlorothieno[3,2-<i>b</i>]pyridin-2-yl)methanol (<b>44</b>)</h3><div class="NLM_p last">To a stirred suspension of aldehyde <b>43</b> (73.7 g, 0.373 mol) in methanol (1.1 L, 0.33 M) at 0 °C was carefully added NaBH<sub>4</sub> (28.2 g, 0.746 mol, 2 equiv) in portions over 30 min. The mixture was allowed to stir for an additional 30 min at 0 °C. The reaction was monitored by LCMS to completion, and the mixture was concentrated in vacuo. The residue was triturated with H<sub>2</sub>O (1 L) and the resulting solid was collected by filtration and dried in vacuo to yield the desired product (71.6 g, 96% yield). <sup>1</sup>H NMR (400 MHz, chloroform-<i>d</i>): δ 8.54 (d, <i>J</i> = 5.1 Hz, 1H), 7.44 (t, <i>J</i> = 1.1 Hz, 1H), 7.26 (d, <i>J</i> = 5.2 Hz, 1H), 5.01 (d, <i>J</i> = 1.1 Hz, 2H). [M + H] 200.0.</div></div><div id="sec5_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i28" class="anchor-spacer"></div><h3 class="article-section__title" id="_i28"> 1-((7-Chlorothieno[3,2-<i>b</i>]pyridin-2-yl)methyl)pyrrolidine-2,5-dione (<b>45</b>)</h3><div class="NLM_p last">To a stirred suspension of alcohol <b>44</b> (21.6 g, 108.2 mmol) in dichloromethane (DCM) (200 mL) was added SOCl<sub>2</sub> (23.5 mL, 324.6 mmol, 3.0 equiv) at room temperature. The mixture was stirred at room temperature for 20 h. Upon completion, the mixture was concentrated in vacuo to afford the desired chloride (27.5 g, 99% yield). To a stirred suspension of this alkyl chloride (7.0 g, 32.1 mmol) and K<sub>2</sub>CO<sub>3</sub> (17.74 g, 128.4 mmol, 4.0 equiv) in acetone (215 mL) was added pyrrolidine-2,5-dione (7.0 g, 70.6 mmol, 2.2 equiv). The mixture was heated to 80 °C and stirred for 24 h and cooled to room temperature. The mixture was then filtered over Celite, rinsing with 10% MeOH in DCM. The filtrate was concentrated in vacuo and purified by flash column chromatography (30–80% ethyl acetate/DCM) to afford the desired product as a white solid (5.7 g, 63% yield). <sup>1</sup>H NMR (400 MHz, chloroform-<i>d</i>): δ 8.56 (d, <i>J</i> = 5.1 Hz, 1H), 7.55 (t, <i>J</i> = 0.8 Hz, 1H), 7.26 (d, <i>J</i> = 5.0 Hz, 1H), 4.96 (s, 2H), 2.78 (s, 4H). [M + H] 281.0.</div></div><div id="sec5_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i29" class="anchor-spacer"></div><h3 class="article-section__title" id="_i29"> 1-((7-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)thieno[3,2-<i>b</i>]pyridin-2-yl)methyl)pyrrolidine-2,5-dione (<b>46</b>)</h3><div class="NLM_p last">To thienopyridine chloride <b>45</b> (185 mg, 0.66 mmol), bis(pinacolato)diboron (160 mg, 0.6 mmol), Pd(dppf)Cl<sub>2</sub> (44 mg, 0.06 mmol), and potassium acetate (176 mg, 1.8 mmol) was added 1,4-dioxane (3 mL). The resulting mixture was heated to 100 °C for 3 h. The reaction mixture was diluted with water (5 mL), extracted with EtOAc (2×), dried over sodium sulfate, filtered, and concentrated under reduced pressure to afford the title compound (161 mg, 99% yield) which was used directly for the next Suzuki coupling (general procedure B).</div></div><div id="sec5_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i30" class="anchor-spacer"></div><h3 class="article-section__title" id="_i30"> 2-(((<i>tert</i>-Butyldimethylsilyl)oxy)methyl)-7-chlorothieno[3,2-<i>b</i>]pyridine (<b>47</b>)</h3><div class="NLM_p last">Alcohol <b>44</b> (30 g, 150.3 mmol) was suspended in DCM (500 mL) followed by the addition of <i>N</i>,<i>N</i>-diisopropylethylamine (105 mL, 601.2 mmol), TBSCl (49.8 g, 330.6 mmol), and 4-dimethylaminopyridine (DMAP) (3.67 g, 30 mmol). The mixture was allowed to stir at room temperature for 16 h. Upon completion, MeOH (100 mL) was added to the mixture and stirred for 2 h at room temperature. The reaction mixture was concentrated in vacuo and dissolved in DCM (500 mL). The organic layer was washed with 2 N HCl (2 × 200 mL), H<sub>2</sub>O (1 × 200 mL), and brine (1 × 200 mL). The organic layer was dried over Na<sub>2</sub>SO<sub>4</sub> and concentrated in vacuo to give the product (40.2 g, 85%).</div></div><div id="sec5_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i31" class="anchor-spacer"></div><h3 class="article-section__title" id="_i31"> 2-(((<i>tert</i>-Butyldimethylsilyl)oxy)methyl)-7-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)thieno[3,2-<i>b</i>]pyridine (<b>48</b>)</h3><div class="NLM_p last">Thienopyridine chloride <b>47</b> (40.2 g, 128.1 mmol), bis(pinacolato)diboron (65 g, 256.1 mmol), potassium acetate (37.7 g, 384.3 mmol), and Pd(dppf)<sub>2</sub>Cl<sub>2</sub> (4.7 g, 6.4 mmol) were suspended in dioxane (173 mL). The mixture was degassed by bubbling with N<sub>2</sub> for 30 min then heated to 100 °C for 4.5 h. Upon completion, the mixture was cooled to room temperature then MeOH (200 mL) was added. The mixture was stirred at room temperature for 1 h before being slowly poured into water (1 L) under vigorous stirring. The solid was filtered and triturated with hexanes yielding the product (20.8 g). The hexane layer was concentrated in vacuo, and the resulting solid was triturated with hexanes yielding the product (22.2 g, combined yield 83%).</div></div><div id="sec5_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i32" class="anchor-spacer"></div><h3 class="article-section__title" id="_i32"> 2-Allyl-6-bromo-4-chlorophenol (<b>50</b>)</h3><div class="NLM_p last">To a solution of 2-bromo-4-chlorophenol (300 g, 1.45 mol) in acetone (0.6 L) was added allyl bromide (184 g, 1.05 equiv) and K<sub>2</sub>CO<sub>3</sub> (220 g, 1.1 equiv). The mixture was stirred at 55 °C for 2 h, then cooled to room temperature. The mixture was filtered and washed with acetone (0.6 L). The filtrate was dried and concentrated to afford the desired allylated product as an oil (358 g), which was used directly in the following step. This oil (358 g) was dissolved in mesitylene (80 mL) and stirred at 180 °C for 24 h. The mixture was cooled to room temperature, and the mesitylene was removed by concentration in vacuo. The desired product was isolated by distillation (90–95 °<a href="/cdn-cgi/l/email-protection" class="__cf_email__" data-cfemail="72313243">[email protected]</a> Torr) to afford the product as a colorless oil (262 g, 73% over 2 steps).</div></div><div id="sec5_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i33" class="anchor-spacer"></div><h3 class="article-section__title" id="_i33"> 2-Bromo-4-chloro-6-(oxiran-2-ylmethyl)phenol (<b>51</b>)</h3><div class="NLM_p last">To a solution of alkene <b>50</b> (180 g, 0.73 mol) in DCM (800 mL) at 0 °C was added <i>m</i>-CPBA (263 g, 1.05 equiv) in portions. The mixture was allowed to stir at room temperature overnight. The reaction was quenched with 2 M aq NaS<sub>2</sub>O<sub>3</sub> solution and half sat. aq NaHCO<sub>3</sub> under stirring. The organic layer was dried over sodium sulfate, filtered, and concentrated in vacuo to afford the product (190 g), which was used directly in the following step.</div></div><div id="sec5_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i34" class="anchor-spacer"></div><h3 class="article-section__title" id="_i34"> (7-Bromo-5-chloro-2,3-dihydrobenzofuran-2-yl)methanol (<b>52</b>)</h3><div class="NLM_p last">To a stirred solution of oxirane <b>51</b> (180 g) in methanol (800 mL) and water (50 mL) was added solid KOH (42 g, 1.1 equiv) in portions. The mixture was stirred at room temperature overnight. The mixture was concentrated under reduced pressure, diluted with water (800 mL) and ethyl acetate (800 mL), and acidified to ∼pH 2 with 6 N aq HCl. The organic layer was washed with water, sat. aq NaHCO<sub>3</sub>, and brine. The organic layer was dried over sodium sulfate and concentrated in vacuo to afford the product (190 g) which was used directly in the following step.</div></div><div id="sec5_11" class="NLM_sec NLM_sec_level_2"><div id="ac_i35" class="anchor-spacer"></div><h3 class="article-section__title" id="_i35"> 7-Bromo-5-chloro-2,3-dihydrobenzofuran-2-carboxylic Acid (<b><i>rac</i>-53</b>)</h3><div class="NLM_p last">To a solution of alcohol <b>52</b> (180 g, 0.68 mol) in THF (600 mL) and sat. aq NaHCO<sub>3</sub> (600 mL) at 0 °C was added TEMPO (21.6 g, 0.2 equiv) and potassium bromide (16.2 g, 0.2 equiv). 13% aq NaOCl (900 mL, 3.0 equiv) was then added dropwise via addition funnel to the stirred mixture. The mixture was warmed to room temperature, and the reaction was monitored by TLC. After 8 h, the mixture was diluted with <i>tert</i>-butyl methyl ether (MTBE) (500 mL), water (800 mL), and 2 M aq Potassium carbonate (100 mL), and the organic layer was removed. The aqueous layer was acidified to pH 2 with 6 M aq HCl, and the mixture was extracted with MTBE (2 × 500 mL). The organic extracts were dried over sodium sulfate, filtered, and concentrated in vacuo. The residue was triturated with a mixture of MTBE/hexanes (1:5) and collected by filtration to afford the desired racemic acid as an off-white solid (105 g, 52% over 3 steps).</div></div><div id="sec5_12" class="NLM_sec NLM_sec_level_2"><div id="ac_i36" class="anchor-spacer"></div><h3 class="article-section__title" id="_i36"> (<i>R</i>)-7-Bromo-5-chloro-2,3-dihydrobenzofuran-2-carboxylic Acid (<b>53</b>)</h3><div class="NLM_p last">To a solution of racemic acid <b><i>rac</i>-53</b> (155 g, 0.56 mol) in methanol (500 mL) was slowly added a solution of (<i>S</i>)-1-(naphthalen-1-yl)ethan-1-amine (101 g, 0.59 mol, 1.05 equiv) in methanol (500 mL). The resulting salt (255 g) was recrystallized from hot methanol (3 L) to afford an isomerically enriched salt (100 g) after collecting the solid by filtration. The filtrate was concentrated and recrystallized from methanol to afford a second crop of isomerically enriched salt (20 g). The combined salts (120 g) were treated with 1 N aq NaOH (200 mL) and washed with MTBE (2 × 200 mL). The aqueous layer was acidified to pH 2 and extracted with EtOAc (2 × 200 mL). The combined organics were washed with water, brine, dried over sodium sulfate and concentrated to afford the title enantioenriched acid as a white solid (65 g, 42% yield, 99% ee).</div></div><div id="sec5_13" class="NLM_sec NLM_sec_level_2"><div id="ac_i37" class="anchor-spacer"></div><h3 class="article-section__title" id="_i37"> <i>tert</i>-Butyl (<i>R</i>)-4-(7-Bromo-5-chloro-2,3-dihydrobenzofuran-2-carbonyl)piperazine-1-carboxylate (<b>55</b>)</h3><div class="NLM_p last">To a suspension of (<i>R</i>)-acid <b>53</b> (4.16 g, 15 mmol), <i>N</i>-Boc-piperazine (3.07 g, 16.5 mmol), and methylimidazole (3.59 mL, 45 mmol) in EtOAc (30 mL) was added a solution of T3P (50% by wt. in EtOAc, 17.9 mL, 30 mmol). The reaction mixture was stirred at room temperature overnight. The reaction mixture was diluted with aq NaOH solution (1 M, 150 mL), extracted with EtOAc (2 × 100 mL), dried over sodium sulfate, filtered, and concentrated in vacuo. The crude residue was purified by flash column chromatography (20–100% EtOAc in hexanes) to afford the title compound (5.4 g, 81% yield). <sup>1</sup>H NMR (400 MHz, chloroform-<i>d</i>): δ 7.27 (s, 1H), 7.12 (s, 1H), 5.47 (dd, <i>J</i> = 9.9, 6.6 Hz, 1H), 4.05 (dd, <i>J</i> = 16.2, 6.6 Hz, 1H), 3.99–3.89 (m, 2H), 3.81–3.63 (m, 2H), 3.53–3.18 (m, 5H), 1.48 (s, 9H). [M + Na] 467.0.</div></div><div id="sec5_14" class="NLM_sec NLM_sec_level_2"><div id="ac_i38" class="anchor-spacer"></div><h3 class="article-section__title" id="_i38"> <i>tert</i>-Butyl (<i>R</i>)-4-(5-Chloro-7-(tributylstannyl)-2,3-dihydrobenzofuran-2-carbonyl)piperazine-1-carboxylate (<b>56</b>)</h3><div class="NLM_p last">A solution of aryl bromide <b>55</b> (3.0 g, 6.73 mmol) and bis(triphenylphosphine)palladium(II) chloride (236 mg, 0.337 mmol) in dioxane (67 mL) was evacuated/backfilled with argon (3×). To this mixture was added tributyl(tributylstannyl)stannane (5.86 g, 10.1 mmol). The resulting mixture was stirred at 110 °C for 18 h. The reaction mixture was allowed to cool to room temperature and solvent was removed under reduced pressure. The crude residue was purified by column chromatography (0–50% EtOAc in hexanes) to afford the title compound (3.2 g, 72% yield) as a clear oil. [M + H] 657.0.</div></div><div id="sec5_15" class="NLM_sec NLM_sec_level_2"><div id="ac_i39" class="anchor-spacer"></div><h3 class="article-section__title" id="_i39"> General Procedure A (Stille Coupling)</h3><div class="NLM_p last">To a solution of stannane <b>56</b> (0.23 mmol) and appropriate chloropyridine (e.g., <b>45</b>, <b>47</b>, or <b>57</b>, 0.23 mmol) in 1,4-dioxane (1.5 mL) was added PdCl<sub>2</sub>(PPh<sub>3</sub>)<sub>2</sub> (16 mg, 0.02 mmol) and copper oxide (33 mg, 0.23 mmol). The resulting mixture was sparged with argon for 5 min and heated to 100 °C under stirring for 6 h. The solvent was removed under reduced pressure and the crude residue was purified by flash column chromatography (0–10% MeOH in DCM) to afford the coupled product.</div></div><div id="sec5_16" class="NLM_sec NLM_sec_level_2"><div id="ac_i40" class="anchor-spacer"></div><h3 class="article-section__title" id="_i40"> General Procedure B (Suzuki Coupling)</h3><div class="NLM_p last">A mixture of pyridine boronic ester (e.g., <b>46</b>, <b>48</b>, or <b>58</b>, 0.86 mmol), appropriate aryl bromide or iodide (e.g., <b>55</b>, <b>62</b>, <b>69</b>, <b>73</b>, or <b>79</b>, 0.86 mmol), dichlorobis(triphenylphosphine)palladium(II) (60 mg, 0.09 mmol), and 1 M aqueous sodium carbonate (2.5 mL) in toluene/ethanol (5 mL, 1:1 v/v) was heated to 85 °C and stirred vigorously for 1–15 h. The reaction mixture was diluted in EtOAc (40 mL), and then, water (20 mL) and brine (20 mL) were added and the organic layer was separated, dried over MgSO<sub>4</sub>, and concentrated. The crude residue was purified by column chromatography (0–10% MeOH in DCM) to afford the coupled product.</div></div><div id="sec5_17" class="NLM_sec NLM_sec_level_2"><div id="ac_i41" class="anchor-spacer"></div><h3 class="article-section__title" id="_i41"> General Procedure C (Boc-Deprotection with HCl)</h3><div class="NLM_p last">Desired Boc-amine (0.7 mmol) was dissolved in DCM (4 mL), and then, HCl (4 M in dioxane, 2 mL) was added. The resulting mixture was stirred at room temperature until complete conversion was achieved (1–3 h). The solvents were then removed in vacuo, and residue was dried on high vacuum for 12 h to afford the final compound as the HCl salt.</div></div><div id="sec5_18" class="NLM_sec NLM_sec_level_2"><div id="ac_i42" class="anchor-spacer"></div><h3 class="article-section__title" id="_i42"> General Procedure D (Boc-Deprotection with TFA)</h3><div class="NLM_p last">Desired Boc-amine (0.63 mmol) was dissolved in DCM (6 mL) at which time TFA (1 mL) was added dropwise. The resulting mixture was stirred at room temperature until complete conversion was reached (1–3 h). The solvents were removed in vacuo and residue was dried on high vacuum for 12 h to afford the final compound as the TFA salt. If necessary, purification by reverse-phase chromatography (0–100% MeCN in water) was performed.</div></div><div id="sec5_19" class="NLM_sec NLM_sec_level_2"><div id="ac_i43" class="anchor-spacer"></div><h3 class="article-section__title" id="_i43"> General Procedure E (Preparation of Free Bases)</h3><div class="NLM_p last">The desired hydrochloride or TFA salt was dissolved in MeOH/DCM (20/80, 2 mL) and filtered through a PL-HCO3 MP SPE column, eluting with MeOH/DCM (20/80). The solvents were removed in vacuo and residue was dried on high vacuum for 12 h to afford the final compound as the free base.</div></div><div id="sec5_20" class="NLM_sec NLM_sec_level_2"><div id="ac_i44" class="anchor-spacer"></div><h3 class="article-section__title" id="_i44"> (7-(2-Aminopyridin-4-yl)-5-chloro-2,3-dihydrobenzofuran-2-yl)(piperazin-1-yl)methanone (<b>7</b>)</h3><div class="NLM_p last">The title compound was synthesized following general procedure B with <i>tert</i>-butyl 4-(7-bromo-5-chloro-2,3-dihydrobenzofuran-2-carbonyl)piperazine-1-carboxylate (<b><i>rac</i>-55</b>) and 2-aminopyridine-4-boronic acid pinacol ester followed by general procedure C to give the desired compound as the HCl salt (20 mg, 50% yield). <sup>1</sup>H NMR (400 MHz, methanol-<i>d</i><sub>4</sub>): δ ppm 7.87 (d, <i>J</i> = 6.9 Hz, 1H), 7.50 (d, <i>J</i> = 2.1 Hz, 1H), 7.45–7.39 (m, 2H), 7.33 (dd, <i>J</i> = 6.9, 1.7 Hz, 1H), 5.88 (dd, <i>J</i> = 9.9, 6.6 Hz, 1H), 4.04–3.75 (m, 4H), 3.65–3.54 (m, 2H), 3.39–3.26 (m, 4H). [M + H] 359.1.</div></div><div id="sec5_21" class="NLM_sec NLM_sec_level_2"><div id="ac_i45" class="anchor-spacer"></div><h3 class="article-section__title" id="_i45"> (5-Chloro-7-(1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridin-4-yl)-2,3-dihydrobenzofuran-2-yl)(piperazin-1-yl)methanone (<b>8</b>)</h3><div class="NLM_p last">The title compound was synthesized following general procedure B with <i>tert</i>-butyl 4-(7-bromo-5-chloro-2,3-dihydrobenzofuran-2-carbonyl)piperazine-1-carboxylate (<b><i>rac</i>-55</b>) and 4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridine followed by general procedures C and E to give the desired compound as the free base (25 mg, 70% yield). <sup>1</sup>H NMR (400 MHz, methanol-<i>d</i><sub>4</sub>): δ ppm 8.23 (br s, 1H), 7.43 (d, <i>J</i> = 3.6 Hz, 1H), 7.40 (d, <i>J</i> = 2 Hz, 1H), 7.32 (s, 1H), 7.28 (s, 1H), 6.55 (d, <i>J</i> = 3.6 Hz, 1H), 5.69 (dd, <i>J</i> = 9.6, 6.8 Hz, 1H), 3.76–2.56 (m, 10H). [M + H] 383.0.</div></div><div id="sec5_22" class="NLM_sec NLM_sec_level_2"><div id="ac_i46" class="anchor-spacer"></div><h3 class="article-section__title" id="_i46"> (<i>R</i>)-(5-Chloro-7-(1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridin-4-yl)-2,3-dihydrobenzofuran-2-yl)(piperazin-1-yl)methanone (<b>9</b>)</h3><div class="NLM_p last">The title compound was synthesized following general procedure B with <i>tert</i>-butyl (<i>R</i>)-4-(7-bromo-5-chloro-2,3-dihydrobenzofuran-2-carbonyl)piperazine-1-carboxylate (<b>55</b>) and 4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridine followed by general procedure C to give the desired compound as the HCl salt (165 mg, 0.431 mmol, 63% yield). <sup>1</sup>H NMR (400 MHz, methanol-<i>d</i><sub>4</sub>): δ 8.44 (d, <i>J</i> = 6.2 Hz, 1H), 7.81 (d, <i>J</i> = 6.1 Hz, 1H), 7.74 (d, <i>J</i> = 3.6 Hz, 1H), 7.56 (d, <i>J</i> = 2.2 Hz, 1H), 7.47 (s, 1H), 7.03 (d, <i>J</i> = 3.6 Hz, 1H), 5.91–5.81 (m, 1H), 4.02–3.76 (m, 4H), 3.77–3.69 (m, 1H), 3.61–3.54 (m, 1H), 3.43–3.04 (m, 4H). [M + H] 383.0.</div></div><div id="sec5_23" class="NLM_sec NLM_sec_level_2"><div id="ac_i47" class="anchor-spacer"></div><h3 class="article-section__title" id="_i47"> (<i>R</i>)-(5-Chloro-7-(thieno[3,2-<i>b</i>]pyridin-7-yl)-2,3-dihydrobenzofuran-2-yl)(piperazin-1-yl)methanone (<b>10</b>)</h3><div class="NLM_p last">The title compound was synthesized following general procedure A with <i>tert</i>-butyl 4-[5-chloro-7-tributylstannyl-2,3-dihydrobenzofuran-2-carbonyl]piperazine-1-carboxylate (<b>56</b>) and 7-chlorothieno[3,2-<i>b</i>]pyridine and purified by reverse-phase HPLC using water (0.1% TFA) and acetonitrile (0.1% TFA) as the eluent followed by general procedure D to give the desired compound as the TFA salt (2.5 mg, 4% yield). <sup>1</sup>H NMR (400 MHz, methanol-<i>d</i><sub>4</sub>, hydrochloric acid salt): δ ppm 8.64 (s, 1H), 8.21 (br s, 1H), 7.86 (br s, 1H), 7.22 (br s, 1H), 7.67 (br s, 1H), 7.53 (s, 1H), 5.89 (m, 1H), 3.86–3.09 (m, 10H). [M + H] 400.0.</div></div><div id="sec5_24" class="NLM_sec NLM_sec_level_2"><div id="ac_i48" class="anchor-spacer"></div><h3 class="article-section__title" id="_i48"> [(2<i>R</i>)-5-Chloro-7-(2-methylthieno[3,2-<i>b</i>]pyridin-7-yl)-2,3-dihydrobenzofuran-2-yl]-piperazin-1-yl-methanone (<b>11</b>)</h3><div class="NLM_p last">The title compound was synthesized following general procedure A with <i>tert</i>-butyl 4-[5-chloro-7-tributylstannyl-2,3-dihydrobenzofuran-2-carbonyl]piperazine-1-carboxylate (<b>56</b>) and 7-chloro-2-methyl-thieno[3,2-<i>b</i>]pyridine followed by general procedure C. The title compound was isolated by flash column chromatography (silica gel, 0–10% MeOH in DCM +0.1 M NH<sub>3</sub>) (14 mg, 29% yield). <sup>1</sup>H NMR (400 MHz, chloroform-<i>d</i>): δ 8.61 (d, <i>J</i> = 4.9 Hz, 1H), 7.44 (d, <i>J</i> = 2.1 Hz, 1H), 7.36–7.19 (m, 3H), 5.46 (dd, <i>J</i> = 9.9, 7.1 Hz, 1H), 4.06–3.89 (m, 1H), 3.89–3.70 (m, 1H), 3.70–3.53 (m, 1H), 3.48–3.29 (m, 2H), 2.93–2.82 (m, 1H), 2.82–2.67 (m, 1H), 2.63 (s, 3H), 2.60–2.46 (m, 1H), 2.46–2.00 (m, 2H). [M + H] 414.1.</div></div><div id="sec5_25" class="NLM_sec NLM_sec_level_2"><div id="ac_i49" class="anchor-spacer"></div><h3 class="article-section__title" id="_i49"> (<i>R</i>)-(5-Chloro-7-(2-(hydroxymethyl)thieno[3,2-<i>b</i>]pyridin-7-yl)-2,3-dihydrobenzofuran-2-yl)(piperazin-1-yl)methanone (<b>12</b>)</h3><div class="NLM_p last">The title compound was synthesized following general procedure A with <i>tert</i>-butyl 4-[5-chloro-7-tributylstannyl-2,3-dihydrobenzofuran-2-carbonyl]piperazine-1-carboxylate (<b>56</b>) and (7-chlorothieno[3,2-<i>b</i>]pyridin-2-yl)methanol and purified by reverse-phase HPLC using water (0.1% TFA) and acetonitrile (0.1% TFA) as the eluent followed by general procedures D and E successively to yield the desired compound as the free base. <sup>1</sup>H NMR (400 MHz, methanol-<i>d</i><sub>4</sub>): δ ppm 8.75 (d, <i>J</i> = 4.4 Hz, 1H), 7.63 (d, <i>J</i> = 4.8 Hz, 1H), 7.61 (d, <i>J</i> = 2.0 Hz, 1H), 7.57 (s, 1H), 7.54 (d, <i>J</i> = 2.0 Hz, 1H), 5.88 (dd, <i>J</i> = 9.6, 6.8 Hz, 1H), 5.06 (s, 2H), 3.92–3.40 (m, 6H), 2.92–2.70 (m, 4H). [M + H] 430.0.</div></div><div id="sec5_26" class="NLM_sec NLM_sec_level_2"><div id="ac_i50" class="anchor-spacer"></div><h3 class="article-section__title" id="_i50"> (<i>R</i>)-(5-Chloro-7-(2-(3-hydroxyoxetan-3-yl)thieno[3,2-<i>b</i>]pyridin-7-yl)-2,3-dihydrobenzofuran-2-yl)(piperazin-1-yl)methanone (<b>13</b>)</h3><div class="NLM_p last">Step 1: to a solution of 7-chlorothieno[3,2-<i>b</i>]pyridine (1.0 g, 5.9 mmol) in THF (20 mL) at −78 °C was added a solution of <i>n</i>-BuLi (2.5 M in hexanes, 1.3 equiv, 3.1 mL). The solution was stirred for 20 min before the addition of 3-oxetanone (850 mg, 11.8 mmol, 2.0 equiv). The solution was allowed to stir for 1 h prior to quenching with sat. aq NH<sub>4</sub>Cl (50 mL). The mixture was extracted with ethyl acetate (2 × 50 mL), and the combined organic layers were dried, filtered, and concentrated to afford a crude compound, which was recrystallized from 80% ethyl acetate in hexanes to afford 3-(7-chlorothieno[3,2-<i>b</i>]pyridin-2-yl)oxetan-3-ol as white crystals (1.12 g, 79% yield). [M + H] 242.0. Step 2: the title compound was synthesized following general procedure A with 3-(7-chlorothieno[3,2-<i>b</i>]pyridin-2-yl)oxetan-3-ol and stannane <b>56</b> followed by general procedure D to give the desired compound as the TFA salt (31 mg, 43% yield). [M + H] 472.0.</div></div><div id="sec5_27" class="NLM_sec NLM_sec_level_2"><div id="ac_i51" class="anchor-spacer"></div><h3 class="article-section__title" id="_i51"> ((2<i>R</i>)-5-Chloro-7-(2-(1-chloro-2,3-dihydroxypropan-2-yl)thieno[3,2-<i>b</i>]pyridin-7-yl)-2,3-dihydrobenzofuran-2-yl)(piperazin-1-yl)methanone (<b>14</b>)</h3><div class="NLM_p last">The title compound was synthesized following general procedures A with stannane <b>56</b> and 3-(7-chlorothieno[3,2-<i>b</i>]pyridin-2-yl)oxetan-3-ol followed by general procedure C to give the desired compound as the HCl salt (27 mg, 30% yield). [M + H] 507.9.</div></div><div id="sec5_28" class="NLM_sec NLM_sec_level_2"><div id="ac_i52" class="anchor-spacer"></div><h3 class="article-section__title" id="_i52"> (<i>R</i>)-3-((7-(5-Chloro-2-(piperazine-1-carbonyl)-2,3-dihydrobenzofuran-7-yl)thieno[3,2-<i>b</i>]pyridin-2-yl)methyl)pyrimidin-4(3<i>H</i>)-one (<b>15</b>)</h3><div class="NLM_p last">Step 1: 7-chloro-2-(chloromethyl)thieno[3,2-<i>b</i>]pyridine (300 mg, 1.38 mmol) was dissolved in DMF (9.2 mL), and then, 1<i>H</i>-pyrimidin-6-one (264 mg, 2.75 mmol) and potassium carbonate (570.29 mg, 4.13 mmol) were added. The reaction was stirred for 15 h. Water was added and the mixture was extracted with ethyl acetate. Then, the organics were washed with water (×2) and brine, dried, concentrated, and purified by column chromatography (1–5% MeOH in DCM) to yield 3-((7-chlorothieno[3,2-<i>b</i>]pyridin-2-yl)methyl)pyrimidin-4(3<i>H</i>)-one (267 mg, 70%). Step 2: the title compound was synthesized following general procedure A with 3-((7-chlorothieno[3,2-<i>b</i>]pyridin-2-yl)methyl)pyrimidin-4(3<i>H</i>)-one and stannane <b>56</b> followed by general procedure C to give the desired compound as the HCl salt. <sup>1</sup>H NMR (400 MHz, methanol-<i>d</i><sub>4</sub>): δ 9.14 (s, 1H), 8.97 (d, <i>J</i> = 6.0 Hz, 1H), 8.18 (d, <i>J</i> = 6.1 Hz, 1H), 8.06 (d, <i>J</i> = 7.0 Hz, 1H), 7.95 (s, 1H), 7.65 (d, <i>J</i> = 2.1 Hz, 1H), 7.56 (dd, <i>J</i> = 2.2, 1.1 Hz, 1H), 6.67 (d, <i>J</i> = 6.9 Hz, 1H), 5.91 (dd, <i>J</i> = 9.7, 7.0 Hz, 1H), 5.70 (d, <i>J</i> = 0.7 Hz, 2H), 3.95–3.10 (m, 10H). [M + H] 508.0.</div></div><div id="sec5_29" class="NLM_sec NLM_sec_level_2"><div id="ac_i53" class="anchor-spacer"></div><h3 class="article-section__title" id="_i53"> (<i>R</i>)-<i>N</i>-((7-(5-Chloro-2-(piperazine-1-carbonyl)-2,3-dihydrobenzofuran-7-yl)thieno[3,2-<i>b</i>]pyridin-2-yl)methyl)acetamide (<b>16</b>)</h3><div class="NLM_p last">Step 1: to a mixture of (7-chlorothieno[3,2-<i>b</i>]pyridin-2-yl)methanol (0.5 g, 2.5 mmol), triphenylphosphine (0.78 g, 1.2 equiv), and phthalimide (0.44 g, 1.2 equiv) in THF was added diisopropyl azodicarboxylate (0.66 mL, 1.3 equiv). The reaction was stirred for 2 h before being concentrated, charged with DCM (10 mL), and filtered to afford 2-((7-chlorothieno[3,2-<i>b</i>]pyridin-2-yl)methyl)isoindoline-1,3-dione as an off-white solid (0.47 g, 57% yield) which was used directly in the following step. Step 2: the above solid (0.47 g, 1.43 mmol) was dissolved in ethanol (10 mL), and hydrazine (0.4 mL, 5 equiv) was added. The reaction mixture was heated to 70 °C for 1 h. The reaction mixture was concentrated in vacuo, diluted with water (10 mL) and ethyl acetate (25 mL), and the aqueous layer was back-extracted with ethyl acetate (25 mL). The combined organic layers were washed with brine, dried over sodium sulfate, filtered, and concentrated to afford (7-chlorothieno[3,2-<i>b</i>]pyridin-2-yl)methanamine (0.28 g, 99% yield) which was used directly in the following step. Step 3: the above material (0.28 g, 1.41 mmol) was dissolved in THF (5 mL), and then, triethylamine (0.3 mL, 1.5 equiv), acetic anhydride (0.036 mL, 2.2 equiv), and pyridine (110 mg, 1.0 equiv) were added. The solution was allowed to stir overnight. The solution was concentrated in vacuo, diluted with water (10 mL), and extracted with ethyl acetate (2 × 10 mL). The combined organic layers were washed with brine, dried, filtered, and concentrated to afford a residue which was purified by flash column chromatography (silica gel, 100% ethyl acetate) to afford <i>N</i>-((7-chlorothieno[3,2-<i>b</i>]pyridin-2-yl)methyl)acetamide (0.19 g, 56% yield). Step 4: the title compound was synthesized following general procedure A with <i>N</i>-((7-chlorothieno[3,2-<i>b</i>]pyridin-2-yl)methyl)acetamide and stannane <b>56</b> followed by general procedure C to give the desired compound as the HCl salt. <sup>1</sup>H NMR (400 MHz, methanol-<i>d</i><sub>4</sub>): δ ppm 8.93 (br s, 1H), 8.12 (s, 1H), 7.72 (s, 1H), 7.63 (s, 1H), 7.54 (s, 1H), 5.90 (br s, 1H), 4.80 (s, 2H), 3.95–3.12 (m, 10H), 2.04 (s, 3H). [M + H] 471.0.</div></div><div id="sec5_30" class="NLM_sec NLM_sec_level_2"><div id="ac_i54" class="anchor-spacer"></div><h3 class="article-section__title" id="_i54"> (<i>R</i>)-1-((7-(5-Chloro-2-(piperazine-1-carbonyl)-2,3-dihydrobenzofuran-7-yl)thieno[3,2-<i>b</i>]pyridin-2-yl)methyl)pyrrolidin-2-one (<b>17</b>)</h3><div class="NLM_p last">Step 1: to 2-pyrrolidone (117 mg, 1.38 mmol, 2.0 equiv) in DMF (2.3 mL) was added sodium hydride (41 mg, 1.03 mmol, 60% dispersion in mineral oil). After 20 min, 7-chloro-2-(chloromethyl)thieno[3,2-<i>b</i>]pyridine was added in one portion. After 30 min, the reaction mixture was quenched with sat. aq ammonium chloride (10 mL) and extracted with ethyl acetate (2 × 10 mL). The organic layers were concentrated, and the residue was purified by flash column chromatography (100% EA, then 0–10% MeOH in DCM) to afford 1-[(7-chlorothieno[3,2-<i>b</i>]pyridine-2-yl)methyl]pyrrolidine-2-one as a thick oil (35 mg, 19% yield). Step 2: the title compound was synthesized following general procedure A with 1-[(7-chlorothieno[3,2-<i>b</i>]pyridine-2-yl)methyl]pyrrolidine-2-one and stannane <b>56</b> followed by general procedures D and E to give the desired compound as the free base. <sup>1</sup>H NMR (400 MHz, methanol-<i>d</i><sub>4</sub>): δ ppm 8.63 (br s, 1H), 7.54 (s, 1H), 7.45 (s, 1H), 7.44 (s, 1H), 7.39 (s, 1H), 5.74 (dd, <i>J</i> = 9.6, 6.8 Hz, 1H), 4.59 (s, 2H), 3.74–3.39 (m, 10H), 2.43 (t, <i>J</i> = 8.0 Hz, 2H), 2.09 (quin, <i>J</i> = 7.2 Hz, 2H). [M + H] 497.0.</div></div><div id="sec5_31" class="NLM_sec NLM_sec_level_2"><div id="ac_i55" class="anchor-spacer"></div><h3 class="article-section__title" id="_i55"> (<i>R</i>)-1-((7-(5-Chloro-2-(piperazine-1-carbonyl)-2,3-dihydrobenzofuran-7-yl)thieno[3,2-<i>b</i>]pyridin-2-yl)methyl)pyrrolidine-2,5-dione (<b>18</b>)</h3><div class="NLM_p last">The title compound was synthesized following general procedure A using stannane <b>56</b> (100 mg, 0.156 mmol) and 1-((7-chlorothieno[3,2-<i>b</i>]pyridin-2-yl)methyl)pyrrolidine-2,5-dione (<b>45</b>) followed by general procedures D and E to afford the desired compound as the free base (15 mg, 0.026 mmol, 17% yield). <sup>1</sup>H NMR (400 MHz, methanol-<i>d</i><sub>4</sub>): δ ppm 8.93 (br s, 1H), 8.08 (br s, 1H), 7.78 (s, 1H), 7.64 (s, 1H), 7.57 (s, 1H), 5.93 (m, 1H), 5.14 (s, 2H), 3.99–3.10 (m, 10H), 2.84 (s, 4H). [M + H] 511.0.</div></div><div id="sec5_32" class="NLM_sec NLM_sec_level_2"><div id="ac_i56" class="anchor-spacer"></div><h3 class="article-section__title" id="_i56"> (<i>R</i>)-1-((7-(2-(4-(Azetidin-1-ylmethyl)oxazol-5-yl)-5-chloro-2,3-dihydrobenzofuran-7-yl)thieno[3,2-<i>b</i>]pyridin-2-yl)methyl)pyrrolidine-2,5-dione (<b>19</b>)</h3><div class="NLM_p last">Step 1: to a solution of (2<i>R</i>)-7-bromo-5-chloro-2,3-dihydrobenzofuran-2-carboxylic acid (<b>53</b>, 1.0 g, 3.6 mmol) in DMF (5.5 mL) was added potassium carbonate (2.0 g, 14.4 mmol), diphenylphosphoryl azide (1.01 mL, 4.7 mmol), and ethyl isocyanoacetate (0.79 mL, 7.2 mmol). After stirring for 15 h, the reaction was diluted with water (50 mL) and brine (50 mL) and extracted with EtOAc (2 × 50 mL). The organics were dried, concentrated, and purified by column chromatography (20–100% EtOAc/hexane) to yield ethyl 5-[(2<i>R</i>)-7-bromo-5-chloro-2,3-dihydrobenzofuran-2-yl]oxazole-4-carboxylate (389 mg, 29%). Step 2: to a solution of ethyl 5-[(2<i>R</i>)-7-bromo-5-chloro-2,3-dihydrobenzofuran-2-yl]oxazole-4-carboxylate (190 mg, 0.53 mmol) in THF (4.5 m) was added water (0.5 mL) and sodium borohydride (100 mg, 2.65 mmol). After stirring vigorously for 3 days, the reaction was diluted with water and extracted with EtOAc (2 × 5 mL). The organics were dried, concentrated, and purified by column chromatography (0–100% EtOAc/hexane) to yield [5-[(2<i>R</i>)-7-bromo-5-chloro-2,3-dihydrobenzofuran-2-yl]oxazol-4-yl]methanol (77 mg, 44%). Step 3: [5-[(2<i>R</i>)-7-bromo-5-chloro-2,3-dihydrobenzofuran-2-yl]oxazol-4-yl]methanol (60 mg, 0.18 mmol) and 1-((7-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)thieno[3,2-<i>b</i>]pyridin-2-yl)methyl)pyrrolidine-2,5-dione (<b>46</b>, 81 mg, 0.22 mmol) were utilized with general procedure B to afford 1-[[7-[(2<i>R</i>)-5-chloro-2-[4-(hydroxymethyl)oxazol-5-yl]-2,3-dihydrobenzofuran-7-yl]thieno[3,2-<i>b</i>]pyridin-2-yl]methyl]pyrrolidine-2,5-dione (7.5 mg, 8%). Step 4: to a solution of 1-[[7-[(2<i>R</i>)-5-chloro-2-[4-(hydroxymethyl)oxazol-5-yl]-2,3-dihydrobenzofuran-7-yl]thieno[3,2-<i>b</i>]pyridin-2-yl]methyl]pyrrolidine-2,5-dione (7.5 mg, 0.015 mmol) in DCM (0.3 mL) was added sodium bicarbonate (2.5 mg, 0.03 mmol) and Dess–Martin periodinane (7.4 mg, 0.017 mmol). This solution was stirred for 1 h, then filtered through Celite and concentrated, and then purified by column chromatography (0–100% EtOAc/hexane) to yield (<i>R</i>)-5-(5-chloro-7-(2-((2,5-dioxopyrrolidin-1-yl)methyl)thieno[3,2-<i>b</i>]pyridin-7-yl)-2,3-dihydrobenzofuran-2-yl)oxazole-4-carbaldehyde (3 mg, 40%). Step 5: to a solution of (<i>R</i>)-5-(5-chloro-7-(2-((2,5-dioxopyrrolidin-1-yl)methyl)thieno[3,2-<i>b</i>]pyridin-7-yl)-2,3-dihydrobenzofuran-2-yl)oxazole-4-carbaldehyde (3 mg, 0.006 mmol) in DCE (0.3 mL) was added azetidine HCl (2.9 mg, 0.03 mmol) and sodium triacetoxyborohydride (2.6 mg, 0.01 mmol). After stirring for 2 h, the reaction was quenched with 1 M NaOH (1 mL) and extracted with DCM (3 × 1 mL). The organics were dried and concentrated and purified by column chromatography (1–10% MeOH/DCM) to give the desired product as the free base. <sup>1</sup>H NMR (400 MHz, chloroform-<i>d</i>): δ 8.78 (d, <i>J</i> = 4.9 Hz, 1H), 8.32 (s, 1H), 7.65 (s, 1H), 7.62 (d, <i>J</i> = 2.4 Hz, 1H), 7.60 (d, <i>J</i> = 2.2 Hz, 1H), 7.58 (d, <i>J</i> = 4.9 Hz, 1H), 6.33 (dd, <i>J</i> = 9.8, 7.4 Hz, 1H), 5.10 (s, 2H), 3.91 (dd, <i>J</i> = 16.3, 9.9 Hz, 1H), 3.76 (dd, <i>J</i> = 16.3, 7.4 Hz, 1H), 3.68 (d, <i>J</i> = 8.1 Hz, 2H), 3.40–3.30 (m, 4H), 2.93 (s, 4H), 2.15 (p, <i>J</i> = 7.1 Hz, 2H). [M + H] 535.0.</div></div><div id="sec5_33" class="NLM_sec NLM_sec_level_2"><div id="ac_i57" class="anchor-spacer"></div><h3 class="article-section__title" id="_i57"> (<i>R</i>)-1-((7-(5-Chloro-2-(4,5,6,7-tetrahydroisoxazolo[4,3-<i>c</i>]pyridin-3-yl)-2,3-dihydrobenzofuran-7-yl)thieno[3,2-<i>b</i>]pyridin-2-yl)methyl)pyrrolidine-2,5-dione (<b>20</b>)</h3><div class="NLM_p last">Step 1: to a stirred solution of (2<i>R</i>)-7-bromo-5-chloro-2,3-dihydrobenzofuran-2-carboxylic acid (<b>53</b>, 9.37 g, 33.8 mmol) in DCM (68 mL) at 0 °C was added DMF (2 drops), followed by oxalyl chloride (5.8 mL, 2.0 equiv) dropwise over 3 min. The solution was allowed to warm to room temperature over 20 min and concentrated in vacuo to give the acid chloride (10 g). In a separate flask, a solution of <i>tert</i>-butyl 4-oxopiperidine-1-carboxylate (10.8 g, 54.2 mmol, 1.6 equiv) in anhydrous THF (125 mL) at −78 °C was added a solution of LiHMDS (54.2 mL, 1 M in THF, 54.2 mmol, 1.6 equiv). The solution was stirred at −78 °C for 50 min before the addition of a solution of the above acid chloride (10.0 g, 33.9 mmol) in THF (5 mL). The resulting mixture was stirred at −78 °C for 1 h and then warmed to 0 °C. The reaction was quenched with half sat. aq NH<sub>4</sub>Cl at 0 °C, and the aqueous layer was extracted with ethyl acetate (2 × 200 mL). The combined organic layers were concentrated and the crude product was purified by column chromatography (5–25% EtOAc/hexanes) to afford <i>tert</i>-butyl 3-((<i>R</i>)-7-bromo-5-chloro-2,3-dihydrobenzofuran-2-carbonyl)-4-oxopiperidine-1-carboxylate (6.8 g, 44%). Step 2: to a solution of <i>tert</i>-butyl 3-((<i>R</i>)-7-bromo-5-chloro-2,3-dihydrobenzofuran-2-carbonyl)-4-oxopiperidine-1-carboxylate (3.3 g, 7.2 mmol) in EtOH (30 mL) was added NH<sub>2</sub>OH·HCl (746 mg, 10.8 mmol, 1.5 equiv), followed by NaOAc·3H<sub>2</sub>O (2.94 g, 21.6 mmol, 3.0 equiv). The mixture was heated to 82 °C for 2 h, then cooled to room temperature, and concentrated in vacuo. The residue was diluted with water (100 mL) and extracted with ethyl acetate (2 × 100 mL). The combined organic layers were washed with sat. aq NaHCO<sub>3</sub>, dried over sodium sulfate, filtered, and concentrated to give the oxime (3.4 g). To this oxime (3.4 g, 7.2 mmol) in DCM (40 mL) was added MsCl (1.81 g, 15.9 mmol) and triethylamine (4.38 mL, 31.0 mmol). The mixture was stirred at room temperature for 2 h and concentrated in vacuo. The residue was extracted with ethyl acetate (200 mL) and the organic layer was washed with 1 M aq HCl (100 mL), water (100 mL), and brine (100 mL). The organic layer was concentrated and the residue was purified by column chromatography (5–30% EtOAc/hexanes) to afford <i>tert</i>-butyl (<i>R</i>)-3-(7-bromo-5-chloro-2,3-dihydrobenzofuran-2-yl)-6,7-dihydroisoxazolo[4,3-<i>c</i>]pyridine-5(4<i>H</i>)-carboxylate (1.8 g, 55%). Step 3: to <i>tert</i>-butyl (<i>R</i>)-3-(7-bromo-5-chloro-2,3-dihydrobenzofuran-2-yl)-6,7-dihydroisoxazolo[4,3-<i>c</i>]pyridine-5(4<i>H</i>)-carboxylate (6.0 g, 13.2 mmol), bis(pinacolato)diboron (4.18 g, 16.5 mmol, 1.25 equiv), potassium acetate (1.62 g, 16.5 mmol, 1.25 equiv), and 1,1′-bis(diphenylphosphino)ferrocene-palladium(II) dichloride (530 mg, 0.72 mmol, 0.06 equiv) was added 1,4-dioxane (60 mL) in a 150 mL sealed tube. The vessel was heated to 100 °C for 6 h, then cooled to room temperature, diluted with ethyl acetate (100 mL), and filtered through a pad of Celite, washing with ethyl acetate. The filtrate was concentrated in vacuo and the residue was purified by flash column chromatography (0–100% EtOAc/hexanes) to afford <i>tert</i>-butyl (<i>R</i>)-3-(5-chloro-7-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-2,3-dihydrobenzofuran-2-yl)-6,7-dihydroisoxazolo[4,3-<i>c</i>]pyridine-5(4<i>H</i>)-carboxylate as a brown foam (5.35 g, 81% yield). Step 4: to a mixture of 1-((7-chlorothieno[3,2-<i>b</i>]pyridin-2-yl)methyl)pyrrolidine-2,5-dione (<b>45</b>, 109 mg, 0.39 mmol), <i>tert</i>-butyl (<i>R</i>)-3-(5-chloro-7-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-2,3-dihydrobenzofuran-2-yl)-6,7-dihydroisoxazolo[4,3-<i>c</i>]pyridine-5(4<i>H</i>)-carboxylate (390 mg, 0.78 mmol, 2.0 equiv), Xphos (18.5 mg, 0.04 mmol, 0.1 equiv), Pd(OAc)<sub>2</sub> (8.7 mg, 0.04 mmol, 0.1 equiv), and K<sub>3</sub>PO<sub>4</sub> (247 mg, 1.16 mmol, 3.0 equiv) was added THF (1.1 mL) and water (0.2 mL). The mixture was sparged with Ar for 5 min and heated to 60 °C under stirring for 5 h in a sealed vial. The mixture was cooled to room temperature and diluted with water (10 mL) and ethyl acetate (10 mL). The organic layer was concentrated and purified by flash column chromatography (50–100% ethyl acetate/hexanes) to afford <i>tert</i>-butyl (<i>R</i>)-3-(5-chloro-7-(2-((2,5-dioxopyrrolidin-1-yl)methyl)thieno[3,2-<i>b</i>]pyridin-7-yl)-2,3-dihydrobenzofuran-2-yl)-6,7-dihydroisoxazolo[4,3-<i>c</i>]pyridine-5(4<i>H</i>)-carboxylate (49 mg, 20% yield). Step 5: the title compound was synthesized following general procedure C with <i>tert</i>-butyl (<i>R</i>)-3-(5-chloro-7-(2-((2,5-dioxopyrrolidin-1-yl)methyl)thieno[3,2-<i>b</i>]pyridin-7-yl)-2,3-dihydrobenzofuran-2-yl)-6,7-dihydroisoxazolo[4,3-<i>c</i>]pyridine-5(4<i>H</i>)-carboxylate (49 mg, 0.08 mmol) to give the desired compound as the HCl salt (44 mg, 99% yield). <sup>1</sup>H NMR (400 MHz, methanol-<i>d</i><sub>4</sub>): δ 8.89 (s, 1H), 7.93 (s, 1H), 7.73 (s, 1H), 7.61 (s, 2H), 6.22 (s, 1H), 5.04 (s, 2H), 4.28–4.12 (m, 1H), 3.89–3.43 (m, 5H), 3.18–3.08 (m, 2H), 2.77 (s, 4H). [M + H] 521.0.</div></div><div id="sec5_34" class="NLM_sec NLM_sec_level_2"><div id="ac_i58" class="anchor-spacer"></div><h3 class="article-section__title" id="_i58"> (<i>R</i>)-1-((7-(5-Chloro-2-(2-methyl-4,5,6,7-tetrahydro-2<i>H</i>-pyrazolo[4,3-<i>c</i>]pyridin-3-yl)-2,3-dihydrobenzofuran-7-yl)thieno[3,2-<i>b</i>]pyridin-2-yl)methyl)pyrrolidine-2,5-dione (<b>21</b>)</h3><div class="NLM_p last">Step 1: to a solution of <i>tert</i>-butyl 3-((<i>R</i>)-7-bromo-5-chloro-2,3-dihydrobenzofuran-2-carbonyl)-4-oxopiperidine-1-carboxylate (5 g, 10.9 mmol) in ethanol (50 mL) was added anhydrous hydrazine (1.4 g, 43.7 mmol, 4 equiv). The mixture was heated to 62 °C for 1.5 h with stirring. The mixture was cooled, concentrated, and partitioned between EtOAc and H<sub>2</sub>O. The organic layer is washed with sat. aq NaHCO<sub>3</sub>, concentrated, and dried over sodium sulfate to afford <i>tert</i>-butyl (<i>R</i>)-3-(7-bromo-5-chloro-2,3-dihydrobenzofuran-2-yl)-2,4,6,7-tetrahydro-5<i>H</i>-pyrazolo[4,3-<i>c</i>]pyridine-5-carboxylate as a white solid (4.9 g, 98%). [M + H] = 454. Step 2: to a stirred suspension of (<i>R</i>)-3-(7-bromo-5-chloro-2,3-dihydrobenzofuran-2-yl)-2,4,6,7-tetrahydro-5<i>H</i>-pyrazolo[4,3-<i>c</i>]pyridine-5-carboxylate (1.6 g, 3.5 mmol) and K<sub>2</sub>CO<sub>3</sub> (1.46 g, 10.6 mmol, 3.0 equiv) in DMF (10 mL) was added methyl iodide (548 μL, 8.8 mmol, 2.5 equiv). The resulting suspension was stirred overnight. The mixture was quenched with water and extracted w/EtOAc (3 × 50 mL). The combined organic layers were washed with water (100 mL) and concentrated in vacuo. The crude mixture was purified by flash column chromatography (0–40% EtOAc in hexanes) to afford <i>tert</i>-butyl (<i>R</i>)-3-(7-bromo-5-chloro-2,3-dihydrobenzofuran-2-yl)-2-methyl-2,4,6,7-tetrahydro-5<i>H</i>-pyrazolo[4,3-<i>c</i>]pyridine-5-carboxylate (958 mg, 58% yield). [M + H] 468. Step 3: the title compound was synthesized following general procedure B with <i>tert</i>-butyl (<i>R</i>)-3-(7-bromo-5-chloro-2,3-dihydrobenzofuran-2-yl)-2-methyl-2,4,6,7-tetrahydro-5<i>H</i>-pyrazolo[4,3-<i>c</i>]pyridine-5-carboxylate and pyridine boronic ester <b>46</b> followed by general procedure C to give the desired product as the HCl salt. <sup>1</sup>H NMR (400 MHz, methanol-<i>d</i><sub>4</sub>): δ 8.60 (d, <i>J</i> = 4.9 Hz, 1H), 7.46 (t, <i>J</i> = 0.8 Hz, 1H), 7.43–7.39 (m, 3H), 5.90 (dd, <i>J</i> = 9.4, 8.0 Hz, 1H), 4.93 (d, <i>J</i> = 0.9 Hz, 2H), 3.91 (q, <i>J</i> = 15.8, 14.7, 14.7 Hz, 2H), 3.73 (s, 3H), 3.70–3.55 (m, 2H), 3.43–3.34 (m, 2H), 2.90 (t, <i>J</i> = 6.1 Hz, 2H), 2.74 (s, 4H). [M + H] 534.0.</div></div><div id="sec5_35" class="NLM_sec NLM_sec_level_2"><div id="ac_i59" class="anchor-spacer"></div><h3 class="article-section__title" id="_i59"> General Procedure F (Mitsunobu Reaction)</h3><div class="NLM_p last">Diisopropyl azodicarboxylate (0.3 mL, 1.5 mmol) was added to a stirring mixture of 2-bromo-4-chloro-6-methylphenol (<b>60</b>, 0.22 g, 1.0 mmol), triphenylphosphine (0.39 g, 1.5 mmol), and an appropriate substituted alcohol (<b>61</b>, 1.2 mmol) in THF (3 mL) and stirred overnight. The reaction mixture was concentrated and purified by column chromatography (0–30% EtOAc in hexane) to give the desired product (<b>62</b>).</div></div><div id="sec5_36" class="NLM_sec NLM_sec_level_2"><div id="ac_i60" class="anchor-spacer"></div><h3 class="article-section__title" id="_i60"> 1-((7-(5-Chloro-2-(((3<i>R</i>,4<i>S</i>)-4-fluoropyrrolidin-3-yl)oxy)phenyl)thieno[3,2-<i>b</i>]pyridin-2-yl)methyl)pyrrolidine-2,5-dione (<b>22</b>)</h3><div class="NLM_p last">The title compound was synthesized following general procedure F using 2-bromo-4-chlorophenol and <i>tert</i>-butyl (3<i>S</i>,4<i>S</i>)-3-fluoro-4-hydroxypyrrolidine-1-carboxylate, followed by general procedure B with 1-((7-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)thieno[3,2-<i>b</i>]pyridin-2-yl)methyl)pyrrolidine-2,5-dione (<b>46</b>) and then general procedure D to give the desired product. <sup>1</sup>H NMR (400 MHz, methanol-<i>d</i><sub>4</sub>): δ 8.66 (m, 1H), 7.53 (m, 3H), 7.45 (m, 1H), 7.32 (m, 1H), 5.46 (m, 1H), 5.19 (m, 1H), 4.96 (s, 2H), 3.69 (m, 1H), 3.59 (m, 2H), 3.16 (m, 2H), 2.71 (s, 4H). [M + H] 462.0.</div></div><div id="sec5_37" class="NLM_sec NLM_sec_level_2"><div id="ac_i61" class="anchor-spacer"></div><h3 class="article-section__title" id="_i61"> 1-((4-(5-Chloro-2-(((3<i>R</i>,4<i>S</i>)-4-fluoropyrrolidin-3-yl)oxy)-3-methylphenyl)thieno[3,2-<i>d</i>]pyrimidin-6-yl)methyl)pyrrolidine-2,5-dione (<b>23</b>)</h3><div class="NLM_p last">The title compound was synthesized following general procedure F using 2-bromo-4-chloro-6-methylphenol (<b>60</b>) and <i>tert</i>-butyl (3<i>S</i>,4<i>S</i>)-3-fluoro-4-hydroxypyrrolidine-1-carboxylate, followed by general procedure B with 1-((7-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)thieno[3,2-<i>b</i>]pyridin-2-yl)methyl)pyrrolidine-2,5-dione (<b>46</b>) and then general procedure D to give the desired product. <sup>1</sup>H NMR (400 MHz, methanol-<i>d</i><sub>4</sub>): δ 8.68 (d, <i>J</i> = 4.9 Hz, 1H), 7.88–7.64 (m, 2H), 7.51–7.26 (m, 2H), 5.02–4.93 (m, 1H), 4.73–4.38 (m, 1H), 4.06–3.79 (m, 1H), 3.30 (s, 4H), 2.99–2.74 (m, 2H), 2.64–2.52 (m, 1H), 2.47 (s, 3H), 2.44–2.26 (m, 1H), 2.01–1.81 (m, 2H). [M + H] 474.1.</div></div><div id="sec5_38" class="NLM_sec NLM_sec_level_2"><div id="ac_i62" class="anchor-spacer"></div><h3 class="article-section__title" id="_i62"> (<i>S</i>)-1-((7-(5-Chloro-3-methyl-2-(piperidin-3-yloxy)phenyl)thieno[3,2-<i>b</i>]pyridin-2-yl)methyl)pyrrolidine-2,5-dione (<b>24</b>)</h3><div class="NLM_p last">The title compound was synthesized following general procedure F using 2-bromo-4-chloro-6-methylphenol (<b>60</b>) and <i>tert</i>-butyl (<i>R</i>)-3-hydroxypiperidine-1-carboxylate, followed by general procedure B with 1-((7-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)thieno[3,2-<i>b</i>]pyridin-2-yl)methyl)pyrrolidine-2,5-dione (<b>46</b>) and then general procedure D to give the desired product. <sup>1</sup>H NMR (400 MHz, methanol-<i>d</i><sub>4</sub>): δ 8.80 (d, <i>J</i> = 5.3 Hz, 1H), 7.68–7.58 (m, 2H), 7.50 (dd, <i>J</i> = 2.7, 0.8 Hz, 1H), 7.41 (dd, <i>J</i> = 2.6, 0.6 Hz, 1H), 5.01 (d, <i>J</i> = 0.9 Hz, 2H), 3.81–3.70 (m, 1H), 3.06–2.94 (m, 2H), 2.94–2.85 (m, 1H), 2.83–2.71 (m, 5H), 2.43 (d, <i>J</i> = 0.7 Hz, 3H), 1.61 (tt, <i>J</i> = 17.2, 9.2 Hz, 2H), 1.44–1.24 (m, 2H). [M + H] 470.0.</div></div><div id="sec5_39" class="NLM_sec NLM_sec_level_2"><div id="ac_i63" class="anchor-spacer"></div><h3 class="article-section__title" id="_i63"> 1-((7-(5-Chloro-3-methyl-2-(piperidin-4-yloxy)phenyl)thieno[3,2-<i>b</i>]pyridin-2-yl)methyl)pyrrolidine-2,5-dione (<b>25</b>)</h3><div class="NLM_p last">The title compound was synthesized following general procedure F using 2-bromo-4-chloro-6-methyl-phenol (<b>60</b>) and <i>tert</i>-butyl 4-hydroxypiperidine-1-carboxylate, followed by general procedure B with 1-((7-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)thieno[3,2-<i>b</i>]pyridin-2-yl)methyl)pyrrolidine-2,5-dione (<b>46</b>) and then general procedure D to give the desired product. <sup>1</sup>H NMR (400 MHz, methanol-<i>d</i><sub>4</sub>): δ 8.77 (d, <i>J</i> = 5.2 Hz, 1H), 7.66–7.56 (m, 2H), 7.49 (dq, <i>J</i> = 2.8, 0.7 Hz, 1H), 7.38 (dd, <i>J</i> = 2.7, 0.7 Hz, 1H), 5.00 (d, <i>J</i> = 1.0 Hz, 2H), 3.93–3.83 (m, 1H), 2.93–2.78 (m, 3H), 2.76 (s, 4H), 2.42 (d, <i>J</i> = 0.7 Hz, 3H), 1.83–1.68 (m, 2H), 1.58–1.44 (m, 2H). [M + H] 470.0.</div></div><div id="sec5_40" class="NLM_sec NLM_sec_level_2"><div id="ac_i64" class="anchor-spacer"></div><h3 class="article-section__title" id="_i64"> 1-((7-(5-Chloro-2-((3-fluoroazetidin-3-yl)methoxy)-3-methylphenyl)thieno[3,2-<i>b</i>]pyridin-2-yl)methyl)pyrrolidine-2,5-dione (<b>26</b>)</h3><div class="NLM_p last">The title compound was synthesized following general procedure F using 2-bromo-4-chloro-6-methylphenol (<b>60</b>) and <i>tert</i>-butyl 3-fluoro-3-(hydroxymethyl)azetidine-1-carboxylate, followed by general procedure B with 1-((7-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)thieno[3,2-<i>b</i>]pyridin-2-yl)methyl)pyrrolidine-2,5-dione (<b>46</b>) and then general procedure D to give the desired product. <sup>1</sup>H NMR (400 MHz, MeOH-<i>d</i><sub>4</sub>): δ 8.66 (m, 1H), 7.51 (m, 1H), 7.42 (m, 2H), 7.34 (m, 1H), 4.96 (m, 2H), 3.70 (s, 2H), 3.47 (m, 2H), 3.21 (m, 2H), 2.75 (s, 4H), 2.39 (s, 3H). [M + H] 475.0.</div></div><div id="sec5_41" class="NLM_sec NLM_sec_level_2"><div id="ac_i65" class="anchor-spacer"></div><h3 class="article-section__title" id="_i65"> 1-((7-(2-((1<i>r</i>,3<i>r</i>)-3-Aminocyclobutoxy)-5-chloro-3-methylphenyl)thieno[3,2-<i>b</i>]pyridin-2-yl)methyl)pyrrolidine-2,5-dione (<b>27</b>)</h3><div class="NLM_p last">The title compound was synthesized following general procedure F using 2-bromo-4-chloro-6-methylphenol (<b>60</b>) and <i>cis</i>-<i>tert</i>-butyl (3-hydroxycyclobutyl)carbamate, followed by general procedure B with 1-((7-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)thieno[3,2-<i>b</i>]pyridin-2-yl)methyl)pyrrolidine-2,5-dione (<b>46</b>) and then general procedure D to give the desired product. <sup>1</sup>H NMR (400 MHz, methanol-<i>d</i><sub>4</sub>): δ 8.77 (d, <i>J</i> = 5.0 Hz, 1H), 7.60 (s, 1H), 7.57 (dd, <i>J</i> = 5.2, 1.0 Hz, 1H), 7.46 (dd, <i>J</i> = 2.6, 0.8 Hz, 1H), 7.37 (dd, <i>J</i> = 2.7, 0.8 Hz, 1H), 5.00 (s, 2H), 4.32–4.23 (m, 1H), 3.52 (dq, <i>J</i> = 8.6, 4.3 Hz, 1H), 2.77 (s, 4H), 2.37 (s, 3H), 2.23–2.14 (m, 2H), 2.06–1.96 (m, 2H). [M + H] 456.0.</div></div><div id="sec5_42" class="NLM_sec NLM_sec_level_2"><div id="ac_i66" class="anchor-spacer"></div><h3 class="article-section__title" id="_i66"> 1-((7-(5-Chloro-3-methyl-2-(((3<i>R</i>,4<i>S</i>)-3-methylpiperidin-4-yl)oxy)phenyl)thieno[3,2-<i>b</i>]pyridin-2-yl)methyl)pyrrolidine-2,5-dione (<b>28</b>)</h3><div class="NLM_p last">The title compound was synthesized following general procedure F using 2-bromo-4-chloro-6-methylphenol (<b>60</b>) and <i>tert</i>-butyl (3<i>R</i>,4<i>R</i>)-4-hydroxy-3-methylpiperidine-1-carboxylate, followed by general procedure B with 1-((7-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)thieno[3,2-<i>b</i>]pyridin-2-yl)methyl)pyrrolidine-2,5-dione (<b>46</b>) and then general procedure D to give the desired product. <sup>1</sup>H NMR (400 MHz, methanol-<i>d</i><sub>4</sub>): δ 8.79 (s, 1H), 7.62–7.51 (m, 2H), 7.44 (d, <i>J</i> = 2.6 Hz, 1H), 7.32 (d, <i>J</i> = 2.6 Hz, 1H), 4.97 (s, 2H), 4.12–3.98 (m, 1H), 2.88 (dd, <i>J</i> = 12.6, 4.0 Hz, 1H), 2.74 (s, 4H), 2.67–2.46 (m, 3H), 2.44 (s, 3H), 2.12–1.80 (m, 2H), 1.58–1.38 (m, 2H), 0.92 (d, <i>J</i> = 6.9 Hz, 3H). [M + H] 484.0.</div></div><div id="sec5_43" class="NLM_sec NLM_sec_level_2"><div id="ac_i67" class="anchor-spacer"></div><h3 class="article-section__title" id="_i67"> General Procedure G (Late-Stage Chlorination/Displacement)</h3><div class="NLM_p last">Step 1: to a solution of TBS-ether (such as <b>64</b> or <b>80</b>, 0.2 mmol) in THF (2 mL) was added tetra-<i>n</i>-butylammonium fluoride (0.3 mL, 0.3 mmol). This solution was allowed to stir at room temperature for 1 h. The solution was concentrated and purified by column chromatography (1–4% MeOH/DCM) to give the primary alcohol. Step 2: this primary alcohol (∼0.2 mmol) was dissolved in DCM (2 mL) after which DIEA (0.11 mL, 0.6 mmol) and methanesulfonyl chloride (0.02 mL, 0.3 mmol) were sequentially added. After stirring at room temperature for 12 h, the mixture was diluted with DCM (5 mL) and washed with 1 N HCl (1 × 5 mL), sat. aq NaHCO<sub>3</sub> (1 × 5 mL), and brine (1 × 5 mL). The organics were dried over Na<sub>2</sub>SO<sub>4</sub> and concentrated to give the benzylic chloride. To this crude material in acetonitrile (2 mL) was added cesium carbonate (195 mg, 0.6 mmol) and the desired cyclic imide (0.6 mmol) and heated to 60 °C for 3 h. After cooling, the reaction was quenched with water along with a small amount of TFA and purified directly by reverse-phase chromatography to give the desired product.</div></div><div id="sec5_44" class="NLM_sec NLM_sec_level_2"><div id="ac_i68" class="anchor-spacer"></div><h3 class="article-section__title" id="_i68"> 3-((7-(5-Chloro-3-methyl-2-(((3<i>S</i>,4<i>R</i>)-3-methylpiperidin-4-yl)oxy)phenyl)thieno[3,2-<i>b</i>]pyridin-2-yl)methyl)-3-azabicyclo[3.1.0]hexane-2,4-dione (<b>29</b>)</h3><div class="NLM_p last">The title compound was synthesized following general procedure F using 2-bromo-4-chloro-6-methylphenol (<b>60</b>) and <i>tert</i>-butyl (3<i>R</i>,4<i>R</i>)-4-hydroxy-3-methylpiperidine-1-carboxylate, then general procedure B with 2-(((<i>tert</i>-butyldimethylsilyl)oxy)methyl)-7-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)thieno[3,2-<i>b</i>]pyridine (<b>48</b>), followed by general procedure G with 3-azabicyclo[3.1.0]hexane-2,4-dione, and then general procedure D to give the desired product. <sup>1</sup>H NMR (400 MHz, methanol-<i>d</i><sub>4</sub>): δ 8.76 (d, <i>J</i> = 5.1 Hz, 1H), 7.58–7.51 (m, 2H), 7.46 (d, <i>J</i> = 2.7 Hz, 1H), 7.34 (d, <i>J</i> = 2.7 Hz, 1H), 4.83 (s, 2H), 4.09 (s, 1H), 2.89 (dd, <i>J</i> = 12.6, 3.9 Hz, 1H), 2.64 (dd, <i>J</i> = 11.1, 6.5 Hz, 1H), 2.60 (d, <i>J</i> = 3.6 Hz, 1H), 2.58 (d, <i>J</i> = 3.6 Hz, 1H), 2.46 (s, 3H), 2.03–1.87 (m, 2H), 1.66–1.57 (m, 1H), 1.59–1.49 (m, 2H), 1.47–1.38 (m, 1H), 0.95 (d, <i>J</i> = 6.9 Hz, 3H). [M + H] 496.0.</div></div><div id="sec5_45" class="NLM_sec NLM_sec_level_2"><div id="ac_i69" class="anchor-spacer"></div><h3 class="article-section__title" id="_i69"> 3-((7-(5-Chloro-3-methyl-2-(((3<i>S</i>,4<i>R</i>)-3-methylpiperidin-4-yl)oxy)phenyl)thieno[3,2-<i>b</i>]pyridin-2-yl)methyl)-6,6-dimethyl-3-azabicyclo[3.1.0]hexane-2,4-dione (<b>30</b>)</h3><div class="NLM_p last">The title compound was synthesized following general procedure F using 2-bromo-4-chloro-6-methylphenol (<b>60</b>) and <i>tert</i>-butyl (3<i>R</i>,4<i>R</i>)-4-hydroxy-3-methylpiperidine-1-carboxylate, then general procedure B with 2-(((<i>tert</i>-butyldimethylsilyl)oxy)methyl)-7-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)thieno[3,2-<i>b</i>]pyridine (<b>48</b>), followed by general procedure G with 6,6-dimethyl-3-azabicyclo[3.1.0]hexane-2,4-dione, and then general procedure D to give the desired product. <sup>1</sup>H NMR (400 MHz, methanol-<i>d</i><sub>4</sub>): δ 8.76 (d, <i>J</i> = 5.1 Hz, 1H), 7.57 (s, 1H), 7.53 (d, <i>J</i> = 5.0 Hz, 1H), 7.46 (d, <i>J</i> = 2.7 Hz, 1H), 7.34 (d, <i>J</i> = 2.7 Hz, 1H), 4.88 (s, 2H), 4.08 (s, 1H), 2.90 (dd, <i>J</i> = 12.7, 4.0 Hz, 1H), 2.68–2.52 (m, 1H), 2.50 (s, 2H), 2.53–2.41 (m, 1H), 2.46 (s, 3H), 2.08–1.85 (m, 2H), 1.62–1.43 (m, 2H), 1.24 (s, 3H), 1.11 (s, 3H), 0.94 (d, <i>J</i> = 7.0 Hz, 3H). [M + H] 524.0.</div></div><div id="sec5_46" class="NLM_sec NLM_sec_level_2"><div id="ac_i70" class="anchor-spacer"></div><h3 class="article-section__title" id="_i70"> 3-((7-(5-Chloro-3-methyl-2-(((3<i>S</i>,4<i>R</i>)-3-methylpiperidin-4-yl)oxy)phenyl)thieno[3,2-<i>b</i>]pyridin-2-yl)methyl)-1-(2,2,2-trifluoroethyl)pyrimidine-2,4(1<i>H</i>,3<i>H</i>)-dione (<b>31</b>)</h3><div class="NLM_p last">The title compound was synthesized following general procedure F using 2-bromo-4-chloro-6-methylphenol (<b>60</b>) and <i>tert</i>-butyl (3<i>R</i>,4<i>R</i>)-4-hydroxy-3-methylpiperidine-1-carboxylate, then general procedure B with 2-(((<i>tert</i>-butyldimethylsilyl)oxy)methyl)-7-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)thieno[3,2-<i>b</i>]pyridine (<b>48</b>), followed by general procedure G with 1-(2,2,2-trifluoroethyl)pyrimidine-2,4(1<i>H</i>,3<i>H</i>)-dione, and then general procedure D to give the desired product as the TFA salt. <sup>1</sup>H NMR (400 MHz, methanol-<i>d</i><sub>4</sub>): δ 8.77 (d, <i>J</i> = 5.1 Hz, 1H), 7.70–7.60 (m, 2H), 7.55 (d, <i>J</i> = 5.1 Hz, 1H), 7.46 (d, <i>J</i> = 2.6 Hz, 1H), 7.34 (d, <i>J</i> = 2.7 Hz, 1H), 5.88 (d, <i>J</i> = 8.0 Hz, 1H), 5.43 (s, 2H), 4.71–4.47 (m, 2H), 4.02 (s, 1H), 2.91–2.75 (m, 1H), 2.73–2.58 (m, 1H), 2.45 (s, 3H), 2.47–2.36 (m, 1H), 2.10–1.81 (m, 2H), 1.63–1.36 (m, 2H), 0.89 (d, <i>J</i> = 6.7 Hz, 3H). [M + H] 579.0.</div></div><div id="sec5_47" class="NLM_sec NLM_sec_level_2"><div id="ac_i71" class="anchor-spacer"></div><h3 class="article-section__title" id="_i71"> 3-((7-(5-Chloro-3-methyl-2-(piperidin-3-yloxy)phenyl)thieno[3,2-<i>b</i>]pyridin-2-yl)methyl)-6,6-dimethyl-3-azabicyclo[3.1.0]hexane-2,4-dione (<b>32</b>)</h3><div class="NLM_p last">The title compound was synthesized following general procedure F using 2-bromo-4-chloro-6-methylphenol (<b>60</b>) and <i>tert</i>-butyl 3-hydroxypiperidine-1-carboxylate, then general procedure B with 2-(((<i>tert</i>-butyldimethylsilyl)oxy)methyl)-7-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)thieno[3,2-<i>b</i>]pyridine (<b>48</b>), followed by general procedure G with 6,6-dimethyl-3-azabicyclo[3.1.0]hexane-2,4-dione, and then general procedure D to give the desired product. [M + H] 510.0.</div></div><div id="sec5_48" class="NLM_sec NLM_sec_level_2"><div id="ac_i72" class="anchor-spacer"></div><h3 class="article-section__title" id="_i72"> 3-((7-(5-Chloro-3-methyl-2-(piperidin-3-ylamino)phenyl)thieno[3,2-<i>b</i>]pyridin-2-yl)methyl)-6,6-dimethyl-3-azabicyclo[3.1.0]hexane-2,4-dione (<b>33</b>)</h3><div class="NLM_p last">Step 1: sodium triacetoxyborohydride (12.96 g, 61.1 mmol) was added to a solution of 2-bromo-4-chloro-6-methylaniline (3.37 g, 15.3 mmol) and 1-Boc-3-piperidone (9.14 g, 34.0 mmol) and acetic acid (7 mL, 122 mmol) in DCM (20 mL), and the reaction mixture was stirred at 60 °C overnight. The reaction was quenched with 1 N NaOH (20 mL) and extracted with EtOAc (3 × 60 mL). The combined organic layers were washed with brine (60 mL), concentrated, and purified by column chromatography (0–100% EtOAc in hexanes) to give <i>tert</i>-butyl 3-((2-bromo-4-chloro-6-methylphenyl)amino)piperidine-1-carboxylate as a light brown viscous oil (2.1 g). Step 2: the title compound was synthesized following general procedure B with <i>tert</i>-butyl 3-((2-bromo-4-chloro-6-methylphenyl)amino)piperidine-1-carboxylate and 2-(((<i>tert</i>-butyldimethylsilyl)oxy)methyl)-7-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)thieno[3,2-<i>b</i>]pyridine (<b>48</b>), followed by general procedure G with 6,6-dimethyl-3-azabicyclo[3.1.0]hexane-2,4-dione, then general procedure D to give the desired product as the TFA salt. <sup>1</sup>H NMR (400 MHz, methanol-<i>d</i><sub>4</sub>): δ 8.64 (d, <i>J</i> = 4.9 Hz, 1H), 7.47 (s, 1H), 7.41 (d, <i>J</i> = 4.9 Hz, 1H), 7.26 (d, <i>J</i> = 2.6 Hz, 1H), 7.08 (d, <i>J</i> = 2.6 Hz, 1H), 5.48 (s, 2H), 2.67–2.55 (m, 2H), 2.47 (s, 2H), 2.43–2.30 (m, 2H), 2.33 (s, 3H), 2.13 (dd, <i>J</i> = 12.0, 9.3 Hz, 1H), 1.48–1.40 (m, 2H), 1.21 (s, 3H), 1.06 (s, 3H), 1.04–0.97 (m, 2H). [M + H] 509.0.</div></div><div id="sec5_49" class="NLM_sec NLM_sec_level_2"><div id="ac_i73" class="anchor-spacer"></div><h3 class="article-section__title" id="_i73"> 3-((7-(5-Chloro-3-methyl-2-(piperidin-3-ylmethyl)phenyl)thieno[3,2-<i>b</i>]pyridin-2-yl)methyl)-6,6-dimethyl-3-azabicyclo[3.1.0]hexane-2,4-dione (<b>34</b>)</h3><div class="NLM_p last">Step 1: a solution of Boc-4-piperidone (3.0 g, 15 mmol) and 1-phenylethylamine (1.82 g, 15 mmol) in toluene (75 mL) was heated to reflux under a Dean Stark apparatus for 12 h. After cooling, the reaction mixture was concentrated to yield <i>tert</i>-butyl 4-((1-phenylethyl)imino)piperidine-1-carboxylate (4.5 g, 99%). Step 2: a solution of <i>tert</i>-butyl 4-(1-phenylethylimino)piperidine-1-carboxylate (2.0 g, 6.6 mmol) in THF (33 mL) was cooled to −78 °C, and then, lithium diisopropylamide (2 M, 3.0 mL, 6.0 mmol) was added dropwise. After stirring for 30 min at −78 °C, a solution of 1-bromo-2-(bromomethyl)-5-chloro-3-methylbenzene (2.0 g, 6.6 mmol) in THF (10 mL) was added dropwise. After stirring for 20 min at −78 °C, the reaction mixture was allowed to slowly warm to room temperature over the course of 1 h. The reaction was quenched with NH<sub>4</sub>Cl (20 mL), extracted with EtOAc, and concentrated. This crude material was dissolved in methanol (10 mL), after which 1 M HCl (10 mL) was added. This mixture was stirred at room temperature overnight. Partial Boc cleavage was also observed; thus, resubjection to standard Boc protection conditions can be employed. The product was purified by column chromatography (0–30% EtOAc in hexane) to yield <i>tert</i>-butyl 3-(2-bromo-4-chloro-6-methylbenzyl)-4-oxopiperidine-1-carboxylate (0.9 g, 62%). Step 3: a solution of <i>tert</i>-butyl 3-(2-bromo-4-chloro-6-methylbenzyl)-4-oxopiperidine-1-carboxylate (200 mg, 0.48 mmol) and 4-methylbenzenesulfonhydrazide (107 mg, 0.58 mmol) in ethanol (2.4 mL) was heated to reflux for 6 h. After cooling, the reaction mixture was concentrated. This crude material was dissolved in THF (2.4 mL) and cooled to 0 °C. Sodium borohydride (280 mg, 7.5 mmol) was added slowly, then the reaction was heated to reflux for 15 h. After cooling, water (5 mL) was added and extracted with EtOAc (3 × 5 mL). The combined organic layers were dried over sodium sulfate, filtered, concentrated, and purified by column chromatography (0–50% EtOAc/hexane) to yield <i>tert</i>-butyl 3-(2-bromo-4-chloro-6-methylbenzyl)piperidine-1-carboxylate (130 mg, 64%). Step 4: the title compound was synthesized following general procedure B with <i>tert</i>-butyl 3-(2-bromo-4-chloro-6-methylbenzyl)piperidine-1-carboxylate and 2-(((<i>tert</i>-butyldimethylsilyl)oxy)methyl)-7-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)thieno[3,2-<i>b</i>]pyridine (<b>48</b>), followed by general procedure G with 6,6-dimethyl-3-azabicyclo[3.1.0]hexane-2,4-dione, and then general procedure D to give the desired product as the TFA salt. <sup>1</sup>H NMR (400 MHz, methanol-<i>d</i><sub>4</sub>): δ 8.75 (d, <i>J</i> = 5.0 Hz, 1H), 7.58 (s, 1H), 7.48–7.38 (m, 2H), 7.18 (d, <i>J</i> = 6.6 Hz, 1H), 4.85 (s, 2H), 3.18 (d, <i>J</i> = 12.6 Hz, 1H), 3.00 (dd, <i>J</i> = 22.6, 12.5 Hz, 1H), 2.81–2.59 (m, 2H), 2.50 (d, <i>J</i> = 2.7 Hz, 2H), 2.47 (s, 3H), 2.43–2.28 (m, 2H), 1.81–1.54 (m, 2H), 1.54–1.27 (m, 2H), 1.24 (s, 3H), 1.09 (d, <i>J</i> = 6.7 Hz, 3H), 0.98–0.79 (m, 1H). [M + H] 508.0.</div></div><div id="sec5_50" class="NLM_sec NLM_sec_level_2"><div id="ac_i74" class="anchor-spacer"></div><h3 class="article-section__title" id="_i74"> 2-(Bromomethyl)-5-chloro-1-iodo-3-methylbenzene (<b>67</b>)</h3><div class="NLM_p last">Step 1: 4-chloro-2-methylbenzoic acid (100 g, 586 mmol) and NIS (158 g, 703 mmol) were dissolved in DMF (1 L, 0.6 M) at which time Pd(OAc)<sub>2</sub> (13.2 g, 58.6 mmol) was added. The mixture was heated to 120 °C for 16 h, cooled, concentrated. The mixture was partitioned between EtOAc and water, and the organic phase washed with brine, dried over Na<sub>2</sub>SO<sub>4</sub>, and concentrated. The crude mixture was purified by silica gel chromatography to yield 4-chloro-2-iodo-6-methylbenzoic acid (51 g, 172 mmol, 30%). Step 2: the above material was dissolved in THF (325 mL), cooled to 0 °C, and added borane dimethylsulfide (DMS; 34.4 mL, 344 mmol). The mixture was heated to 50 °C and stirred for 20 h. Upon completion, the mixture was cooled to 0 °C then quenched carefully with MeOH. The mixture was concentrated, and water was added to precipitate the product. The solid was purified by silica gel chromatography to furnish (4-chloro-2-iodo-6-methylphenyl)methanol (35.3 g, 125 mmol, 73%). Step 3: the above material was dissolved in DCM (410 mL), cooled to 0 °C, and added PBr<sub>3</sub> (23.6 mL, 250 mmol). The mixture was allowed to warm to room temperature and stirred 3 h. The mixture was cooled to 0 °C then quenched with sat. NaHCO<sub>3</sub>. The layers were separated, and the aqueous layer extracted with DCM (3 × 200 mL). The combined organic layers were washed with brine, dried over Na<sub>2</sub>SO<sub>4</sub>, and concentrated to afford the title compound (38 g, 88%). <sup>1</sup>H NMR (400 MHz, chloroform-<i>d</i>): δ 7.71 (d, <i>J</i> = 2.1 Hz, 1H), 7.17 (d, <i>J</i> = 2.1 Hz, 1H), 4.65 (s, 2H), 2.47 (s, 3H).</div></div><div id="sec5_51" class="NLM_sec NLM_sec_level_2"><div id="ac_i75" class="anchor-spacer"></div><h3 class="article-section__title" id="_i75"> General Procedure H (Piperazine Substitution)</h3><div class="NLM_p last">To desired mono-Boc-protected piperazine (<b>68</b>, 2.0 mmol) in DMF (5 mL) was added sodium hydride (0.16 g, 4.0 mmol). The mixture was stirred for 5 min at which time 2-(bromomethyl)-5-chloro-1-iodo-3-methylbenzene (<b>67</b>, 0.83 g, 2.4 mmol) was added. The mixture was stirred for 35 min and partitioned between sat. NH<sub>4</sub>Cl (2 mL), H<sub>2</sub>O (3 mL), and 50% EtOAc/Hexane (15 mL). The organic layer was separated, concentrated, and purified by silica gel chromatography (0–40% EtOAc in hexane) to afford the desired product (<b>69</b>).</div></div><div id="sec5_52" class="NLM_sec NLM_sec_level_2"><div id="ac_i76" class="anchor-spacer"></div><h3 class="article-section__title" id="_i76"> 1-((7-(5-Chloro-3-methyl-2-(piperazin-1-ylmethyl)phenyl)thieno[3,2-<i>b</i>]pyridin-2-yl)methyl)pyrrolidine-2,5-dione (<b>35</b>)</h3><div class="NLM_p last">The title compound was synthesized following general procedure H with 2-(bromomethyl)-5-chloro-1-iodo-3-methylbenzene (<b>67</b>) and <i>tert</i>-butyl piperazine-1-carboxylate, followed by general procedure B with 1-((7-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)thieno[3,2-<i>b</i>]pyridin-2-yl)methyl)pyrrolidine-2,5-dione (<b>46</b>), and then general procedure D to give the desired product. <sup>1</sup>H NMR (400 MHz, methanol-<i>d</i><sub>4</sub>): δ 8.99 (br s, 1H), 7.97 (s, 1H), 7.85 (s, 1H), 7.59 (s, 1H), 7.39 (s, 1H), 5.08 (s, 2H), 4.15 (br s, 1H), 3.71 (br s, 1H), 3.02 (br s, 4H), 2.78 (s, 4H), 2.68 (br s, 4H), 2.60 (s, 3H). [M + H] 469.0.</div></div><div id="sec5_53" class="NLM_sec NLM_sec_level_2"><div id="ac_i77" class="anchor-spacer"></div><h3 class="article-section__title" id="_i77"> (<i>S</i>)-1-((7-(5-Chloro-3-methyl-2-((2-methylpiperazin-1-yl)methyl)phenyl)thieno[3,2-<i>b</i>]pyridin-2-yl)methyl)pyrrolidine-2,5-dione (<b>36</b>)</h3><div class="NLM_p last">The title compound was synthesized following general procedure H with 2-(bromomethyl)-5-chloro-1-iodo-3-methylbenzene (<b>67</b>) and <i>tert</i>-butyl (S)-3-methylpiperazine-1-carboxylate, followed by general procedure B with 1-((7-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)thieno[3,2-<i>b</i>]pyridin-2-yl)methyl)pyrrolidine-2,5-dione (<b>46</b>), and then general procedure D to give the desired product. <sup>1</sup>H NMR (400 MHz, methanol-<i>d</i><sub>4</sub>): δ 8.87 (br s, 1H), 7.70 (s, 1H), 7.66 (s, 1H), 7.47 (s, 1H), 7.27 (s, 1H), 5.03 (s, 2H), 4.29–4.08 (m, 4H), 3.11–2.91 (m, 2H), 2.77 (s, 4H), 2.64–2.56 (m, 1H), 2.52 (s, 3H), 2.45–1.99 (m, 3H), 1.27 (d, <i>J</i> = 7.2 Hz, 3H). [M + H] 483.0.</div></div><div id="sec5_54" class="NLM_sec NLM_sec_level_2"><div id="ac_i78" class="anchor-spacer"></div><h3 class="article-section__title" id="_i78"> 1-((7-(5-Chloro-2-(((2<i>S</i>,6<i>S</i>)-2,6-dimethylpiperazin-1-yl)methyl)-3-methylphenyl)thieno[3,2-<i>b</i>]pyridin-2-yl)methyl)pyrrolidine-2,5-dione (<b>37</b>)</h3><div class="NLM_p last">The title compound was synthesized following general procedure H with 2-(bromomethyl)-5-chloro-1-iodo-3-methylbenzene (<b>67</b>) and <i>tert</i>-butyl (3<i>S</i>,5<i>S</i>)-3,5-dimethylpiperazine-1-carboxylate, followed by general procedure B with 1-((7-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)thieno[3,2-<i>b</i>]pyridin-2-yl)methyl)pyrrolidine-2,5-dione (<b>46</b>), and then general procedure D to give the desired product. <sup>1</sup>H NMR (400 MHz, methanol-<i>d</i><sub>4</sub>): δ 9.00 (s, 1H), 8.02 (s, 1H), 7.93 (s, 1H), 7.55 (s, 1H), 7.38 (s, 1H), 5.07 (s, 2H), 4.33–3.95 (m, 2H), 3.15–2.54 (m, 4H), 2.79 (s, 3H), 2.68 (d, <i>J</i> = 11.0 Hz, 4H), 0.93 (br s, 3H), 0.84 (br s, 3H). [M + H] 497.1.</div></div><div id="sec5_55" class="NLM_sec NLM_sec_level_2"><div id="ac_i79" class="anchor-spacer"></div><h3 class="article-section__title" id="_i79"> General Procedure I (Morpholine Synthesis)</h3><div class="NLM_p last">Step 1: to diisopropylamine (0.31 mL, 2.2 mmol) in THF (10 mL) at 0 °C was added <i>n</i>-butyllithium (2.5 M in hexane, 0.88 mL, 2.2 mmol) dropwise, and the solution was stirred at 0 °C for 45 min. The mixture was cooled to −78 °C at which time substituted PMB-morpholinone (<b>71</b>, 2.0 mmol) in THF (5 mL) was added dropwise. After stirring at −78 °C for 1 h, 2-(bromomethyl)-5-chloro-1-iodo-3-methylbenzene (<b>67</b>, 1.04 g, 3.0 mmol) in THF (5 mL) was added dropwise. The mixture was allowed to warm to rt and stirred 16 h. To this was added sat. aq NH<sub>4</sub>Cl (20 mL), extracted with EtOAc (2 × 20 mL), dried over Na<sub>2</sub>SO<sub>4</sub>, and concentrated. Silica gel chromatography afforded the alkylated morpholinone. Step 2: to the above alkylated morpholinone (1.58 mmol) in THF (3 mL) was added borane THF (2.0 M in THF, 2.37 mL, 4.73 mmol) dropwise. The mixture was stirred at 70 °C overnight, then cooled to 0 °C, and quenched carefully with 1:1 THF/H<sub>2</sub>O (10 mL). Sat. aq Rochelle’s salt (10 mL) was added, and the mixture vigorously stirred at rt. The mixture was extracted with EtOAc (2 × 20 mL) and purified by silica gel chromatography to furnish the desired morpholine (<b>72</b>). Step 3: to the above morpholine (<b>72</b>, 1.39 mmol) in DCE (13 mL) was added chloroethyl chloroformate (0.45 mL, 4.15 mmol). The mixture was stirred overnight and concentrated. Methanol (13 mL) was added and the mixture was heated to 70 °C for 3 h. The mixture was cooled, concentrated, and purified by silica gel chromatography (2–10% MeOH/DCM) to afford the <i>N</i>–H morpholine (cleavage of PMB group). This material was then dissolved in THF (6 mL) after which di-<i>tert</i>-butyl dicarbonate (455 mg, 2.08 mmol) and imidazole (283 mg, 4.15 mmol) were added. After stirring at room temperature overnight, the mixture was concentrated and directly purified by column chromatography (5–30% EtOAc/hexane) to give the desired Boc-morpholine (<b>73</b>). For enantioenriched material, the racemic morpholine was subjected to chiral SFC separation.</div></div><div id="sec5_56" class="NLM_sec NLM_sec_level_2"><div id="ac_i80" class="anchor-spacer"></div><h3 class="article-section__title" id="_i80"> 3-((7-(5-Chloro-3-methyl-2-(((<i>R</i>)-morpholin-2-yl)methyl)phenyl)thieno[3,2-<i>b</i>]pyridin-2-yl)methyl)-3-azabicyclo[3.1.0]hexane-2,4-dione (<b>38</b>)</h3><div class="NLM_p last">The title compound was synthesized following general procedure I with 2-(bromomethyl)-5-chloro-1-iodo-3-methylbenzene (<b>67</b>) and 4-(4-methoxybenzyl)morpholin-3-one, followed by general procedure B with 3-((7-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)thieno[3,2-<i>b</i>]pyridin-2-yl)methyl)-3-azabicyclo[3.1.0]hexane-2,4-dione, and then general procedure D to give the desired product. <sup>1</sup>H NMR (400 MHz, methanol-<i>d</i><sub>4</sub>): δ 8.87 (dd, <i>J</i> = 5.8, 2.6 Hz, 1H), 7.81–7.63 (m, 2H), 7.49 (d, <i>J</i> = 2.2 Hz, 1H), 7.24 (dd, <i>J</i> = 13.2, 2.3 Hz, 1H), 4.88 (d, <i>J</i> = 6.5 Hz, 2H), 3.89 (dd, <i>J</i> = 13.0, 3.7 Hz, 1H), 3.65–3.38 (m, 2H), 3.21–3.02 (m, 2H), 2.95 (ddd, <i>J</i> = 17.8, 13.6, 3.6 Hz, 1H), 2.87–2.62 (m, 3H), 2.59 (dt, <i>J</i> = 8.1, 3.3 Hz, 2H), 2.48 (s, 3H), 1.63 (tdd, <i>J</i> = 7.9, 4.6, 3.0 Hz, 1H), 1.47 (p, <i>J</i> = 3.6 Hz, 1H). [M + H] 482.0.</div></div><div id="sec5_57" class="NLM_sec NLM_sec_level_2"><div id="ac_i81" class="anchor-spacer"></div><h3 class="article-section__title" id="_i81"> <i>rac</i>-3-((7-(5-Chloro-3-methyl-2-(((2<i>R</i>,3<i>R</i>)-3-methylmorpholin-2-yl)methyl)phenyl)thieno[3,2-<i>b</i>]pyridin-2-yl)methyl)-3-azabicyclo[3.1.0]hexane-2,4-dione (<b>39</b>)</h3><div class="NLM_p last">Step 1: to diisopropylamine (2.3 mL, 16.4 mmol) in THF (50 mL) at 0 °C was added <i>n</i>-butyllithium (2.5 M in hexane, 6.6 mL, 16.4 mmol) dropwise, and the solution was stirred at 0 °C for 45 min. The mixture was cooled to −78 °C at which time <i>tert</i>-butyl 3-oxomorpholine-4-carboxylate (3.0 g, 14.9 mmol) in THF (10 mL) was added dropwise. After stirring at −78 °C for 1 h, 2-(bromomethyl)-5-chloro-1-iodo-3-methylbenzene (<b>67</b>, 10.3 g, 30 mmol) in THF (20 mL) was added dropwise. The mixture was allowed to warm to rt and stirred for 2 h. To this was added sat. aq NH<sub>4</sub>Cl (100 mL), extracted with EtOAc (2 × 100 mL), dried over Na<sub>2</sub>SO<sub>4</sub>, and concentrated. Silica gel chromatography afforded <i>tert</i>-butyl 2-(4-chloro-2-iodo-6-methylbenzyl)-3-oxomorpholine-4-carboxylate (2.64 g, 30%). Step 2: the above compound (800 mg, 1.7 mmol) was dissolved in diethyl ether (15 mL) and cooled to −78 °C. Then, methylmagnesium bromide (3 M, 1.14 mL, 3.4 mmol) was added dropwise, and the solution was stirred for 3 h. The reaction was quenched with sat. aq NH<sub>4</sub>Cl (20 mL), extracted with EtOAc (2 × 20 mL), and purified by column chromatography to yield <i>tert</i>-butyl (2-((1-(4-chloro-2-iodo-6-methylphenyl)-3-oxobutan-2-yl)oxy)ethyl)carbamate (510 mg, ∼90% purity). Step 3: the above material (510 mg) was dissolved in methanol (10 mL), and then conc. HCl (0.72 mL, 8.6 mmol) was added. After stirring for 15 h, the mixture was concentrated and then dissolved in DCE (10 mL). To this were added sodium triacetoxyborohydride (725 mg, 3.4 mmol) and a drop of acetic acid. After stirring for 15 h, the mixture was concentrated and purified by column chromatography to yield <i>trans</i>-2-(4-chloro-2-iodo-6-methylbenzyl)-3-methylmorpholine (200 mg, 32% over 2 steps). Step 4: the above compound (200 mg, 0.54 mmol) along with di-<i>tert</i>-butyl dicarbonate (143 mg, 0.65 mmol) and DMAP (73 mg, 0.60 mmol) were dissolved in acetonitrile (5 mL) and stirred for 15 h. After diluting with DCM (50 mL), the solution was washed with 1 N HCl (1 × 30 mL), aq NaHCO<sub>3</sub> (1 × 30 mL), and brine (1 × 30 mL) and then purified by column chromatography to yield <i>tert</i>-butyl (2<i>R</i>,3<i>R</i>)-2-(4-chloro-2-iodo-6-methylbenzyl)-3-methylmorpholine-4-carboxylate (186 mg, 73%). Step 5: the title compound was synthesized following general procedure B with the above compound and 3-((7-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)thieno[3,2-<i>b</i>]pyridin-2-yl)methyl)-3-azabicyclo[3.1.0]hexane-2,4-dione and then general procedure D to give the desired product. <sup>1</sup>H NMR (400 MHz, methanol-<i>d</i><sub>4</sub>): δ 8.77 (d, <i>J</i> = 5.2 Hz, 1H), 7.59–7.46 (m, 2H), 7.43 (dd, <i>J</i> = 4.0, 2.2 Hz, 1H), 7.20 (dd, <i>J</i> = 12.3, 2.2 Hz, 1H), 4.84 (s, 2H), 4.37–4.28 (m, 1H), 4.16 (ddd, <i>J</i> = 12.0, 6.1, 2.5 Hz, 1H), 3.60 (dd, <i>J</i> = 13.1, 3.6 Hz, 1H), 3.45–3.31 (m, 1H), 3.16–3.03 (m, 2H), 2.98–2.82 (m, 2H), 2.62–2.55 (m, 2H), 2.47 (s, 3H), 1.65–1.43 (m, 2H), 0.96 (dd, <i>J</i> = 12.8, 6.5 Hz, 3H). [M + H] 496.0.</div></div><div id="sec5_58" class="NLM_sec NLM_sec_level_2"><div id="ac_i82" class="anchor-spacer"></div><h3 class="article-section__title" id="_i82"> <i>rac</i>-3-((7-(5-Chloro-3-methyl-2-(((2<i>R</i>,6<i>R</i>)-6-methylmorpholin-2-yl)methyl)phenyl)thieno[3,2-<i>b</i>]pyridin-2-yl)methyl)-3-azabicyclo[3.1.0]hexane-2,4-dione (<b>40</b>)</h3><div class="NLM_p last">The title compound was synthesized following general procedure I with 2-(bromomethyl)-5-chloro-1-iodo-3-methylbenzene (<b>67</b>) and 4-(4-methoxybenzyl)-6-methylmorpholin-3-one, followed by general procedure B with 3-((7-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)thieno[3,2-<i>b</i>]pyridin-2-yl)methyl)-3-azabicyclo[3.1.0]hexane-2,4-dione, and then general procedure D to give the desired product. <sup>1</sup>H NMR (400 MHz, methanol-<i>d</i><sub>4</sub>): δ 8.73 (d, <i>J</i> = 5.1 Hz, 1H), 7.53 (d, <i>J</i> = 1.4 Hz, 1H), 7.51–7.38 (m, 2H), 7.20 (d, <i>J</i> = 25.8 Hz, 1H), 4.81 (d, <i>J</i> = 3.0 Hz, 2H), 3.72–3.41 (m, 2H), 3.19–2.85 (m, 3H), 2.66–2.51 (m, 5H), 2.47 (d, <i>J</i> = 2.8 Hz, 3H), 1.61 (td, <i>J</i> = 8.1, 4.6 Hz, 1H), 1.43 (p, <i>J</i> = 4.8 Hz, 1H), 1.14–0.79 (m, 3H). [M + H] 496.0.</div></div><div id="sec5_59" class="NLM_sec NLM_sec_level_2"><div id="ac_i83" class="anchor-spacer"></div><h3 class="article-section__title" id="_i83"> 2-(2-Bromo-4-chloro-6-methylbenzyl)oxirane (<b>76</b>)</h3><div class="NLM_p last">Step 1: 2-bromo-4-chloro-6-methylaniline (60 g, 272 mmol) was added over 30 min to a cooled, stirring solution of <i>t</i>BuONO (48.5 mL, 408 mmol) and allyl bromide (353 mL, 4081 mmol) in acetonitrile (272 mL) with maintaining internal temperature <5 °C. The mixture was then stirred at room temperature for 20 h. Upon completion, the mixture was concentrated and then partitioned between H<sub>2</sub>O/EtOAc. The layers were separated and the aqueous extracted with EtOAc (3 × 200 mL). The combined organic layers were washed with brine, dried over Na<sub>2</sub>SO<sub>4</sub>, and then concentrated. The crude was purified by silica gel plug (100% hexanes) to yield the allyl arene (49 g, 73%). Step 2: this material (49 g, 201 mmol) was dissolved in DCM (400 mL) and then cooled to 0 °C. <i>m</i>-CPBA (69.4 g, 301.8 mmol) was added to the stirring mixture in portions over 35 min with maintaining internal temperature <5 °C. The mixture was then stirred at room temperature for 20 h. Upon completion, the mixture was cooled to 0 °C and quenched with sat. Na<sub>2</sub>S<sub>2</sub>O<sub>3</sub> with internal temperature <20 °C. The excess <i>m</i>-chlorobenzoic acid was filtered off. The layers were separated and the aqueous was extracted with DCM (2 × 100 mL). The combined organic layers were washed with sat. NaHCO<sub>3</sub>, dried over Na<sub>2</sub>SO<sub>4</sub>, and then concentrated. The crude was purified by column chromatography to yield the title compound (33.1 g, 63%). <sup>1</sup>H NMR (400 MHz, chloroform-<i>d</i>): δ 7.43 (d, <i>J</i> = 2.2 Hz, 1H), 7.12 (d, <i>J</i> = 2.2 Hz, 1H), 3.23–3.13 (m, 2H), 3.09 (dd, <i>J</i> = 15.4, 6.0 Hz, 1H), 2.75 (dd, <i>J</i> = 5.0, 3.7 Hz, 1H), 2.50 (dd, <i>J</i> = 4.9, 2.4 Hz, 1H), 2.38 (s, 3H).</div></div><div id="sec5_60" class="NLM_sec NLM_sec_level_2"><div id="ac_i84" class="anchor-spacer"></div><h3 class="article-section__title" id="_i84"> Large-Scale Synthesis of <i>tert</i>-Butyl (<i>R</i>)-2-(2-Bromo-4-chloro-6-methylbenzyl)morpholine-4-carboxylate (<b>79</b>)</h3><div class="NLM_p last">Step 1: ethanol amine (30 mL) was added to 2-(2-bromo-4-chloro-6-methylbenzyl)oxirane (<b>76</b>, 13 g, 49.7 mmol) in THF (30 mL) at room temperature. The reaction mixture was stirred at 60 °C for 16 h, then poured into water (1 L), and stirred for 1 h. The resultant white solid was filtrated and rinsed with water (400 mL) to give the crude diol (<b>77</b>). Solid can be wet for next step. Step 2: in a 1 L flask, diol <b>77</b> was suspended in THF (200 mL) and di-<i>tert</i>-butyl dicarbonate (16.3 g, 74 mmol) was added portion wise. This was stirred at room temperature for 1 h. Imidazole (3.4 g, 49.7 mmol) was added and the solvent was partially removed on the rotavap for 15 min at 40 °C. The crude mixture was diluted in 50% ethyl acetate/hexanes (400 mL) and rinsed 2 times with 1 M HCl (300 mL) and once with brine (100 mL). The organics were dried over sodium sulfate, filtered, and concentrated to afford a white solid (∼19 g, 90%). Step 3: in a 1 L flask, this solid (19 g, 44.8 mmol) was suspended in MTBE (250 mL). This was heated at 50 °C for 20 min to obtain a light cloudy solution. At 0 °C, triphenylphosphine (14.1 g, 53.8 mmol) was added in one portion. When the triphenylphosphine was all dissolved, diisopropyl azodicarboxylate (10.6 mL, 53.8 mmol) was added dropwise over 15 min at 0 °C. The reaction was stirred overnight at room temperature and a solid precipitated over time. The solution was concentrated and a thick gum was obtained. This was triturated with hexanes (500 mL) to obtain a white solid. The solid was collected by filtration and dried to obtain a white/light yellow solid (19 g, 105%)—about 80% pure by NMR as the Boc-morpholine. Step 4: the above Boc-morpholine (∼19 g, 46 mmol) was dissolved in DCM (200 mL). 4 N HCl in dioxane (30 mL) was added, and the reaction was stirred at room temperature for 16 h. White solid slowly formed over time. Diethyl ether (200 mL) was added, and the reaction was stirred for 15 min. The solid was filtered and rinsed with ether (50 mL) to give the racemic morpholine as the HCl salt (<b>78</b>, 9.1 g, 29.3 mmol, 59% from epoxide <b>76</b>). Step 5: the morpholine HCl salt was dissolved in DCM and rinsed with 1 M NaOH. The organic phase was collected, dried with Na<sub>2</sub>SO<sub>4</sub>, and concentrated to afford the morpholine free base as a colorless gum. Step 6: the morpholine free base was dissolved in DCE (100 mg morpholine per 1 mL DCE). <i>N</i>-Ac-<span class="smallcaps smallerCapital">d</span>-Leu (unnatural enantiomer, 0.5 equiv rel. to free base) was added, and the DCE solution stirred and warmed until the solution became homogeneous. Stirring was stopped, and the solution was removed from heat. Heptane (equal volume to DCE) was then added, and the solution was swirled until homogeneous. The solution was allowed to stand, cooling to room temperature. After 1–2 h, large amounts of crystalline white solid appeared. The mixture was allowed to stand overnight. The solid was then collected by filtration (this solid is typically 80% ee in the first batch), and the filtrate (containing mostly the undesired enantiomer) was set aside. The solid was returned to the original flask and dissolved in hot DCE (85–90 °C, 100 mg morpholine per 1 mL DCE). Once homogeneous, the solution was removed from the heat and heptane (equal volume to DCE) was then added to the warm mixture and the solution was swirled until homogeneous. The solution was allowed to stand, cooling to room temperature. Once most of the solid had emerged from solution, the solid was collected by filtration (typically 95% ee in the second crystallization) and the filtrate was added to the previous filtrate and set aside. The recrystallization procedure was repeated a third time to afford solid of >99% ee. Step 7: to the above enantioenriched morpholine (5.55 g, 11.62 mmol) in DCM (50 mL) was added triethylamine (4.84 mL, 34.85 mmol) and di-<i>tert</i>-butyl dicarbonate (3.8 g, 17.42 mmol). This was stirred at room temperature for 1 h, then imidazole (1.19 g, 17.4 mmol) was added. After stirring for an additional 30 min, the mixture was diluted with 1 M aq HCl and stirred vigorously for 1 min. The organic layer was washed with water and then 1 M NaOH, and then the aqueous layer was back extracted 2× with DCM. The combined organics were dried, filtered, and concentrated to give the final product, enantioenriched morpholine <b>79</b> (31% over 3 steps). <sup>1</sup>H NMR (400 MHz, chloroform-<i>d</i>): δ 7.42 (d, <i>J</i> = 2.2 Hz, 1H), 7.10 (d, <i>J</i> = 2.4 Hz, 1H), 3.94 (br s, 1H), 3.80 (dd, <i>J</i> = 11.7, 3.4 Hz, 2H), 3.62 (br s, 1H), 3.40 (td, <i>J</i> = 11.8, 2.8 Hz, 1H), 2.98–2.83 (m, 3H), 2.72 (br s, 1H), 2.38 (s, 3H), 1.45 (s, 9H). [M + Na] 426.0.</div></div><div id="sec5_61" class="NLM_sec NLM_sec_level_2"><div id="ac_i85" class="anchor-spacer"></div><h3 class="article-section__title" id="_i85"> 3-((7-(5-Chloro-3-methyl-2-(((<i>R</i>)-morpholin-2-yl)methyl)phenyl)thieno[3,2-<i>b</i>]pyridin-2-yl)methyl)-6,6-dimethyl-3-azabicyclo[3.1.0]hexane-2,4-dione (<b>41</b>)</h3><div class="NLM_p last">The title compound was synthesized following general procedure B with enantioenriched morpholine <b>79</b> and 2-(((<i>tert</i>-butyldimethylsilyl)oxy)methyl)-7-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)thieno[3,2-<i>b</i>]pyridine (<b>48</b>), followed by general procedure G with 6,6-dimethyl-3-azabicyclo[3.1.0]hexane-2,4-dione, and then general procedure C to give the desired product. <sup>1</sup>H NMR (400 MHz, methanol-<i>d</i><sub>4</sub>): δ 8.88 (t, <i>J</i> = 4.8, 3.8 Hz, 1H), 7.81–7.65 (m, 2H), 7.49 (d, <i>J</i> = 2.3 Hz, 1H), 7.22 (dd, <i>J</i> = 11.2, 2.3 Hz, 1H), 4.93 (d, <i>J</i> = 5.0 Hz, 2H), 3.89 (dd, <i>J</i> = 13.0, 3.7 Hz, 1H), 3.67–3.39 (m, 2H), 3.20–3.02 (m, 2H), 3.02–2.89 (m, 1H), 2.88–2.54 (m, 3H), 2.52 (d, <i>J</i> = 3.6 Hz, 2H), 2.48 (s, 3H), 1.25 (d, <i>J</i> = 2.0 Hz, 3H), 1.13 (d, <i>J</i> = 8.5 Hz, 3H). [M + H] 510.0.</div></div><div id="sec5_62" class="NLM_sec NLM_sec_level_2"><div id="ac_i86" class="anchor-spacer"></div><h3 class="article-section__title" id="_i86"> X-ray Co-Crystallography</h3><div class="NLM_p last">Amino acids 208–560 of human USP7 were expressed in <i>Escherichia coli</i> and purified using a GST-tag. The GST-tag was cleaved off via PreScission protease after affinity purification and the GST-tag was removed by an additional affinity purification step on GSTrap. Finally, a size exclusion chromatography step was performed using a S-200 26/60 column in 20 mM tris 8.0, 100 mM NaCl, 10% glycerol, 5 mM dithiothreitol (DTT) buffer and the sample was concentrated to 27 mg/mL. Crystallization was performed at 4 °C by vapor diffusion method at a protein concentration of 17 mg/mL and a ligand concentration of 10 mM [10% dimethyl sulfoxide (DMSO)]. The incubation time for the soak was 2 days. The crystallization reservoir condition contained 22.00 %w/v PEG 3350 and 0.50 M NH4 Acetate. Crystals were cryo-protected by 25% glycerol in reservoir solution. Diffraction data were collected at the Swiss Light Source (SLS).</div></div><div id="sec5_63" class="NLM_sec NLM_sec_level_2"><div id="ac_i87" class="anchor-spacer"></div><h3 class="article-section__title" id="_i87"> Computational Details</h3><div class="NLM_p last">The cocrystal structure of compound <b>7</b> in complex with USP7 was prepared for modeling at pH 7.3 using the Protein Preparation Wizard in Maestro 11.2 (Schrödinger, LLC, New York, NY, 2017). This method first adds hydrogens, assigns bond orders to the ligand, and then optimizes the hydrogen-bonding network of the receptor. An all-atom minimization is then performed, with a 0.3 Å heavy-atom root-mean-square deviation cutoff applied using the OPLS3 forcefield.<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> WaterMap, described in detail elsewhere,<a onclick="showRef(event, 'ref30 ref31'); return false;" href="javascript:void(0);" class="ref ref30 ref31">(30,31)</a> uses a molecular dynamics approach to predict the thermodynamic properties of water molecules in a protein environment. This includes each water site’s entropy, enthalpy, and free energy. WaterMap calculations were run with default settings (2 ns simulation time with waters analyzed with 10 Å of the ligand), using the prepared cocrystal structure of compound <b>7</b> in complex with USP7 (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6VN5">6VN5</a>), both with and without the ligand present. FEP+ calculations were carried out using the 2017-2 release of the Schrödinger suite with the OPLS3 forcefield. Default lambda schedules and REST<a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a> regions were used in FEP+ while simulation time ranged from 10 to 15 ns, to allow for convergence. Ligands were prepared using LigPrep<a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">(33)</a> and docked using Glide<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a> with default settings. In cases where ligand alignment was insufficient, flexible ligand alignment in Maestro was used starting from the native ligand conformation as reference.</div></div><div id="sec5_64" class="NLM_sec NLM_sec_level_2"><div id="ac_i88" class="anchor-spacer"></div><h3 class="article-section__title" id="_i88"> USP7 Biochemical Assay</h3><div class="NLM_p last">A 25 μL reaction volume containing recombinant full-length USP7 (62 pM) in 20 mM 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid pH 7.3, 150 mM NaCl, 1 mM tris(2-carboxyethyl)phosphine, and 125 μg/mL bovine serum albumin was assembled in wells of 384 well plates. Compounds were dispensed with a Hewlett Packard D300 digital dispenser (1% final DMSO). Following a 30 min incubation at room temperature, ubiquitin-rhodamine (Boston Biochem) was added with the D300 to a final concentration of 100 nM, and the reaction was allowed to proceed for 1 h at room temperature protected from light. The reaction was stopped by the addition of 5 μL 1 M acetic acid. Rhodamine fluorescence was measured using an Envision plate reader (PerkinElmer), and IC<sub>50</sub> values were determined by nonlinear regression using a 4-parameter fit in the Dotmatics software package. Values presented are the average of <i>n</i> = 2 or more determinations, where the value of each determination is within a 3-fold difference of each other.</div></div><div id="sec5_65" class="NLM_sec NLM_sec_level_2"><div id="ac_i89" class="anchor-spacer"></div><h3 class="article-section__title" id="_i89"> DUB Selectivity Profiling</h3><div class="NLM_p last">DUB selectivity profiling was conducted by Ubiquigent (Dundee, UK) using a similar assay protocol with the following changes: assay buffer was 40 mM Tris/HCl pH 7.4, 5% glycerol, 0.005% Tween-20, 1 mM DTT, 0.05 mg/mL ovalbumin, and the reaction was stopped by the addition of 5 μL 100 mM <i>N</i>-ethylmaleimide.</div></div><div id="sec5_66" class="NLM_sec NLM_sec_level_2"><div id="ac_i90" class="anchor-spacer"></div><h3 class="article-section__title" id="_i90"> p53-Luciferase Reporter Gene Assay</h3><div class="NLM_p last">RKO cells stably transfected with a p53 luciferase reporter vector (Signosis) were seeded at 2500 cells per well in 25 μL of recommended media in 384-well black-walled tissue plates (Greiner). Compounds were added with a D300 digital dispenser (0.5% final DMSO). Following an 18 h incubation, p53-dependent luciferase levels were measured via Bright-Glo Luciferase (Promega), following the manufacturer’s instructions, using a CLARIOstar plate reader (BMG LABTECH). IC<sub>50</sub> values were determined by nonlinear regression using a 4-parameter fit in the Dotmatics software package.</div></div><div id="sec5_67" class="NLM_sec NLM_sec_level_2"><div id="ac_i91" class="anchor-spacer"></div><h3 class="article-section__title" id="_i91"> Cell Culture, Cell Treatments, and Viability Assays (MM.1S, H526, RKO)</h3><div class="NLM_p last">All cell lines were purchased from American Type Culture Collection. For all cell lines, identity was confirmed by short tandem repeat profiling, and culturing was performed in recommended growth medium. For studies evaluating cellular effects of compound treatment, 250–2000 cells in 40 μL of recommended medium were seeded per well in 384-well plates (Corning 3764). DMSO-solubilized compounds were added in duplicate in a two-fold dilution series using a D300e Digital Dispenser (Hewlett-Packard). Following a 5 day incubation, cell viability was measured using CellTiter-Glo (Promega) following the manufacturer’s instructions. Luminescence was measured using a CLARIOstar plate reader (BMG LABTECH) and normalized to that of DMSO-treated cells. IC<sub>50</sub> values were determined by nonlinear regression using a 4-parameter fit in Prism (GraphPad Software).</div></div><div id="sec5_68" class="NLM_sec NLM_sec_level_2"><div id="ac_i92" class="anchor-spacer"></div><h3 class="article-section__title" id="_i92"> Animal Experiments</h3><div class="NLM_p last">MM.1S and H526 xenograft studies were conducted at Crown Bio (Beijing, China) and RAPT Therapeutics, respectively, according to the guidelines approved by the respective Institutional Animal Care and Use Committees (IACUC). MM.1S cells were inoculated in phosphate-buffered saline (PBS) into irradiated NOD/SCID mice, while H526 cells were inoculated in PBS/Matrigel (Corning) into Nu/Nu mice (Jackson Laboratories). At the start of the study, NOD/SCID mice were 9–10 weeks old and 17.2–22.3 g in weight, while Nu/Nu mice were 7 weeks old and 18.1–25.4 g in weight. Mice were randomized into groups when mean tumor size reached 150 mm<sup>3</sup> (MM.1S) or 50–100 mm<sup>3</sup> (H526), respectively, with 10 mice per group. Drug administration by oral gavage was started on day of randomization. Tumor volumes and body weights were subsequently measured twice per week. Tumor volumes were calculated using the formula: <i>V</i> = 0.5(<i>A</i> × <i>B</i><sup>2</sup>), where <i>A</i> and <i>B</i> are the long and short diameters of the tumor, respectively. If the animal’s body weight dropped to less than 90% of the original weight, a dosing holiday was given until their body weight surpassed the 90% mark. All animals were included in the tumor growth plots, regardless of whether they received a dosing holiday.</div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i93"><a href="/doi/suppl/10.1021/acs.jmedchem.0c00245" class="ext-link">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_67786" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_67786" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge at <a href="/doi/10.1021/acs.jmedchem.0c00245?goto=supporting-info" class="ext-link">https://pubs.acs.org/doi/10.1021/acs.jmedchem.0c00245</a>.<ul class="NLM_list-list_type-label" id="silist"><li><p class="inline">Molecular formula strings; biochemical and cellular potency correlation; target engagement for compound <b>30</b>; DUB selectivity profile for compound <b>30</b>; view of USP7 showing solvent-exposed Tyr-465; and PK curves for compound <b>41</b> (<a href="/doi/suppl/10.1021/acs.jmedchem.0c00245/suppl_file/jm0c00245_si_001.pdf" class="ext-link">PDF</a>)</p></li><li><p class="inline">Coordinates and structure factors for compounds <b>1</b>, <b>7</b>, <b>14</b>, <b>18</b>, and <b>23</b> in complex with USP7 have been deposited (PDB codes <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6VN4">6VN4</a>, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6VN5">6VN5</a>, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6VN6">6VN6</a>, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6VN2">6VN2</a>, and <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6VN3">6VN3</a>, respectively). Authors will release the atomic coordinates upon article publication (<a href="/doi/suppl/10.1021/acs.jmedchem.0c00245/suppl_file/jm0c00245_si_002.csv" class="ext-link">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.0c00245/suppl_file/jm0c00245_si_001.pdf">jm0c00245_si_001.pdf (982.69 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.0c00245/suppl_file/jm0c00245_si_002.csv">jm0c00245_si_002.csv (2.95 kb)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/acs.jmedchem.0c00245" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_46433" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_46433" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">David J. Wustrow</span> - <span class="hlFld-Affiliation affiliation">RAPT
Therapeutics, Inc., 561
Eccles Avenue, South San Francisco, California 94080, United States</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#3f5b484a4c4b4d50487f4d5e4f4b115c5052"><span class="__cf_email__" data-cfemail="56322123252224392116243726227835393b">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Paul R. Leger</span> - <span class="hlFld-Affiliation affiliation">RAPT
Therapeutics, Inc., 561
Eccles Avenue, South San Francisco, California 94080, United States</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-3490-6412" title="Orcid link">http://orcid.org/0000-0002-3490-6412</a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Dennis X. Hu</span> - <span class="hlFld-Affiliation affiliation">RAPT
Therapeutics, Inc., 561
Eccles Avenue, South San Francisco, California 94080, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Berenger Biannic</span> - <span class="hlFld-Affiliation affiliation">RAPT
Therapeutics, Inc., 561
Eccles Avenue, South San Francisco, California 94080, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Minna Bui</span> - <span class="hlFld-Affiliation affiliation">RAPT
Therapeutics, Inc., 561
Eccles Avenue, South San Francisco, California 94080, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Xinping Han</span> - <span class="hlFld-Affiliation affiliation">RAPT
Therapeutics, Inc., 561
Eccles Avenue, South San Francisco, California 94080, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Emily Karbarz</span> - <span class="hlFld-Affiliation affiliation">RAPT
Therapeutics, Inc., 561
Eccles Avenue, South San Francisco, California 94080, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jack Maung</span> - <span class="hlFld-Affiliation affiliation">RAPT
Therapeutics, Inc., 561
Eccles Avenue, South San Francisco, California 94080, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Akinori Okano</span> - <span class="hlFld-Affiliation affiliation">RAPT
Therapeutics, Inc., 561
Eccles Avenue, South San Francisco, California 94080, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Maksim Osipov</span> - <span class="hlFld-Affiliation affiliation">RAPT
Therapeutics, Inc., 561
Eccles Avenue, South San Francisco, California 94080, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Grant M. Shibuya</span> - <span class="hlFld-Affiliation affiliation">RAPT
Therapeutics, Inc., 561
Eccles Avenue, South San Francisco, California 94080, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Kyle Young</span> - <span class="hlFld-Affiliation affiliation">RAPT
Therapeutics, Inc., 561
Eccles Avenue, South San Francisco, California 94080, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Christopher Higgs</span> - <span class="hlFld-Affiliation affiliation">Schrödinger, 120 West 45th Street, New
York, New York 10036, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Betty Abraham</span> - <span class="hlFld-Affiliation affiliation">RAPT
Therapeutics, Inc., 561
Eccles Avenue, South San Francisco, California 94080, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Delia Bradford</span> - <span class="hlFld-Affiliation affiliation">RAPT
Therapeutics, Inc., 561
Eccles Avenue, South San Francisco, California 94080, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Cynthia Cho</span> - <span class="hlFld-Affiliation affiliation">RAPT
Therapeutics, Inc., 561
Eccles Avenue, South San Francisco, California 94080, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Christophe Colas</span> - <span class="hlFld-Affiliation affiliation">RAPT
Therapeutics, Inc., 561
Eccles Avenue, South San Francisco, California 94080, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Scott Jacobson</span> - <span class="hlFld-Affiliation affiliation">RAPT
Therapeutics, Inc., 561
Eccles Avenue, South San Francisco, California 94080, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Yamini M. Ohol</span> - <span class="hlFld-Affiliation affiliation">RAPT
Therapeutics, Inc., 561
Eccles Avenue, South San Francisco, California 94080, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Deepa Pookot</span> - <span class="hlFld-Affiliation affiliation">RAPT
Therapeutics, Inc., 561
Eccles Avenue, South San Francisco, California 94080, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Payal Rana</span> - <span class="hlFld-Affiliation affiliation">RAPT
Therapeutics, Inc., 561
Eccles Avenue, South San Francisco, California 94080, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jerick Sanchez</span> - <span class="hlFld-Affiliation affiliation">RAPT
Therapeutics, Inc., 561
Eccles Avenue, South San Francisco, California 94080, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Niket Shah</span> - <span class="hlFld-Affiliation affiliation">RAPT
Therapeutics, Inc., 561
Eccles Avenue, South San Francisco, California 94080, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Michael Sun</span> - <span class="hlFld-Affiliation affiliation">RAPT
Therapeutics, Inc., 561
Eccles Avenue, South San Francisco, California 94080, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Steve Wong</span> - <span class="hlFld-Affiliation affiliation">RAPT
Therapeutics, Inc., 561
Eccles Avenue, South San Francisco, California 94080, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Dirk G. Brockstedt</span> - <span class="hlFld-Affiliation affiliation">RAPT
Therapeutics, Inc., 561
Eccles Avenue, South San Francisco, California 94080, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Paul D. Kassner</span> - <span class="hlFld-Affiliation affiliation">RAPT
Therapeutics, Inc., 561
Eccles Avenue, South San Francisco, California 94080, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jacob B. Schwarz</span> - <span class="hlFld-Affiliation affiliation">RAPT
Therapeutics, Inc., 561
Eccles Avenue, South San Francisco, California 94080, United States</span></div></li></ul></li><li><span class="author-information-subsection-header">Author Contributions</span><p>P.R.L. and D.X.H. contributed equally to the preparation of this manuscript. All authors have given approval to the final version of the manuscript.</p></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare the following competing financial interest(s): The majority of authors of this manuscript are or were employees of RAPT Therapeutics, Inc. (formerly known as FLX Bio, Inc.).<br /></br></div></li></ul></div><div class="ack" id="ack1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i95">Acknowledgments</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_58140" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_58140" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">We would like to thank Alan Hao and Joseph Fan from AIM Biosciences for helping to produce large quantities of some important synthetic intermediates. Stephan Krapp and Michael Blaesse from Proteros Biostructures GmbH are acknowledged for helping solve the X-ray crystal structures presented in this manuscript. Finally, we would like to thank all current and former RAPT Therapeutics employees for all their hard work, dedication, and helpful discussions related to our USP7 program.</p></div><table summary="" class="NLM_def-list" id="dl1"><tr><td colspan="2" class="NLM_title">Abbreviations</td></tr><tr><td class="NLM_term">USP7</td><td class="NLM_def"><p class="first last">ubiquitin-specific protease 7</p></td></tr><tr><td class="NLM_term">DUB</td><td class="NLM_def"><p class="first last">deubiquitinase</p></td></tr><tr><td class="NLM_term">MDM2</td><td class="NLM_def"><p class="first last">mouse double minute 2 homolog</p></td></tr><tr><td class="NLM_term">p53</td><td class="NLM_def"><p class="first last">tumor protein p53</p></td></tr><tr><td class="NLM_term">FOXP3</td><td class="NLM_def"><p class="first last">forkhead box P3</p></td></tr><tr><td class="NLM_term">USP1</td><td class="NLM_def"><p class="first last">ubiquitin-specific protease 1</p></td></tr><tr><td class="NLM_term">UCH-L3</td><td class="NLM_def"><p class="first last">ubiquitin carboxy-terminal hydrolase isozyme L3</p></td></tr><tr><td class="NLM_term">USP47</td><td class="NLM_def"><p class="first last">ubiquitin-specific protease 47</p></td></tr><tr><td class="NLM_term">LipE</td><td class="NLM_def"><p class="first last">lipophilic efficiency</p></td></tr><tr><td class="NLM_term">IV</td><td class="NLM_def"><p class="first last">intravenous</p></td></tr><tr><td class="NLM_term">PO</td><td class="NLM_def"><p class="first last">per os (administered orally)</p></td></tr><tr><td class="NLM_term">AUC</td><td class="NLM_def"><p class="first last">area under the curve</p></td></tr><tr><td class="NLM_term">SAR</td><td class="NLM_def"><p class="first last">structure–activity relationship</p></td></tr><tr><td class="NLM_term">PK</td><td class="NLM_def"><p class="first last">pharmacokinetics</p></td></tr><tr><td class="NLM_term">hERG</td><td class="NLM_def"><p class="first last">human ether-a-go-go-related gene potassium ion channel</p></td></tr><tr><td class="NLM_term">CYP</td><td class="NLM_def"><p class="first last">cytochrome P450</p></td></tr><tr><td class="NLM_term">FEP+</td><td class="NLM_def"><p class="first last">free energy perturbation</p></td></tr><tr><td class="NLM_term">NOD/SCID</td><td class="NLM_def"><p class="first last">nonobese diabetic/severe combined immunodeficient</p></td></tr><tr><td class="NLM_term">DMF</td><td class="NLM_def"><p class="first last">dimethylformamide</p></td></tr><tr><td class="NLM_term"><i>m</i>-CPBA</td><td class="NLM_def"><p class="first last"><i>meta</i>-chloroperoxybenzoic acid</p></td></tr><tr><td class="NLM_term">TEMPO</td><td class="NLM_def"><p class="first last">(2,2,6,6-tetramethylpiperidin-1-yl)oxyl</p></td></tr><tr><td class="NLM_term">T3P</td><td class="NLM_def"><p class="first last">propylphosphonic acid anhydride</p></td></tr><tr><td class="NLM_term">TBS</td><td class="NLM_def"><p class="first last"><i>tert</i>-butyldimethylsilyl</p></td></tr><tr><td class="NLM_term">PMB</td><td class="NLM_def"><p class="first last"><i>para</i>-methoxybenzyl</p></td></tr><tr><td class="NLM_term">TLC</td><td class="NLM_def"><p class="first last">thin layer chromatography</p></td></tr></table><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i97">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_18601" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_18601" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 34 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bhattacharya, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chakraborty, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Basu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ghosh, M. K.</span></span> <span> </span><span class="NLM_article-title">Emerging Insights into HAUSP (USP7) in Physiology, Cancer, and Other Diseases</span>. <i>Signal Transduction Targeted Ther.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>3</i></span>,  <span class="NLM_fpage">17</span>, <span class="refDoi"> DOI: 10.1038/s41392-018-0012-y</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00245&amp;key=10.1038%2Fs41392-018-0012-y" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00245&amp;key=29967688" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00245&amp;key=1%3ACAS%3A280%3ADC%252BB3c%252FktlSgsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2018&pages=17&author=S.+Bhattacharyaauthor=D.+Chakrabortyauthor=M.+Basuauthor=M.+K.+Ghosh&title=Emerging+Insights+into+HAUSP+%28USP7%29+in+Physiology%2C+Cancer%2C+and+Other+Diseases&doi=10.1038%2Fs41392-018-0012-y"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Emerging insights into HAUSP (USP7) in physiology, cancer and other diseases</span></div><div class="casAuthors">Bhattacharya Seemana; Chakraborty Dipankar; Ghosh Mrinal K; Basu Malini</div><div class="citationInfo"><span class="NLM_cas:title">Signal transduction and targeted therapy</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">17</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Herpesvirus-associated ubiquitin-specific protease (HAUSP) is a USP family deubiquitinase.  HAUSP is a protein of immense biological importance as it is involved in several cellular processes, including host-virus interactions, oncogenesis and tumor suppression, DNA damage and repair processes, DNA dynamics and epigenetic modulations, regulation of gene expression and protein function, spatio-temporal distribution, and immune functions.  Since its discovery in the late 1990s as a protein interacting with a herpes virus regulatory protein, extensive studies have assessed its complex roles in p53-MDM2-related networks, identified numerous additional interacting partners, and elucidated the different roles of HAUSP in the context of cancer, development, and metabolic and neurological pathologies.  Recent analyses have provided new insights into its biochemical and functional dynamics.  In this review, we provide a comprehensive account of our current knowledge about emerging insights into HAUSP in physiology and diseases, which shed light on fundamental biological questions and promise to provide a potential target for therapeutic intervention.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcT7k3GWdDMbmlQKX3ooHxWjfW6udTcc2easRxw7ovV_qLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BB3c%252FktlSgsQ%253D%253D&md5=adfbf970228028f40e2cfb875dc0a810</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1038%2Fs41392-018-0012-y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41392-018-0012-y%26sid%3Dliteratum%253Aachs%26aulast%3DBhattacharya%26aufirst%3DS.%26aulast%3DChakraborty%26aufirst%3DD.%26aulast%3DBasu%26aufirst%3DM.%26aulast%3DGhosh%26aufirst%3DM.%2BK.%26atitle%3DEmerging%2520Insights%2520into%2520HAUSP%2520%2528USP7%2529%2520in%2520Physiology%252C%2520Cancer%252C%2520and%2520Other%2520Diseases%26jtitle%3DSignal%2520Transduction%2520Targeted%2520Ther.%26date%3D2018%26volume%3D3%26spage%3D17%26doi%3D10.1038%2Fs41392-018-0012-y" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tavana, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gu, W.</span></span> <span> </span><span class="NLM_article-title">Modulation of the p53/MDM2 Interplay by HAUSP Inhibitors</span>. <i>J. Mol. Cell Biol.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">45</span>– <span class="NLM_lpage">52</span>, <span class="refDoi"> DOI: 10.1093/jmcb/mjw049</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00245&amp;key=10.1093%2Fjmcb%2Fmjw049" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00245&amp;key=27927749" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00245&amp;key=1%3ACAS%3A528%3ADC%252BC1cXitFCrsrvL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2017&pages=45-52&author=O.+Tavanaauthor=W.+Gu&title=Modulation+of+the+p53%2FMDM2+Interplay+by+HAUSP+Inhibitors&doi=10.1093%2Fjmcb%2Fmjw049"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Modulation of the p53/MDM2 interplay by HAUSP inhibitors</span></div><div class="casAuthors">Tavana, Omid; Gu, Wei</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Molecular Cell Biology (Oxford, United Kingdom)</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">45-52</span>CODEN:
                <span class="NLM_cas:coden">JMCBCU</span>;
        ISSN:<span class="NLM_cas:issn">1759-4685</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">It is well established that both p53 and MDM2 are short-lived proteins whose stabilities are tightly controlled through ubiquitination-mediated degrdn.  Although numerous studies indicate that the MDM2 E3 ligase activity, as well as the protein- protein interaction between p53 and MDM2, is the major focus for this regulation, emerging evidence suggests that the deubiquitinase herpesvirus-assocd. ubiquitin-specific protease (HAUSP, also known as USP7) plays a crit. role.  Furthermore, HAUSP inhibition elevates p53 stability and might be beneficial for therapeutic purposes.  In this review, we discuss the advances of this dynamic pathway and the contributions of pos. and neg. regulators affecting HAUSP activity.  We also highlight the roles of HAUSP in cancer justifying the prodn. of the first generation of HAUSP inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr425eMtyLDyrVg90H21EOLACvtfcHk0lhhmc1jy9E9uw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXitFCrsrvL&md5=e68decb8e9639edb9c998da49cb0a496</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1093%2Fjmcb%2Fmjw049&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fjmcb%252Fmjw049%26sid%3Dliteratum%253Aachs%26aulast%3DTavana%26aufirst%3DO.%26aulast%3DGu%26aufirst%3DW.%26atitle%3DModulation%2520of%2520the%2520p53%252FMDM2%2520Interplay%2520by%2520HAUSP%2520Inhibitors%26jtitle%3DJ.%2520Mol.%2520Cell%2520Biol.%26date%3D2017%26volume%3D9%26spage%3D45%26epage%3D52%26doi%3D10.1093%2Fjmcb%2Fmjw049" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">van
Loosdregt, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fleskens, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brenkman, A. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bekker, C. P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pals, C. E. M. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meerding, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berkers, C. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barbi, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gröne, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sijts, A. J. A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maurice, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kalkhoven, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prakken, B. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ovaa, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pan, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zaiss, D. M. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coffer, P. J.</span></span> <span> </span><span class="NLM_article-title">Stabilization of the Transcription Factor Foxp3 by the Deubiquitinase USP7 Increases Treg-Cell-Suppressive Capacity</span>. <i>Immunity</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>39</i></span>,  <span class="NLM_fpage">259</span>– <span class="NLM_lpage">271</span>, <span class="refDoi"> DOI: 10.1016/j.immuni.2013.05.018</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00245&amp;key=10.1016%2Fj.immuni.2013.05.018" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00245&amp;key=23973222" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00245&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtlCgtr3F" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=2013&pages=259-271&author=J.+van%0ALoosdregtauthor=V.+Fleskensauthor=J.+Fuauthor=A.+B.+Brenkmanauthor=C.+P.+J.+Bekkerauthor=C.+E.+M.+G.+Palsauthor=J.+Meerdingauthor=C.+R.+Berkersauthor=J.+Barbiauthor=A.+Gr%C3%B6neauthor=A.+J.+A.+M.+Sijtsauthor=M.+M.+Mauriceauthor=E.+Kalkhovenauthor=B.+J.+Prakkenauthor=H.+Ovaaauthor=F.+Panauthor=D.+M.+W.+Zaissauthor=P.+J.+Coffer&title=Stabilization+of+the+Transcription+Factor+Foxp3+by+the+Deubiquitinase+USP7+Increases+Treg-Cell-Suppressive+Capacity&doi=10.1016%2Fj.immuni.2013.05.018"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Stabilization of the Transcription Factor Foxp3 by the Deubiquitinase USP7 Increases Treg-Cell-Suppressive Capacity</span></div><div class="casAuthors">van Loosdregt, Jorg; Fleskens, Veerle; Fu, Juan; Brenkman, Arjan B.; Bekker, Cornelis P. J.; Pals, Cornelieke E. G. M.; Meerding, Jenny; Berkers, Celia R.; Barbi, Joseph; Grone, Andrea; Sijts, Alice J. A. M.; Maurice, Madelon M.; Kalkhoven, Eric; Prakken, Berent J.; Ovaa, Huib; Pan, Fan; Zaiss, Dietmar M. W.; Coffer, Paul J.</div><div class="citationInfo"><span class="NLM_cas:title">Immunity</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">39</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">259-271</span>CODEN:
                <span class="NLM_cas:coden">IUNIEH</span>;
        ISSN:<span class="NLM_cas:issn">1074-7613</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">Stable Foxp3 expression is required for the development of functional regulatory T (Treg) cells.  Here, we demonstrate that the expression of the transcription factor Foxp3 can be regulated through the polyubiquitination of multiple lysine residues, resulting in proteasome-mediated degrdn.  Expression of the deubiquitinase (DUB) USP7 was found to be upregulated and active in Treg cells, being assocd. with Foxp3 in the nucleus.  Ectopic expression of USP7 decreased Foxp3 polyubiquitination and increased Foxp3 expression.  Conversely, either treatment with DUB inhibitor or USP7 knockdown decreased endogenous Foxp3 protein expression and decreased Treg-cell-mediated suppression in vitro.  Furthermore, in a murine adoptive-transfer-induced colitis model, either inhibition of DUB activity or USP7 knockdown in Treg cells abrogated their ability to resolve inflammation in vivo.  Our data reveal a mol. mechanism in which rapid temporal control of Foxp3 expression in Treg cells can be regulated by USP7, thereby modulating Treg cell nos. and function.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr5Zpb6_zouu7Vg90H21EOLACvtfcHk0lhVnNWSJ33brQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtlCgtr3F&md5=78bd3e51a661ecac49461a3811d2e768</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1016%2Fj.immuni.2013.05.018&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.immuni.2013.05.018%26sid%3Dliteratum%253Aachs%26aulast%3Dvan%2BLoosdregt%26aufirst%3DJ.%26aulast%3DFleskens%26aufirst%3DV.%26aulast%3DFu%26aufirst%3DJ.%26aulast%3DBrenkman%26aufirst%3DA.%2BB.%26aulast%3DBekker%26aufirst%3DC.%2BP.%2BJ.%26aulast%3DPals%26aufirst%3DC.%2BE.%2BM.%2BG.%26aulast%3DMeerding%26aufirst%3DJ.%26aulast%3DBerkers%26aufirst%3DC.%2BR.%26aulast%3DBarbi%26aufirst%3DJ.%26aulast%3DGr%25C3%25B6ne%26aufirst%3DA.%26aulast%3DSijts%26aufirst%3DA.%2BJ.%2BA.%2BM.%26aulast%3DMaurice%26aufirst%3DM.%2BM.%26aulast%3DKalkhoven%26aufirst%3DE.%26aulast%3DPrakken%26aufirst%3DB.%2BJ.%26aulast%3DOvaa%26aufirst%3DH.%26aulast%3DPan%26aufirst%3DF.%26aulast%3DZaiss%26aufirst%3DD.%2BM.%2BW.%26aulast%3DCoffer%26aufirst%3DP.%2BJ.%26atitle%3DStabilization%2520of%2520the%2520Transcription%2520Factor%2520Foxp3%2520by%2520the%2520Deubiquitinase%2520USP7%2520Increases%2520Treg-Cell-Suppressive%2520Capacity%26jtitle%3DImmunity%26date%3D2013%26volume%3D39%26spage%3D259%26epage%3D271%26doi%3D10.1016%2Fj.immuni.2013.05.018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Agathanggelou, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davies, N. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kwok, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zlatanou, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oldreive, C. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mao, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Da Costa, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yadollahi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perry, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kearns, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Skowronska, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yates, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parry, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hillmen, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reverdy, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Delansorne, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paneesha, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pratt, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moss, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taylor, A. M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stewart, G. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stankovic, T.</span></span> <span> </span><span class="NLM_article-title">USP7 Inhibition Alters Homologous Recombination Repair and Targets CLL Cells Independently of ATM/p53 Functional Status</span>. <i>Blood</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>130</i></span>,  <span class="NLM_fpage">156</span>– <span class="NLM_lpage">166</span>, <span class="refDoi"> DOI: 10.1182/blood-2016-12-758219</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00245&amp;key=10.1182%2Fblood-2016-12-758219" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00245&amp;key=28495793" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00245&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhs1WnurnJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=130&publication_year=2017&pages=156-166&author=A.+Agathanggelouauthor=E.+Smithauthor=N.+J.+Daviesauthor=M.+Kwokauthor=A.+Zlatanouauthor=C.+E.+Oldreiveauthor=J.+Maoauthor=D.+Da+Costaauthor=S.+Yadollahiauthor=T.+Perryauthor=P.+Kearnsauthor=A.+Skowronskaauthor=E.+Yatesauthor=H.+Parryauthor=P.+Hillmenauthor=C.+Reverdyauthor=R.+Delansorneauthor=S.+Paneeshaauthor=G.+Prattauthor=P.+Mossauthor=A.+M.+R.+Taylorauthor=G.+S.+Stewartauthor=T.+Stankovic&title=USP7+Inhibition+Alters+Homologous+Recombination+Repair+and+Targets+CLL+Cells+Independently+of+ATM%2Fp53+Functional+Status&doi=10.1182%2Fblood-2016-12-758219"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">USP7 inhibition alters homologous recombination repair and targets CLL cells independently of ATM/p53 functional status</span></div><div class="casAuthors">Agathanggelou, Angelo; Smith, Edward; Davies, Nicholas J.; Kwok, Marwan; Zlatanou, Anastasia; Oldreive, Ceri E.; Mao, Jingwen; Costa, David Da; Yadollahi, Sina; Perry, Tracey; Kearns, Pamela; Skowronska, Anna; Yates, Elliot; Parry, Helen; Hillmen, Peter; Reverdy, Celine; Delansorne, Remi; Paneesha, Shankara; Pratt, Guy; Moss, Paul; Taylor, A. Malcolm R.; Stewart, Grant S.; Stankovic, Tatjana</div><div class="citationInfo"><span class="NLM_cas:title">Blood</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">130</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">156-166</span>CODEN:
                <span class="NLM_cas:coden">BLOOAW</span>;
        ISSN:<span class="NLM_cas:issn">1528-0020</span>.
    
            (<span class="NLM_cas:orgname">American Society of Hematology</span>)
        </div><div class="casAbstract">The role of deubiquitylase ubiquitin-specific protease 7 (USP7) in the regulation of the p53-dependent DNA damage response (DDR) pathway is well established.  Whereas previous studies have mostly focused on the mechanisms underlying how USP7 directly controls p53 stability, we recently showed that USP7 modulates the stability of the DNA damage responsive E3 ubiquitin ligase RAD18.  This suggests that targeting USP7 may have therapeutic potential even in tumors with defective p53 or ibrutinib resistance.  To test this hypothesis, we studied the effect of USP7 inhibition in chronic lymphocytic leukemia (CLL) where the ataxia telangiectasia mutated (ATM)-p53 pathway is inactivated with relatively high frequency, leading to treatment resistance and poor clin. outcome.  We demonstrate that USP7 is upregulated in CLL cells, and its loss or inhibition disrupts homologous recombination repair (HRR).  Consequently, USP7 inhibition induces significant tumor-cell killing independently of ATM and p53 through the accumulation of genotoxic levels of DNA damage.  Moreover, USP7 inhibition sensitized p53-defective, chemotherapy-resistant CLL cells to clin. achievable doses of HRR-inducing chemotherapeutic agents in vitro and in vivo in a murine xenograft model.  Together, these results identify USP7 as a promising therapeutic target for the treatment of hematol. malignancies with DDR defects, where ATM/p53-dependent apoptosis is compromised.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrxu8cU2EjofrVg90H21EOLACvtfcHk0lhVnNWSJ33brQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhs1WnurnJ&md5=bfde319950ac91d43cd96aa35ded6cef</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1182%2Fblood-2016-12-758219&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1182%252Fblood-2016-12-758219%26sid%3Dliteratum%253Aachs%26aulast%3DAgathanggelou%26aufirst%3DA.%26aulast%3DSmith%26aufirst%3DE.%26aulast%3DDavies%26aufirst%3DN.%2BJ.%26aulast%3DKwok%26aufirst%3DM.%26aulast%3DZlatanou%26aufirst%3DA.%26aulast%3DOldreive%26aufirst%3DC.%2BE.%26aulast%3DMao%26aufirst%3DJ.%26aulast%3DDa%2BCosta%26aufirst%3DD.%26aulast%3DYadollahi%26aufirst%3DS.%26aulast%3DPerry%26aufirst%3DT.%26aulast%3DKearns%26aufirst%3DP.%26aulast%3DSkowronska%26aufirst%3DA.%26aulast%3DYates%26aufirst%3DE.%26aulast%3DParry%26aufirst%3DH.%26aulast%3DHillmen%26aufirst%3DP.%26aulast%3DReverdy%26aufirst%3DC.%26aulast%3DDelansorne%26aufirst%3DR.%26aulast%3DPaneesha%26aufirst%3DS.%26aulast%3DPratt%26aufirst%3DG.%26aulast%3DMoss%26aufirst%3DP.%26aulast%3DTaylor%26aufirst%3DA.%2BM.%2BR.%26aulast%3DStewart%26aufirst%3DG.%2BS.%26aulast%3DStankovic%26aufirst%3DT.%26atitle%3DUSP7%2520Inhibition%2520Alters%2520Homologous%2520Recombination%2520Repair%2520and%2520Targets%2520CLL%2520Cells%2520Independently%2520of%2520ATM%252Fp53%2520Functional%2520Status%26jtitle%3DBlood%26date%3D2017%26volume%3D130%26spage%3D156%26epage%3D166%26doi%3D10.1182%2Fblood-2016-12-758219" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Li, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, H.-M.</span></span> <span> </span><span class="NLM_article-title">Recent Advances in the Development of Ubiquitin-Specific-Processing Protease 7 (USP7) Inhibitors</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>191</i></span>,  <span class="NLM_fpage">112107</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2020.112107</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00245&amp;key=10.1016%2Fj.ejmech.2020.112107" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00245&amp;key=32092586" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00245&amp;key=1%3ACAS%3A528%3ADC%252BB3cXjvVGqur4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=191&publication_year=2020&pages=112107&author=P.+Liauthor=H.-M.+Liu&title=Recent+Advances+in+the+Development+of+Ubiquitin-Specific-Processing+Protease+7+%28USP7%29+Inhibitors&doi=10.1016%2Fj.ejmech.2020.112107"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Recent advances in the development of ubiquitin-specific-processing protease 7 (USP7) inhibitors</span></div><div class="casAuthors">Li, Peng; Liu, Hong-Min</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">191</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">112107</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">A review.  Ubiquitin-specific-processing protease 7 (USP7) is one among the several deubiquitinating enzymes gaining central attention in the current cancer research.  Most recent studies have focused on illustrating how USP7 is involved in the cancer process, while few articles reported the development of small mol. USP7 inhibitors.  Although some review articles dealt with USP7, they mainly focused on its physiol. role and not on the development of USP7 inhibitors.  In this review, we systematically summarise the structures, activities and structure-activity relationship (SAR) of small mol. USP7 inhibitors, recently disclosed in scientific articles and patents from 2000 to 2019.  The binding modes of typical compds. and their interactions with USP7 are also presented, while other deubiquitinase inhibitors are described in detail.  Meanwhile, we briefly introduce the biochem. and physiol. functions of USP7.  Finally, challenges and potential strategies in developing small mol. USP7 inhibitors are also discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoCKYtfXngDkbVg90H21EOLACvtfcHk0lhVnNWSJ33brQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXjvVGqur4%253D&md5=3dc04b7fdb4f6e7195b71e8749b76277</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2020.112107&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2020.112107%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DP.%26aulast%3DLiu%26aufirst%3DH.-M.%26atitle%3DRecent%2520Advances%2520in%2520the%2520Development%2520of%2520Ubiquitin-Specific-Processing%2520Protease%25207%2520%2528USP7%2529%2520Inhibitors%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2020%26volume%3D191%26spage%3D112107%26doi%3D10.1016%2Fj.ejmech.2020.112107" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Colland, F.</span>; <span class="NLM_string-name">Gourdel, M.-E.</span></span> <span> </span><span class="NLM_article-title">Selective and Reversible Inhibitors of Ubiquitin Specific Protease 7</span>. <span class="NLM_patent">WO 2013030218 A1</span>, <span class="NLM_year">2013</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2013&author=F.+Colland&author=M.-E.+Gourdel&title=Selective+and+Reversible+Inhibitors+of+Ubiquitin+Specific+Protease+7"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DColland%26aufirst%3DF.%26atitle%3DSelective%2520and%2520Reversible%2520Inhibitors%2520of%2520Ubiquitin%2520Specific%2520Protease%25207%26date%3D2013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Turnbull, A. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ioannidis, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krajewski, W. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pinto-Fernandez, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heride, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martin, A. C. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tonkin, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Townsend, E. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buker, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lancia, D. R.,  Jr.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Caravella, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Toms, A. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Charlton, T. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lahdenranta, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilker, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Follows, B. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Evans, N. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stead, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alli, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zarayskiy, V. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Talbot, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buckmelter, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McKinnon, C. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saab, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McGouran, J. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Century, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gersch, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pittman, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marshall, C. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Raynham, T. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Simcox, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stewart, L. M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McLoughlin, S. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Escobedo, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bair, K. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dinsmore, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hammonds, T. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Urbé, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clague, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kessler, B. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Komander, D.</span></span> <span> </span><span class="NLM_article-title">Molecular basis of USP7 inhibition by selective small-molecule inhibitors</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>550</i></span>,  <span class="NLM_fpage">481</span>– <span class="NLM_lpage">486</span>, <span class="refDoi"> DOI: 10.1038/nature24451</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00245&amp;key=10.1038%2Fnature24451" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00245&amp;key=29045389" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00245&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhs1OhtrnK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=550&publication_year=2017&pages=481-486&author=A.+P.+Turnbullauthor=S.+Ioannidisauthor=W.+W.+Krajewskiauthor=A.+Pinto-Fernandezauthor=C.+Herideauthor=A.+C.+L.+Martinauthor=L.+M.+Tonkinauthor=E.+C.+Townsendauthor=S.+M.+Bukerauthor=D.+R.+Lanciaauthor=J.+A.+Caravellaauthor=A.+V.+Tomsauthor=T.+M.+Charltonauthor=J.+Lahdenrantaauthor=E.+Wilkerauthor=B.+C.+Followsauthor=N.+J.+Evansauthor=L.+Steadauthor=C.+Alliauthor=V.+V.+Zarayskiyauthor=A.+C.+Talbotauthor=A.+J.+Buckmelterauthor=M.+Wangauthor=C.+L.+McKinnonauthor=F.+Saabauthor=J.+F.+McGouranauthor=H.+Centuryauthor=M.+Gerschauthor=M.+S.+Pittmanauthor=C.+G.+Marshallauthor=T.+M.+Raynhamauthor=M.+Simcoxauthor=L.+M.+D.+Stewartauthor=S.+B.+McLoughlinauthor=J.+A.+Escobedoauthor=K.+W.+Bairauthor=C.+J.+Dinsmoreauthor=T.+R.+Hammondsauthor=S.+Kimauthor=S.+Urb%C3%A9author=M.+J.+Clagueauthor=B.+M.+Kesslerauthor=D.+Komander&title=Molecular+basis+of+USP7+inhibition+by+selective+small-molecule+inhibitors&doi=10.1038%2Fnature24451"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular basis of USP7 inhibition by selective small-molecule inhibitors</span></div><div class="casAuthors">Turnbull, Andrew P.; Ioannidis, Stephanos; Krajewski, Wojciech W.; Pinto-Fernandez, Adan; Heride, Claire; Martin, Agnes C. L.; Tonkin, Louise M.; Townsend, Elizabeth C.; Buker, Shane M.; Lancia, David R.; Caravella, Justin A.; Toms, Angela V.; Charlton, Thomas M.; Lahdenranta, Johanna; Wilker, Erik; Follows, Bruce C.; Evans, Nicola J.; Stead, Lucy; Alli, Cristina; Zarayskiy, Vladislav V.; Talbot, Adam C.; Buckmelter, Alexandre J.; Wang, Minghua; McKinnon, Crystal L.; Saab, Fabienne; McGouran, Joanna F.; Century, Hannah; Gersch, Malte; Pittman, Marc S.; Marshall, C. Gary; Raynham, Tony M.; Simcox, Mary; Stewart, Lorna M. D.; McLoughlin, Sheila B.; Escobedo, Jaime A.; Bair, Kenneth W.; Dinsmore, Christopher J.; Hammonds, Tim R.; Kim, Sunkyu; Urbe, Sylvie; Clague, Michael J.; Kessler, Benedikt M.; Komander, David</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">550</span>
        (<span class="NLM_cas:issue">7677</span>),
    <span class="NLM_cas:pages">481-486</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Research</span>)
        </div><div class="casAbstract">Ubiquitination controls the stability of most cellular proteins, and its deregulation contributes to human diseases including cancer.  Deubiquitinases remove ubiquitin from proteins, and their inhibition can induce the degrdn. of selected proteins, potentially including otherwise 'undruggable' targets.  For example, the inhibition of ubiquitin-specific protease 7 (USP7) results in the degrdn. of the oncogenic E3 ligase MDM2, and leads to reactivation of the tumor suppressor p53 in various cancers.  Here the authors report that two compds., FT671 and FT827, inhibit USP7 with high affinity and specificity in vitro and within human cells.  Cocrystal structures reveal that both compds. target a dynamic pocket near the catalytic center of the auto-inhibited apo form of USP7, which differs from other USP deubiquitinases.  Consistent with USP7 target engagement in cells, FT671 destabilizes USP7 substrates including MDM2, increases levels of p53, and results in the transcription of p53 target genes, induction of the tumor suppressor p21, and inhibition of tumor growth in mice.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqR8apmCZU85rVg90H21EOLACvtfcHk0liNQ7h0xpt9qA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhs1OhtrnK&md5=166efb5b9de6304829c09fa3e4fb540a</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1038%2Fnature24451&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature24451%26sid%3Dliteratum%253Aachs%26aulast%3DTurnbull%26aufirst%3DA.%2BP.%26aulast%3DIoannidis%26aufirst%3DS.%26aulast%3DKrajewski%26aufirst%3DW.%2BW.%26aulast%3DPinto-Fernandez%26aufirst%3DA.%26aulast%3DHeride%26aufirst%3DC.%26aulast%3DMartin%26aufirst%3DA.%2BC.%2BL.%26aulast%3DTonkin%26aufirst%3DL.%2BM.%26aulast%3DTownsend%26aufirst%3DE.%2BC.%26aulast%3DBuker%26aufirst%3DS.%2BM.%26aulast%3DLancia%26aufirst%3DD.%2BR.%26aulast%3DCaravella%26aufirst%3DJ.%2BA.%26aulast%3DToms%26aufirst%3DA.%2BV.%26aulast%3DCharlton%26aufirst%3DT.%2BM.%26aulast%3DLahdenranta%26aufirst%3DJ.%26aulast%3DWilker%26aufirst%3DE.%26aulast%3DFollows%26aufirst%3DB.%2BC.%26aulast%3DEvans%26aufirst%3DN.%2BJ.%26aulast%3DStead%26aufirst%3DL.%26aulast%3DAlli%26aufirst%3DC.%26aulast%3DZarayskiy%26aufirst%3DV.%2BV.%26aulast%3DTalbot%26aufirst%3DA.%2BC.%26aulast%3DBuckmelter%26aufirst%3DA.%2BJ.%26aulast%3DWang%26aufirst%3DM.%26aulast%3DMcKinnon%26aufirst%3DC.%2BL.%26aulast%3DSaab%26aufirst%3DF.%26aulast%3DMcGouran%26aufirst%3DJ.%2BF.%26aulast%3DCentury%26aufirst%3DH.%26aulast%3DGersch%26aufirst%3DM.%26aulast%3DPittman%26aufirst%3DM.%2BS.%26aulast%3DMarshall%26aufirst%3DC.%2BG.%26aulast%3DRaynham%26aufirst%3DT.%2BM.%26aulast%3DSimcox%26aufirst%3DM.%26aulast%3DStewart%26aufirst%3DL.%2BM.%2BD.%26aulast%3DMcLoughlin%26aufirst%3DS.%2BB.%26aulast%3DEscobedo%26aufirst%3DJ.%2BA.%26aulast%3DBair%26aufirst%3DK.%2BW.%26aulast%3DDinsmore%26aufirst%3DC.%2BJ.%26aulast%3DHammonds%26aufirst%3DT.%2BR.%26aulast%3DKim%26aufirst%3DS.%26aulast%3DUrb%25C3%25A9%26aufirst%3DS.%26aulast%3DClague%26aufirst%3DM.%2BJ.%26aulast%3DKessler%26aufirst%3DB.%2BM.%26aulast%3DKomander%26aufirst%3DD.%26atitle%3DMolecular%2520basis%2520of%2520USP7%2520inhibition%2520by%2520selective%2520small-molecule%2520inhibitors%26jtitle%3DNature%26date%3D2017%26volume%3D550%26spage%3D481%26epage%3D486%26doi%3D10.1038%2Fnature24451" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gavory, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Dowd, C. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Helm, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Flasz, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arkoudis, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dossang, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hughes, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cassidy, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McClelland, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Odrzywol, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Page, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barker, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miel, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harrison, T.</span></span> <span> </span><span class="NLM_article-title">Discovery and Characterization of Highly Potent and Selective Allosteric USP7 Inhibitors</span>. <i>Nat. Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">118</span>– <span class="NLM_lpage">125</span>, <span class="refDoi"> DOI: 10.1038/nchembio.2528</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00245&amp;key=10.1038%2Fnchembio.2528" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00245&amp;key=29200206" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00245&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhvFWgs77F" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2018&pages=118-125&author=G.+Gavoryauthor=C.+R.+O%E2%80%99Dowdauthor=M.+D.+Helmauthor=J.+Flaszauthor=E.+Arkoudisauthor=A.+Dossangauthor=C.+Hughesauthor=E.+Cassidyauthor=K.+McClellandauthor=E.+Odrzywolauthor=N.+Pageauthor=O.+Barkerauthor=H.+Mielauthor=T.+Harrison&title=Discovery+and+Characterization+of+Highly+Potent+and+Selective+Allosteric+USP7+Inhibitors&doi=10.1038%2Fnchembio.2528"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery and characterization of highly potent and selective allosteric USP7 inhibitors</span></div><div class="casAuthors">Gavory, Gerald; O'Dowd, Colin R.; Helm, Matthew D.; Flasz, Jakub; Arkoudis, Elias; Dossang, Anthony; Hughes, Caroline; Cassidy, Eamon; McClelland, Keeva; Odrzywol, Ewa; Page, Natalie; Barker, Oliver; Miel, Hugues; Harrison, Timothy</div><div class="citationInfo"><span class="NLM_cas:title">Nature Chemical Biology</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">118-125</span>CODEN:
                <span class="NLM_cas:coden">NCBABT</span>;
        ISSN:<span class="NLM_cas:issn">1552-4450</span>.
    
            (<span class="NLM_cas:orgname">Nature Research</span>)
        </div><div class="casAbstract">Given the importance of ubiquitin-specific protease 7 (USP7) in oncogenic pathways, identification of USP7 inhibitors has attracted considerable interest.  Despite substantial efforts, however, the development of validated deubiquitinase (DUB) inhibitors that exhibit drug-like properties and a well-defined mechanism of action has proven particularly challenging.  In this article, we describe the identification, optimization and detailed characterization of highly potent (IC50 < 10 nM), selective USP7 inhibitors together with their less active, enantiomeric counterparts.  We also disclose, for the first time, co-crystal structures of a human DUB enzyme complexed with small-mol. inhibitors, which reveal a previously undisclosed allosteric binding site.  Finally, we report the identification of cancer cell lines hypersensitive to USP7 inhibition (EC50 < 30 nM) and demonstrate equal or superior activity in these cell models compared to clin. relevant MDM2 antagonists.  Overall, these findings demonstrate the tractability and druggability of DUBs, and provide important tools for addnl. target validation studies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqe5GeOEWbfz7Vg90H21EOLACvtfcHk0liNQ7h0xpt9qA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhvFWgs77F&md5=de6068d105b681c319e76e81ebfe9676</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1038%2Fnchembio.2528&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnchembio.2528%26sid%3Dliteratum%253Aachs%26aulast%3DGavory%26aufirst%3DG.%26aulast%3DO%25E2%2580%2599Dowd%26aufirst%3DC.%2BR.%26aulast%3DHelm%26aufirst%3DM.%2BD.%26aulast%3DFlasz%26aufirst%3DJ.%26aulast%3DArkoudis%26aufirst%3DE.%26aulast%3DDossang%26aufirst%3DA.%26aulast%3DHughes%26aufirst%3DC.%26aulast%3DCassidy%26aufirst%3DE.%26aulast%3DMcClelland%26aufirst%3DK.%26aulast%3DOdrzywol%26aufirst%3DE.%26aulast%3DPage%26aufirst%3DN.%26aulast%3DBarker%26aufirst%3DO.%26aulast%3DMiel%26aufirst%3DH.%26aulast%3DHarrison%26aufirst%3DT.%26atitle%3DDiscovery%2520and%2520Characterization%2520of%2520Highly%2520Potent%2520and%2520Selective%2520Allosteric%2520USP7%2520Inhibitors%26jtitle%3DNat.%2520Chem.%2520Biol.%26date%3D2018%26volume%3D14%26spage%3D118%26epage%3D125%26doi%3D10.1038%2Fnchembio.2528" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kotschy, A.</span>; <span class="NLM_string-name">Wéber, C.</span>; <span class="NLM_string-name">Vasas, A.</span>; <span class="NLM_string-name">Molnár, B.</span>; <span class="NLM_string-name">Kiss, Á.</span>; <span class="NLM_string-name">Macias, A.</span>; <span class="NLM_string-name">Murray, J. B.</span>; <span class="NLM_string-name">Lewkowicz, E.</span>; <span class="NLM_string-name">Geneste, O.</span>; <span class="NLM_string-name">Chanrion, M.</span>; <span class="NLM_string-name">Demarles, D.</span></span> <span> </span><span class="NLM_article-title">New (Hetero)aryl-Substituted-Piperidinyl Derivatives, A Process for Their Preparation and Pharmaceutical Compositions Containing Them</span>. <span class="NLM_patent">EP 2017064062 B1</span>, <span class="NLM_year">2017</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2017&author=A.+Kotschy&author=C.+W%C3%A9ber&author=A.+Vasas&author=B.+Moln%C3%A1r&author=%C3%81.+Kiss&author=A.+Macias&author=J.+B.+Murray&author=E.+Lewkowicz&author=O.+Geneste&author=M.+Chanrion&author=D.+Demarles&title=New+%28Hetero%29aryl-Substituted-Piperidinyl+Derivatives%2C+A+Process+for+Their+Preparation+and+Pharmaceutical+Compositions+Containing+Them"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DKotschy%26aufirst%3DA.%26atitle%3DNew%2520%2528Hetero%2529aryl-Substituted-Piperidinyl%2520Derivatives%252C%2520A%2520Process%2520for%2520Their%2520Preparation%2520and%2520Pharmaceutical%2520Compositions%2520Containing%2520Them%26date%3D2017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lamberto, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seo, H.-S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schauer, N. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iacob, R. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Das, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mikhailova, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weisberg, E. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Engen, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anderson, K. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chauhan, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dhe-Paganon, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buhrlage, S. J.</span></span> <span> </span><span class="NLM_article-title">Structure-Guided Development of a Potent and Selective Non-Covalent Active-Site Inhibitor of USP7</span>. <i>Cell Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>24</i></span>,  <span class="NLM_fpage">1490</span>– <span class="NLM_lpage">1500</span>, <span class="refDoi"> DOI: 10.1016/j.chembiol.2017.09.003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00245&amp;key=10.1016%2Fj.chembiol.2017.09.003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00245&amp;key=29056421" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00245&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhs1yrt7bM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2017&pages=1490-1500&author=I.+Lambertoauthor=X.+Liuauthor=H.-S.+Seoauthor=N.+J.+Schauerauthor=R.+E.+Iacobauthor=W.+Huauthor=D.+Dasauthor=T.+Mikhailovaauthor=E.+L.+Weisbergauthor=J.+R.+Engenauthor=K.+C.+Andersonauthor=D.+Chauhanauthor=S.+Dhe-Paganonauthor=S.+J.+Buhrlage&title=Structure-Guided+Development+of+a+Potent+and+Selective+Non-Covalent+Active-Site+Inhibitor+of+USP7&doi=10.1016%2Fj.chembiol.2017.09.003"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-Guided Development of a Potent and Selective Non-covalent Active-Site Inhibitor of USP7</span></div><div class="casAuthors">Lamberto, Ilaria; Liu, Xiaoxi; Seo, Hyuk-Soo; Schauer, Nathan J.; Iacob, Roxana E.; Hu, Wanyi; Das, Deepika; Mikhailova, Tatiana; Weisberg, Ellen L.; Engen, John R.; Anderson, Kenneth C.; Chauhan, Dharminder; Dhe-Paganon, Sirano; Buhrlage, Sara J.</div><div class="citationInfo"><span class="NLM_cas:title">Cell Chemical Biology</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1490-1500.e11</span>CODEN:
                <span class="NLM_cas:coden">CCBEBM</span>;
        ISSN:<span class="NLM_cas:issn">2451-9448</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Deubiquitinating enzymes (DUBs) have garnered significant attention as drug targets in the last 5-10 years.  The excitement stems in large part from the powerful ability of DUB inhibitors to promote degrdn. of oncogenic proteins, esp. proteins that are challenging to directly target but which are stabilized by DUB family members.  Highly optimized and well-characterized DUB inhibitors have thus become highly sought after tools.  Most reported DUB inhibitors, however, are polypharmacol. agents possessing weak (micromolar) potency toward their primary target, limiting their utility in target validation and mechanism studies.  Due to a lack of high-resoln. DUB·small-mol. ligand complex structures, no structure-guided optimization efforts have been reported for a mammalian DUB.  Here, we report a small-mol.·ubiquitin-specific protease (USP) family DUB co-structure and rapid design of potent and selective inhibitors of USP7 guided by the structure.  Interestingly, the compds. are non-covalent active-site inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrW3w_hVGZmXLVg90H21EOLACvtfcHk0ljKXLiRiBpsUg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhs1yrt7bM&md5=9a61dfb2740f07d027d10772d6f513ea</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1016%2Fj.chembiol.2017.09.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.chembiol.2017.09.003%26sid%3Dliteratum%253Aachs%26aulast%3DLamberto%26aufirst%3DI.%26aulast%3DLiu%26aufirst%3DX.%26aulast%3DSeo%26aufirst%3DH.-S.%26aulast%3DSchauer%26aufirst%3DN.%2BJ.%26aulast%3DIacob%26aufirst%3DR.%2BE.%26aulast%3DHu%26aufirst%3DW.%26aulast%3DDas%26aufirst%3DD.%26aulast%3DMikhailova%26aufirst%3DT.%26aulast%3DWeisberg%26aufirst%3DE.%2BL.%26aulast%3DEngen%26aufirst%3DJ.%2BR.%26aulast%3DAnderson%26aufirst%3DK.%2BC.%26aulast%3DChauhan%26aufirst%3DD.%26aulast%3DDhe-Paganon%26aufirst%3DS.%26aulast%3DBuhrlage%26aufirst%3DS.%2BJ.%26atitle%3DStructure-Guided%2520Development%2520of%2520a%2520Potent%2520and%2520Selective%2520Non-Covalent%2520Active-Site%2520Inhibitor%2520of%2520USP7%26jtitle%3DCell%2520Chem.%2520Biol.%26date%3D2017%26volume%3D24%26spage%3D1490%26epage%3D1500%26doi%3D10.1016%2Fj.chembiol.2017.09.003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kategaya, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Di Lello, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rougé, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pastor, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clark, K. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Drummond, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kleinheinz, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Upton, J.-P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prakash, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heideker, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McCleland, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ritorto, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alessi, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trost, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bainbridge, T. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kwok, M. C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, T. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stiffler, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brasher, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jaishankar, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hearn, B. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Renslo, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arkin, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cohen, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peale, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gnad, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chang, M. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Klijn, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blackwood, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martin, S. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Forrest, W. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ernst, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ndubaku, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beresini, M. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsui, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schwerdtfeger, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blake, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murray, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maurer, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wertz, I. E.</span></span> <span> </span><span class="NLM_article-title">USP7 Small-Molecule Inhibitors Interfere with Ubiquitin Binding</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>550</i></span>,  <span class="NLM_fpage">534</span>– <span class="NLM_lpage">538</span>, <span class="refDoi"> DOI: 10.1038/nature24006</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00245&amp;key=10.1038%2Fnature24006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00245&amp;key=29045385" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00245&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhs1OhtrjL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=550&publication_year=2017&pages=534-538&author=L.+Kategayaauthor=P.+Di+Lelloauthor=L.+Roug%C3%A9author=R.+Pastorauthor=K.+R.+Clarkauthor=J.+Drummondauthor=T.+Kleinheinzauthor=E.+Linauthor=J.-P.+Uptonauthor=S.+Prakashauthor=J.+Heidekerauthor=M.+McClelandauthor=M.+S.+Ritortoauthor=D.+R.+Alessiauthor=M.+Trostauthor=T.+W.+Bainbridgeauthor=M.+C.+M.+Kwokauthor=T.+P.+Maauthor=Z.+Stifflerauthor=B.+Brasherauthor=Y.+Tangauthor=P.+Jaishankarauthor=B.+R.+Hearnauthor=A.+R.+Rensloauthor=M.+R.+Arkinauthor=F.+Cohenauthor=K.+Yuauthor=F.+Pealeauthor=F.+Gnadauthor=M.+T.+Changauthor=C.+Klijnauthor=E.+Blackwoodauthor=S.+E.+Martinauthor=W.+F.+Forrestauthor=J.+A.+Ernstauthor=C.+Ndubakuauthor=X.+Wangauthor=M.+H.+Beresiniauthor=V.+Tsuiauthor=C.+Schwerdtfegerauthor=R.+A.+Blakeauthor=J.+Murrayauthor=T.+Maurerauthor=I.+E.+Wertz&title=USP7+Small-Molecule+Inhibitors+Interfere+with+Ubiquitin+Binding&doi=10.1038%2Fnature24006"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">USP7 small-molecule inhibitors interfere with ubiquitin binding</span></div><div class="casAuthors">Kategaya, Lorna; Di Lello, Paola; Rouge, Lionel; Pastor, Richard; Clark, Kevin R.; Drummond, Jason; Kleinheinz, Tracy; Lin, Eva; Upton, John-Paul; Prakash, Sumit; Heideker, Johanna; McCleland, Mark; Ritorto, Maria Stella; Alessi, Dario R.; Trost, Matthias; Bainbridge, Travis W.; Kwok, Michael C. M.; Ma, Taylur P.; Stiffler, Zachary; Brasher, Bradley; Tang, Yinyan; Jaishankar, Priyadarshini; Hearn, Brian R.; Renslo, Adam R.; Arkin, Michelle R.; Cohen, Frederick; Yu, Kebing; Peale, Frank; Gnad, Florian; Chang, Matthew T.; Klijn, Christiaan; Blackwood, Elizabeth; Martin, Scott E.; Forrest, William F.; Ernst, James A.; Ndubaku, Chudi; Wang, Xiaojing; Beresini, Maureen H.; Tsui, Vickie; Schwerdtfeger, Carsten; Blake, Robert A.; Murray, Jeremy; Maurer, Till; Wertz, Ingrid E.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">550</span>
        (<span class="NLM_cas:issue">7677</span>),
    <span class="NLM_cas:pages">534-538</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Research</span>)
        </div><div class="casAbstract">The ubiquitin system regulates essential cellular processes in eukaryotes.  Ubiquitin is ligated to substrate proteins as monomers or chains and the topol. of ubiquitin modifications regulates substrate interactions with specific proteins.  Thus, ubiquitination directs a variety of substrate fates including proteasomal degrdn.  Deubiquitinases cleave ubiquitin from substrates and are implicated in disease; e.g., ubiquitin-specific protease-7 (USP7) regulates the stability of the p53 tumor suppressor and other proteins crit. for tumor cell survival.  However, developing selective deubiquitinase inhibitors has been challenging and no co-crystal structures have been solved with small-mol. inhibitors.  Here, using NMR-based screening and structure-based design, we describe the development of the selective USP7 inhibitors, GNE-6640 and GNE-6776.  These compds. induce tumor cell death and enhance cytotoxicity with chemotherapeutic agents and targeted compds., including PIM kinase inhibitors.  Structural studies revealed that GNE-6640 and GNE-6776 non-covalently targeted USP7 12 Å distant from the catalytic Cys residue.  The compds. attenuated ubiquitin binding and thus inhibited USP7 deubiquitinase activity.  GNE-6640 and GNE-6776 interacted with acidic residues that mediate H-bond interactions with the ubiquitin Lys-48 side-chain, suggesting that USP7 preferentially interacts with and cleaves ubiquitin moieties that have free Lys-48 side-chains.  We investigated this idea by engineering di-ubiquitin chains contg. differential proximal and distal isotopic labels and measuring USP7 binding by NMR.  This preferential binding protracted the depolymn. kinetics of Lys-48-linked ubiquitin chains relative to Lys-63-linked chains.  In summary, engineering compds. that inhibit USP7 activity by attenuating ubiquitin binding suggests opportunities for developing other deubiquitinase inhibitors and may be a strategy more broadly applicable to inhibiting proteins that require ubiquitin binding for full functional activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqDUMQKwY0VGbVg90H21EOLACvtfcHk0ljKXLiRiBpsUg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhs1OhtrjL&md5=85af379796b4026105815b5ffdd01f8d</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1038%2Fnature24006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature24006%26sid%3Dliteratum%253Aachs%26aulast%3DKategaya%26aufirst%3DL.%26aulast%3DDi%2BLello%26aufirst%3DP.%26aulast%3DRoug%25C3%25A9%26aufirst%3DL.%26aulast%3DPastor%26aufirst%3DR.%26aulast%3DClark%26aufirst%3DK.%2BR.%26aulast%3DDrummond%26aufirst%3DJ.%26aulast%3DKleinheinz%26aufirst%3DT.%26aulast%3DLin%26aufirst%3DE.%26aulast%3DUpton%26aufirst%3DJ.-P.%26aulast%3DPrakash%26aufirst%3DS.%26aulast%3DHeideker%26aufirst%3DJ.%26aulast%3DMcCleland%26aufirst%3DM.%26aulast%3DRitorto%26aufirst%3DM.%2BS.%26aulast%3DAlessi%26aufirst%3DD.%2BR.%26aulast%3DTrost%26aufirst%3DM.%26aulast%3DBainbridge%26aufirst%3DT.%2BW.%26aulast%3DKwok%26aufirst%3DM.%2BC.%2BM.%26aulast%3DMa%26aufirst%3DT.%2BP.%26aulast%3DStiffler%26aufirst%3DZ.%26aulast%3DBrasher%26aufirst%3DB.%26aulast%3DTang%26aufirst%3DY.%26aulast%3DJaishankar%26aufirst%3DP.%26aulast%3DHearn%26aufirst%3DB.%2BR.%26aulast%3DRenslo%26aufirst%3DA.%2BR.%26aulast%3DArkin%26aufirst%3DM.%2BR.%26aulast%3DCohen%26aufirst%3DF.%26aulast%3DYu%26aufirst%3DK.%26aulast%3DPeale%26aufirst%3DF.%26aulast%3DGnad%26aufirst%3DF.%26aulast%3DChang%26aufirst%3DM.%2BT.%26aulast%3DKlijn%26aufirst%3DC.%26aulast%3DBlackwood%26aufirst%3DE.%26aulast%3DMartin%26aufirst%3DS.%2BE.%26aulast%3DForrest%26aufirst%3DW.%2BF.%26aulast%3DErnst%26aufirst%3DJ.%2BA.%26aulast%3DNdubaku%26aufirst%3DC.%26aulast%3DWang%26aufirst%3DX.%26aulast%3DBeresini%26aufirst%3DM.%2BH.%26aulast%3DTsui%26aufirst%3DV.%26aulast%3DSchwerdtfeger%26aufirst%3DC.%26aulast%3DBlake%26aufirst%3DR.%2BA.%26aulast%3DMurray%26aufirst%3DJ.%26aulast%3DMaurer%26aufirst%3DT.%26aulast%3DWertz%26aufirst%3DI.%2BE.%26atitle%3DUSP7%2520Small-Molecule%2520Inhibitors%2520Interfere%2520with%2520Ubiquitin%2520Binding%26jtitle%3DNature%26date%3D2017%26volume%3D550%26spage%3D534%26epage%3D538%26doi%3D10.1038%2Fnature24006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Di
Lello, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pastor, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murray, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blake, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cohen, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Crawford, T. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Drobnick, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Drummond, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kategaya, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kleinheinz, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maurer, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rougé, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wertz, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ndubaku, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsui, V.</span></span> <span> </span><span class="NLM_article-title">Discovery of Small-Molecule Inhibitors of Ubiquitin Specific Protease 7 (USP7) Using Integrated NMR and in Silico Techniques</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">10056</span>– <span class="NLM_lpage">10070</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.7b01293</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.7b01293" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00245&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhvVGgsbfF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=10056-10070&author=P.+Di%0ALelloauthor=R.+Pastorauthor=J.+M.+Murrayauthor=R.+A.+Blakeauthor=F.+Cohenauthor=T.+D.+Crawfordauthor=J.+Drobnickauthor=J.+Drummondauthor=L.+Kategayaauthor=T.+Kleinheinzauthor=T.+Maurerauthor=L.+Roug%C3%A9author=X.+Zhaoauthor=I.+Wertzauthor=C.+Ndubakuauthor=V.+Tsui&title=Discovery+of+Small-Molecule+Inhibitors+of+Ubiquitin+Specific+Protease+7+%28USP7%29+Using+Integrated+NMR+and+in+Silico+Techniques&doi=10.1021%2Facs.jmedchem.7b01293"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of Small-Molecule Inhibitors of Ubiquitin Specific Protease 7 (USP7) Using Integrated NMR and in Silico Techniques</span></div><div class="casAuthors">Di Lello, Paola; Pastor, Richard; Murray, Jeremy M.; Blake, Robert A.; Cohen, Frederick; Crawford, Terry D.; Drobnick, Joy; Drummond, Jason; Kategaya, Lorna; Kleinheinz, Tracy; Maurer, Till; Rouge, Lionel; Zhao, Xianrui; Wertz, Ingrid; Ndubaku, Chudi; Tsui, Vickie</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">10056-10070</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">USP7 is a deubiquitinase implicated in destabilizing the tumor suppressor p53, and for this reason it has gained increasing attention as a potential oncol. target for small mol. inhibitors.  Herein the authors describe the biophys., biochem., and computational approaches that led to the identification of 4-(2-aminopyridin-3-yl)phenol compds. described by Kategaya (Nature 2017, 550, 534-538) as specific inhibitors of USP7.  Fragment based lead discovery (FBLD) by NMR combined with virtual screening and remining of biochem. high-throughput screening (HTS) hits led to the discovery of a series of ligands that bind in the "palm" region of the catalytic domain of USP7 and inhibit its catalytic activity.  These ligands were then optimized by structure-based design to yield cell-active mols. with reasonable phys. properties.  This discovery process not only involved multiple techniques working in concert but also illustrated a unique way in which hits from orthogonal screening approaches complemented each other for lead identification.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr-Gro2-OKmz7Vg90H21EOLACvtfcHk0ljjJxgtgssdpA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhvVGgsbfF&md5=5eab272a1b4e03eb50857acf49f661d7</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.7b01293&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.7b01293%26sid%3Dliteratum%253Aachs%26aulast%3DDi%2BLello%26aufirst%3DP.%26aulast%3DPastor%26aufirst%3DR.%26aulast%3DMurray%26aufirst%3DJ.%2BM.%26aulast%3DBlake%26aufirst%3DR.%2BA.%26aulast%3DCohen%26aufirst%3DF.%26aulast%3DCrawford%26aufirst%3DT.%2BD.%26aulast%3DDrobnick%26aufirst%3DJ.%26aulast%3DDrummond%26aufirst%3DJ.%26aulast%3DKategaya%26aufirst%3DL.%26aulast%3DKleinheinz%26aufirst%3DT.%26aulast%3DMaurer%26aufirst%3DT.%26aulast%3DRoug%25C3%25A9%26aufirst%3DL.%26aulast%3DZhao%26aufirst%3DX.%26aulast%3DWertz%26aufirst%3DI.%26aulast%3DNdubaku%26aufirst%3DC.%26aulast%3DTsui%26aufirst%3DV.%26atitle%3DDiscovery%2520of%2520Small-Molecule%2520Inhibitors%2520of%2520Ubiquitin%2520Specific%2520Protease%25207%2520%2528USP7%2529%2520Using%2520Integrated%2520NMR%2520and%2520in%2520Silico%2520Techniques%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26spage%3D10056%26epage%3D10070%26doi%3D10.1021%2Facs.jmedchem.7b01293" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kumar, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arsenault, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mattern, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weinstock, J.</span></span> <span> </span><span class="NLM_article-title">Chemical Approaches to Intervening in Ubiquitin Specific Protease 7 (USP7) Function for Oncology and Immune Oncology Therapies</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">422</span>– <span class="NLM_lpage">443</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.7b00498</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.7b00498" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00245&amp;key=1%3ACAS%3A528%3ADC%252BC2sXht1KrurjF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2018&pages=422-443&author=J.+Wuauthor=S.+Kumarauthor=F.+Wangauthor=H.+Wangauthor=L.+Chenauthor=P.+Arsenaultauthor=M.+Matternauthor=J.+Weinstock&title=Chemical+Approaches+to+Intervening+in+Ubiquitin+Specific+Protease+7+%28USP7%29+Function+for+Oncology+and+Immune+Oncology+Therapies&doi=10.1021%2Facs.jmedchem.7b00498"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Chemical Approaches to Intervening in Ubiquitin Specific Protease 7 (USP7) Function for Oncology and Immune Oncology Therapies</span></div><div class="casAuthors">Wu, Jian; Kumar, Suresh; Wang, Feng; Wang, Hui; Chen, Lijia; Arsenault, Patrick; Mattern, Michael; Weinstock, Joseph</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">422-443</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Ubiquitin specific protease 7 (USP7), the most widely studied among the nearly 100 deubiquitinating enzymes, supports cancer by pos. affecting tumor growth and neg. affecting the patient's immune response to tumors.  Great interest exists, therefore, in developing USP7 inhibitors for clin. evaluation.  While the proteasome inhibitor field has enjoyed clin. success, very few clin. appropriate effectors of deubiquitinating (protease) or ubiquitinating (ligase) enzymes have appeared.  The ubiquitin protease/ligase field is moving from the initial discovery of potent, selective modulators with cell proof of concept and in vivo activity to the optimization of these mols. to impart drug-like properties or the discovery of new inhibitor scaffolds by improved screening or rational design.  This Perspective focuses on the current status of USP7 inhibitors from various organizations active in developing these compds. for the clinic and suggests undertakings that are both achievable and necessary to lead to successful clin. outcomes for USP7 inhibitors in cancer treatment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpvx5pZ7h4PzLVg90H21EOLACvtfcHk0ljjJxgtgssdpA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXht1KrurjF&md5=0e0bf309fb8ce8d79cb018b0734b5a37</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.7b00498&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.7b00498%26sid%3Dliteratum%253Aachs%26aulast%3DWu%26aufirst%3DJ.%26aulast%3DKumar%26aufirst%3DS.%26aulast%3DWang%26aufirst%3DF.%26aulast%3DWang%26aufirst%3DH.%26aulast%3DChen%26aufirst%3DL.%26aulast%3DArsenault%26aufirst%3DP.%26aulast%3DMattern%26aufirst%3DM.%26aulast%3DWeinstock%26aufirst%3DJ.%26atitle%3DChemical%2520Approaches%2520to%2520Intervening%2520in%2520Ubiquitin%2520Specific%2520Protease%25207%2520%2528USP7%2529%2520Function%2520for%2520Oncology%2520and%2520Immune%2520Oncology%2520Therapies%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2018%26volume%3D61%26spage%3D422%26epage%3D443%26doi%3D10.1021%2Facs.jmedchem.7b00498" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pozhidaeva, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Valles, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sterner, D. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nguyen, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weinstock, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kumar, K. G. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kanyo, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wright, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bezsonova, I.</span></span> <span> </span><span class="NLM_article-title">USP7-Specific Inhibitors Target and Modify the Enzyme’s Active Site via Distinct Chemical Mechanisms</span>. <i>Cell Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>24</i></span>,  <span class="NLM_fpage">1501</span>– <span class="NLM_lpage">1512</span>, <span class="refDoi"> DOI: 10.1016/j.chembiol.2017.09.004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00245&amp;key=10.1016%2Fj.chembiol.2017.09.004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00245&amp;key=29056420" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00245&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhs1yrt7nI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2017&pages=1501-1512&author=A.+Pozhidaevaauthor=G.+Vallesauthor=F.+Wangauthor=J.+Wuauthor=D.+E.+Sternerauthor=P.+Nguyenauthor=J.+Weinstockauthor=K.+G.+S.+Kumarauthor=J.+Kanyoauthor=D.+Wrightauthor=I.+Bezsonova&title=USP7-Specific+Inhibitors+Target+and+Modify+the+Enzyme%E2%80%99s+Active+Site+via+Distinct+Chemical+Mechanisms&doi=10.1016%2Fj.chembiol.2017.09.004"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">USP7-Specific Inhibitors Target and Modify the Enzyme's Active Site via Distinct Chemical Mechanisms</span></div><div class="casAuthors">Pozhidaeva, Alexandra; Valles, Gabrielle; Wang, Feng; Wu, Jian; Sterner, David E.; Nguyen, Phuong; Weinstock, Joseph; Kumar, K. G. Suresh; Kanyo, Jean; Wright, Dennis; Bezsonova, Irina</div><div class="citationInfo"><span class="NLM_cas:title">Cell Chemical Biology</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1501-1512.e5</span>CODEN:
                <span class="NLM_cas:coden">CCBEBM</span>;
        ISSN:<span class="NLM_cas:issn">2451-9448</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">USP7 is a deubiquitinating enzyme that plays a pivotal role in multiple oncogenic pathways and therefore is a desirable target for new anti-cancer therapies.  However, the lack of structural information about the USP7-inhibitor interactions has been a crit. gap in the development of potent inhibitors.  USP7 is unique among USPs in that its active site is catalytically incompetent, and is postulated to rearrange into a productive conformation only upon binding to ubiquitin.  Surprisingly, we found that ubiquitin alone does not induce an active conformation in soln.  Using a combination of NMR, mass spectrometry, computational modeling, and cell-based assays, we found that DUB inhibitors P22077 and P50429 covalently modify the catalytic cysteine of USP7 and induce a conformational switch in the enzyme assocd. with active site rearrangement.  This work represents the first exptl. insights into USP7 activation and inhibition and provides a structural basis for rational development of potent anti-cancer therapeutics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpq6cfJxLOHFLVg90H21EOLACvtfcHk0ljiGUhSksAORQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhs1yrt7nI&md5=8d8baef989ebbfb010640b2ecfd95ae4</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1016%2Fj.chembiol.2017.09.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.chembiol.2017.09.004%26sid%3Dliteratum%253Aachs%26aulast%3DPozhidaeva%26aufirst%3DA.%26aulast%3DValles%26aufirst%3DG.%26aulast%3DWang%26aufirst%3DF.%26aulast%3DWu%26aufirst%3DJ.%26aulast%3DSterner%26aufirst%3DD.%2BE.%26aulast%3DNguyen%26aufirst%3DP.%26aulast%3DWeinstock%26aufirst%3DJ.%26aulast%3DKumar%26aufirst%3DK.%2BG.%2BS.%26aulast%3DKanyo%26aufirst%3DJ.%26aulast%3DWright%26aufirst%3DD.%26aulast%3DBezsonova%26aufirst%3DI.%26atitle%3DUSP7-Specific%2520Inhibitors%2520Target%2520and%2520Modify%2520the%2520Enzyme%25E2%2580%2599s%2520Active%2520Site%2520via%2520Distinct%2520Chemical%2520Mechanisms%26jtitle%3DCell%2520Chem.%2520Biol.%26date%3D2017%26volume%3D24%26spage%3D1501%26epage%3D1512%26doi%3D10.1016%2Fj.chembiol.2017.09.004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ohol, Y. M.</span>; <span class="NLM_string-name">Sun, M. T.</span>; <span class="NLM_string-name">Cutler, G.</span>; <span class="NLM_string-name">Leger, P.</span>; <span class="NLM_string-name">Hu, D.</span>; <span class="NLM_string-name">Biannic, B.</span>; <span class="NLM_string-name">Rana, P.</span>; <span class="NLM_string-name">Cho, C.</span>; <span class="NLM_string-name">Jacobson, S.</span>; <span class="NLM_string-name">Wong, S.</span>; <span class="NLM_string-name">Sanchez, J.</span>; <span class="NLM_string-name">Shah, N.</span>; <span class="NLM_string-name">Young, K.</span>; <span class="NLM_string-name">Han, X.</span>; <span class="NLM_string-name">Bradford, D.</span>; <span class="NLM_string-name">Kozon, N.</span>; <span class="NLM_string-name">Abraham, B.</span>; <span class="NLM_string-name">Pookot, D.</span>; <span class="NLM_string-name">Okano, A.</span>; <span class="NLM_string-name">Maung, J.</span>; <span class="NLM_string-name">Suthram, S.</span>; <span class="NLM_string-name">Adusumilli, L.</span>; <span class="NLM_string-name">Kaveri, D.</span>; <span class="NLM_string-name">Talay, O.</span>; <span class="NLM_string-name">Marshall, L.</span>; <span class="NLM_string-name">Colas, C.</span>; <span class="NLM_string-name">Kim, A.</span>; <span class="NLM_string-name">Schwarz, J.</span>; <span class="NLM_string-name">Wustrow, D.</span>; <span class="NLM_string-name">Brockstedt, D.</span>; <span class="NLM_string-name">Kassner, P.</span></span> <span> </span><span class="NLM_article-title">Novel, Selective Inhibitors of USP7 Uncover Multiple Mechanisms of Antitumor Activity in Vitro and in Vivo</span>. Manuscript in submission, <span class="NLM_year" style="font-weight: bold;">2020</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2020&author=Y.+M.+Ohol&author=M.+T.+Sun&author=G.+Cutler&author=P.+Leger&author=D.+Hu&author=B.+Biannic&author=P.+Rana&author=C.+Cho&author=S.+Jacobson&author=S.+Wong&author=J.+Sanchez&author=N.+Shah&author=K.+Young&author=X.+Han&author=D.+Bradford&author=N.+Kozon&author=B.+Abraham&author=D.+Pookot&author=A.+Okano&author=J.+Maung&author=S.+Suthram&author=L.+Adusumilli&author=D.+Kaveri&author=O.+Talay&author=L.+Marshall&author=C.+Colas&author=A.+Kim&author=J.+Schwarz&author=D.+Wustrow&author=D.+Brockstedt&author=P.+Kassner&title=Novel%2C+Selective+Inhibitors+of+USP7+Uncover+Multiple+Mechanisms+of+Antitumor+Activity+in+Vitro+and+in+Vivo"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DOhol%26aufirst%3DY.%2BM.%26atitle%3DNovel%252C%2520Selective%2520Inhibitors%2520of%2520USP7%2520Uncover%2520Multiple%2520Mechanisms%2520of%2520Antitumor%2520Activity%2520in%2520Vitro%2520and%2520in%2520Vivo%26date%3D2020" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span> <i>Schrödinger Release 2016-2: WaterMap</i>; <span class="NLM_publisher-name">Schrödinger, LLC</span>: <span class="NLM_publisher-loc">New York,
NY</span>, <span class="NLM_year">2016</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=+Schr%C3%B6dinger+Release+2016-2%3A+WaterMap%3B+Schr%C3%B6dinger%2C+LLC%3A+New+York%2C%0ANY%2C+2016."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcomputer-program%26sid%3Dliteratum%253Aachs%26jtitle%3DSchr%25C3%25B6dinger%2520Release%25202016-2%253A%2520WaterMap%26pub%3DSchr%25C3%25B6dinger%252C%2520LLC%26date%3D2016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="note"><p class="first last">Data not shown. See ref <a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a>.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="note"><p class="first last">A strong correlation between USP7 biochemical potency and cellular p53 response suggests that this response is due to USP7 inhibitor-mediated MDM2 destabilization. See <a href="/doi/suppl/10.1021/acs.jmedchem.0c00245/suppl_file/jm0c00245_si_001.pdf" class="ext-link">Figure S1</a>.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Takahashi, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">D’Amico, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chiba, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buchhagen, D. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Minna, J. D.</span></span> <span> </span><span class="NLM_article-title">Identification of Intronic Point Mutations as an Alternative Mechanism for p53 Inactivation in Lung Cancer</span>. <i>J. Clin. Invest.</i> <span class="NLM_year" style="font-weight: bold;">1990</span>,  <span class="NLM_volume"><i>86</i></span>,  <span class="NLM_fpage">363</span>– <span class="NLM_lpage">369</span>, <span class="refDoi"> DOI: 10.1172/jci114710</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00245&amp;key=10.1172%2FJCI114710" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00245&amp;key=2164047" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00245&amp;key=1%3ACAS%3A528%3ADyaK3cXkvFamtbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=86&publication_year=1990&pages=363-369&author=T.+Takahashiauthor=D.+D%E2%80%99Amicoauthor=I.+Chibaauthor=D.+L.+Buchhagenauthor=J.+D.+Minna&title=Identification+of+Intronic+Point+Mutations+as+an+Alternative+Mechanism+for+p53+Inactivation+in+Lung+Cancer&doi=10.1172%2Fjci114710"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of intronic point mutations as an alternative mechanism for p53 inactivation in lung cancer</span></div><div class="casAuthors">Takahashi, Takashi; D'Amico, Domenico; Chiba, Itsuo; Buchhagen, Dorothy L.; Minna, John D.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Investigation</span>
        (<span class="NLM_cas:date">1990</span>),
    <span class="NLM_cas:volume">86</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">363-9</span>CODEN:
                <span class="NLM_cas:coden">JCINAO</span>;
        ISSN:<span class="NLM_cas:issn">0021-9738</span>.
    </div><div class="casAbstract">The p53 gene initially was thought to be an oncogene, but recent evidence suggests that wild-type p53 can function as a tumor suppressor gene in lung, colon, and breast cancer as well as less common malignancies.  This study reports the first identification of intronic point mutations as a mechanism for inactivation of the p53 tumor suppressor gene.  Abnormally sized p53 mRNAs found in a small cell and a non-small cell lung cancer cell line were characterized by sequence anal. of cDNA/PCR products, the RNase protection assay and immunopptn.  These mRNAs were found to represent aberrant splicing leading to the prodn. of abnormal or no p53 protein.  Sequence anal. of genomic DNA revealed that a point mutation at the splice acceptor site in the third intron or the splice donor site in the 7th intron accounts for the abnormal mRNA splicing.  In 1 patient the same intronic point mutation was found in the tumor cell line derived from a bone marrow metastasis and in multiple liver metastases but not in normal DNA, indicating that it occurred as a somatic event before the development of these metastases.  These findings further support the role of inactivation of the p53 gene in the pathogenesis of lung cancer and indicate the role of intronic point mutation in this process.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGph_25qBqYdN7Vg90H21EOLACvtfcHk0ljiGUhSksAORQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3cXkvFamtbo%253D&md5=467e19fb66cf750d8de53ce6c63a02b1</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1172%2FJCI114710&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1172%252FJCI114710%26sid%3Dliteratum%253Aachs%26aulast%3DTakahashi%26aufirst%3DT.%26aulast%3DD%25E2%2580%2599Amico%26aufirst%3DD.%26aulast%3DChiba%26aufirst%3DI.%26aulast%3DBuchhagen%26aufirst%3DD.%2BL.%26aulast%3DMinna%26aufirst%3DJ.%2BD.%26atitle%3DIdentification%2520of%2520Intronic%2520Point%2520Mutations%2520as%2520an%2520Alternative%2520Mechanism%2520for%2520p53%2520Inactivation%2520in%2520Lung%2520Cancer%26jtitle%3DJ.%2520Clin.%2520Invest.%26date%3D1990%26volume%3D86%26spage%3D363%26epage%3D369%26doi%3D10.1172%2Fjci114710" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="note"><p class="first last">See <a href="/doi/suppl/10.1021/acs.jmedchem.0c00245/suppl_file/jm0c00245_si_001.pdf" class="ext-link">Figure S2</a> and ref <a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> for target engagement assay.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="note"><p class="first last">See <a href="/doi/suppl/10.1021/acs.jmedchem.0c00245/suppl_file/jm0c00245_si_001.pdf" class="ext-link">Figure S3</a> for a complete list of DUBs tested in the selectivity panel.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deng, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pierce, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krilov, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lupyan, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robinson, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dahlgren, M. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Greenwood, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Romero, D. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Masse, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Knight, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Steinbrecher, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beuming, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Damm, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harder, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sherman, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brewer, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wester, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murcko, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frye, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Farid, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mobley, D. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jorgensen, W. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berne, B. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Friesner, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abel, R.</span></span> <span> </span><span class="NLM_article-title">Accurate and Reliable Prediction of Relative Ligand Binding Potency in Prospective Drug Discovery by Way of a Modern Free-Energy Calculation Protocol and Force Field</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>137</i></span>,  <span class="NLM_fpage">2695</span>– <span class="NLM_lpage">2703</span>, <span class="refDoi"> DOI: 10.1021/ja512751q</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja512751q" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00245&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhsF2iuro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=137&publication_year=2015&pages=2695-2703&author=L.+Wangauthor=Y.+Wuauthor=Y.+Dengauthor=B.+Kimauthor=L.+Pierceauthor=G.+Krilovauthor=D.+Lupyanauthor=S.+Robinsonauthor=M.+K.+Dahlgrenauthor=J.+Greenwoodauthor=D.+L.+Romeroauthor=C.+Masseauthor=J.+L.+Knightauthor=T.+Steinbrecherauthor=T.+Beumingauthor=W.+Dammauthor=E.+Harderauthor=W.+Shermanauthor=M.+Brewerauthor=R.+Westerauthor=M.+Murckoauthor=L.+Fryeauthor=R.+Faridauthor=T.+Linauthor=D.+L.+Mobleyauthor=W.+L.+Jorgensenauthor=B.+J.+Berneauthor=R.+A.+Friesnerauthor=R.+Abel&title=Accurate+and+Reliable+Prediction+of+Relative+Ligand+Binding+Potency+in+Prospective+Drug+Discovery+by+Way+of+a+Modern+Free-Energy+Calculation+Protocol+and+Force+Field&doi=10.1021%2Fja512751q"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Accurate and Reliable Prediction of Relative Ligand Binding Potency in Prospective Drug Discovery by Way of a Modern Free-Energy Calculation Protocol and Force Field</span></div><div class="casAuthors">Wang, Lingle; Wu, Yujie; Deng, Yuqing; Kim, Byungchan; Pierce, Levi; Krilov, Goran; Lupyan, Dmitry; Robinson, Shaughnessy; Dahlgren, Markus K.; Greenwood, Jeremy; Romero, Donna L.; Masse, Craig; Knight, Jennifer L.; Steinbrecher, Thomas; Beuming, Thijs; Damm, Wolfgang; Harder, Ed; Sherman, Woody; Brewer, Mark; Wester, Ron; Murcko, Mark; Frye, Leah; Farid, Ramy; Lin, Teng; Mobley, David L.; Jorgensen, William L.; Berne, Bruce J.; Friesner, Richard A.; Abel, Robert</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">137</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">2695-2703</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Designing tight-binding ligands is a primary objective of small-mol. drug discovery.  Over the past few decades, free-energy calcns. have benefited from improved force fields and sampling algorithms, as well as the advent of low-cost parallel computing.  However, it has proven to be challenging to reliably achieve the level of accuracy that would be needed to guide lead optimization (∼5× in binding affinity) for a wide range of ligands and protein targets.  Not surprisingly, widespread com. application of free-energy simulations has been limited due to the lack of large-scale validation coupled with the tech. challenges traditionally assocd. with running these types of calcns.  Here, we report an approach that achieves an unprecedented level of accuracy across a broad range of target classes and ligands, with retrospective results encompassing 200 ligands and a wide variety of chem. perturbations, many of which involve significant changes in ligand chem. structures.  In addn., we have applied the method in prospective drug discovery projects and found a significant improvement in the quality of the compds. synthesized that have been predicted to be potent.  Compds. predicted to be potent by this approach have a substantial redn. in false positives relative to compds. synthesized on the basis of other computational or medicinal chem. approaches.  Furthermore, the results are consistent with those obtained from our retrospective studies, demonstrating the robustness and broad range of applicability of this approach, which can be used to drive decisions in lead optimization.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGor9UtXEyLPpLVg90H21EOLACvtfcHk0ljxrQm8W0-tPw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhsF2iuro%253D&md5=37a4f4a6c085f47ed531342643b6c33b</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1021%2Fja512751q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja512751q%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DL.%26aulast%3DWu%26aufirst%3DY.%26aulast%3DDeng%26aufirst%3DY.%26aulast%3DKim%26aufirst%3DB.%26aulast%3DPierce%26aufirst%3DL.%26aulast%3DKrilov%26aufirst%3DG.%26aulast%3DLupyan%26aufirst%3DD.%26aulast%3DRobinson%26aufirst%3DS.%26aulast%3DDahlgren%26aufirst%3DM.%2BK.%26aulast%3DGreenwood%26aufirst%3DJ.%26aulast%3DRomero%26aufirst%3DD.%2BL.%26aulast%3DMasse%26aufirst%3DC.%26aulast%3DKnight%26aufirst%3DJ.%2BL.%26aulast%3DSteinbrecher%26aufirst%3DT.%26aulast%3DBeuming%26aufirst%3DT.%26aulast%3DDamm%26aufirst%3DW.%26aulast%3DHarder%26aufirst%3DE.%26aulast%3DSherman%26aufirst%3DW.%26aulast%3DBrewer%26aufirst%3DM.%26aulast%3DWester%26aufirst%3DR.%26aulast%3DMurcko%26aufirst%3DM.%26aulast%3DFrye%26aufirst%3DL.%26aulast%3DFarid%26aufirst%3DR.%26aulast%3DLin%26aufirst%3DT.%26aulast%3DMobley%26aufirst%3DD.%2BL.%26aulast%3DJorgensen%26aufirst%3DW.%2BL.%26aulast%3DBerne%26aufirst%3DB.%2BJ.%26aulast%3DFriesner%26aufirst%3DR.%2BA.%26aulast%3DAbel%26aufirst%3DR.%26atitle%3DAccurate%2520and%2520Reliable%2520Prediction%2520of%2520Relative%2520Ligand%2520Binding%2520Potency%2520in%2520Prospective%2520Drug%2520Discovery%2520by%2520Way%2520of%2520a%2520Modern%2520Free-Energy%2520Calculation%2520Protocol%2520and%2520Force%2520Field%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2015%26volume%3D137%26spage%3D2695%26epage%3D2703%26doi%3D10.1021%2Fja512751q" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="note"><p class="first last">See <a href="/doi/suppl/10.1021/acs.jmedchem.0c00245/suppl_file/jm0c00245_si_001.pdf" class="ext-link">Figure S4</a> for a visualization of solvent-exposed Tyr-465.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="note"><p class="first last">See <a href="/doi/suppl/10.1021/acs.jmedchem.0c00245/suppl_file/jm0c00245_si_001.pdf" class="ext-link">Figure S5</a> for PK curves of compound <b>41</b> in different mouse species.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="note"><p class="first last">Compound <b>41</b> is measured to be 95.3% bound to mouse plasma proteins as measured by ultracentrifugation.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Luzzio, M. J.</span>; <span class="NLM_string-name">Yang, B. V.</span>; <span class="NLM_string-name">Marx, M. A.</span></span> <span> </span><span class="NLM_article-title">Thiophene Derivatives Useful as Anticancer Agents</span>. U.S. Patent <span class="NLM_patent">20,020,004,511 A1</span>, <span class="NLM_year">2002</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2002&author=M.+J.+Luzzio&author=B.+V.+Yang&author=M.+A.+Marx&title=Thiophene+Derivatives+Useful+as+Anticancer+Agents"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DLuzzio%26aufirst%3DM.%2BJ.%26atitle%3DThiophene%2520Derivatives%2520Useful%2520as%2520Anticancer%2520Agents%26date%3D2002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Amézquita-Valencia, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alper, H.</span></span> <span> </span><span class="NLM_article-title">PdI<sub>2</sub>-Catalyzed Regioselective Cyclocarbonylation of 2-Allyl Phenols to Dihydrocoumarins</span>. <i>Org. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>16</i></span>,  <span class="NLM_fpage">5827</span>– <span class="NLM_lpage">5829</span>, <span class="refDoi"> DOI: 10.1021/ol5029157</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ol5029157" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00245&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhvV2ntLzK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2014&pages=5827-5829&author=M.+Am%C3%A9zquita-Valenciaauthor=H.+Alper&title=PdI2-Catalyzed+Regioselective+Cyclocarbonylation+of+2-Allyl+Phenols+to+Dihydrocoumarins&doi=10.1021%2Fol5029157"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">PdI2-Catalyzed Regioselective Cyclocarbonylation of 2-Allyl Phenols to Dihydrocoumarins</span></div><div class="casAuthors">Amezquita-Valencia, Manuel; Alper, Howard</div><div class="citationInfo"><span class="NLM_cas:title">Organic Letters</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">5827-5829</span>CODEN:
                <span class="NLM_cas:coden">ORLEF7</span>;
        ISSN:<span class="NLM_cas:issn">1523-7052</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A simple, efficient, and regioselective synthesis of 3-methyl-3,4-dihydrocoumarins is reported.  The reaction of 2-allyl phenols with synthesis gas was catalyzed by PdI2, and 1,3,5,7-tetramethyl-6-phenyl-2,4,8-trioxa-6-phosphaadamantane and 1,3,5,7-tetramethyl-6-tetradecyl-2,4,8-trioxa-6-phosphaadamantane were effective as ligands, affording good product selectivity in all cases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGprj-SK54g2KrVg90H21EOLACvtfcHk0ljxrQm8W0-tPw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhvV2ntLzK&md5=29bd7d70108f80693e41547563385d09</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1021%2Fol5029157&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fol5029157%26sid%3Dliteratum%253Aachs%26aulast%3DAm%25C3%25A9zquita-Valencia%26aufirst%3DM.%26aulast%3DAlper%26aufirst%3DH.%26atitle%3DPdI2-Catalyzed%2520Regioselective%2520Cyclocarbonylation%2520of%25202-Allyl%2520Phenols%2520to%2520Dihydrocoumarins%26jtitle%3DOrg.%2520Lett.%26date%3D2014%26volume%3D16%26spage%3D5827%26epage%3D5829%26doi%3D10.1021%2Fol5029157" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ek, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Axelsson, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wistrand, L.-G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frejd, T.</span></span> <span> </span><span class="NLM_article-title">Aromatic Allylation via Diazotization: Metal-Free C–C Bond Formation</span>. <i>J. Org. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>67</i></span>,  <span class="NLM_fpage">6376</span>– <span class="NLM_lpage">6381</span>, <span class="refDoi"> DOI: 10.1021/jo0258103</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jo0258103" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00245&amp;key=1%3ACAS%3A528%3ADC%252BD38XmtVyms7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=2002&pages=6376-6381&author=F.+Ekauthor=O.+Axelssonauthor=L.-G.+Wistrandauthor=T.+Frejd&title=Aromatic+Allylation+via+Diazotization%3A+Metal-Free+C%E2%80%93C+Bond+Formation&doi=10.1021%2Fjo0258103"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Aromatic Allylation via Diazotization: Metal-Free C-C Bond Formation</span></div><div class="casAuthors">Ek, Fredrik; Axelsson, Oskar; Wistrand, Lars-Goeran; Frejd, Torbjoern</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Organic Chemistry</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">67</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">6376-6381</span>CODEN:
                <span class="NLM_cas:coden">JOCEAH</span>;
        ISSN:<span class="NLM_cas:issn">0022-3263</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A new method for the synthesis of allyl arom. compds. not involving any metal-contg. reagent or catalyst has been developed.  Arylamines substituted with a large no. of different substituents were converted via diazotizative deamination with tert-Bu nitrite in allyl bromide and acetonitrile to the corresponding allyl arom. compds.  The allylation reaction was found to be suitable for larger scale synthesis due to short reaction times, a nonextractive workup, and robustness toward moisture, air, and type of solvent.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqVu48CPEkasbVg90H21EOLACvtfcHk0ljxrQm8W0-tPw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XmtVyms7g%253D&md5=713411ad987ca70a82dc91179e38f55e</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1021%2Fjo0258103&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo0258103%26sid%3Dliteratum%253Aachs%26aulast%3DEk%26aufirst%3DF.%26aulast%3DAxelsson%26aufirst%3DO.%26aulast%3DWistrand%26aufirst%3DL.-G.%26aulast%3DFrejd%26aufirst%3DT.%26atitle%3DAromatic%2520Allylation%2520via%2520Diazotization%253A%2520Metal-Free%2520C%25E2%2580%2593C%2520Bond%2520Formation%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D2002%26volume%3D67%26spage%3D6376%26epage%3D6381%26doi%3D10.1021%2Fjo0258103" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Harder, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Damm, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maple, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reboul, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xiang, J. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lupyan, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dahlgren, M. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Knight, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaus, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cerutti, D. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krilov, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jorgensen, W. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abel, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Friesner, R. A.</span></span> <span> </span><span class="NLM_article-title">OPLS3: A Force Field Providing Broad Coverage of Drug-like Small Molecules and Proteins</span>. <i>J. Chem. Theory Comput.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">281</span>– <span class="NLM_lpage">296</span>, <span class="refDoi"> DOI: 10.1021/acs.jctc.5b00864</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jctc.5b00864" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00245&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhvVCjtbfE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2016&pages=281-296&author=E.+Harderauthor=W.+Dammauthor=J.+Mapleauthor=C.+Wuauthor=M.+Reboulauthor=J.+Y.+Xiangauthor=L.+Wangauthor=D.+Lupyanauthor=M.+K.+Dahlgrenauthor=J.+L.+Knightauthor=J.+W.+Kausauthor=D.+S.+Ceruttiauthor=G.+Krilovauthor=W.+L.+Jorgensenauthor=R.+Abelauthor=R.+A.+Friesner&title=OPLS3%3A+A+Force+Field+Providing+Broad+Coverage+of+Drug-like+Small+Molecules+and+Proteins&doi=10.1021%2Facs.jctc.5b00864"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">OPLS3: A Force Field Providing Broad Coverage of Drug-like Small Molecules and Proteins</span></div><div class="casAuthors">Harder, Edward; Damm, Wolfgang; Maple, Jon; Wu, Chuanjie; Reboul, Mark; Xiang, Jin Yu; Wang, Lingle; Lupyan, Dmitry; Dahlgren, Markus K.; Knight, Jennifer L.; Kaus, Joseph W.; Cerutti, David S.; Krilov, Goran; Jorgensen, William L.; Abel, Robert; Friesner, Richard A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Chemical Theory and Computation</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">281-296</span>CODEN:
                <span class="NLM_cas:coden">JCTCCE</span>;
        ISSN:<span class="NLM_cas:issn">1549-9618</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The parametrization and validation of the OPLS3 force field for small mols. and proteins are reported.  Enhancements with respect to the previous version (OPLS2.1) include the addn. of off-atom charge sites to represent halogen bonding and aryl nitrogen lone pairs as well as a complete refit of peptide dihedral parameters to better model the native structure of proteins.  To adequately cover medicinal chem. space, OPLS3 employs over an order of magnitude more ref. data and assocd. parameter types relative to other commonly used small mol. force fields (e.g., MMFF and OPLS_2005).  As a consequence, OPLS3 achieves a high level of accuracy across performance benchmarks that assess small mol. conformational propensities and solvation.  The newly fitted peptide dihedrals lead to significant improvements in the representation of secondary structure elements in simulated peptides and native structure stability over a no. of proteins.  Together, the improvements made to both the small mol. and protein force field lead to a high level of accuracy in predicting protein-ligand binding measured over a wide range of targets and ligands (less than 1 kcal/mol RMS error) representing a 30% improvement over earlier variants of the OPLS force field.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqY_jrOhcBRgrVg90H21EOLACvtfcHk0lg2TThJTpaefQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhvVCjtbfE&md5=42663f8cfa84b80a67132bbb13b9b7ce</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1021%2Facs.jctc.5b00864&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jctc.5b00864%26sid%3Dliteratum%253Aachs%26aulast%3DHarder%26aufirst%3DE.%26aulast%3DDamm%26aufirst%3DW.%26aulast%3DMaple%26aufirst%3DJ.%26aulast%3DWu%26aufirst%3DC.%26aulast%3DReboul%26aufirst%3DM.%26aulast%3DXiang%26aufirst%3DJ.%2BY.%26aulast%3DWang%26aufirst%3DL.%26aulast%3DLupyan%26aufirst%3DD.%26aulast%3DDahlgren%26aufirst%3DM.%2BK.%26aulast%3DKnight%26aufirst%3DJ.%2BL.%26aulast%3DKaus%26aufirst%3DJ.%2BW.%26aulast%3DCerutti%26aufirst%3DD.%2BS.%26aulast%3DKrilov%26aufirst%3DG.%26aulast%3DJorgensen%26aufirst%3DW.%2BL.%26aulast%3DAbel%26aufirst%3DR.%26aulast%3DFriesner%26aufirst%3DR.%2BA.%26atitle%3DOPLS3%253A%2520A%2520Force%2520Field%2520Providing%2520Broad%2520Coverage%2520of%2520Drug-like%2520Small%2520Molecules%2520and%2520Proteins%26jtitle%3DJ.%2520Chem.%2520Theory%2520Comput.%26date%3D2016%26volume%3D12%26spage%3D281%26epage%3D296%26doi%3D10.1021%2Facs.jctc.5b00864" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Young, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abel, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berne, B. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Friesner, R. A.</span></span> <span> </span><span class="NLM_article-title">Motifs for Molecular Recognition Exploiting Hydrophobic Enclosure in Protein-Ligand Binding</span>. <i>Proc. Natl. Acad. Sci. U.S.A.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>104</i></span>,  <span class="NLM_fpage">808</span>– <span class="NLM_lpage">813</span>, <span class="refDoi"> DOI: 10.1073/pnas.0610202104</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00245&amp;key=10.1073%2Fpnas.0610202104" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00245&amp;key=17204562" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00245&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtVegtr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=104&publication_year=2007&pages=808-813&author=T.+Youngauthor=R.+Abelauthor=B.+Kimauthor=B.+J.+Berneauthor=R.+A.+Friesner&title=Motifs+for+Molecular+Recognition+Exploiting+Hydrophobic+Enclosure+in+Protein-Ligand+Binding&doi=10.1073%2Fpnas.0610202104"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Motifs for molecular recognition exploiting hydrophobic enclosure in protein-ligand binding</span></div><div class="casAuthors">Young, Tom; Abel, Robert; Kim, Byungchan; Berne, Bruce J.; Friesner, Richard A.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">104</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">808-813</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">The thermodn. properties and phase behavior of water in confined regions can vary significantly from that obsd. in the bulk.  This is particularly true for systems in which the confinement is on the mol.-length scale.  In this study, we use mol. dynamics simulations and a powerful solvent anal. technique based on inhomogeneous solvation theory to investigate the properties of water mols. that solvate the confined regions of protein active sites.  Our simulations and anal. indicate that the solvation of protein active sites that are characterized by hydrophobic enclosure and correlated hydrogen bonds induce atypical entropic and enthalpic penalties of hydration.  These penalties apparently stabilize the protein-ligand complex with respect to the independently solvated ligand and protein, which leads to enhanced binding affinities.  Our anal. elucidates several challenging cases, including the super affinity of the streptavidin-biotin system.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqWumQ61YTqILVg90H21EOLACvtfcHk0lg2TThJTpaefQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtVegtr4%253D&md5=1109e3f48670cd910885f7fd527eb880</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1073%2Fpnas.0610202104&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.0610202104%26sid%3Dliteratum%253Aachs%26aulast%3DYoung%26aufirst%3DT.%26aulast%3DAbel%26aufirst%3DR.%26aulast%3DKim%26aufirst%3DB.%26aulast%3DBerne%26aufirst%3DB.%2BJ.%26aulast%3DFriesner%26aufirst%3DR.%2BA.%26atitle%3DMotifs%2520for%2520Molecular%2520Recognition%2520Exploiting%2520Hydrophobic%2520Enclosure%2520in%2520Protein-Ligand%2520Binding%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2007%26volume%3D104%26spage%3D808%26epage%3D813%26doi%3D10.1073%2Fpnas.0610202104" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Abel, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Young, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Farid, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berne, B. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Friesner, R. A.</span></span> <span> </span><span class="NLM_article-title">Role of the Active-Site Solvent in the Thermodynamics of Factor Xa Ligand Binding</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>130</i></span>,  <span class="NLM_fpage">2817</span>– <span class="NLM_lpage">2831</span>, <span class="refDoi"> DOI: 10.1021/ja0771033</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja0771033" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00245&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhvFWgurk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=130&publication_year=2008&pages=2817-2831&author=R.+Abelauthor=T.+Youngauthor=R.+Faridauthor=B.+J.+Berneauthor=R.+A.+Friesner&title=Role+of+the+Active-Site+Solvent+in+the+Thermodynamics+of+Factor+Xa+Ligand+Binding&doi=10.1021%2Fja0771033"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Role of the Active-Site Solvent in the Thermodynamics of Factor Xa Ligand Binding</span></div><div class="casAuthors">Abel, Robert; Young, Tom; Farid, Ramy; Berne, Bruce J.; Friesner, Richard A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">130</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">2817-2831</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Understanding the underlying physics of the binding of small-mol. ligands to protein active sites is a key objective of computational chem. and biol.  It is widely believed that displacement of water mols. from the active site by the ligand is a principal (if not the dominant) source of binding free energy.  Although continuum theories of hydration are routinely used to describe the contributions of the solvent to the binding affinity of the complex, it is still an unsettled question as to whether or not these continuum solvation theories describe the underlying mol. physics with sufficient accuracy to reliably rank the binding affinities of a set of ligands for a given protein.  Here we develop a novel, computationally efficient descriptor of the contribution of the solvent to the binding free energy of a small mol. and its assocd. receptor that captures the effects of the ligand displacing the solvent from the protein active site with at. detail.  This descriptor quant. predicts (R2 = 0.81) the binding free energy differences between congeneric ligand pairs for the test system factor Xa, elucidates phys. properties of the active site solvent that appear to be missing in most continuum theories of hydration, and identifies several features of the hydration of the factor Xa active site relevant to the structure-activity relationship of its inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoS42r59nNXH7Vg90H21EOLACvtfcHk0lg2TThJTpaefQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhvFWgurk%253D&md5=8eefe76547a82bccaea38f2c84e6cd5f</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1021%2Fja0771033&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja0771033%26sid%3Dliteratum%253Aachs%26aulast%3DAbel%26aufirst%3DR.%26aulast%3DYoung%26aufirst%3DT.%26aulast%3DFarid%26aufirst%3DR.%26aulast%3DBerne%26aufirst%3DB.%2BJ.%26aulast%3DFriesner%26aufirst%3DR.%2BA.%26atitle%3DRole%2520of%2520the%2520Active-Site%2520Solvent%2520in%2520the%2520Thermodynamics%2520of%2520Factor%2520Xa%2520Ligand%2520Binding%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2008%26volume%3D130%26spage%3D2817%26epage%3D2831%26doi%3D10.1021%2Fja0771033" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Friesner, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berne, B. J.</span></span> <span> </span><span class="NLM_article-title">Replica Exchange with Solute Scaling: a More Efficient Version of Replica Exchange with Solute Tempering (REST2)</span>. <i>J. Phys. Chem. B</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>115</i></span>,  <span class="NLM_fpage">9431</span>– <span class="NLM_lpage">9438</span>, <span class="refDoi"> DOI: 10.1021/jp204407d</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jp204407d" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00245&amp;key=1%3ACAS%3A528%3ADC%252BC3MXosFymurs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=115&publication_year=2011&pages=9431-9438&author=L.+Wangauthor=R.+A.+Friesnerauthor=B.+J.+Berne&title=Replica+Exchange+with+Solute+Scaling%3A+a+More+Efficient+Version+of+Replica+Exchange+with+Solute+Tempering+%28REST2%29&doi=10.1021%2Fjp204407d"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Replica Exchange with Solute Scaling: A More Efficient Version of Replica Exchange with Solute Tempering (REST2)</span></div><div class="casAuthors">Wang, Lingle; Friesner, Richard A.; Berne, B. J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Physical Chemistry B</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">115</span>
        (<span class="NLM_cas:issue">30</span>),
    <span class="NLM_cas:pages">9431-9438</span>CODEN:
                <span class="NLM_cas:coden">JPCBFK</span>;
        ISSN:<span class="NLM_cas:issn">1520-5207</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A small change in the Hamiltonian scaling in Replica Exchange with Solute Tempering (REST) is found to improve its sampling efficiency greatly, esp. for the sampling of aq. protein solns. in which there are large-scale solute conformation changes.  Like the original REST (REST1), the new version (which the authors call REST2) also bypasses the poor scaling with system size of the std. Temp. Replica Exchange Method (TREM), reducing the no. of replicas (parallel processes) from what must be used in TREM.  This redn. is accomplished by deforming the Hamiltonian function for each replica in such a way that the acceptance probability for the exchange of replica configurations does not depend on the no. of explicit water mols. in the system.  For proof of concept, REST2 is compared with TREM and with REST1 for the folding of the trpcage and β-hairpin in water.  The comparisons confirm that REST2 greatly reduces the no. of CPUs required by regular replica exchange and greatly increases the sampling efficiency over REST1.  This method reduces the CPU time required for calcg. thermodn. avs. and for the ab initio folding of proteins in explicit water.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqYjGgEHE_cMbVg90H21EOLACvtfcHk0ljuH1vllR5zhg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXosFymurs%253D&md5=8acb0d670bcb70eacfc30e32d5dfb6dd</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1021%2Fjp204407d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjp204407d%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DL.%26aulast%3DFriesner%26aufirst%3DR.%2BA.%26aulast%3DBerne%26aufirst%3DB.%2BJ.%26atitle%3DReplica%2520Exchange%2520with%2520Solute%2520Scaling%253A%2520a%2520More%2520Efficient%2520Version%2520of%2520Replica%2520Exchange%2520with%2520Solute%2520Tempering%2520%2528REST2%2529%26jtitle%3DJ.%2520Phys.%2520Chem.%2520B%26date%3D2011%26volume%3D115%26spage%3D9431%26epage%3D9438%26doi%3D10.1021%2Fjp204407d" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span> <i>Schrödinger Release 2017-2: LigPrep</i>; <span class="NLM_publisher-name">Schrödinger, LLC</span>: <span class="NLM_publisher-loc">New York,
NY</span>, <span class="NLM_year">2017</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=+Schr%C3%B6dinger+Release+2017-2%3A+LigPrep%3B+Schr%C3%B6dinger%2C+LLC%3A+New+York%2C%0ANY%2C+2017."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcomputer-program%26sid%3Dliteratum%253Aachs%26jtitle%3DSchr%25C3%25B6dinger%2520Release%25202017-2%253A%2520LigPrep%26pub%3DSchr%25C3%25B6dinger%252C%2520LLC%26date%3D2017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Friesner, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Banks, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murphy, R. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Halgren, T. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Klicic, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mainz, D. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Repasky, M. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Knoll, E. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shelley, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perry, J. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shaw, D. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Francis, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shenkin, P. S.</span></span> <span> </span><span class="NLM_article-title">Glide: A New Approach for Rapid, Accurate Docking and Scoring. 1. Method and Assessment of Docking Accuracy</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>47</i></span>,  <span class="NLM_fpage">1739</span>– <span class="NLM_lpage">1749</span>, <span class="refDoi"> DOI: 10.1021/jm0306430</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm0306430" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00245&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhsFyit74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2004&pages=1739-1749&author=R.+A.+Friesnerauthor=J.+L.+Banksauthor=R.+B.+Murphyauthor=T.+A.+Halgrenauthor=J.+J.+Klicicauthor=D.+T.+Mainzauthor=M.+P.+Repaskyauthor=E.+H.+Knollauthor=M.+Shelleyauthor=J.+K.+Perryauthor=D.+E.+Shawauthor=P.+Francisauthor=P.+S.+Shenkin&title=Glide%3A+A+New+Approach+for+Rapid%2C+Accurate+Docking+and+Scoring.+1.+Method+and+Assessment+of+Docking+Accuracy&doi=10.1021%2Fjm0306430"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Glide: A new approach for rapid, accurate docking and scoring. 1. method and assessment of docking accuracy</span></div><div class="casAuthors">Friesner, Richard A.; Banks, Jay L.; Murphy, Robert B.; Halgren, Thomas A.; Klicic, Jasna J.; Mainz, Daniel T.; Repasky, Matthew P.; Knoll, Eric H.; Shelley, Mee; Perry, Jason K.; Shaw, David E.; Francis, Perry; Shenkin, Peter S.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">47</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1739-1749</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Unlike other methods for docking ligands to the rigid 3D structure of a known protein receptor, Glide approximates a complete systematic search of the conformational, orientational, and positional space of the docked ligand.  In this search, an initial rough positioning and scoring phase that dramatically narrows the search space is followed by torsionally flexible energy optimization on an OPLS-AA nonbonded potential grid for a few hundred surviving candidate poses.  The very best candidates are further refined via a Monte Carlo sampling of pose conformation; in some cases, this is crucial to obtaining an accurate docked pose.  Selection of the best docked pose uses a model energy function that combines empirical and force-field-based terms.  Docking accuracy is assessed by redocking ligands from 282 cocrystd. PDB complexes starting from conformationally optimized ligand geometries that bear no memory of the correctly docked pose.  Errors in geometry for the top-ranked pose are less than 1 Å in nearly half of the cases and are greater than 2 Å in only about one-third of them.  Comparisons to published data on rms deviations show that Glide is nearly twice as accurate as GOLD and more than twice as accurate as FlexX for ligands having up to 20 rotatable bonds.  Glide is also found to be more accurate than the recently described Surflex method.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrPuigu31qMMLVg90H21EOLACvtfcHk0ljuH1vllR5zhg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhsFyit74%253D&md5=8cc2f0022318b12dd972e9c493375bf9</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1021%2Fjm0306430&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0306430%26sid%3Dliteratum%253Aachs%26aulast%3DFriesner%26aufirst%3DR.%2BA.%26aulast%3DBanks%26aufirst%3DJ.%2BL.%26aulast%3DMurphy%26aufirst%3DR.%2BB.%26aulast%3DHalgren%26aufirst%3DT.%2BA.%26aulast%3DKlicic%26aufirst%3DJ.%2BJ.%26aulast%3DMainz%26aufirst%3DD.%2BT.%26aulast%3DRepasky%26aufirst%3DM.%2BP.%26aulast%3DKnoll%26aufirst%3DE.%2BH.%26aulast%3DShelley%26aufirst%3DM.%26aulast%3DPerry%26aufirst%3DJ.%2BK.%26aulast%3DShaw%26aufirst%3DD.%2BE.%26aulast%3DFrancis%26aufirst%3DP.%26aulast%3DShenkin%26aufirst%3DP.%2BS.%26atitle%3DGlide%253A%2520A%2520New%2520Approach%2520for%2520Rapid%252C%2520Accurate%2520Docking%2520and%2520Scoring.%25201.%2520Method%2520and%2520Assessment%2520of%2520Docking%2520Accuracy%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2004%26volume%3D47%26spage%3D1739%26epage%3D1749%26doi%3D10.1021%2Fjm0306430" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':[],'ref18':[],'ref19':['cit19'],'ref20':[],'ref21':[],'ref22':['cit22'],'ref23':[],'ref24':[],'ref25':[],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 12 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Luan Carvalho Martins, Elio A. Cino, <span class="NLM_string-name hlFld-ContribAuthor">Rafaela Salgado Ferreira</span>. </span><span class="cited-content_cbyCitation_article-title">PyAutoFEP: An Automated Free Energy Perturbation Workflow for GROMACS Integrating Enhanced Sampling Methods. </span><span class="cited-content_cbyCitation_journal-name">Journal of Chemical Theory and Computation</span><span> <strong>2021,</strong> <em>17 </em>
                                    (7)
                                     , 4262-4273. <a href="https://doi.org/10.1021/acs.jctc.1c00194" title="DOI URL">https://doi.org/10.1021/acs.jctc.1c00194</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jctc.1c00194&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jctc.1c00194%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Chemical%2520Theory%2520and%2520Computation%26atitle%3DPyAutoFEP%25253A%252BAn%252BAutomated%252BFree%252BEnergy%252BPerturbation%252BWorkflow%252Bfor%252BGROMACS%252BIntegrating%252BEnhanced%252BSampling%252BMethods%26aulast%3DCarvalho%2BMartins%26aufirst%3DLuan%26date%3D2021%26date%3D2021%26date%3D2021%26date%3D23022021%26date%3D18062021%26volume%3D17%26issue%3D7%26spage%3D4262%26epage%3D4273" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Robert S.  Magin</span>, <span class="hlFld-ContribAuthor ">Xiaoxi  Liu</span>, <span class="hlFld-ContribAuthor ">Alejandra  Felix</span>, <span class="hlFld-ContribAuthor ">Ariana S.  Bratt</span>, <span class="hlFld-ContribAuthor ">Wai Cheung  Chan</span>, <span class="hlFld-ContribAuthor ">Sara J.  Buhrlage</span>. </span><span class="cited-content_cbyCitation_article-title">Small molecules as tools for functional assessment of deubiquitinating enzyme function. </span><span class="cited-content_cbyCitation_journal-name">Cell Chemical Biology</span><span> <strong>2021,</strong> <em>28 </em>
                                    (7)
                                     , 1090-1100. <a href="https://doi.org/10.1016/j.chembiol.2021.04.021" title="DOI URL">https://doi.org/10.1016/j.chembiol.2021.04.021</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.chembiol.2021.04.021&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.chembiol.2021.04.021%26sid%3Dliteratum%253Aachs%26jtitle%3DCell%2520Chemical%2520Biology%26atitle%3DSmall%252Bmolecules%252Bas%252Btools%252Bfor%252Bfunctional%252Bassessment%252Bof%252Bdeubiquitinating%252Benzyme%252Bfunction%26aulast%3DMagin%26aufirst%3DRobert%2BS.%26date%3D2021%26volume%3D28%26issue%3D7%26spage%3D1090%26epage%3D1100" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jun-Nan  Guo</span>, <span class="hlFld-ContribAuthor ">Bai-Rong  Xia</span>, <span class="hlFld-ContribAuthor ">Shen-Hui  Deng</span>, <span class="hlFld-ContribAuthor ">Chang  Yang</span>, <span class="hlFld-ContribAuthor ">Ya-Nan  Pi</span>, <span class="hlFld-ContribAuthor ">Bin-Bin  Cui</span>, <span class="hlFld-ContribAuthor ">Wei-Lin  Jin</span>. </span><span class="cited-content_cbyCitation_article-title">Deubiquitinating Enzymes Orchestrate the Cancer Stem Cell-Immunosuppressive Niche Dialogue: New Perspectives and Therapeutic Potential. </span><span class="cited-content_cbyCitation_journal-name">Frontiers in Cell and Developmental Biology</span><span> <strong>2021,</strong> <em>9 </em><a href="https://doi.org/10.3389/fcell.2021.680100" title="DOI URL">https://doi.org/10.3389/fcell.2021.680100</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3389/fcell.2021.680100&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3389%2Ffcell.2021.680100%26sid%3Dliteratum%253Aachs%26jtitle%3DFrontiers%2520in%2520Cell%2520and%2520Developmental%2520Biology%26atitle%3DDeubiquitinating%252BEnzymes%252BOrchestrate%252Bthe%252BCancer%252BStem%252BCell-Immunosuppressive%252BNiche%252BDialogue%25253A%252BNew%252BPerspectives%252Band%252BTherapeutic%252BPotential%26aulast%3DGuo%26aufirst%3DJun-Nan%26date%3D2021%26date%3D2021%26volume%3D9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Anthony C.  Varca</span>, <span class="hlFld-ContribAuthor ">Dominick  Casalena</span>, <span class="hlFld-ContribAuthor ">Wai Cheung  Chan</span>, <span class="hlFld-ContribAuthor ">Bin  Hu</span>, <span class="hlFld-ContribAuthor ">Robert S.  Magin</span>, <span class="hlFld-ContribAuthor ">Rebekka M.  Roberts</span>, <span class="hlFld-ContribAuthor ">Xiaoxi  Liu</span>, <span class="hlFld-ContribAuthor ">He  Zhu</span>, <span class="hlFld-ContribAuthor ">Hyuk-Soo  Seo</span>, <span class="hlFld-ContribAuthor ">Sirano  Dhe-Paganon</span>, <span class="hlFld-ContribAuthor ">Jarrod A.  Marto</span>, <span class="hlFld-ContribAuthor ">Douglas  Auld</span>, <span class="hlFld-ContribAuthor ">Sara J.  Buhrlage</span>. </span><span class="cited-content_cbyCitation_article-title">Identification and validation of selective deubiquitinase inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Cell Chemical Biology</span><span> <strong>2021,</strong> <em>63 </em><a href="https://doi.org/10.1016/j.chembiol.2021.05.012" title="DOI URL">https://doi.org/10.1016/j.chembiol.2021.05.012</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.chembiol.2021.05.012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.chembiol.2021.05.012%26sid%3Dliteratum%253Aachs%26jtitle%3DCell%2520Chemical%2520Biology%26atitle%3DIdentification%252Band%252Bvalidation%252Bof%252Bselective%252Bdeubiquitinase%252Binhibitors%26aulast%3DVarca%26aufirst%3DAnthony%2BC.%26date%3D2021%26volume%3D63" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Zefeng  Zhao</span>, <span class="hlFld-ContribAuthor ">Jiangxin  Yue</span>, <span class="hlFld-ContribAuthor ">Xiaotong  Ji</span>, <span class="hlFld-ContribAuthor ">Meng  Nian</span>, <span class="hlFld-ContribAuthor ">Kaiwen  Kang</span>, <span class="hlFld-ContribAuthor ">Haifa  Qiao</span>, <span class="hlFld-ContribAuthor ">Xiaohui  Zheng</span>. </span><span class="cited-content_cbyCitation_article-title">Research progress in biological activities of succinimide derivatives. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic Chemistry</span><span> <strong>2021,</strong> <em>108 </em>, 104557. <a href="https://doi.org/10.1016/j.bioorg.2020.104557" title="DOI URL">https://doi.org/10.1016/j.bioorg.2020.104557</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bioorg.2020.104557&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bioorg.2020.104557%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520Chemistry%26atitle%3DResearch%252Bprogress%252Bin%252Bbiological%252Bactivities%252Bof%252Bsuccinimide%252Bderivatives%26aulast%3DZhao%26aufirst%3DZefeng%26date%3D2021%26volume%3D108%26spage%3D104557" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">S. V.  Fedoseev</span>, <span class="hlFld-ContribAuthor ">O. E.  Ershov</span>. </span><span class="cited-content_cbyCitation_article-title">Reaction of 4-Halo-3-hydroxyfuro[3,4-c]pyridin-1(3H)-ones with Morpholine and Thiomorpholine. </span><span class="cited-content_cbyCitation_journal-name">Russian Journal of Organic Chemistry</span><span> <strong>2021,</strong> <em>57 </em>
                                    (3)
                                     , 483-485. <a href="https://doi.org/10.1134/S1070428021030234" title="DOI URL">https://doi.org/10.1134/S1070428021030234</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1134/S1070428021030234&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1134%2FS1070428021030234%26sid%3Dliteratum%253Aachs%26jtitle%3DRussian%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DReaction%252Bof%252B4-Halo-3-hydroxyfuro%25255B3%25252C4-c%25255Dpyridin-1%2525283H%252529-ones%252Bwith%252BMorpholine%252Band%252BThiomorpholine%26aulast%3DFedoseev%26aufirst%3DS.%2BV.%26date%3D2021%26date%3D2021%26volume%3D57%26issue%3D3%26spage%3D483%26epage%3D485" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Zheng‐Jun  Chen</span>, <span class="hlFld-ContribAuthor ">Wei  Liang</span>, <span class="hlFld-ContribAuthor ">Zhuo  Chen</span>, <span class="hlFld-ContribAuthor ">Lin  Chen</span>. </span><span class="cited-content_cbyCitation_article-title">Phase‐Transfer Catalytic Strategy: Rapid Synthesis of Spiro‐Fused Heterocycles, Integrated with Four Pharmacophores‐Succinimide, Pyrrolidine, Oxindole, and Trifluoromethyl Group. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Organic Chemistry</span><span> <strong>2021,</strong> <em>2021 </em>
                                    (5)
                                     , 788-793. <a href="https://doi.org/10.1002/ejoc.202001409" title="DOI URL">https://doi.org/10.1002/ejoc.202001409</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/ejoc.202001409&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fejoc.202001409%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DPhase%2525E2%252580%252590Transfer%252BCatalytic%252BStrategy%25253A%252BRapid%252BSynthesis%252Bof%252BSpiro%2525E2%252580%252590Fused%252BHeterocycles%25252C%252BIntegrated%252Bwith%252BFour%252BPharmacophores%2525E2%252580%252590Succinimide%25252C%252BPyrrolidine%25252C%252BOxindole%25252C%252Band%252BTrifluoromethyl%252BGroup%26aulast%3DChen%26aufirst%3DZheng%25E2%2580%2590Jun%26date%3D2021%26date%3D2020%26volume%3D2021%26issue%3D5%26spage%3D788%26epage%3D793" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Priyadharshini  Ramakrishnan</span>, <span class="hlFld-ContribAuthor ">T  Pavan kumar</span>, <span class="hlFld-ContribAuthor ">GR  Saraswathy</span>, <span class="hlFld-ContribAuthor ">S  Sujatha</span>. </span><span class="cited-content_cbyCitation_article-title">In silico evaluation of drugs used in treatment of oral lichen planus. </span><span class="cited-content_cbyCitation_journal-name">Journal of Oral Pathology & Medicine</span><span> <strong>2020,</strong> <em>49 </em>
                                    (9)
                                     , 926-932. <a href="https://doi.org/10.1111/jop.13100" title="DOI URL">https://doi.org/10.1111/jop.13100</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1111/jop.13100&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1111%2Fjop.13100%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Oral%2520Pathology%2520%2526%2520Medicine%26atitle%3DIn%252Bsilico%252Bevaluation%252Bof%252Bdrugs%252Bused%252Bin%252Btreatment%252Bof%252Boral%252Blichen%252Bplanus%26aulast%3DRamakrishnan%26aufirst%3DPriyadharshini%26date%3D2020%26date%3D2020%26volume%3D49%26issue%3D9%26spage%3D926%26epage%3D932" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yamini M.  Ohol</span>, <span class="hlFld-ContribAuthor ">Michael T.  Sun</span>, <span class="hlFld-ContribAuthor ">Gene  Cutler</span>, <span class="hlFld-ContribAuthor ">Paul R.  Leger</span>, <span class="hlFld-ContribAuthor ">Dennis X.  Hu</span>, <span class="hlFld-ContribAuthor ">Berenger  Biannic</span>, <span class="hlFld-ContribAuthor ">Payal  Rana</span>, <span class="hlFld-ContribAuthor ">Cynthia  Cho</span>, <span class="hlFld-ContribAuthor ">Scott  Jacobson</span>, <span class="hlFld-ContribAuthor ">Steve T.  Wong</span>, <span class="hlFld-ContribAuthor ">Jerick  Sanchez</span>, <span class="hlFld-ContribAuthor ">Niket  Shah</span>, <span class="hlFld-ContribAuthor ">Deepa  Pookot</span>, <span class="hlFld-ContribAuthor ">Betty  Abraham</span>, <span class="hlFld-ContribAuthor ">Kyle  Young</span>, <span class="hlFld-ContribAuthor ">Silpa  Suthram</span>, <span class="hlFld-ContribAuthor ">Lisa A.  Marshall</span>, <span class="hlFld-ContribAuthor ">Delia  Bradford</span>, <span class="hlFld-ContribAuthor ">Nathan  Kozon</span>, <span class="hlFld-ContribAuthor ">Xinping  Han</span>, <span class="hlFld-ContribAuthor ">Akinori  Okano</span>, <span class="hlFld-ContribAuthor ">Jack  Maung</span>, <span class="hlFld-ContribAuthor ">Christophe  Colas</span>, <span class="hlFld-ContribAuthor ">Jacob  Schwarz</span>, <span class="hlFld-ContribAuthor ">David  Wustrow</span>, <span class="hlFld-ContribAuthor ">Dirk G.  Brockstedt</span>, <span class="hlFld-ContribAuthor ">Paul D.  Kassner</span>. </span><span class="cited-content_cbyCitation_article-title">Novel, Selective Inhibitors of USP7 Uncover Multiple Mechanisms of Antitumor Activity
              In Vitro
              and
              In Vivo. </span><span class="cited-content_cbyCitation_journal-name">Molecular Cancer Therapeutics</span><span> <strong>2020,</strong> <em>19 </em>
                                    (10)
                                     , 1970-1980. <a href="https://doi.org/10.1158/1535-7163.MCT-20-0184" title="DOI URL">https://doi.org/10.1158/1535-7163.MCT-20-0184</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1158/1535-7163.MCT-20-0184&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1158%2F1535-7163.MCT-20-0184%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecular%2520Cancer%2520Therapeutics%26atitle%3DNovel%25252C%252BSelective%252BInhibitors%252Bof%252BUSP7%252BUncover%252BMultiple%252BMechanisms%252Bof%252BAntitumor%252BActivity%252BIn%252BVitro%252Band%252BIn%252BVivo%26aulast%3DOhol%26aufirst%3DYamini%2BM.%26date%3D2020%26date%3D2020%26volume%3D19%26issue%3D10%26spage%3D1970%26epage%3D1980" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Binita  Shah</span>, <span class="hlFld-ContribAuthor ">Dan  Sindhikara</span>, <span class="hlFld-ContribAuthor ">Ken  Borrelli</span>, <span class="hlFld-ContribAuthor ">Abba E.  Leffler</span>. </span><span class="cited-content_cbyCitation_article-title">Water Thermodynamics of Peptide Toxin Binding Sites on Ion Channels. </span><span class="cited-content_cbyCitation_journal-name">Toxins</span><span> <strong>2020,</strong> <em>12 </em>
                                    (10)
                                     , 652. <a href="https://doi.org/10.3390/toxins12100652" title="DOI URL">https://doi.org/10.3390/toxins12100652</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/toxins12100652&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Ftoxins12100652%26sid%3Dliteratum%253Aachs%26jtitle%3DToxins%26atitle%3DWater%252BThermodynamics%252Bof%252BPeptide%252BToxin%252BBinding%252BSites%252Bon%252BIon%252BChannels%26aulast%3DShah%26aufirst%3DBinita%26date%3D2020%26date%3D2020%26volume%3D12%26issue%3D10%26spage%3D652" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Eli  Grunblatt</span>, <span class="hlFld-ContribAuthor ">Nan  Wu</span>, <span class="hlFld-ContribAuthor ">Huajia  Zhang</span>, <span class="hlFld-ContribAuthor ">Xiaoli  Liu</span>, <span class="hlFld-ContribAuthor ">Justin P.  Norton</span>, <span class="hlFld-ContribAuthor ">Yamini  Ohol</span>, <span class="hlFld-ContribAuthor ">Paul  Leger</span>, <span class="hlFld-ContribAuthor ">Joseph B.  Hiatt</span>, <span class="hlFld-ContribAuthor ">Emily C.  Eastwood</span>, <span class="hlFld-ContribAuthor ">Rhiana  Thomas</span>, <span class="hlFld-ContribAuthor ">Ali H.  Ibrahim</span>, <span class="hlFld-ContribAuthor ">Deshui  Jia</span>, <span class="hlFld-ContribAuthor ">Ryan  Basom</span>, <span class="hlFld-ContribAuthor ">Keith D.  Eaton</span>, <span class="hlFld-ContribAuthor ">Renato  Martins</span>, <span class="hlFld-ContribAuthor ">A. McGarry  Houghton</span>, <span class="hlFld-ContribAuthor ">David  MacPherson</span>. </span><span class="cited-content_cbyCitation_article-title">MYCN
              drives chemoresistance in small cell lung cancer while USP7 inhibition can restore chemosensitivity. </span><span class="cited-content_cbyCitation_journal-name">Genes & Development</span><span> <strong>2020,</strong> <em>34 </em>
                                    (17-18)
                                     , 1210-1226. <a href="https://doi.org/10.1101/gad.340133.120" title="DOI URL">https://doi.org/10.1101/gad.340133.120</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1101/gad.340133.120&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1101%2Fgad.340133.120%26sid%3Dliteratum%253Aachs%26jtitle%3DGenes%2520%2526%2520Development%26atitle%3DMYCN%252Bdrives%252Bchemoresistance%252Bin%252Bsmall%252Bcell%252Blung%252Bcancer%252Bwhile%252BUSP7%252Binhibition%252Bcan%252Brestore%252Bchemosensitivity%26aulast%3DGrunblatt%26aufirst%3DEli%26date%3D2020%26date%3D2020%26volume%3D34%26issue%3D17-18%26spage%3D1210%26epage%3D1226" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Francesca  Bufalieri</span>, <span class="hlFld-ContribAuthor ">Ludovica  Lospinoso Severini</span>, <span class="hlFld-ContribAuthor ">Miriam  Caimano</span>, <span class="hlFld-ContribAuthor ">Paola  Infante</span>, <span class="hlFld-ContribAuthor ">Lucia  Di Marcotullio</span>. </span><span class="cited-content_cbyCitation_article-title">DUBs Activating the Hedgehog Signaling Pathway: A Promising Therapeutic Target in Cancer. </span><span class="cited-content_cbyCitation_journal-name">Cancers</span><span> <strong>2020,</strong> <em>12 </em>
                                    (6)
                                     , 1518. <a href="https://doi.org/10.3390/cancers12061518" title="DOI URL">https://doi.org/10.3390/cancers12061518</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/cancers12061518&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fcancers12061518%26sid%3Dliteratum%253Aachs%26jtitle%3DCancers%26atitle%3DDUBs%252BActivating%252Bthe%252BHedgehog%252BSignaling%252BPathway%25253A%252BA%252BPromising%252BTherapeutic%252BTarget%252Bin%252BCancer%26aulast%3DBufalieri%26aufirst%3DFrancesca%26date%3D2020%26date%3D2020%26volume%3D12%26issue%3D6%26spage%3D1518" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="_i1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.0c00245/20200520/images/medium/jm0c00245_0029.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.0c00245/20200520/images/large/jm0c00245_0029.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00245&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.0c00245/20200520/images/medium/jm0c00245_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.0c00245/20200520/images/large/jm0c00245_0001.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Examples of previously described USP7 inhibitors.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.0c00245/20200520/images/large/jm0c00245_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00245&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.0c00245/20200520/images/medium/jm0c00245_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.0c00245/20200520/images/large/jm0c00245_0003.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. (Left) Schematic of the catalytic domain of USP7 (orange) bound to ubiquitin (blue), with the palm region (below purple dashed line), tunnel area (red box), and catalytic site (green circle) highlighted. The yellow arrow indicates the compound binding region highlighted in the structures on the right. (Right) Comparison of cocrystal structures of 4-hydroxy piperidine inhibitor <b>1</b> and pyridylbenzofuran compound <b>7</b>. Both inhibitors bind to the same allosteric site of USP7 and are selective inhibitors of USP7. The PDB code for <b>1</b> bound to USP7 is <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6VN4">6VN4</a>. The PDB code for <b>7</b> bound to USP7 is <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6VN5">6VN5</a>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.0c00245/20200520/images/large/jm0c00245_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00245&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.0c00245/20200520/images/medium/jm0c00245_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.0c00245/20200520/images/large/jm0c00245_0004.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Comparison of USP7 binding interactions of 4-hydroxy piperidine inhibitor <b>1</b> and pyridylbenzofuran inhibitor <b>7</b>. Boxed residues indicate potential hydrogen-bonding interactions that are not utilized by compound <b>7</b>. The PDB code for <b>1</b> bound to USP7 is <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6VN4">6VN4</a>. The PDB code for <b>7</b> bound to USP7 is <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6VN5">6VN5</a>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.0c00245/20200520/images/large/jm0c00245_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00245&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.0c00245/20200520/images/medium/jm0c00245_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.0c00245/20200520/images/large/jm0c00245_0005.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. WaterMap analysis of USP7 binding pocket. Hydration sites are shown as spheres colored by their predicted free energies (Δ<i>G</i>). Green spheres indicate a favorable free energy Δ<i>G</i> while red spheres indicate an unfavorable Δ<i>G</i>. (A) Hydration sites calculated with the ligand (compound <b>7</b>) removed. Overlay of compound <b>7</b> indicates that the magnified (enlarged) spheres are predicted to be displaced by compound <b>7</b> while the other (smaller) spheres are not. (B) Hydration sites with compound <b>7</b> present. Three unfavorable water sites (red/orange) near the 2-aminopyridyl headgroup of <b>7</b> suggest opportunities to further improve the potency of this inhibitor. WaterMap analysis based on cocrystal structure of compound <b>7</b> and USP7, PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6VN5">6VN5</a>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.0c00245/20200520/images/large/jm0c00245_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00245&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.0c00245/20200520/images/medium/jm0c00245_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.0c00245/20200520/images/large/jm0c00245_0006.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Compound <b>14</b> cocrystal structure with USP7, highlighting key interactions with the binding pocket. The PDB code for <b>14</b> bound to USP7 is <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6VN6">6VN6</a>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.0c00245/20200520/images/large/jm0c00245_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00245&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig6" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.0c00245/20200520/images/medium/jm0c00245_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.0c00245/20200520/images/large/jm0c00245_0007.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. X-ray cocrystal structure of compound <b>18</b> with USP7, highlighting key interactions with the binding pocket. The PDB code for <b>18</b> bound to USP7 is <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6VN2">6VN2</a>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.0c00245/20200520/images/large/jm0c00245_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00245&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig7" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.0c00245/20200520/images/medium/jm0c00245_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.0c00245/20200520/images/large/jm0c00245_0008.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Scaffold switch from the benzofuran-amide to a simplified ether is productive with the inclusion of an <i>ortho</i>-methyl group.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.0c00245/20200520/images/large/jm0c00245_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00245&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig8" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.0c00245/20200520/images/medium/jm0c00245_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.0c00245/20200520/images/large/jm0c00245_0009.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. X-ray cocrystal structure of ether <b>23</b> with USP7, highlighting key interactions with the binding pocket. The PDB code for <b>23</b> bound to USP7 is <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6VN3">6VN3</a>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.0c00245/20200520/images/large/jm0c00245_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00245&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig9" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.0c00245/20200520/images/medium/jm0c00245_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.0c00245/20200520/images/large/jm0c00245_0010.jpeg" id="rightTab-gr9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 9. Biochemical and cellular potencies with oxygen-, nitrogen-, and carbon-linked compounds.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.0c00245/20200520/images/large/jm0c00245_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00245&amp;id=fig9"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig10" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 10</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.0c00245/20200520/images/medium/jm0c00245_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.0c00245/20200520/images/large/jm0c00245_0002.jpeg" id="rightTab-gr10" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 10. Xenograft studies with (a) NOD-SCID mice engrafted with MM.1S tumors, or (b) athymic nude mice engrafted with H526 tumors. For each study, compound <b>41</b> was dosed PO at 50 mg/kg BID for the indicated time and tumor volume was measured. If the tumor volume exceeded 1500 mm<sup>3</sup>, the animals were taken down from the study (****<i>p</i> < 0.0001).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.0c00245/20200520/images/large/jm0c00245_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00245&amp;id=fig10"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.0c00245/20200520/images/medium/jm0c00245_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.0c00245/20200520/images/large/jm0c00245_0011.jpeg" id="rightTab-gr11" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of Thienopyridine Pieces<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.0c00245/20200520/images/large/jm0c00245_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00245&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents: (a) <i>n</i>-BuLi, −78 °C, DMF, 90%. (b) NaBH<sub>4</sub>, MeOH, 96%. (c) SOCl<sub>2</sub>, DCM, 99%. (d) Pyrrolidine-2,5-dione, K<sub>2</sub>CO<sub>3</sub>, acetone, 63%. (e) B<sub>2</sub>Pin<sub>2</sub>, Pd(dppf)Cl<sub>2</sub>, dppf, KOAc, dioxane, 110 °C, 83–99%. (f) TBS-Cl, imidazole, DMF, 85%.</p></p></figure><figure data-id="sch2" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.0c00245/20200520/images/medium/jm0c00245_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.0c00245/20200520/images/large/jm0c00245_0012.jpeg" id="rightTab-gr12" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis of Benzofuran-Amide USP7 Inhibitors<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.0c00245/20200520/images/large/jm0c00245_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00245&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>(a) Allyl bromide, K<sub>2</sub>CO<sub>3</sub>, acetone, 55 °C. (b) Mesitylene, 180 °C, 73% over 2 steps. (c) <i>m</i>-CPBA, DCM. (d) KOH, MeOH/H<sub>2</sub>O. (e) TEMPO (cat.), KBr (cat.), NaOCl, NaHCO<sub>3</sub>, THF, H<sub>2</sub>O, 0 °C (52% over 3 steps). (f) <b>54</b>, MeOH, recrystallization (x2), 42%. (g) <i>N</i>-Boc-piperazine, 1-methylimidazole, propanephosphonic anhydride, EtOAc, 81%. (h) PdCl<sub>2</sub>(PPh<sub>3</sub>)<sub>2</sub> (cat.), (Sn(<i>n</i>-Bu)<sub>3</sub>)<sub>2</sub>, 1,4-dioxane, 110 °C, 72%. (i) Pd(PPh<sub>3</sub>)<sub>2</sub>Cl<sub>2</sub>, Cu<sub>2</sub>O, 1,4-dioxane, 100 °C. (j) HCl or TFA, DCM, 90–99%. (k) Pd(PPh<sub>3</sub>)<sub>2</sub>Cl<sub>2</sub>, aq Na<sub>2</sub>CO<sub>3</sub>, EtOH, PhMe, 85 °C.</p></p></figure><figure data-id="sch3" data-index="13" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.0c00245/20200520/images/medium/jm0c00245_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.0c00245/20200520/images/large/jm0c00245_0013.jpeg" id="rightTab-gr13" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Synthesis of the Simplified Ether Series of Compounds<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.0c00245/20200520/images/large/jm0c00245_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00245&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents: (a) PPh<sub>3</sub>, DIAD, THF, 51–80%. (b) <b>46</b>, Pd(PPh<sub>3</sub>)<sub>2</sub>Cl<sub>2</sub>, aq Na<sub>2</sub>CO<sub>3</sub>, EtOH, PhMe, 85 °C, 20–69%. (c) TFA or HCl, DCM, 90–99%. (d) <b>48</b>, Pd(PPh<sub>3</sub>)<sub>2</sub>Cl<sub>2</sub>, aq Na<sub>2</sub>CO<sub>3</sub>, EtOH, PhMe, 85 °C, 21–61%. (e) TBAF, THF, 67–94%. (f) MsCl, DIPEA, DCM, then cyclic imide, Cs<sub>2</sub>CO<sub>3</sub>, MeCN, 60 °C, 45–65%.</p></p></figure><figure data-id="sch4" data-index="14" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.0c00245/20200520/images/medium/jm0c00245_0014.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.0c00245/20200520/images/large/jm0c00245_0014.jpeg" id="rightTab-gr14" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. Synthesis of Carbon-Linked Compounds: Piperazines and Morpholines<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.0c00245/20200520/images/large/jm0c00245_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00245&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents: (a) NIS, Pd(OAc)<sub>2</sub>, DMF, 120 °C, 30%. (b) Borane-DMS, THF, 50 °C, 73%. (c) PBr<sub>3</sub>, DCM, 88%. (d) NaH, DMF, 42–83%. (e) <b>46</b>, Pd(PPh<sub>3</sub>)<sub>2</sub>Cl<sub>2</sub>, aq Na<sub>2</sub>CO<sub>3</sub>, EtOH, PhMe, 85 °C, 20–69%. (f) TFA, or HCl, DCM 90–99%. (g) LDA, THF, −78 °C, 43–62%. (h) Borane-THF, THF, 70 °C, 62–88%. (i) Chloroethyl chloroformate, DCE, then MeOH, 70 °C, 84–98%. (j) Boc<sub>2</sub>O, imidazole, THF, 63–99%. (k) Chiral SFC separation.</p></p></figure><figure data-id="sch5" data-index="15" class="article__inlineFigure"><h2 class="fig-label">Scheme 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.0c00245/20200520/images/medium/jm0c00245_0015.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.0c00245/20200520/images/large/jm0c00245_0015.jpeg" id="rightTab-gr15" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 5. Synthetic Route to Access Multigram Quantities of Enantiopure Compound <b>41</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.0c00245/20200520/images/large/jm0c00245_0015.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00245&amp;id=sch5"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents: (a) allyl bromide, <i>t</i>BuONO, MeCN, 73%. (b) <i>m</i>-CPBA, DCM, 63%. (c) Ethanol amine, THF, 60 °C. (d) Boc<sub>2</sub>O, imidazole, THF. (e) DIAD, PPh<sub>3</sub>, MTBE. (f) HCl, DCM, 59% over 4 steps. (g) NaOH, DCM. (h) <i>N</i>-Ac-<span class="smallcaps smallerCapital">d</span>-Leu (0.5 equiv), DCE, recrystallization (x3). (i) Boc<sub>2</sub>O, Et<sub>3</sub>N, DCM, 31% over 3 steps. (j) <b>48</b>, Pd(PPh<sub>3</sub>)<sub>2</sub>Cl<sub>2</sub>, Na<sub>2</sub>CO<sub>3</sub>, EtOH, PhMe, 85 °C. (k) TBAF, THF, 78% over 2 steps. (l) MsCl, DIPEA, DCM, then 6,6-dimethyl-3-azabicyclo[3.1.0]hexane-2,4-dione, Cs<sub>2</sub>CO<sub>3</sub>, MeCN, 60 °C. (m) HCl, DCM, 65% over 2 steps.</p></p></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i97">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_50084" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_50084" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 34 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bhattacharya, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chakraborty, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Basu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ghosh, M. K.</span></span> <span> </span><span class="NLM_article-title">Emerging Insights into HAUSP (USP7) in Physiology, Cancer, and Other Diseases</span>. <i>Signal Transduction Targeted Ther.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>3</i></span>,  <span class="NLM_fpage">17</span>, <span class="refDoi"> DOI: 10.1038/s41392-018-0012-y</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00245&amp;key=10.1038%2Fs41392-018-0012-y" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00245&amp;key=29967688" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00245&amp;key=1%3ACAS%3A280%3ADC%252BB3c%252FktlSgsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2018&pages=17&author=S.+Bhattacharyaauthor=D.+Chakrabortyauthor=M.+Basuauthor=M.+K.+Ghosh&title=Emerging+Insights+into+HAUSP+%28USP7%29+in+Physiology%2C+Cancer%2C+and+Other+Diseases&doi=10.1038%2Fs41392-018-0012-y"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Emerging insights into HAUSP (USP7) in physiology, cancer and other diseases</span></div><div class="casAuthors">Bhattacharya Seemana; Chakraborty Dipankar; Ghosh Mrinal K; Basu Malini</div><div class="citationInfo"><span class="NLM_cas:title">Signal transduction and targeted therapy</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">17</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Herpesvirus-associated ubiquitin-specific protease (HAUSP) is a USP family deubiquitinase.  HAUSP is a protein of immense biological importance as it is involved in several cellular processes, including host-virus interactions, oncogenesis and tumor suppression, DNA damage and repair processes, DNA dynamics and epigenetic modulations, regulation of gene expression and protein function, spatio-temporal distribution, and immune functions.  Since its discovery in the late 1990s as a protein interacting with a herpes virus regulatory protein, extensive studies have assessed its complex roles in p53-MDM2-related networks, identified numerous additional interacting partners, and elucidated the different roles of HAUSP in the context of cancer, development, and metabolic and neurological pathologies.  Recent analyses have provided new insights into its biochemical and functional dynamics.  In this review, we provide a comprehensive account of our current knowledge about emerging insights into HAUSP in physiology and diseases, which shed light on fundamental biological questions and promise to provide a potential target for therapeutic intervention.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcT7k3GWdDMbmlQKX3ooHxWjfW6udTcc2eaPVerCI5hClLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BB3c%252FktlSgsQ%253D%253D&md5=adfbf970228028f40e2cfb875dc0a810</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1038%2Fs41392-018-0012-y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41392-018-0012-y%26sid%3Dliteratum%253Aachs%26aulast%3DBhattacharya%26aufirst%3DS.%26aulast%3DChakraborty%26aufirst%3DD.%26aulast%3DBasu%26aufirst%3DM.%26aulast%3DGhosh%26aufirst%3DM.%2BK.%26atitle%3DEmerging%2520Insights%2520into%2520HAUSP%2520%2528USP7%2529%2520in%2520Physiology%252C%2520Cancer%252C%2520and%2520Other%2520Diseases%26jtitle%3DSignal%2520Transduction%2520Targeted%2520Ther.%26date%3D2018%26volume%3D3%26spage%3D17%26doi%3D10.1038%2Fs41392-018-0012-y" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tavana, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gu, W.</span></span> <span> </span><span class="NLM_article-title">Modulation of the p53/MDM2 Interplay by HAUSP Inhibitors</span>. <i>J. Mol. Cell Biol.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">45</span>– <span class="NLM_lpage">52</span>, <span class="refDoi"> DOI: 10.1093/jmcb/mjw049</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00245&amp;key=10.1093%2Fjmcb%2Fmjw049" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00245&amp;key=27927749" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00245&amp;key=1%3ACAS%3A528%3ADC%252BC1cXitFCrsrvL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2017&pages=45-52&author=O.+Tavanaauthor=W.+Gu&title=Modulation+of+the+p53%2FMDM2+Interplay+by+HAUSP+Inhibitors&doi=10.1093%2Fjmcb%2Fmjw049"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Modulation of the p53/MDM2 interplay by HAUSP inhibitors</span></div><div class="casAuthors">Tavana, Omid; Gu, Wei</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Molecular Cell Biology (Oxford, United Kingdom)</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">45-52</span>CODEN:
                <span class="NLM_cas:coden">JMCBCU</span>;
        ISSN:<span class="NLM_cas:issn">1759-4685</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">It is well established that both p53 and MDM2 are short-lived proteins whose stabilities are tightly controlled through ubiquitination-mediated degrdn.  Although numerous studies indicate that the MDM2 E3 ligase activity, as well as the protein- protein interaction between p53 and MDM2, is the major focus for this regulation, emerging evidence suggests that the deubiquitinase herpesvirus-assocd. ubiquitin-specific protease (HAUSP, also known as USP7) plays a crit. role.  Furthermore, HAUSP inhibition elevates p53 stability and might be beneficial for therapeutic purposes.  In this review, we discuss the advances of this dynamic pathway and the contributions of pos. and neg. regulators affecting HAUSP activity.  We also highlight the roles of HAUSP in cancer justifying the prodn. of the first generation of HAUSP inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr425eMtyLDyrVg90H21EOLACvtfcHk0ljOzV8As3WL0A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXitFCrsrvL&md5=e68decb8e9639edb9c998da49cb0a496</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1093%2Fjmcb%2Fmjw049&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fjmcb%252Fmjw049%26sid%3Dliteratum%253Aachs%26aulast%3DTavana%26aufirst%3DO.%26aulast%3DGu%26aufirst%3DW.%26atitle%3DModulation%2520of%2520the%2520p53%252FMDM2%2520Interplay%2520by%2520HAUSP%2520Inhibitors%26jtitle%3DJ.%2520Mol.%2520Cell%2520Biol.%26date%3D2017%26volume%3D9%26spage%3D45%26epage%3D52%26doi%3D10.1093%2Fjmcb%2Fmjw049" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">van
Loosdregt, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fleskens, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brenkman, A. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bekker, C. P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pals, C. E. M. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meerding, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berkers, C. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barbi, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gröne, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sijts, A. J. A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maurice, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kalkhoven, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prakken, B. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ovaa, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pan, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zaiss, D. M. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coffer, P. J.</span></span> <span> </span><span class="NLM_article-title">Stabilization of the Transcription Factor Foxp3 by the Deubiquitinase USP7 Increases Treg-Cell-Suppressive Capacity</span>. <i>Immunity</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>39</i></span>,  <span class="NLM_fpage">259</span>– <span class="NLM_lpage">271</span>, <span class="refDoi"> DOI: 10.1016/j.immuni.2013.05.018</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00245&amp;key=10.1016%2Fj.immuni.2013.05.018" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00245&amp;key=23973222" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00245&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtlCgtr3F" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=2013&pages=259-271&author=J.+van%0ALoosdregtauthor=V.+Fleskensauthor=J.+Fuauthor=A.+B.+Brenkmanauthor=C.+P.+J.+Bekkerauthor=C.+E.+M.+G.+Palsauthor=J.+Meerdingauthor=C.+R.+Berkersauthor=J.+Barbiauthor=A.+Gr%C3%B6neauthor=A.+J.+A.+M.+Sijtsauthor=M.+M.+Mauriceauthor=E.+Kalkhovenauthor=B.+J.+Prakkenauthor=H.+Ovaaauthor=F.+Panauthor=D.+M.+W.+Zaissauthor=P.+J.+Coffer&title=Stabilization+of+the+Transcription+Factor+Foxp3+by+the+Deubiquitinase+USP7+Increases+Treg-Cell-Suppressive+Capacity&doi=10.1016%2Fj.immuni.2013.05.018"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Stabilization of the Transcription Factor Foxp3 by the Deubiquitinase USP7 Increases Treg-Cell-Suppressive Capacity</span></div><div class="casAuthors">van Loosdregt, Jorg; Fleskens, Veerle; Fu, Juan; Brenkman, Arjan B.; Bekker, Cornelis P. J.; Pals, Cornelieke E. G. M.; Meerding, Jenny; Berkers, Celia R.; Barbi, Joseph; Grone, Andrea; Sijts, Alice J. A. M.; Maurice, Madelon M.; Kalkhoven, Eric; Prakken, Berent J.; Ovaa, Huib; Pan, Fan; Zaiss, Dietmar M. W.; Coffer, Paul J.</div><div class="citationInfo"><span class="NLM_cas:title">Immunity</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">39</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">259-271</span>CODEN:
                <span class="NLM_cas:coden">IUNIEH</span>;
        ISSN:<span class="NLM_cas:issn">1074-7613</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">Stable Foxp3 expression is required for the development of functional regulatory T (Treg) cells.  Here, we demonstrate that the expression of the transcription factor Foxp3 can be regulated through the polyubiquitination of multiple lysine residues, resulting in proteasome-mediated degrdn.  Expression of the deubiquitinase (DUB) USP7 was found to be upregulated and active in Treg cells, being assocd. with Foxp3 in the nucleus.  Ectopic expression of USP7 decreased Foxp3 polyubiquitination and increased Foxp3 expression.  Conversely, either treatment with DUB inhibitor or USP7 knockdown decreased endogenous Foxp3 protein expression and decreased Treg-cell-mediated suppression in vitro.  Furthermore, in a murine adoptive-transfer-induced colitis model, either inhibition of DUB activity or USP7 knockdown in Treg cells abrogated their ability to resolve inflammation in vivo.  Our data reveal a mol. mechanism in which rapid temporal control of Foxp3 expression in Treg cells can be regulated by USP7, thereby modulating Treg cell nos. and function.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr5Zpb6_zouu7Vg90H21EOLACvtfcHk0ljOzV8As3WL0A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtlCgtr3F&md5=78bd3e51a661ecac49461a3811d2e768</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1016%2Fj.immuni.2013.05.018&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.immuni.2013.05.018%26sid%3Dliteratum%253Aachs%26aulast%3Dvan%2BLoosdregt%26aufirst%3DJ.%26aulast%3DFleskens%26aufirst%3DV.%26aulast%3DFu%26aufirst%3DJ.%26aulast%3DBrenkman%26aufirst%3DA.%2BB.%26aulast%3DBekker%26aufirst%3DC.%2BP.%2BJ.%26aulast%3DPals%26aufirst%3DC.%2BE.%2BM.%2BG.%26aulast%3DMeerding%26aufirst%3DJ.%26aulast%3DBerkers%26aufirst%3DC.%2BR.%26aulast%3DBarbi%26aufirst%3DJ.%26aulast%3DGr%25C3%25B6ne%26aufirst%3DA.%26aulast%3DSijts%26aufirst%3DA.%2BJ.%2BA.%2BM.%26aulast%3DMaurice%26aufirst%3DM.%2BM.%26aulast%3DKalkhoven%26aufirst%3DE.%26aulast%3DPrakken%26aufirst%3DB.%2BJ.%26aulast%3DOvaa%26aufirst%3DH.%26aulast%3DPan%26aufirst%3DF.%26aulast%3DZaiss%26aufirst%3DD.%2BM.%2BW.%26aulast%3DCoffer%26aufirst%3DP.%2BJ.%26atitle%3DStabilization%2520of%2520the%2520Transcription%2520Factor%2520Foxp3%2520by%2520the%2520Deubiquitinase%2520USP7%2520Increases%2520Treg-Cell-Suppressive%2520Capacity%26jtitle%3DImmunity%26date%3D2013%26volume%3D39%26spage%3D259%26epage%3D271%26doi%3D10.1016%2Fj.immuni.2013.05.018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Agathanggelou, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davies, N. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kwok, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zlatanou, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oldreive, C. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mao, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Da Costa, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yadollahi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perry, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kearns, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Skowronska, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yates, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parry, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hillmen, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reverdy, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Delansorne, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paneesha, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pratt, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moss, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taylor, A. M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stewart, G. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stankovic, T.</span></span> <span> </span><span class="NLM_article-title">USP7 Inhibition Alters Homologous Recombination Repair and Targets CLL Cells Independently of ATM/p53 Functional Status</span>. <i>Blood</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>130</i></span>,  <span class="NLM_fpage">156</span>– <span class="NLM_lpage">166</span>, <span class="refDoi"> DOI: 10.1182/blood-2016-12-758219</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00245&amp;key=10.1182%2Fblood-2016-12-758219" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00245&amp;key=28495793" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00245&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhs1WnurnJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=130&publication_year=2017&pages=156-166&author=A.+Agathanggelouauthor=E.+Smithauthor=N.+J.+Daviesauthor=M.+Kwokauthor=A.+Zlatanouauthor=C.+E.+Oldreiveauthor=J.+Maoauthor=D.+Da+Costaauthor=S.+Yadollahiauthor=T.+Perryauthor=P.+Kearnsauthor=A.+Skowronskaauthor=E.+Yatesauthor=H.+Parryauthor=P.+Hillmenauthor=C.+Reverdyauthor=R.+Delansorneauthor=S.+Paneeshaauthor=G.+Prattauthor=P.+Mossauthor=A.+M.+R.+Taylorauthor=G.+S.+Stewartauthor=T.+Stankovic&title=USP7+Inhibition+Alters+Homologous+Recombination+Repair+and+Targets+CLL+Cells+Independently+of+ATM%2Fp53+Functional+Status&doi=10.1182%2Fblood-2016-12-758219"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">USP7 inhibition alters homologous recombination repair and targets CLL cells independently of ATM/p53 functional status</span></div><div class="casAuthors">Agathanggelou, Angelo; Smith, Edward; Davies, Nicholas J.; Kwok, Marwan; Zlatanou, Anastasia; Oldreive, Ceri E.; Mao, Jingwen; Costa, David Da; Yadollahi, Sina; Perry, Tracey; Kearns, Pamela; Skowronska, Anna; Yates, Elliot; Parry, Helen; Hillmen, Peter; Reverdy, Celine; Delansorne, Remi; Paneesha, Shankara; Pratt, Guy; Moss, Paul; Taylor, A. Malcolm R.; Stewart, Grant S.; Stankovic, Tatjana</div><div class="citationInfo"><span class="NLM_cas:title">Blood</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">130</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">156-166</span>CODEN:
                <span class="NLM_cas:coden">BLOOAW</span>;
        ISSN:<span class="NLM_cas:issn">1528-0020</span>.
    
            (<span class="NLM_cas:orgname">American Society of Hematology</span>)
        </div><div class="casAbstract">The role of deubiquitylase ubiquitin-specific protease 7 (USP7) in the regulation of the p53-dependent DNA damage response (DDR) pathway is well established.  Whereas previous studies have mostly focused on the mechanisms underlying how USP7 directly controls p53 stability, we recently showed that USP7 modulates the stability of the DNA damage responsive E3 ubiquitin ligase RAD18.  This suggests that targeting USP7 may have therapeutic potential even in tumors with defective p53 or ibrutinib resistance.  To test this hypothesis, we studied the effect of USP7 inhibition in chronic lymphocytic leukemia (CLL) where the ataxia telangiectasia mutated (ATM)-p53 pathway is inactivated with relatively high frequency, leading to treatment resistance and poor clin. outcome.  We demonstrate that USP7 is upregulated in CLL cells, and its loss or inhibition disrupts homologous recombination repair (HRR).  Consequently, USP7 inhibition induces significant tumor-cell killing independently of ATM and p53 through the accumulation of genotoxic levels of DNA damage.  Moreover, USP7 inhibition sensitized p53-defective, chemotherapy-resistant CLL cells to clin. achievable doses of HRR-inducing chemotherapeutic agents in vitro and in vivo in a murine xenograft model.  Together, these results identify USP7 as a promising therapeutic target for the treatment of hematol. malignancies with DDR defects, where ATM/p53-dependent apoptosis is compromised.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrxu8cU2EjofrVg90H21EOLACvtfcHk0ljOzV8As3WL0A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhs1WnurnJ&md5=bfde319950ac91d43cd96aa35ded6cef</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1182%2Fblood-2016-12-758219&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1182%252Fblood-2016-12-758219%26sid%3Dliteratum%253Aachs%26aulast%3DAgathanggelou%26aufirst%3DA.%26aulast%3DSmith%26aufirst%3DE.%26aulast%3DDavies%26aufirst%3DN.%2BJ.%26aulast%3DKwok%26aufirst%3DM.%26aulast%3DZlatanou%26aufirst%3DA.%26aulast%3DOldreive%26aufirst%3DC.%2BE.%26aulast%3DMao%26aufirst%3DJ.%26aulast%3DDa%2BCosta%26aufirst%3DD.%26aulast%3DYadollahi%26aufirst%3DS.%26aulast%3DPerry%26aufirst%3DT.%26aulast%3DKearns%26aufirst%3DP.%26aulast%3DSkowronska%26aufirst%3DA.%26aulast%3DYates%26aufirst%3DE.%26aulast%3DParry%26aufirst%3DH.%26aulast%3DHillmen%26aufirst%3DP.%26aulast%3DReverdy%26aufirst%3DC.%26aulast%3DDelansorne%26aufirst%3DR.%26aulast%3DPaneesha%26aufirst%3DS.%26aulast%3DPratt%26aufirst%3DG.%26aulast%3DMoss%26aufirst%3DP.%26aulast%3DTaylor%26aufirst%3DA.%2BM.%2BR.%26aulast%3DStewart%26aufirst%3DG.%2BS.%26aulast%3DStankovic%26aufirst%3DT.%26atitle%3DUSP7%2520Inhibition%2520Alters%2520Homologous%2520Recombination%2520Repair%2520and%2520Targets%2520CLL%2520Cells%2520Independently%2520of%2520ATM%252Fp53%2520Functional%2520Status%26jtitle%3DBlood%26date%3D2017%26volume%3D130%26spage%3D156%26epage%3D166%26doi%3D10.1182%2Fblood-2016-12-758219" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Li, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, H.-M.</span></span> <span> </span><span class="NLM_article-title">Recent Advances in the Development of Ubiquitin-Specific-Processing Protease 7 (USP7) Inhibitors</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>191</i></span>,  <span class="NLM_fpage">112107</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2020.112107</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00245&amp;key=10.1016%2Fj.ejmech.2020.112107" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00245&amp;key=32092586" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00245&amp;key=1%3ACAS%3A528%3ADC%252BB3cXjvVGqur4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=191&publication_year=2020&pages=112107&author=P.+Liauthor=H.-M.+Liu&title=Recent+Advances+in+the+Development+of+Ubiquitin-Specific-Processing+Protease+7+%28USP7%29+Inhibitors&doi=10.1016%2Fj.ejmech.2020.112107"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Recent advances in the development of ubiquitin-specific-processing protease 7 (USP7) inhibitors</span></div><div class="casAuthors">Li, Peng; Liu, Hong-Min</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">191</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">112107</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">A review.  Ubiquitin-specific-processing protease 7 (USP7) is one among the several deubiquitinating enzymes gaining central attention in the current cancer research.  Most recent studies have focused on illustrating how USP7 is involved in the cancer process, while few articles reported the development of small mol. USP7 inhibitors.  Although some review articles dealt with USP7, they mainly focused on its physiol. role and not on the development of USP7 inhibitors.  In this review, we systematically summarise the structures, activities and structure-activity relationship (SAR) of small mol. USP7 inhibitors, recently disclosed in scientific articles and patents from 2000 to 2019.  The binding modes of typical compds. and their interactions with USP7 are also presented, while other deubiquitinase inhibitors are described in detail.  Meanwhile, we briefly introduce the biochem. and physiol. functions of USP7.  Finally, challenges and potential strategies in developing small mol. USP7 inhibitors are also discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoCKYtfXngDkbVg90H21EOLACvtfcHk0lg9vJvzusRrXw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXjvVGqur4%253D&md5=3dc04b7fdb4f6e7195b71e8749b76277</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2020.112107&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2020.112107%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DP.%26aulast%3DLiu%26aufirst%3DH.-M.%26atitle%3DRecent%2520Advances%2520in%2520the%2520Development%2520of%2520Ubiquitin-Specific-Processing%2520Protease%25207%2520%2528USP7%2529%2520Inhibitors%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2020%26volume%3D191%26spage%3D112107%26doi%3D10.1016%2Fj.ejmech.2020.112107" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Colland, F.</span>; <span class="NLM_string-name">Gourdel, M.-E.</span></span> <span> </span><span class="NLM_article-title">Selective and Reversible Inhibitors of Ubiquitin Specific Protease 7</span>. <span class="NLM_patent">WO 2013030218 A1</span>, <span class="NLM_year">2013</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2013&author=F.+Colland&author=M.-E.+Gourdel&title=Selective+and+Reversible+Inhibitors+of+Ubiquitin+Specific+Protease+7"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DColland%26aufirst%3DF.%26atitle%3DSelective%2520and%2520Reversible%2520Inhibitors%2520of%2520Ubiquitin%2520Specific%2520Protease%25207%26date%3D2013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Turnbull, A. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ioannidis, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krajewski, W. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pinto-Fernandez, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heride, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martin, A. C. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tonkin, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Townsend, E. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buker, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lancia, D. R.,  Jr.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Caravella, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Toms, A. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Charlton, T. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lahdenranta, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilker, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Follows, B. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Evans, N. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stead, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alli, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zarayskiy, V. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Talbot, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buckmelter, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McKinnon, C. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saab, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McGouran, J. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Century, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gersch, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pittman, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marshall, C. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Raynham, T. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Simcox, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stewart, L. M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McLoughlin, S. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Escobedo, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bair, K. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dinsmore, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hammonds, T. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Urbé, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clague, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kessler, B. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Komander, D.</span></span> <span> </span><span class="NLM_article-title">Molecular basis of USP7 inhibition by selective small-molecule inhibitors</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>550</i></span>,  <span class="NLM_fpage">481</span>– <span class="NLM_lpage">486</span>, <span class="refDoi"> DOI: 10.1038/nature24451</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00245&amp;key=10.1038%2Fnature24451" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00245&amp;key=29045389" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00245&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhs1OhtrnK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=550&publication_year=2017&pages=481-486&author=A.+P.+Turnbullauthor=S.+Ioannidisauthor=W.+W.+Krajewskiauthor=A.+Pinto-Fernandezauthor=C.+Herideauthor=A.+C.+L.+Martinauthor=L.+M.+Tonkinauthor=E.+C.+Townsendauthor=S.+M.+Bukerauthor=D.+R.+Lanciaauthor=J.+A.+Caravellaauthor=A.+V.+Tomsauthor=T.+M.+Charltonauthor=J.+Lahdenrantaauthor=E.+Wilkerauthor=B.+C.+Followsauthor=N.+J.+Evansauthor=L.+Steadauthor=C.+Alliauthor=V.+V.+Zarayskiyauthor=A.+C.+Talbotauthor=A.+J.+Buckmelterauthor=M.+Wangauthor=C.+L.+McKinnonauthor=F.+Saabauthor=J.+F.+McGouranauthor=H.+Centuryauthor=M.+Gerschauthor=M.+S.+Pittmanauthor=C.+G.+Marshallauthor=T.+M.+Raynhamauthor=M.+Simcoxauthor=L.+M.+D.+Stewartauthor=S.+B.+McLoughlinauthor=J.+A.+Escobedoauthor=K.+W.+Bairauthor=C.+J.+Dinsmoreauthor=T.+R.+Hammondsauthor=S.+Kimauthor=S.+Urb%C3%A9author=M.+J.+Clagueauthor=B.+M.+Kesslerauthor=D.+Komander&title=Molecular+basis+of+USP7+inhibition+by+selective+small-molecule+inhibitors&doi=10.1038%2Fnature24451"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular basis of USP7 inhibition by selective small-molecule inhibitors</span></div><div class="casAuthors">Turnbull, Andrew P.; Ioannidis, Stephanos; Krajewski, Wojciech W.; Pinto-Fernandez, Adan; Heride, Claire; Martin, Agnes C. L.; Tonkin, Louise M.; Townsend, Elizabeth C.; Buker, Shane M.; Lancia, David R.; Caravella, Justin A.; Toms, Angela V.; Charlton, Thomas M.; Lahdenranta, Johanna; Wilker, Erik; Follows, Bruce C.; Evans, Nicola J.; Stead, Lucy; Alli, Cristina; Zarayskiy, Vladislav V.; Talbot, Adam C.; Buckmelter, Alexandre J.; Wang, Minghua; McKinnon, Crystal L.; Saab, Fabienne; McGouran, Joanna F.; Century, Hannah; Gersch, Malte; Pittman, Marc S.; Marshall, C. Gary; Raynham, Tony M.; Simcox, Mary; Stewart, Lorna M. D.; McLoughlin, Sheila B.; Escobedo, Jaime A.; Bair, Kenneth W.; Dinsmore, Christopher J.; Hammonds, Tim R.; Kim, Sunkyu; Urbe, Sylvie; Clague, Michael J.; Kessler, Benedikt M.; Komander, David</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">550</span>
        (<span class="NLM_cas:issue">7677</span>),
    <span class="NLM_cas:pages">481-486</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Research</span>)
        </div><div class="casAbstract">Ubiquitination controls the stability of most cellular proteins, and its deregulation contributes to human diseases including cancer.  Deubiquitinases remove ubiquitin from proteins, and their inhibition can induce the degrdn. of selected proteins, potentially including otherwise 'undruggable' targets.  For example, the inhibition of ubiquitin-specific protease 7 (USP7) results in the degrdn. of the oncogenic E3 ligase MDM2, and leads to reactivation of the tumor suppressor p53 in various cancers.  Here the authors report that two compds., FT671 and FT827, inhibit USP7 with high affinity and specificity in vitro and within human cells.  Cocrystal structures reveal that both compds. target a dynamic pocket near the catalytic center of the auto-inhibited apo form of USP7, which differs from other USP deubiquitinases.  Consistent with USP7 target engagement in cells, FT671 destabilizes USP7 substrates including MDM2, increases levels of p53, and results in the transcription of p53 target genes, induction of the tumor suppressor p21, and inhibition of tumor growth in mice.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqR8apmCZU85rVg90H21EOLACvtfcHk0lg9vJvzusRrXw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhs1OhtrnK&md5=166efb5b9de6304829c09fa3e4fb540a</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1038%2Fnature24451&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature24451%26sid%3Dliteratum%253Aachs%26aulast%3DTurnbull%26aufirst%3DA.%2BP.%26aulast%3DIoannidis%26aufirst%3DS.%26aulast%3DKrajewski%26aufirst%3DW.%2BW.%26aulast%3DPinto-Fernandez%26aufirst%3DA.%26aulast%3DHeride%26aufirst%3DC.%26aulast%3DMartin%26aufirst%3DA.%2BC.%2BL.%26aulast%3DTonkin%26aufirst%3DL.%2BM.%26aulast%3DTownsend%26aufirst%3DE.%2BC.%26aulast%3DBuker%26aufirst%3DS.%2BM.%26aulast%3DLancia%26aufirst%3DD.%2BR.%26aulast%3DCaravella%26aufirst%3DJ.%2BA.%26aulast%3DToms%26aufirst%3DA.%2BV.%26aulast%3DCharlton%26aufirst%3DT.%2BM.%26aulast%3DLahdenranta%26aufirst%3DJ.%26aulast%3DWilker%26aufirst%3DE.%26aulast%3DFollows%26aufirst%3DB.%2BC.%26aulast%3DEvans%26aufirst%3DN.%2BJ.%26aulast%3DStead%26aufirst%3DL.%26aulast%3DAlli%26aufirst%3DC.%26aulast%3DZarayskiy%26aufirst%3DV.%2BV.%26aulast%3DTalbot%26aufirst%3DA.%2BC.%26aulast%3DBuckmelter%26aufirst%3DA.%2BJ.%26aulast%3DWang%26aufirst%3DM.%26aulast%3DMcKinnon%26aufirst%3DC.%2BL.%26aulast%3DSaab%26aufirst%3DF.%26aulast%3DMcGouran%26aufirst%3DJ.%2BF.%26aulast%3DCentury%26aufirst%3DH.%26aulast%3DGersch%26aufirst%3DM.%26aulast%3DPittman%26aufirst%3DM.%2BS.%26aulast%3DMarshall%26aufirst%3DC.%2BG.%26aulast%3DRaynham%26aufirst%3DT.%2BM.%26aulast%3DSimcox%26aufirst%3DM.%26aulast%3DStewart%26aufirst%3DL.%2BM.%2BD.%26aulast%3DMcLoughlin%26aufirst%3DS.%2BB.%26aulast%3DEscobedo%26aufirst%3DJ.%2BA.%26aulast%3DBair%26aufirst%3DK.%2BW.%26aulast%3DDinsmore%26aufirst%3DC.%2BJ.%26aulast%3DHammonds%26aufirst%3DT.%2BR.%26aulast%3DKim%26aufirst%3DS.%26aulast%3DUrb%25C3%25A9%26aufirst%3DS.%26aulast%3DClague%26aufirst%3DM.%2BJ.%26aulast%3DKessler%26aufirst%3DB.%2BM.%26aulast%3DKomander%26aufirst%3DD.%26atitle%3DMolecular%2520basis%2520of%2520USP7%2520inhibition%2520by%2520selective%2520small-molecule%2520inhibitors%26jtitle%3DNature%26date%3D2017%26volume%3D550%26spage%3D481%26epage%3D486%26doi%3D10.1038%2Fnature24451" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gavory, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Dowd, C. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Helm, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Flasz, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arkoudis, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dossang, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hughes, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cassidy, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McClelland, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Odrzywol, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Page, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barker, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miel, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harrison, T.</span></span> <span> </span><span class="NLM_article-title">Discovery and Characterization of Highly Potent and Selective Allosteric USP7 Inhibitors</span>. <i>Nat. Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">118</span>– <span class="NLM_lpage">125</span>, <span class="refDoi"> DOI: 10.1038/nchembio.2528</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00245&amp;key=10.1038%2Fnchembio.2528" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00245&amp;key=29200206" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00245&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhvFWgs77F" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2018&pages=118-125&author=G.+Gavoryauthor=C.+R.+O%E2%80%99Dowdauthor=M.+D.+Helmauthor=J.+Flaszauthor=E.+Arkoudisauthor=A.+Dossangauthor=C.+Hughesauthor=E.+Cassidyauthor=K.+McClellandauthor=E.+Odrzywolauthor=N.+Pageauthor=O.+Barkerauthor=H.+Mielauthor=T.+Harrison&title=Discovery+and+Characterization+of+Highly+Potent+and+Selective+Allosteric+USP7+Inhibitors&doi=10.1038%2Fnchembio.2528"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery and characterization of highly potent and selective allosteric USP7 inhibitors</span></div><div class="casAuthors">Gavory, Gerald; O'Dowd, Colin R.; Helm, Matthew D.; Flasz, Jakub; Arkoudis, Elias; Dossang, Anthony; Hughes, Caroline; Cassidy, Eamon; McClelland, Keeva; Odrzywol, Ewa; Page, Natalie; Barker, Oliver; Miel, Hugues; Harrison, Timothy</div><div class="citationInfo"><span class="NLM_cas:title">Nature Chemical Biology</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">118-125</span>CODEN:
                <span class="NLM_cas:coden">NCBABT</span>;
        ISSN:<span class="NLM_cas:issn">1552-4450</span>.
    
            (<span class="NLM_cas:orgname">Nature Research</span>)
        </div><div class="casAbstract">Given the importance of ubiquitin-specific protease 7 (USP7) in oncogenic pathways, identification of USP7 inhibitors has attracted considerable interest.  Despite substantial efforts, however, the development of validated deubiquitinase (DUB) inhibitors that exhibit drug-like properties and a well-defined mechanism of action has proven particularly challenging.  In this article, we describe the identification, optimization and detailed characterization of highly potent (IC50 < 10 nM), selective USP7 inhibitors together with their less active, enantiomeric counterparts.  We also disclose, for the first time, co-crystal structures of a human DUB enzyme complexed with small-mol. inhibitors, which reveal a previously undisclosed allosteric binding site.  Finally, we report the identification of cancer cell lines hypersensitive to USP7 inhibition (EC50 < 30 nM) and demonstrate equal or superior activity in these cell models compared to clin. relevant MDM2 antagonists.  Overall, these findings demonstrate the tractability and druggability of DUBs, and provide important tools for addnl. target validation studies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqe5GeOEWbfz7Vg90H21EOLACvtfcHk0ljpOVnJfgmi-w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhvFWgs77F&md5=de6068d105b681c319e76e81ebfe9676</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1038%2Fnchembio.2528&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnchembio.2528%26sid%3Dliteratum%253Aachs%26aulast%3DGavory%26aufirst%3DG.%26aulast%3DO%25E2%2580%2599Dowd%26aufirst%3DC.%2BR.%26aulast%3DHelm%26aufirst%3DM.%2BD.%26aulast%3DFlasz%26aufirst%3DJ.%26aulast%3DArkoudis%26aufirst%3DE.%26aulast%3DDossang%26aufirst%3DA.%26aulast%3DHughes%26aufirst%3DC.%26aulast%3DCassidy%26aufirst%3DE.%26aulast%3DMcClelland%26aufirst%3DK.%26aulast%3DOdrzywol%26aufirst%3DE.%26aulast%3DPage%26aufirst%3DN.%26aulast%3DBarker%26aufirst%3DO.%26aulast%3DMiel%26aufirst%3DH.%26aulast%3DHarrison%26aufirst%3DT.%26atitle%3DDiscovery%2520and%2520Characterization%2520of%2520Highly%2520Potent%2520and%2520Selective%2520Allosteric%2520USP7%2520Inhibitors%26jtitle%3DNat.%2520Chem.%2520Biol.%26date%3D2018%26volume%3D14%26spage%3D118%26epage%3D125%26doi%3D10.1038%2Fnchembio.2528" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kotschy, A.</span>; <span class="NLM_string-name">Wéber, C.</span>; <span class="NLM_string-name">Vasas, A.</span>; <span class="NLM_string-name">Molnár, B.</span>; <span class="NLM_string-name">Kiss, Á.</span>; <span class="NLM_string-name">Macias, A.</span>; <span class="NLM_string-name">Murray, J. B.</span>; <span class="NLM_string-name">Lewkowicz, E.</span>; <span class="NLM_string-name">Geneste, O.</span>; <span class="NLM_string-name">Chanrion, M.</span>; <span class="NLM_string-name">Demarles, D.</span></span> <span> </span><span class="NLM_article-title">New (Hetero)aryl-Substituted-Piperidinyl Derivatives, A Process for Their Preparation and Pharmaceutical Compositions Containing Them</span>. <span class="NLM_patent">EP 2017064062 B1</span>, <span class="NLM_year">2017</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2017&author=A.+Kotschy&author=C.+W%C3%A9ber&author=A.+Vasas&author=B.+Moln%C3%A1r&author=%C3%81.+Kiss&author=A.+Macias&author=J.+B.+Murray&author=E.+Lewkowicz&author=O.+Geneste&author=M.+Chanrion&author=D.+Demarles&title=New+%28Hetero%29aryl-Substituted-Piperidinyl+Derivatives%2C+A+Process+for+Their+Preparation+and+Pharmaceutical+Compositions+Containing+Them"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DKotschy%26aufirst%3DA.%26atitle%3DNew%2520%2528Hetero%2529aryl-Substituted-Piperidinyl%2520Derivatives%252C%2520A%2520Process%2520for%2520Their%2520Preparation%2520and%2520Pharmaceutical%2520Compositions%2520Containing%2520Them%26date%3D2017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lamberto, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seo, H.-S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schauer, N. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iacob, R. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Das, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mikhailova, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weisberg, E. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Engen, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anderson, K. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chauhan, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dhe-Paganon, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buhrlage, S. J.</span></span> <span> </span><span class="NLM_article-title">Structure-Guided Development of a Potent and Selective Non-Covalent Active-Site Inhibitor of USP7</span>. <i>Cell Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>24</i></span>,  <span class="NLM_fpage">1490</span>– <span class="NLM_lpage">1500</span>, <span class="refDoi"> DOI: 10.1016/j.chembiol.2017.09.003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00245&amp;key=10.1016%2Fj.chembiol.2017.09.003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00245&amp;key=29056421" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00245&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhs1yrt7bM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2017&pages=1490-1500&author=I.+Lambertoauthor=X.+Liuauthor=H.-S.+Seoauthor=N.+J.+Schauerauthor=R.+E.+Iacobauthor=W.+Huauthor=D.+Dasauthor=T.+Mikhailovaauthor=E.+L.+Weisbergauthor=J.+R.+Engenauthor=K.+C.+Andersonauthor=D.+Chauhanauthor=S.+Dhe-Paganonauthor=S.+J.+Buhrlage&title=Structure-Guided+Development+of+a+Potent+and+Selective+Non-Covalent+Active-Site+Inhibitor+of+USP7&doi=10.1016%2Fj.chembiol.2017.09.003"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-Guided Development of a Potent and Selective Non-covalent Active-Site Inhibitor of USP7</span></div><div class="casAuthors">Lamberto, Ilaria; Liu, Xiaoxi; Seo, Hyuk-Soo; Schauer, Nathan J.; Iacob, Roxana E.; Hu, Wanyi; Das, Deepika; Mikhailova, Tatiana; Weisberg, Ellen L.; Engen, John R.; Anderson, Kenneth C.; Chauhan, Dharminder; Dhe-Paganon, Sirano; Buhrlage, Sara J.</div><div class="citationInfo"><span class="NLM_cas:title">Cell Chemical Biology</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1490-1500.e11</span>CODEN:
                <span class="NLM_cas:coden">CCBEBM</span>;
        ISSN:<span class="NLM_cas:issn">2451-9448</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Deubiquitinating enzymes (DUBs) have garnered significant attention as drug targets in the last 5-10 years.  The excitement stems in large part from the powerful ability of DUB inhibitors to promote degrdn. of oncogenic proteins, esp. proteins that are challenging to directly target but which are stabilized by DUB family members.  Highly optimized and well-characterized DUB inhibitors have thus become highly sought after tools.  Most reported DUB inhibitors, however, are polypharmacol. agents possessing weak (micromolar) potency toward their primary target, limiting their utility in target validation and mechanism studies.  Due to a lack of high-resoln. DUB·small-mol. ligand complex structures, no structure-guided optimization efforts have been reported for a mammalian DUB.  Here, we report a small-mol.·ubiquitin-specific protease (USP) family DUB co-structure and rapid design of potent and selective inhibitors of USP7 guided by the structure.  Interestingly, the compds. are non-covalent active-site inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrW3w_hVGZmXLVg90H21EOLACvtfcHk0ljpOVnJfgmi-w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhs1yrt7bM&md5=9a61dfb2740f07d027d10772d6f513ea</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1016%2Fj.chembiol.2017.09.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.chembiol.2017.09.003%26sid%3Dliteratum%253Aachs%26aulast%3DLamberto%26aufirst%3DI.%26aulast%3DLiu%26aufirst%3DX.%26aulast%3DSeo%26aufirst%3DH.-S.%26aulast%3DSchauer%26aufirst%3DN.%2BJ.%26aulast%3DIacob%26aufirst%3DR.%2BE.%26aulast%3DHu%26aufirst%3DW.%26aulast%3DDas%26aufirst%3DD.%26aulast%3DMikhailova%26aufirst%3DT.%26aulast%3DWeisberg%26aufirst%3DE.%2BL.%26aulast%3DEngen%26aufirst%3DJ.%2BR.%26aulast%3DAnderson%26aufirst%3DK.%2BC.%26aulast%3DChauhan%26aufirst%3DD.%26aulast%3DDhe-Paganon%26aufirst%3DS.%26aulast%3DBuhrlage%26aufirst%3DS.%2BJ.%26atitle%3DStructure-Guided%2520Development%2520of%2520a%2520Potent%2520and%2520Selective%2520Non-Covalent%2520Active-Site%2520Inhibitor%2520of%2520USP7%26jtitle%3DCell%2520Chem.%2520Biol.%26date%3D2017%26volume%3D24%26spage%3D1490%26epage%3D1500%26doi%3D10.1016%2Fj.chembiol.2017.09.003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kategaya, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Di Lello, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rougé, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pastor, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clark, K. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Drummond, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kleinheinz, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Upton, J.-P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prakash, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heideker, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McCleland, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ritorto, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alessi, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trost, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bainbridge, T. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kwok, M. C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, T. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stiffler, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brasher, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jaishankar, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hearn, B. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Renslo, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arkin, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cohen, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peale, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gnad, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chang, M. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Klijn, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blackwood, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martin, S. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Forrest, W. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ernst, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ndubaku, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beresini, M. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsui, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schwerdtfeger, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blake, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murray, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maurer, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wertz, I. E.</span></span> <span> </span><span class="NLM_article-title">USP7 Small-Molecule Inhibitors Interfere with Ubiquitin Binding</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>550</i></span>,  <span class="NLM_fpage">534</span>– <span class="NLM_lpage">538</span>, <span class="refDoi"> DOI: 10.1038/nature24006</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00245&amp;key=10.1038%2Fnature24006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00245&amp;key=29045385" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00245&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhs1OhtrjL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=550&publication_year=2017&pages=534-538&author=L.+Kategayaauthor=P.+Di+Lelloauthor=L.+Roug%C3%A9author=R.+Pastorauthor=K.+R.+Clarkauthor=J.+Drummondauthor=T.+Kleinheinzauthor=E.+Linauthor=J.-P.+Uptonauthor=S.+Prakashauthor=J.+Heidekerauthor=M.+McClelandauthor=M.+S.+Ritortoauthor=D.+R.+Alessiauthor=M.+Trostauthor=T.+W.+Bainbridgeauthor=M.+C.+M.+Kwokauthor=T.+P.+Maauthor=Z.+Stifflerauthor=B.+Brasherauthor=Y.+Tangauthor=P.+Jaishankarauthor=B.+R.+Hearnauthor=A.+R.+Rensloauthor=M.+R.+Arkinauthor=F.+Cohenauthor=K.+Yuauthor=F.+Pealeauthor=F.+Gnadauthor=M.+T.+Changauthor=C.+Klijnauthor=E.+Blackwoodauthor=S.+E.+Martinauthor=W.+F.+Forrestauthor=J.+A.+Ernstauthor=C.+Ndubakuauthor=X.+Wangauthor=M.+H.+Beresiniauthor=V.+Tsuiauthor=C.+Schwerdtfegerauthor=R.+A.+Blakeauthor=J.+Murrayauthor=T.+Maurerauthor=I.+E.+Wertz&title=USP7+Small-Molecule+Inhibitors+Interfere+with+Ubiquitin+Binding&doi=10.1038%2Fnature24006"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">USP7 small-molecule inhibitors interfere with ubiquitin binding</span></div><div class="casAuthors">Kategaya, Lorna; Di Lello, Paola; Rouge, Lionel; Pastor, Richard; Clark, Kevin R.; Drummond, Jason; Kleinheinz, Tracy; Lin, Eva; Upton, John-Paul; Prakash, Sumit; Heideker, Johanna; McCleland, Mark; Ritorto, Maria Stella; Alessi, Dario R.; Trost, Matthias; Bainbridge, Travis W.; Kwok, Michael C. M.; Ma, Taylur P.; Stiffler, Zachary; Brasher, Bradley; Tang, Yinyan; Jaishankar, Priyadarshini; Hearn, Brian R.; Renslo, Adam R.; Arkin, Michelle R.; Cohen, Frederick; Yu, Kebing; Peale, Frank; Gnad, Florian; Chang, Matthew T.; Klijn, Christiaan; Blackwood, Elizabeth; Martin, Scott E.; Forrest, William F.; Ernst, James A.; Ndubaku, Chudi; Wang, Xiaojing; Beresini, Maureen H.; Tsui, Vickie; Schwerdtfeger, Carsten; Blake, Robert A.; Murray, Jeremy; Maurer, Till; Wertz, Ingrid E.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">550</span>
        (<span class="NLM_cas:issue">7677</span>),
    <span class="NLM_cas:pages">534-538</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Research</span>)
        </div><div class="casAbstract">The ubiquitin system regulates essential cellular processes in eukaryotes.  Ubiquitin is ligated to substrate proteins as monomers or chains and the topol. of ubiquitin modifications regulates substrate interactions with specific proteins.  Thus, ubiquitination directs a variety of substrate fates including proteasomal degrdn.  Deubiquitinases cleave ubiquitin from substrates and are implicated in disease; e.g., ubiquitin-specific protease-7 (USP7) regulates the stability of the p53 tumor suppressor and other proteins crit. for tumor cell survival.  However, developing selective deubiquitinase inhibitors has been challenging and no co-crystal structures have been solved with small-mol. inhibitors.  Here, using NMR-based screening and structure-based design, we describe the development of the selective USP7 inhibitors, GNE-6640 and GNE-6776.  These compds. induce tumor cell death and enhance cytotoxicity with chemotherapeutic agents and targeted compds., including PIM kinase inhibitors.  Structural studies revealed that GNE-6640 and GNE-6776 non-covalently targeted USP7 12 Å distant from the catalytic Cys residue.  The compds. attenuated ubiquitin binding and thus inhibited USP7 deubiquitinase activity.  GNE-6640 and GNE-6776 interacted with acidic residues that mediate H-bond interactions with the ubiquitin Lys-48 side-chain, suggesting that USP7 preferentially interacts with and cleaves ubiquitin moieties that have free Lys-48 side-chains.  We investigated this idea by engineering di-ubiquitin chains contg. differential proximal and distal isotopic labels and measuring USP7 binding by NMR.  This preferential binding protracted the depolymn. kinetics of Lys-48-linked ubiquitin chains relative to Lys-63-linked chains.  In summary, engineering compds. that inhibit USP7 activity by attenuating ubiquitin binding suggests opportunities for developing other deubiquitinase inhibitors and may be a strategy more broadly applicable to inhibiting proteins that require ubiquitin binding for full functional activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqDUMQKwY0VGbVg90H21EOLACvtfcHk0lh1mtw1JM8aKA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhs1OhtrjL&md5=85af379796b4026105815b5ffdd01f8d</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1038%2Fnature24006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature24006%26sid%3Dliteratum%253Aachs%26aulast%3DKategaya%26aufirst%3DL.%26aulast%3DDi%2BLello%26aufirst%3DP.%26aulast%3DRoug%25C3%25A9%26aufirst%3DL.%26aulast%3DPastor%26aufirst%3DR.%26aulast%3DClark%26aufirst%3DK.%2BR.%26aulast%3DDrummond%26aufirst%3DJ.%26aulast%3DKleinheinz%26aufirst%3DT.%26aulast%3DLin%26aufirst%3DE.%26aulast%3DUpton%26aufirst%3DJ.-P.%26aulast%3DPrakash%26aufirst%3DS.%26aulast%3DHeideker%26aufirst%3DJ.%26aulast%3DMcCleland%26aufirst%3DM.%26aulast%3DRitorto%26aufirst%3DM.%2BS.%26aulast%3DAlessi%26aufirst%3DD.%2BR.%26aulast%3DTrost%26aufirst%3DM.%26aulast%3DBainbridge%26aufirst%3DT.%2BW.%26aulast%3DKwok%26aufirst%3DM.%2BC.%2BM.%26aulast%3DMa%26aufirst%3DT.%2BP.%26aulast%3DStiffler%26aufirst%3DZ.%26aulast%3DBrasher%26aufirst%3DB.%26aulast%3DTang%26aufirst%3DY.%26aulast%3DJaishankar%26aufirst%3DP.%26aulast%3DHearn%26aufirst%3DB.%2BR.%26aulast%3DRenslo%26aufirst%3DA.%2BR.%26aulast%3DArkin%26aufirst%3DM.%2BR.%26aulast%3DCohen%26aufirst%3DF.%26aulast%3DYu%26aufirst%3DK.%26aulast%3DPeale%26aufirst%3DF.%26aulast%3DGnad%26aufirst%3DF.%26aulast%3DChang%26aufirst%3DM.%2BT.%26aulast%3DKlijn%26aufirst%3DC.%26aulast%3DBlackwood%26aufirst%3DE.%26aulast%3DMartin%26aufirst%3DS.%2BE.%26aulast%3DForrest%26aufirst%3DW.%2BF.%26aulast%3DErnst%26aufirst%3DJ.%2BA.%26aulast%3DNdubaku%26aufirst%3DC.%26aulast%3DWang%26aufirst%3DX.%26aulast%3DBeresini%26aufirst%3DM.%2BH.%26aulast%3DTsui%26aufirst%3DV.%26aulast%3DSchwerdtfeger%26aufirst%3DC.%26aulast%3DBlake%26aufirst%3DR.%2BA.%26aulast%3DMurray%26aufirst%3DJ.%26aulast%3DMaurer%26aufirst%3DT.%26aulast%3DWertz%26aufirst%3DI.%2BE.%26atitle%3DUSP7%2520Small-Molecule%2520Inhibitors%2520Interfere%2520with%2520Ubiquitin%2520Binding%26jtitle%3DNature%26date%3D2017%26volume%3D550%26spage%3D534%26epage%3D538%26doi%3D10.1038%2Fnature24006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Di
Lello, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pastor, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murray, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blake, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cohen, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Crawford, T. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Drobnick, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Drummond, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kategaya, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kleinheinz, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maurer, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rougé, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wertz, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ndubaku, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsui, V.</span></span> <span> </span><span class="NLM_article-title">Discovery of Small-Molecule Inhibitors of Ubiquitin Specific Protease 7 (USP7) Using Integrated NMR and in Silico Techniques</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">10056</span>– <span class="NLM_lpage">10070</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.7b01293</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.7b01293" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00245&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhvVGgsbfF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=10056-10070&author=P.+Di%0ALelloauthor=R.+Pastorauthor=J.+M.+Murrayauthor=R.+A.+Blakeauthor=F.+Cohenauthor=T.+D.+Crawfordauthor=J.+Drobnickauthor=J.+Drummondauthor=L.+Kategayaauthor=T.+Kleinheinzauthor=T.+Maurerauthor=L.+Roug%C3%A9author=X.+Zhaoauthor=I.+Wertzauthor=C.+Ndubakuauthor=V.+Tsui&title=Discovery+of+Small-Molecule+Inhibitors+of+Ubiquitin+Specific+Protease+7+%28USP7%29+Using+Integrated+NMR+and+in+Silico+Techniques&doi=10.1021%2Facs.jmedchem.7b01293"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of Small-Molecule Inhibitors of Ubiquitin Specific Protease 7 (USP7) Using Integrated NMR and in Silico Techniques</span></div><div class="casAuthors">Di Lello, Paola; Pastor, Richard; Murray, Jeremy M.; Blake, Robert A.; Cohen, Frederick; Crawford, Terry D.; Drobnick, Joy; Drummond, Jason; Kategaya, Lorna; Kleinheinz, Tracy; Maurer, Till; Rouge, Lionel; Zhao, Xianrui; Wertz, Ingrid; Ndubaku, Chudi; Tsui, Vickie</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">10056-10070</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">USP7 is a deubiquitinase implicated in destabilizing the tumor suppressor p53, and for this reason it has gained increasing attention as a potential oncol. target for small mol. inhibitors.  Herein the authors describe the biophys., biochem., and computational approaches that led to the identification of 4-(2-aminopyridin-3-yl)phenol compds. described by Kategaya (Nature 2017, 550, 534-538) as specific inhibitors of USP7.  Fragment based lead discovery (FBLD) by NMR combined with virtual screening and remining of biochem. high-throughput screening (HTS) hits led to the discovery of a series of ligands that bind in the "palm" region of the catalytic domain of USP7 and inhibit its catalytic activity.  These ligands were then optimized by structure-based design to yield cell-active mols. with reasonable phys. properties.  This discovery process not only involved multiple techniques working in concert but also illustrated a unique way in which hits from orthogonal screening approaches complemented each other for lead identification.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr-Gro2-OKmz7Vg90H21EOLACvtfcHk0lh1mtw1JM8aKA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhvVGgsbfF&md5=5eab272a1b4e03eb50857acf49f661d7</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.7b01293&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.7b01293%26sid%3Dliteratum%253Aachs%26aulast%3DDi%2BLello%26aufirst%3DP.%26aulast%3DPastor%26aufirst%3DR.%26aulast%3DMurray%26aufirst%3DJ.%2BM.%26aulast%3DBlake%26aufirst%3DR.%2BA.%26aulast%3DCohen%26aufirst%3DF.%26aulast%3DCrawford%26aufirst%3DT.%2BD.%26aulast%3DDrobnick%26aufirst%3DJ.%26aulast%3DDrummond%26aufirst%3DJ.%26aulast%3DKategaya%26aufirst%3DL.%26aulast%3DKleinheinz%26aufirst%3DT.%26aulast%3DMaurer%26aufirst%3DT.%26aulast%3DRoug%25C3%25A9%26aufirst%3DL.%26aulast%3DZhao%26aufirst%3DX.%26aulast%3DWertz%26aufirst%3DI.%26aulast%3DNdubaku%26aufirst%3DC.%26aulast%3DTsui%26aufirst%3DV.%26atitle%3DDiscovery%2520of%2520Small-Molecule%2520Inhibitors%2520of%2520Ubiquitin%2520Specific%2520Protease%25207%2520%2528USP7%2529%2520Using%2520Integrated%2520NMR%2520and%2520in%2520Silico%2520Techniques%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26spage%3D10056%26epage%3D10070%26doi%3D10.1021%2Facs.jmedchem.7b01293" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kumar, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arsenault, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mattern, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weinstock, J.</span></span> <span> </span><span class="NLM_article-title">Chemical Approaches to Intervening in Ubiquitin Specific Protease 7 (USP7) Function for Oncology and Immune Oncology Therapies</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">422</span>– <span class="NLM_lpage">443</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.7b00498</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.7b00498" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00245&amp;key=1%3ACAS%3A528%3ADC%252BC2sXht1KrurjF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2018&pages=422-443&author=J.+Wuauthor=S.+Kumarauthor=F.+Wangauthor=H.+Wangauthor=L.+Chenauthor=P.+Arsenaultauthor=M.+Matternauthor=J.+Weinstock&title=Chemical+Approaches+to+Intervening+in+Ubiquitin+Specific+Protease+7+%28USP7%29+Function+for+Oncology+and+Immune+Oncology+Therapies&doi=10.1021%2Facs.jmedchem.7b00498"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Chemical Approaches to Intervening in Ubiquitin Specific Protease 7 (USP7) Function for Oncology and Immune Oncology Therapies</span></div><div class="casAuthors">Wu, Jian; Kumar, Suresh; Wang, Feng; Wang, Hui; Chen, Lijia; Arsenault, Patrick; Mattern, Michael; Weinstock, Joseph</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">422-443</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Ubiquitin specific protease 7 (USP7), the most widely studied among the nearly 100 deubiquitinating enzymes, supports cancer by pos. affecting tumor growth and neg. affecting the patient's immune response to tumors.  Great interest exists, therefore, in developing USP7 inhibitors for clin. evaluation.  While the proteasome inhibitor field has enjoyed clin. success, very few clin. appropriate effectors of deubiquitinating (protease) or ubiquitinating (ligase) enzymes have appeared.  The ubiquitin protease/ligase field is moving from the initial discovery of potent, selective modulators with cell proof of concept and in vivo activity to the optimization of these mols. to impart drug-like properties or the discovery of new inhibitor scaffolds by improved screening or rational design.  This Perspective focuses on the current status of USP7 inhibitors from various organizations active in developing these compds. for the clinic and suggests undertakings that are both achievable and necessary to lead to successful clin. outcomes for USP7 inhibitors in cancer treatment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpvx5pZ7h4PzLVg90H21EOLACvtfcHk0liNcb96fzDu6A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXht1KrurjF&md5=0e0bf309fb8ce8d79cb018b0734b5a37</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.7b00498&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.7b00498%26sid%3Dliteratum%253Aachs%26aulast%3DWu%26aufirst%3DJ.%26aulast%3DKumar%26aufirst%3DS.%26aulast%3DWang%26aufirst%3DF.%26aulast%3DWang%26aufirst%3DH.%26aulast%3DChen%26aufirst%3DL.%26aulast%3DArsenault%26aufirst%3DP.%26aulast%3DMattern%26aufirst%3DM.%26aulast%3DWeinstock%26aufirst%3DJ.%26atitle%3DChemical%2520Approaches%2520to%2520Intervening%2520in%2520Ubiquitin%2520Specific%2520Protease%25207%2520%2528USP7%2529%2520Function%2520for%2520Oncology%2520and%2520Immune%2520Oncology%2520Therapies%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2018%26volume%3D61%26spage%3D422%26epage%3D443%26doi%3D10.1021%2Facs.jmedchem.7b00498" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pozhidaeva, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Valles, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sterner, D. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nguyen, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weinstock, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kumar, K. G. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kanyo, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wright, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bezsonova, I.</span></span> <span> </span><span class="NLM_article-title">USP7-Specific Inhibitors Target and Modify the Enzyme’s Active Site via Distinct Chemical Mechanisms</span>. <i>Cell Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>24</i></span>,  <span class="NLM_fpage">1501</span>– <span class="NLM_lpage">1512</span>, <span class="refDoi"> DOI: 10.1016/j.chembiol.2017.09.004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00245&amp;key=10.1016%2Fj.chembiol.2017.09.004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00245&amp;key=29056420" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00245&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhs1yrt7nI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2017&pages=1501-1512&author=A.+Pozhidaevaauthor=G.+Vallesauthor=F.+Wangauthor=J.+Wuauthor=D.+E.+Sternerauthor=P.+Nguyenauthor=J.+Weinstockauthor=K.+G.+S.+Kumarauthor=J.+Kanyoauthor=D.+Wrightauthor=I.+Bezsonova&title=USP7-Specific+Inhibitors+Target+and+Modify+the+Enzyme%E2%80%99s+Active+Site+via+Distinct+Chemical+Mechanisms&doi=10.1016%2Fj.chembiol.2017.09.004"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">USP7-Specific Inhibitors Target and Modify the Enzyme's Active Site via Distinct Chemical Mechanisms</span></div><div class="casAuthors">Pozhidaeva, Alexandra; Valles, Gabrielle; Wang, Feng; Wu, Jian; Sterner, David E.; Nguyen, Phuong; Weinstock, Joseph; Kumar, K. G. Suresh; Kanyo, Jean; Wright, Dennis; Bezsonova, Irina</div><div class="citationInfo"><span class="NLM_cas:title">Cell Chemical Biology</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1501-1512.e5</span>CODEN:
                <span class="NLM_cas:coden">CCBEBM</span>;
        ISSN:<span class="NLM_cas:issn">2451-9448</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">USP7 is a deubiquitinating enzyme that plays a pivotal role in multiple oncogenic pathways and therefore is a desirable target for new anti-cancer therapies.  However, the lack of structural information about the USP7-inhibitor interactions has been a crit. gap in the development of potent inhibitors.  USP7 is unique among USPs in that its active site is catalytically incompetent, and is postulated to rearrange into a productive conformation only upon binding to ubiquitin.  Surprisingly, we found that ubiquitin alone does not induce an active conformation in soln.  Using a combination of NMR, mass spectrometry, computational modeling, and cell-based assays, we found that DUB inhibitors P22077 and P50429 covalently modify the catalytic cysteine of USP7 and induce a conformational switch in the enzyme assocd. with active site rearrangement.  This work represents the first exptl. insights into USP7 activation and inhibition and provides a structural basis for rational development of potent anti-cancer therapeutics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpq6cfJxLOHFLVg90H21EOLACvtfcHk0liNcb96fzDu6A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhs1yrt7nI&md5=8d8baef989ebbfb010640b2ecfd95ae4</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1016%2Fj.chembiol.2017.09.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.chembiol.2017.09.004%26sid%3Dliteratum%253Aachs%26aulast%3DPozhidaeva%26aufirst%3DA.%26aulast%3DValles%26aufirst%3DG.%26aulast%3DWang%26aufirst%3DF.%26aulast%3DWu%26aufirst%3DJ.%26aulast%3DSterner%26aufirst%3DD.%2BE.%26aulast%3DNguyen%26aufirst%3DP.%26aulast%3DWeinstock%26aufirst%3DJ.%26aulast%3DKumar%26aufirst%3DK.%2BG.%2BS.%26aulast%3DKanyo%26aufirst%3DJ.%26aulast%3DWright%26aufirst%3DD.%26aulast%3DBezsonova%26aufirst%3DI.%26atitle%3DUSP7-Specific%2520Inhibitors%2520Target%2520and%2520Modify%2520the%2520Enzyme%25E2%2580%2599s%2520Active%2520Site%2520via%2520Distinct%2520Chemical%2520Mechanisms%26jtitle%3DCell%2520Chem.%2520Biol.%26date%3D2017%26volume%3D24%26spage%3D1501%26epage%3D1512%26doi%3D10.1016%2Fj.chembiol.2017.09.004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ohol, Y. M.</span>; <span class="NLM_string-name">Sun, M. T.</span>; <span class="NLM_string-name">Cutler, G.</span>; <span class="NLM_string-name">Leger, P.</span>; <span class="NLM_string-name">Hu, D.</span>; <span class="NLM_string-name">Biannic, B.</span>; <span class="NLM_string-name">Rana, P.</span>; <span class="NLM_string-name">Cho, C.</span>; <span class="NLM_string-name">Jacobson, S.</span>; <span class="NLM_string-name">Wong, S.</span>; <span class="NLM_string-name">Sanchez, J.</span>; <span class="NLM_string-name">Shah, N.</span>; <span class="NLM_string-name">Young, K.</span>; <span class="NLM_string-name">Han, X.</span>; <span class="NLM_string-name">Bradford, D.</span>; <span class="NLM_string-name">Kozon, N.</span>; <span class="NLM_string-name">Abraham, B.</span>; <span class="NLM_string-name">Pookot, D.</span>; <span class="NLM_string-name">Okano, A.</span>; <span class="NLM_string-name">Maung, J.</span>; <span class="NLM_string-name">Suthram, S.</span>; <span class="NLM_string-name">Adusumilli, L.</span>; <span class="NLM_string-name">Kaveri, D.</span>; <span class="NLM_string-name">Talay, O.</span>; <span class="NLM_string-name">Marshall, L.</span>; <span class="NLM_string-name">Colas, C.</span>; <span class="NLM_string-name">Kim, A.</span>; <span class="NLM_string-name">Schwarz, J.</span>; <span class="NLM_string-name">Wustrow, D.</span>; <span class="NLM_string-name">Brockstedt, D.</span>; <span class="NLM_string-name">Kassner, P.</span></span> <span> </span><span class="NLM_article-title">Novel, Selective Inhibitors of USP7 Uncover Multiple Mechanisms of Antitumor Activity in Vitro and in Vivo</span>. Manuscript in submission, <span class="NLM_year" style="font-weight: bold;">2020</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2020&author=Y.+M.+Ohol&author=M.+T.+Sun&author=G.+Cutler&author=P.+Leger&author=D.+Hu&author=B.+Biannic&author=P.+Rana&author=C.+Cho&author=S.+Jacobson&author=S.+Wong&author=J.+Sanchez&author=N.+Shah&author=K.+Young&author=X.+Han&author=D.+Bradford&author=N.+Kozon&author=B.+Abraham&author=D.+Pookot&author=A.+Okano&author=J.+Maung&author=S.+Suthram&author=L.+Adusumilli&author=D.+Kaveri&author=O.+Talay&author=L.+Marshall&author=C.+Colas&author=A.+Kim&author=J.+Schwarz&author=D.+Wustrow&author=D.+Brockstedt&author=P.+Kassner&title=Novel%2C+Selective+Inhibitors+of+USP7+Uncover+Multiple+Mechanisms+of+Antitumor+Activity+in+Vitro+and+in+Vivo"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DOhol%26aufirst%3DY.%2BM.%26atitle%3DNovel%252C%2520Selective%2520Inhibitors%2520of%2520USP7%2520Uncover%2520Multiple%2520Mechanisms%2520of%2520Antitumor%2520Activity%2520in%2520Vitro%2520and%2520in%2520Vivo%26date%3D2020" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span> <i>Schrödinger Release 2016-2: WaterMap</i>; <span class="NLM_publisher-name">Schrödinger, LLC</span>: <span class="NLM_publisher-loc">New York,
NY</span>, <span class="NLM_year">2016</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=+Schr%C3%B6dinger+Release+2016-2%3A+WaterMap%3B+Schr%C3%B6dinger%2C+LLC%3A+New+York%2C%0ANY%2C+2016."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcomputer-program%26sid%3Dliteratum%253Aachs%26jtitle%3DSchr%25C3%25B6dinger%2520Release%25202016-2%253A%2520WaterMap%26pub%3DSchr%25C3%25B6dinger%252C%2520LLC%26date%3D2016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="note"><p class="first last">Data not shown. See ref <a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a>.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="note"><p class="first last">A strong correlation between USP7 biochemical potency and cellular p53 response suggests that this response is due to USP7 inhibitor-mediated MDM2 destabilization. See <a href="/doi/suppl/10.1021/acs.jmedchem.0c00245/suppl_file/jm0c00245_si_001.pdf" class="ext-link">Figure S1</a>.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Takahashi, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">D’Amico, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chiba, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buchhagen, D. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Minna, J. D.</span></span> <span> </span><span class="NLM_article-title">Identification of Intronic Point Mutations as an Alternative Mechanism for p53 Inactivation in Lung Cancer</span>. <i>J. Clin. Invest.</i> <span class="NLM_year" style="font-weight: bold;">1990</span>,  <span class="NLM_volume"><i>86</i></span>,  <span class="NLM_fpage">363</span>– <span class="NLM_lpage">369</span>, <span class="refDoi"> DOI: 10.1172/jci114710</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00245&amp;key=10.1172%2FJCI114710" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00245&amp;key=2164047" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00245&amp;key=1%3ACAS%3A528%3ADyaK3cXkvFamtbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=86&publication_year=1990&pages=363-369&author=T.+Takahashiauthor=D.+D%E2%80%99Amicoauthor=I.+Chibaauthor=D.+L.+Buchhagenauthor=J.+D.+Minna&title=Identification+of+Intronic+Point+Mutations+as+an+Alternative+Mechanism+for+p53+Inactivation+in+Lung+Cancer&doi=10.1172%2Fjci114710"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of intronic point mutations as an alternative mechanism for p53 inactivation in lung cancer</span></div><div class="casAuthors">Takahashi, Takashi; D'Amico, Domenico; Chiba, Itsuo; Buchhagen, Dorothy L.; Minna, John D.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Investigation</span>
        (<span class="NLM_cas:date">1990</span>),
    <span class="NLM_cas:volume">86</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">363-9</span>CODEN:
                <span class="NLM_cas:coden">JCINAO</span>;
        ISSN:<span class="NLM_cas:issn">0021-9738</span>.
    </div><div class="casAbstract">The p53 gene initially was thought to be an oncogene, but recent evidence suggests that wild-type p53 can function as a tumor suppressor gene in lung, colon, and breast cancer as well as less common malignancies.  This study reports the first identification of intronic point mutations as a mechanism for inactivation of the p53 tumor suppressor gene.  Abnormally sized p53 mRNAs found in a small cell and a non-small cell lung cancer cell line were characterized by sequence anal. of cDNA/PCR products, the RNase protection assay and immunopptn.  These mRNAs were found to represent aberrant splicing leading to the prodn. of abnormal or no p53 protein.  Sequence anal. of genomic DNA revealed that a point mutation at the splice acceptor site in the third intron or the splice donor site in the 7th intron accounts for the abnormal mRNA splicing.  In 1 patient the same intronic point mutation was found in the tumor cell line derived from a bone marrow metastasis and in multiple liver metastases but not in normal DNA, indicating that it occurred as a somatic event before the development of these metastases.  These findings further support the role of inactivation of the p53 gene in the pathogenesis of lung cancer and indicate the role of intronic point mutation in this process.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGph_25qBqYdN7Vg90H21EOLACvtfcHk0liNcb96fzDu6A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3cXkvFamtbo%253D&md5=467e19fb66cf750d8de53ce6c63a02b1</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1172%2FJCI114710&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1172%252FJCI114710%26sid%3Dliteratum%253Aachs%26aulast%3DTakahashi%26aufirst%3DT.%26aulast%3DD%25E2%2580%2599Amico%26aufirst%3DD.%26aulast%3DChiba%26aufirst%3DI.%26aulast%3DBuchhagen%26aufirst%3DD.%2BL.%26aulast%3DMinna%26aufirst%3DJ.%2BD.%26atitle%3DIdentification%2520of%2520Intronic%2520Point%2520Mutations%2520as%2520an%2520Alternative%2520Mechanism%2520for%2520p53%2520Inactivation%2520in%2520Lung%2520Cancer%26jtitle%3DJ.%2520Clin.%2520Invest.%26date%3D1990%26volume%3D86%26spage%3D363%26epage%3D369%26doi%3D10.1172%2Fjci114710" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="note"><p class="first last">See <a href="/doi/suppl/10.1021/acs.jmedchem.0c00245/suppl_file/jm0c00245_si_001.pdf" class="ext-link">Figure S2</a> and ref <a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> for target engagement assay.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="note"><p class="first last">See <a href="/doi/suppl/10.1021/acs.jmedchem.0c00245/suppl_file/jm0c00245_si_001.pdf" class="ext-link">Figure S3</a> for a complete list of DUBs tested in the selectivity panel.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deng, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pierce, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krilov, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lupyan, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robinson, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dahlgren, M. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Greenwood, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Romero, D. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Masse, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Knight, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Steinbrecher, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beuming, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Damm, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harder, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sherman, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brewer, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wester, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murcko, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frye, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Farid, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mobley, D. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jorgensen, W. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berne, B. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Friesner, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abel, R.</span></span> <span> </span><span class="NLM_article-title">Accurate and Reliable Prediction of Relative Ligand Binding Potency in Prospective Drug Discovery by Way of a Modern Free-Energy Calculation Protocol and Force Field</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>137</i></span>,  <span class="NLM_fpage">2695</span>– <span class="NLM_lpage">2703</span>, <span class="refDoi"> DOI: 10.1021/ja512751q</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja512751q" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00245&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhsF2iuro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=137&publication_year=2015&pages=2695-2703&author=L.+Wangauthor=Y.+Wuauthor=Y.+Dengauthor=B.+Kimauthor=L.+Pierceauthor=G.+Krilovauthor=D.+Lupyanauthor=S.+Robinsonauthor=M.+K.+Dahlgrenauthor=J.+Greenwoodauthor=D.+L.+Romeroauthor=C.+Masseauthor=J.+L.+Knightauthor=T.+Steinbrecherauthor=T.+Beumingauthor=W.+Dammauthor=E.+Harderauthor=W.+Shermanauthor=M.+Brewerauthor=R.+Westerauthor=M.+Murckoauthor=L.+Fryeauthor=R.+Faridauthor=T.+Linauthor=D.+L.+Mobleyauthor=W.+L.+Jorgensenauthor=B.+J.+Berneauthor=R.+A.+Friesnerauthor=R.+Abel&title=Accurate+and+Reliable+Prediction+of+Relative+Ligand+Binding+Potency+in+Prospective+Drug+Discovery+by+Way+of+a+Modern+Free-Energy+Calculation+Protocol+and+Force+Field&doi=10.1021%2Fja512751q"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Accurate and Reliable Prediction of Relative Ligand Binding Potency in Prospective Drug Discovery by Way of a Modern Free-Energy Calculation Protocol and Force Field</span></div><div class="casAuthors">Wang, Lingle; Wu, Yujie; Deng, Yuqing; Kim, Byungchan; Pierce, Levi; Krilov, Goran; Lupyan, Dmitry; Robinson, Shaughnessy; Dahlgren, Markus K.; Greenwood, Jeremy; Romero, Donna L.; Masse, Craig; Knight, Jennifer L.; Steinbrecher, Thomas; Beuming, Thijs; Damm, Wolfgang; Harder, Ed; Sherman, Woody; Brewer, Mark; Wester, Ron; Murcko, Mark; Frye, Leah; Farid, Ramy; Lin, Teng; Mobley, David L.; Jorgensen, William L.; Berne, Bruce J.; Friesner, Richard A.; Abel, Robert</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">137</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">2695-2703</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Designing tight-binding ligands is a primary objective of small-mol. drug discovery.  Over the past few decades, free-energy calcns. have benefited from improved force fields and sampling algorithms, as well as the advent of low-cost parallel computing.  However, it has proven to be challenging to reliably achieve the level of accuracy that would be needed to guide lead optimization (∼5× in binding affinity) for a wide range of ligands and protein targets.  Not surprisingly, widespread com. application of free-energy simulations has been limited due to the lack of large-scale validation coupled with the tech. challenges traditionally assocd. with running these types of calcns.  Here, we report an approach that achieves an unprecedented level of accuracy across a broad range of target classes and ligands, with retrospective results encompassing 200 ligands and a wide variety of chem. perturbations, many of which involve significant changes in ligand chem. structures.  In addn., we have applied the method in prospective drug discovery projects and found a significant improvement in the quality of the compds. synthesized that have been predicted to be potent.  Compds. predicted to be potent by this approach have a substantial redn. in false positives relative to compds. synthesized on the basis of other computational or medicinal chem. approaches.  Furthermore, the results are consistent with those obtained from our retrospective studies, demonstrating the robustness and broad range of applicability of this approach, which can be used to drive decisions in lead optimization.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGor9UtXEyLPpLVg90H21EOLACvtfcHk0lhmqsKqnxBORw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhsF2iuro%253D&md5=37a4f4a6c085f47ed531342643b6c33b</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1021%2Fja512751q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja512751q%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DL.%26aulast%3DWu%26aufirst%3DY.%26aulast%3DDeng%26aufirst%3DY.%26aulast%3DKim%26aufirst%3DB.%26aulast%3DPierce%26aufirst%3DL.%26aulast%3DKrilov%26aufirst%3DG.%26aulast%3DLupyan%26aufirst%3DD.%26aulast%3DRobinson%26aufirst%3DS.%26aulast%3DDahlgren%26aufirst%3DM.%2BK.%26aulast%3DGreenwood%26aufirst%3DJ.%26aulast%3DRomero%26aufirst%3DD.%2BL.%26aulast%3DMasse%26aufirst%3DC.%26aulast%3DKnight%26aufirst%3DJ.%2BL.%26aulast%3DSteinbrecher%26aufirst%3DT.%26aulast%3DBeuming%26aufirst%3DT.%26aulast%3DDamm%26aufirst%3DW.%26aulast%3DHarder%26aufirst%3DE.%26aulast%3DSherman%26aufirst%3DW.%26aulast%3DBrewer%26aufirst%3DM.%26aulast%3DWester%26aufirst%3DR.%26aulast%3DMurcko%26aufirst%3DM.%26aulast%3DFrye%26aufirst%3DL.%26aulast%3DFarid%26aufirst%3DR.%26aulast%3DLin%26aufirst%3DT.%26aulast%3DMobley%26aufirst%3DD.%2BL.%26aulast%3DJorgensen%26aufirst%3DW.%2BL.%26aulast%3DBerne%26aufirst%3DB.%2BJ.%26aulast%3DFriesner%26aufirst%3DR.%2BA.%26aulast%3DAbel%26aufirst%3DR.%26atitle%3DAccurate%2520and%2520Reliable%2520Prediction%2520of%2520Relative%2520Ligand%2520Binding%2520Potency%2520in%2520Prospective%2520Drug%2520Discovery%2520by%2520Way%2520of%2520a%2520Modern%2520Free-Energy%2520Calculation%2520Protocol%2520and%2520Force%2520Field%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2015%26volume%3D137%26spage%3D2695%26epage%3D2703%26doi%3D10.1021%2Fja512751q" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="note"><p class="first last">See <a href="/doi/suppl/10.1021/acs.jmedchem.0c00245/suppl_file/jm0c00245_si_001.pdf" class="ext-link">Figure S4</a> for a visualization of solvent-exposed Tyr-465.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="note"><p class="first last">See <a href="/doi/suppl/10.1021/acs.jmedchem.0c00245/suppl_file/jm0c00245_si_001.pdf" class="ext-link">Figure S5</a> for PK curves of compound <b>41</b> in different mouse species.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="note"><p class="first last">Compound <b>41</b> is measured to be 95.3% bound to mouse plasma proteins as measured by ultracentrifugation.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Luzzio, M. J.</span>; <span class="NLM_string-name">Yang, B. V.</span>; <span class="NLM_string-name">Marx, M. A.</span></span> <span> </span><span class="NLM_article-title">Thiophene Derivatives Useful as Anticancer Agents</span>. U.S. Patent <span class="NLM_patent">20,020,004,511 A1</span>, <span class="NLM_year">2002</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2002&author=M.+J.+Luzzio&author=B.+V.+Yang&author=M.+A.+Marx&title=Thiophene+Derivatives+Useful+as+Anticancer+Agents"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DLuzzio%26aufirst%3DM.%2BJ.%26atitle%3DThiophene%2520Derivatives%2520Useful%2520as%2520Anticancer%2520Agents%26date%3D2002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Amézquita-Valencia, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alper, H.</span></span> <span> </span><span class="NLM_article-title">PdI<sub>2</sub>-Catalyzed Regioselective Cyclocarbonylation of 2-Allyl Phenols to Dihydrocoumarins</span>. <i>Org. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>16</i></span>,  <span class="NLM_fpage">5827</span>– <span class="NLM_lpage">5829</span>, <span class="refDoi"> DOI: 10.1021/ol5029157</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ol5029157" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00245&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhvV2ntLzK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2014&pages=5827-5829&author=M.+Am%C3%A9zquita-Valenciaauthor=H.+Alper&title=PdI2-Catalyzed+Regioselective+Cyclocarbonylation+of+2-Allyl+Phenols+to+Dihydrocoumarins&doi=10.1021%2Fol5029157"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">PdI2-Catalyzed Regioselective Cyclocarbonylation of 2-Allyl Phenols to Dihydrocoumarins</span></div><div class="casAuthors">Amezquita-Valencia, Manuel; Alper, Howard</div><div class="citationInfo"><span class="NLM_cas:title">Organic Letters</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">5827-5829</span>CODEN:
                <span class="NLM_cas:coden">ORLEF7</span>;
        ISSN:<span class="NLM_cas:issn">1523-7052</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A simple, efficient, and regioselective synthesis of 3-methyl-3,4-dihydrocoumarins is reported.  The reaction of 2-allyl phenols with synthesis gas was catalyzed by PdI2, and 1,3,5,7-tetramethyl-6-phenyl-2,4,8-trioxa-6-phosphaadamantane and 1,3,5,7-tetramethyl-6-tetradecyl-2,4,8-trioxa-6-phosphaadamantane were effective as ligands, affording good product selectivity in all cases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGprj-SK54g2KrVg90H21EOLACvtfcHk0lhmqsKqnxBORw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhvV2ntLzK&md5=29bd7d70108f80693e41547563385d09</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1021%2Fol5029157&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fol5029157%26sid%3Dliteratum%253Aachs%26aulast%3DAm%25C3%25A9zquita-Valencia%26aufirst%3DM.%26aulast%3DAlper%26aufirst%3DH.%26atitle%3DPdI2-Catalyzed%2520Regioselective%2520Cyclocarbonylation%2520of%25202-Allyl%2520Phenols%2520to%2520Dihydrocoumarins%26jtitle%3DOrg.%2520Lett.%26date%3D2014%26volume%3D16%26spage%3D5827%26epage%3D5829%26doi%3D10.1021%2Fol5029157" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ek, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Axelsson, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wistrand, L.-G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frejd, T.</span></span> <span> </span><span class="NLM_article-title">Aromatic Allylation via Diazotization: Metal-Free C–C Bond Formation</span>. <i>J. Org. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>67</i></span>,  <span class="NLM_fpage">6376</span>– <span class="NLM_lpage">6381</span>, <span class="refDoi"> DOI: 10.1021/jo0258103</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jo0258103" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00245&amp;key=1%3ACAS%3A528%3ADC%252BD38XmtVyms7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=2002&pages=6376-6381&author=F.+Ekauthor=O.+Axelssonauthor=L.-G.+Wistrandauthor=T.+Frejd&title=Aromatic+Allylation+via+Diazotization%3A+Metal-Free+C%E2%80%93C+Bond+Formation&doi=10.1021%2Fjo0258103"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Aromatic Allylation via Diazotization: Metal-Free C-C Bond Formation</span></div><div class="casAuthors">Ek, Fredrik; Axelsson, Oskar; Wistrand, Lars-Goeran; Frejd, Torbjoern</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Organic Chemistry</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">67</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">6376-6381</span>CODEN:
                <span class="NLM_cas:coden">JOCEAH</span>;
        ISSN:<span class="NLM_cas:issn">0022-3263</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A new method for the synthesis of allyl arom. compds. not involving any metal-contg. reagent or catalyst has been developed.  Arylamines substituted with a large no. of different substituents were converted via diazotizative deamination with tert-Bu nitrite in allyl bromide and acetonitrile to the corresponding allyl arom. compds.  The allylation reaction was found to be suitable for larger scale synthesis due to short reaction times, a nonextractive workup, and robustness toward moisture, air, and type of solvent.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqVu48CPEkasbVg90H21EOLACvtfcHk0lgwP4VbkTOlbw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XmtVyms7g%253D&md5=713411ad987ca70a82dc91179e38f55e</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1021%2Fjo0258103&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo0258103%26sid%3Dliteratum%253Aachs%26aulast%3DEk%26aufirst%3DF.%26aulast%3DAxelsson%26aufirst%3DO.%26aulast%3DWistrand%26aufirst%3DL.-G.%26aulast%3DFrejd%26aufirst%3DT.%26atitle%3DAromatic%2520Allylation%2520via%2520Diazotization%253A%2520Metal-Free%2520C%25E2%2580%2593C%2520Bond%2520Formation%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D2002%26volume%3D67%26spage%3D6376%26epage%3D6381%26doi%3D10.1021%2Fjo0258103" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Harder, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Damm, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maple, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reboul, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xiang, J. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lupyan, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dahlgren, M. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Knight, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaus, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cerutti, D. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krilov, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jorgensen, W. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abel, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Friesner, R. A.</span></span> <span> </span><span class="NLM_article-title">OPLS3: A Force Field Providing Broad Coverage of Drug-like Small Molecules and Proteins</span>. <i>J. Chem. Theory Comput.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">281</span>– <span class="NLM_lpage">296</span>, <span class="refDoi"> DOI: 10.1021/acs.jctc.5b00864</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jctc.5b00864" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00245&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhvVCjtbfE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2016&pages=281-296&author=E.+Harderauthor=W.+Dammauthor=J.+Mapleauthor=C.+Wuauthor=M.+Reboulauthor=J.+Y.+Xiangauthor=L.+Wangauthor=D.+Lupyanauthor=M.+K.+Dahlgrenauthor=J.+L.+Knightauthor=J.+W.+Kausauthor=D.+S.+Ceruttiauthor=G.+Krilovauthor=W.+L.+Jorgensenauthor=R.+Abelauthor=R.+A.+Friesner&title=OPLS3%3A+A+Force+Field+Providing+Broad+Coverage+of+Drug-like+Small+Molecules+and+Proteins&doi=10.1021%2Facs.jctc.5b00864"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">OPLS3: A Force Field Providing Broad Coverage of Drug-like Small Molecules and Proteins</span></div><div class="casAuthors">Harder, Edward; Damm, Wolfgang; Maple, Jon; Wu, Chuanjie; Reboul, Mark; Xiang, Jin Yu; Wang, Lingle; Lupyan, Dmitry; Dahlgren, Markus K.; Knight, Jennifer L.; Kaus, Joseph W.; Cerutti, David S.; Krilov, Goran; Jorgensen, William L.; Abel, Robert; Friesner, Richard A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Chemical Theory and Computation</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">281-296</span>CODEN:
                <span class="NLM_cas:coden">JCTCCE</span>;
        ISSN:<span class="NLM_cas:issn">1549-9618</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The parametrization and validation of the OPLS3 force field for small mols. and proteins are reported.  Enhancements with respect to the previous version (OPLS2.1) include the addn. of off-atom charge sites to represent halogen bonding and aryl nitrogen lone pairs as well as a complete refit of peptide dihedral parameters to better model the native structure of proteins.  To adequately cover medicinal chem. space, OPLS3 employs over an order of magnitude more ref. data and assocd. parameter types relative to other commonly used small mol. force fields (e.g., MMFF and OPLS_2005).  As a consequence, OPLS3 achieves a high level of accuracy across performance benchmarks that assess small mol. conformational propensities and solvation.  The newly fitted peptide dihedrals lead to significant improvements in the representation of secondary structure elements in simulated peptides and native structure stability over a no. of proteins.  Together, the improvements made to both the small mol. and protein force field lead to a high level of accuracy in predicting protein-ligand binding measured over a wide range of targets and ligands (less than 1 kcal/mol RMS error) representing a 30% improvement over earlier variants of the OPLS force field.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqY_jrOhcBRgrVg90H21EOLACvtfcHk0lgwP4VbkTOlbw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhvVCjtbfE&md5=42663f8cfa84b80a67132bbb13b9b7ce</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1021%2Facs.jctc.5b00864&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jctc.5b00864%26sid%3Dliteratum%253Aachs%26aulast%3DHarder%26aufirst%3DE.%26aulast%3DDamm%26aufirst%3DW.%26aulast%3DMaple%26aufirst%3DJ.%26aulast%3DWu%26aufirst%3DC.%26aulast%3DReboul%26aufirst%3DM.%26aulast%3DXiang%26aufirst%3DJ.%2BY.%26aulast%3DWang%26aufirst%3DL.%26aulast%3DLupyan%26aufirst%3DD.%26aulast%3DDahlgren%26aufirst%3DM.%2BK.%26aulast%3DKnight%26aufirst%3DJ.%2BL.%26aulast%3DKaus%26aufirst%3DJ.%2BW.%26aulast%3DCerutti%26aufirst%3DD.%2BS.%26aulast%3DKrilov%26aufirst%3DG.%26aulast%3DJorgensen%26aufirst%3DW.%2BL.%26aulast%3DAbel%26aufirst%3DR.%26aulast%3DFriesner%26aufirst%3DR.%2BA.%26atitle%3DOPLS3%253A%2520A%2520Force%2520Field%2520Providing%2520Broad%2520Coverage%2520of%2520Drug-like%2520Small%2520Molecules%2520and%2520Proteins%26jtitle%3DJ.%2520Chem.%2520Theory%2520Comput.%26date%3D2016%26volume%3D12%26spage%3D281%26epage%3D296%26doi%3D10.1021%2Facs.jctc.5b00864" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Young, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abel, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berne, B. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Friesner, R. A.</span></span> <span> </span><span class="NLM_article-title">Motifs for Molecular Recognition Exploiting Hydrophobic Enclosure in Protein-Ligand Binding</span>. <i>Proc. Natl. Acad. Sci. U.S.A.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>104</i></span>,  <span class="NLM_fpage">808</span>– <span class="NLM_lpage">813</span>, <span class="refDoi"> DOI: 10.1073/pnas.0610202104</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00245&amp;key=10.1073%2Fpnas.0610202104" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00245&amp;key=17204562" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00245&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtVegtr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=104&publication_year=2007&pages=808-813&author=T.+Youngauthor=R.+Abelauthor=B.+Kimauthor=B.+J.+Berneauthor=R.+A.+Friesner&title=Motifs+for+Molecular+Recognition+Exploiting+Hydrophobic+Enclosure+in+Protein-Ligand+Binding&doi=10.1073%2Fpnas.0610202104"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Motifs for molecular recognition exploiting hydrophobic enclosure in protein-ligand binding</span></div><div class="casAuthors">Young, Tom; Abel, Robert; Kim, Byungchan; Berne, Bruce J.; Friesner, Richard A.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">104</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">808-813</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">The thermodn. properties and phase behavior of water in confined regions can vary significantly from that obsd. in the bulk.  This is particularly true for systems in which the confinement is on the mol.-length scale.  In this study, we use mol. dynamics simulations and a powerful solvent anal. technique based on inhomogeneous solvation theory to investigate the properties of water mols. that solvate the confined regions of protein active sites.  Our simulations and anal. indicate that the solvation of protein active sites that are characterized by hydrophobic enclosure and correlated hydrogen bonds induce atypical entropic and enthalpic penalties of hydration.  These penalties apparently stabilize the protein-ligand complex with respect to the independently solvated ligand and protein, which leads to enhanced binding affinities.  Our anal. elucidates several challenging cases, including the super affinity of the streptavidin-biotin system.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqWumQ61YTqILVg90H21EOLACvtfcHk0lg0RRPoq44-Cw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtVegtr4%253D&md5=1109e3f48670cd910885f7fd527eb880</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1073%2Fpnas.0610202104&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.0610202104%26sid%3Dliteratum%253Aachs%26aulast%3DYoung%26aufirst%3DT.%26aulast%3DAbel%26aufirst%3DR.%26aulast%3DKim%26aufirst%3DB.%26aulast%3DBerne%26aufirst%3DB.%2BJ.%26aulast%3DFriesner%26aufirst%3DR.%2BA.%26atitle%3DMotifs%2520for%2520Molecular%2520Recognition%2520Exploiting%2520Hydrophobic%2520Enclosure%2520in%2520Protein-Ligand%2520Binding%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2007%26volume%3D104%26spage%3D808%26epage%3D813%26doi%3D10.1073%2Fpnas.0610202104" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Abel, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Young, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Farid, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berne, B. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Friesner, R. A.</span></span> <span> </span><span class="NLM_article-title">Role of the Active-Site Solvent in the Thermodynamics of Factor Xa Ligand Binding</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>130</i></span>,  <span class="NLM_fpage">2817</span>– <span class="NLM_lpage">2831</span>, <span class="refDoi"> DOI: 10.1021/ja0771033</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja0771033" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00245&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhvFWgurk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=130&publication_year=2008&pages=2817-2831&author=R.+Abelauthor=T.+Youngauthor=R.+Faridauthor=B.+J.+Berneauthor=R.+A.+Friesner&title=Role+of+the+Active-Site+Solvent+in+the+Thermodynamics+of+Factor+Xa+Ligand+Binding&doi=10.1021%2Fja0771033"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Role of the Active-Site Solvent in the Thermodynamics of Factor Xa Ligand Binding</span></div><div class="casAuthors">Abel, Robert; Young, Tom; Farid, Ramy; Berne, Bruce J.; Friesner, Richard A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">130</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">2817-2831</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Understanding the underlying physics of the binding of small-mol. ligands to protein active sites is a key objective of computational chem. and biol.  It is widely believed that displacement of water mols. from the active site by the ligand is a principal (if not the dominant) source of binding free energy.  Although continuum theories of hydration are routinely used to describe the contributions of the solvent to the binding affinity of the complex, it is still an unsettled question as to whether or not these continuum solvation theories describe the underlying mol. physics with sufficient accuracy to reliably rank the binding affinities of a set of ligands for a given protein.  Here we develop a novel, computationally efficient descriptor of the contribution of the solvent to the binding free energy of a small mol. and its assocd. receptor that captures the effects of the ligand displacing the solvent from the protein active site with at. detail.  This descriptor quant. predicts (R2 = 0.81) the binding free energy differences between congeneric ligand pairs for the test system factor Xa, elucidates phys. properties of the active site solvent that appear to be missing in most continuum theories of hydration, and identifies several features of the hydration of the factor Xa active site relevant to the structure-activity relationship of its inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoS42r59nNXH7Vg90H21EOLACvtfcHk0lg0RRPoq44-Cw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhvFWgurk%253D&md5=8eefe76547a82bccaea38f2c84e6cd5f</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1021%2Fja0771033&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja0771033%26sid%3Dliteratum%253Aachs%26aulast%3DAbel%26aufirst%3DR.%26aulast%3DYoung%26aufirst%3DT.%26aulast%3DFarid%26aufirst%3DR.%26aulast%3DBerne%26aufirst%3DB.%2BJ.%26aulast%3DFriesner%26aufirst%3DR.%2BA.%26atitle%3DRole%2520of%2520the%2520Active-Site%2520Solvent%2520in%2520the%2520Thermodynamics%2520of%2520Factor%2520Xa%2520Ligand%2520Binding%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2008%26volume%3D130%26spage%3D2817%26epage%3D2831%26doi%3D10.1021%2Fja0771033" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Friesner, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berne, B. J.</span></span> <span> </span><span class="NLM_article-title">Replica Exchange with Solute Scaling: a More Efficient Version of Replica Exchange with Solute Tempering (REST2)</span>. <i>J. Phys. Chem. B</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>115</i></span>,  <span class="NLM_fpage">9431</span>– <span class="NLM_lpage">9438</span>, <span class="refDoi"> DOI: 10.1021/jp204407d</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jp204407d" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00245&amp;key=1%3ACAS%3A528%3ADC%252BC3MXosFymurs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=115&publication_year=2011&pages=9431-9438&author=L.+Wangauthor=R.+A.+Friesnerauthor=B.+J.+Berne&title=Replica+Exchange+with+Solute+Scaling%3A+a+More+Efficient+Version+of+Replica+Exchange+with+Solute+Tempering+%28REST2%29&doi=10.1021%2Fjp204407d"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Replica Exchange with Solute Scaling: A More Efficient Version of Replica Exchange with Solute Tempering (REST2)</span></div><div class="casAuthors">Wang, Lingle; Friesner, Richard A.; Berne, B. J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Physical Chemistry B</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">115</span>
        (<span class="NLM_cas:issue">30</span>),
    <span class="NLM_cas:pages">9431-9438</span>CODEN:
                <span class="NLM_cas:coden">JPCBFK</span>;
        ISSN:<span class="NLM_cas:issn">1520-5207</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A small change in the Hamiltonian scaling in Replica Exchange with Solute Tempering (REST) is found to improve its sampling efficiency greatly, esp. for the sampling of aq. protein solns. in which there are large-scale solute conformation changes.  Like the original REST (REST1), the new version (which the authors call REST2) also bypasses the poor scaling with system size of the std. Temp. Replica Exchange Method (TREM), reducing the no. of replicas (parallel processes) from what must be used in TREM.  This redn. is accomplished by deforming the Hamiltonian function for each replica in such a way that the acceptance probability for the exchange of replica configurations does not depend on the no. of explicit water mols. in the system.  For proof of concept, REST2 is compared with TREM and with REST1 for the folding of the trpcage and β-hairpin in water.  The comparisons confirm that REST2 greatly reduces the no. of CPUs required by regular replica exchange and greatly increases the sampling efficiency over REST1.  This method reduces the CPU time required for calcg. thermodn. avs. and for the ab initio folding of proteins in explicit water.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqYjGgEHE_cMbVg90H21EOLACvtfcHk0lg0RRPoq44-Cw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXosFymurs%253D&md5=8acb0d670bcb70eacfc30e32d5dfb6dd</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1021%2Fjp204407d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjp204407d%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DL.%26aulast%3DFriesner%26aufirst%3DR.%2BA.%26aulast%3DBerne%26aufirst%3DB.%2BJ.%26atitle%3DReplica%2520Exchange%2520with%2520Solute%2520Scaling%253A%2520a%2520More%2520Efficient%2520Version%2520of%2520Replica%2520Exchange%2520with%2520Solute%2520Tempering%2520%2528REST2%2529%26jtitle%3DJ.%2520Phys.%2520Chem.%2520B%26date%3D2011%26volume%3D115%26spage%3D9431%26epage%3D9438%26doi%3D10.1021%2Fjp204407d" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span> <i>Schrödinger Release 2017-2: LigPrep</i>; <span class="NLM_publisher-name">Schrödinger, LLC</span>: <span class="NLM_publisher-loc">New York,
NY</span>, <span class="NLM_year">2017</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=+Schr%C3%B6dinger+Release+2017-2%3A+LigPrep%3B+Schr%C3%B6dinger%2C+LLC%3A+New+York%2C%0ANY%2C+2017."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcomputer-program%26sid%3Dliteratum%253Aachs%26jtitle%3DSchr%25C3%25B6dinger%2520Release%25202017-2%253A%2520LigPrep%26pub%3DSchr%25C3%25B6dinger%252C%2520LLC%26date%3D2017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Friesner, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Banks, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murphy, R. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Halgren, T. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Klicic, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mainz, D. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Repasky, M. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Knoll, E. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shelley, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perry, J. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shaw, D. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Francis, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shenkin, P. S.</span></span> <span> </span><span class="NLM_article-title">Glide: A New Approach for Rapid, Accurate Docking and Scoring. 1. Method and Assessment of Docking Accuracy</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>47</i></span>,  <span class="NLM_fpage">1739</span>– <span class="NLM_lpage">1749</span>, <span class="refDoi"> DOI: 10.1021/jm0306430</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm0306430" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00245&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhsFyit74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2004&pages=1739-1749&author=R.+A.+Friesnerauthor=J.+L.+Banksauthor=R.+B.+Murphyauthor=T.+A.+Halgrenauthor=J.+J.+Klicicauthor=D.+T.+Mainzauthor=M.+P.+Repaskyauthor=E.+H.+Knollauthor=M.+Shelleyauthor=J.+K.+Perryauthor=D.+E.+Shawauthor=P.+Francisauthor=P.+S.+Shenkin&title=Glide%3A+A+New+Approach+for+Rapid%2C+Accurate+Docking+and+Scoring.+1.+Method+and+Assessment+of+Docking+Accuracy&doi=10.1021%2Fjm0306430"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Glide: A new approach for rapid, accurate docking and scoring. 1. method and assessment of docking accuracy</span></div><div class="casAuthors">Friesner, Richard A.; Banks, Jay L.; Murphy, Robert B.; Halgren, Thomas A.; Klicic, Jasna J.; Mainz, Daniel T.; Repasky, Matthew P.; Knoll, Eric H.; Shelley, Mee; Perry, Jason K.; Shaw, David E.; Francis, Perry; Shenkin, Peter S.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">47</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1739-1749</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Unlike other methods for docking ligands to the rigid 3D structure of a known protein receptor, Glide approximates a complete systematic search of the conformational, orientational, and positional space of the docked ligand.  In this search, an initial rough positioning and scoring phase that dramatically narrows the search space is followed by torsionally flexible energy optimization on an OPLS-AA nonbonded potential grid for a few hundred surviving candidate poses.  The very best candidates are further refined via a Monte Carlo sampling of pose conformation; in some cases, this is crucial to obtaining an accurate docked pose.  Selection of the best docked pose uses a model energy function that combines empirical and force-field-based terms.  Docking accuracy is assessed by redocking ligands from 282 cocrystd. PDB complexes starting from conformationally optimized ligand geometries that bear no memory of the correctly docked pose.  Errors in geometry for the top-ranked pose are less than 1 Å in nearly half of the cases and are greater than 2 Å in only about one-third of them.  Comparisons to published data on rms deviations show that Glide is nearly twice as accurate as GOLD and more than twice as accurate as FlexX for ligands having up to 20 rotatable bonds.  Glide is also found to be more accurate than the recently described Surflex method.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrPuigu31qMMLVg90H21EOLACvtfcHk0ljBjHK1sa7spQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhsFyit74%253D&md5=8cc2f0022318b12dd972e9c493375bf9</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1021%2Fjm0306430&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0306430%26sid%3Dliteratum%253Aachs%26aulast%3DFriesner%26aufirst%3DR.%2BA.%26aulast%3DBanks%26aufirst%3DJ.%2BL.%26aulast%3DMurphy%26aufirst%3DR.%2BB.%26aulast%3DHalgren%26aufirst%3DT.%2BA.%26aulast%3DKlicic%26aufirst%3DJ.%2BJ.%26aulast%3DMainz%26aufirst%3DD.%2BT.%26aulast%3DRepasky%26aufirst%3DM.%2BP.%26aulast%3DKnoll%26aufirst%3DE.%2BH.%26aulast%3DShelley%26aufirst%3DM.%26aulast%3DPerry%26aufirst%3DJ.%2BK.%26aulast%3DShaw%26aufirst%3DD.%2BE.%26aulast%3DFrancis%26aufirst%3DP.%26aulast%3DShenkin%26aufirst%3DP.%2BS.%26atitle%3DGlide%253A%2520A%2520New%2520Approach%2520for%2520Rapid%252C%2520Accurate%2520Docking%2520and%2520Scoring.%25201.%2520Method%2520and%2520Assessment%2520of%2520Docking%2520Accuracy%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2004%26volume%3D47%26spage%3D1739%26epage%3D1749%26doi%3D10.1021%2Fjm0306430" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><div class="accessionCode mb-5"><div class="toolbar-section accession-codes"><ul><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6VN4" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6VN4','PDB','6VN4'); return false;">PDB: 6VN4</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6VN5" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6VN5','PDB','6VN5'); return false;">PDB: 6VN5</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6VN6" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6VN6','PDB','6VN6'); return false;">PDB: 6VN6</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6VN2" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6VN2','PDB','6VN2'); return false;">PDB: 6VN2</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6VN3" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6VN3','PDB','6VN3'); return false;">PDB: 6VN3</a></li></ul></div></div><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i93"><a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.0c00245">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_53642"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge at <a class="ext-link" href="/doi/10.1021/acs.jmedchem.0c00245?goto=supporting-info">https://pubs.acs.org/doi/10.1021/acs.jmedchem.0c00245</a>.<ul id="rightTab-silist" class="NLM_list-list_type-label"><li><p class="inline">Molecular formula strings; biochemical and cellular potency correlation; target engagement for compound <b>30</b>; DUB selectivity profile for compound <b>30</b>; view of USP7 showing solvent-exposed Tyr-465; and PK curves for compound <b>41</b> (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.0c00245/suppl_file/jm0c00245_si_001.pdf">PDF</a>)</p></li><li><p class="inline">Coordinates and structure factors for compounds <b>1</b>, <b>7</b>, <b>14</b>, <b>18</b>, and <b>23</b> in complex with USP7 have been deposited (PDB codes <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6VN4">6VN4</a>, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6VN5">6VN5</a>, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6VN6">6VN6</a>, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6VN2">6VN2</a>, and <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6VN3">6VN3</a>, respectively). Authors will release the atomic coordinates upon article publication (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.0c00245/suppl_file/jm0c00245_si_002.csv">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.0c00245/suppl_file/jm0c00245_si_001.pdf">jm0c00245_si_001.pdf (982.69 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.0c00245/suppl_file/jm0c00245_si_002.csv">jm0c00245_si_002.csv (2.95 kb)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.0c00245&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.0c00245%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2020.63.issue-10" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.0c00245" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                6MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"679a2e0c3b021975","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
